drug_internal_id,drug_id,drug_name,mechanism_id,mechanism_of_action,action_type,target_internal_id,target_id,target_name,direct_interaction,molecular_mechanism,disease_efficacy,mechanism_comment,selectivity_comment
111491,CHEMBL1003,CLAVULANATE POTASSIUM,1667,Bacterial beta-lactamase TEM inhibitor,INHIBITOR,106170.0,CHEMBL2364670,Beta-lactamase TEM,1,1,1,,Broad spectrum
112480,CHEMBL1006,AMIFOSTINE,2167,Reactive metabolite scavenging agent,,,,,1,1,1,Prodrug. Scavenge of reactive oxygen species and reactive metabolites of cisplatin,
112655,CHEMBL1009,LEVODOPA,246,Dopamine D3 receptor agonist,AGONIST,130.0,CHEMBL234,D(3) dopamine receptor,1,1,1,,
12417,CHEMBL101,PHENYLBUTAZONE,1205,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
112665,CHEMBL1010,CEFOTAXIME SODIUM,1722,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
116349,CHEMBL1014,CANDESARTAN CILEXETIL,225,Type-1 angiotensin II receptor antagonist,ANTAGONIST,115.0,CHEMBL227,Type-1 angiotensin II receptor,1,1,1,,
116949,CHEMBL1017,TELMISARTAN,227,Type-1 angiotensin II receptor antagonist,ANTAGONIST,115.0,CHEMBL227,Type-1 angiotensin II receptor,1,1,1,,
117108,CHEMBL1018,DIENESTROL,863,Estrogen receptor alpha agonist,AGONIST,19.0,CHEMBL206,Estrogen receptor,1,1,1,,
119162,CHEMBL1021,NEPAFENAC,1183,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
119498,CHEMBL1023,BEXAROTENE,1576,Retinoid X receptor agonist,AGONIST,105765.0,CHEMBL2363070,Retinoid X receptor,1,1,1,,
119640,CHEMBL1024,IFOSFAMIDE,1869,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
119717,CHEMBL1025,ISOFLUROPHATE,742,Acetylcholinesterase inhibitor,INHIBITOR,93.0,CHEMBL220,Acetylcholinesterase,1,1,1,,
121124,CHEMBL1026,FENOLDOPAM MESYLATE,851,Dopamine D1 receptor agonist,AGONIST,88.0,CHEMBL2056,D(1A) dopamine receptor,1,1,1,,
122901,CHEMBL1029,MIGLUSTAT,853,Ceramide glucosyltransferase inhibitor,INHIBITOR,286.0,CHEMBL2063,Ceramide glucosyltransferase,1,1,1,,
12825,CHEMBL103,PROGESTERONE,1018,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,
123693,CHEMBL1034,DICLOFENAC SODIUM,1176,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
13494,CHEMBL104,CLOTRIMAZOLE,1442,Cytochrome P450 51 inhibitor,INHIBITOR,58.0,CHEMBL1780,Lanosterol 14-alpha demethylase,1,1,1,"Has also been implicated as a therapy for sickle cell anemia, by inhibiting the gardos channel, causing dehydration of the cells (PMID: 8636434)",
125294,CHEMBL1042,CHOLECALCIFEROL,515,Vitamin D receptor agonist,AGONIST,64.0,CHEMBL1977,Vitamin D3 receptor,1,1,1,,
126356,CHEMBL1043,DAPSONE,1747,Dihydropteroate synthase 1 inhibitor,INHIBITOR,105705.0,CHEMBL2362993,Dihydropteroate synthase,1,1,1,,
127755,CHEMBL1046,AMINOCAPROIC ACID,86,Plasminogen inhibitor,INHIBITOR,12.0,CHEMBL1801,Plasminogen,1,1,1,,
127755,CHEMBL1046,AMINOCAPROIC ACID,336,Tissue-type plasminogen activator inhibitor,INHIBITOR,11399.0,CHEMBL1873,Tissue-type plasminogen activator,1,1,1,,
13590,CHEMBL105,MITOMYCIN,1864,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
132003,CHEMBL1051,LATANOPROST,642,Prostanoid FP receptor agonist,AGONIST,140.0,CHEMBL1987,Prostaglandin F2-alpha receptor,1,1,1,,
134100,CHEMBL1054,TRICHLORMETHIAZIDE,353,Thiazide-sensitive sodium-chloride cotransporter inhibitor,INHIBITOR,151.0,CHEMBL1876,Solute carrier family 12 member 3,1,1,1,,
134333,CHEMBL1055,CHLORTHALIDONE,354,Thiazide-sensitive sodium-chloride cotransporter inhibitor,INHIBITOR,151.0,CHEMBL1876,Solute carrier family 12 member 3,1,1,1,,
136161,CHEMBL1059,PREGABALIN,1920,Voltage-gated calcium channel modulator,MODULATOR,105734.0,CHEMBL2363032,Voltage-gated calcium channel,1,1,1,,
13758,CHEMBL106,FLUCONAZOLE,1450,Cytochrome P450 51 inhibitor,INHIBITOR,58.0,CHEMBL1780,Lanosterol 14-alpha demethylase,1,1,1,,
136282,CHEMBL1060,"SODIUM PHOSPHATE, DIBASIC, ANHYDROUS",8746,Saline laxative,,,,,1,1,1,Mechanism for sodium phosphate monobasic monohydrate/sodium phosphate dibasic anhydrous,
138562,CHEMBL1064,SIMVASTATIN,1059,HMG-CoA reductase inhibitor,INHIBITOR,24.0,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,1,1,1,,
139014,CHEMBL1068,OXCARBAZEPINE,1986,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
139045,CHEMBL1069,VALSARTAN,222,Type-1 angiotensin II receptor antagonist,ANTAGONIST,115.0,CHEMBL227,Type-1 angiotensin II receptor,1,1,1,,
14440,CHEMBL107,COLCHICINE,1106,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,Inhibits microtubule assembly,
139210,CHEMBL1070,NABUMETONE,1460,Cyclooxygenase-2 inhibitor,INHIBITOR,126.0,CHEMBL230,Prostaglandin G/H synthase 2,1,1,1,,
139225,CHEMBL1071,OXAPROZIN,1204,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
139281,CHEMBL1072,BUMETANIDE,337,Sodium-(potassium)-chloride cotransporter 2 inhibitor,INHIBITOR,167.0,CHEMBL1874,Solute carrier family 12 member 1,1,1,1,,
139286,CHEMBL1073,GLIPIZIDE,1249,"Sulfonylurea receptor 1, Kir6.2 blocker",BLOCKER,104852.0,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",1,1,1,,
614499,CHEMBL1076903,VARENICLINE,8912,Neuronal acetylcholine receptor; alpha4/beta2 partial agonist,PARTIAL AGONIST,104283.0,CHEMBL1907589,Neuronal acetylcholine receptor; alpha4/beta2,1,1,1,,
617563,CHEMBL1078178,MOMELOTINIB,5280,Tyrosine-protein kinase JAK1 inhibitor,INHIBITOR,10919.0,CHEMBL2835,Tyrosine-protein kinase JAK1,1,1,1,,
617563,CHEMBL1078178,MOMELOTINIB,5281,Tyrosine-protein kinase JAK2 inhibitor,INHIBITOR,10938.0,CHEMBL2971,Tyrosine-protein kinase JAK2,1,1,1,,
611647,CHEMBL1079742,ERLOTINIB HYDROCHLORIDE,243,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,,
15086,CHEMBL108,CARBAMAZEPINE,1972,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
143284,CHEMBL1082,AMOXICILLIN,1710,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
630886,CHEMBL1082407,ENZALUTAMIDE,1331,Androgen Receptor antagonist,ANTAGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
631502,CHEMBL1082607,SALMETEROL XINAFOATE,1344,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
630396,CHEMBL1083385,CLOPIDOGREL BISULFATE,1501,Purinergic receptor P2Y12 antagonist,ANTAGONIST,176.0,CHEMBL2001,P2Y purinoceptor 12,1,1,1,Irreversible inhibitor,
630322,CHEMBL1083659,SUVOREXANT,2285,Orexin receptor antagonist,ANTAGONIST,108439.0,CHEMBL3307226,Orexin receptor,1,1,1,,
630439,CHEMBL1083993,AMIODARONE HYDROCHLORIDE,502,HERG blocker,BLOCKER,165.0,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,1,1,1,,
631810,CHEMBL1084172,VILANTEROL TRIFENATATE,1337,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
8209,CHEMBL10878,AGOMELATINE,6445,Melatonin receptor agonist,AGONIST,104733.0,CHEMBL2094268,Melatonin receptor,1,1,1,Agomelatine behaves both as a potent agonist at melatonin MT1 and MT2 receptors and as a neutral antagonist at 5-HT2C receptors.,"Melatonin receptor MT1, Ki=0.1nM / MT2, Ki=0.12nM 5-HT2C receptor, Ki=631nM"
8209,CHEMBL10878,AGOMELATINE,6886,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,Agomelatine behaves both as a potent agonist at melatonin MT1 and MT2 receptors and as a neutral antagonist at 5-HT2C receptors.,"Melatonin receptor MT1, Ki=0.1nM / MT2, Ki=0.12nM 5-HT2C receptor, Ki=631nM"
621308,CHEMBL1089221,BENDAZAC,6206,Xanthine dehydrogenase inhibitor,INHIBITOR,149.0,CHEMBL1929,Xanthine dehydrogenase/oxidase,1,1,1,"Bendazac has anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties, but its principal effect is to inhibit the denaturation of proteins. It protects lens proteins from denaturation, aggregation and precipitation in the medical treatment of senile cataract. Inhibits xanthine oxidase (XO) but not xanthine dehydrogenase (XDH). The oxidation of -SH groups near the active center, during the conversion of XDH to reversible XO, produces a conformational modification which allows bendazac to bind to reversible XO inhibiting the enzyme activity. The lysine salt is better absorbed than the parent compound after oral administration.",
622408,CHEMBL1089318,OPICAPONE,7762,Catechol O-methyltransferase inhibitor,INHIBITOR,91.0,CHEMBL2023,Catechol O-methyltransferase,1,1,1,"Selective and reversible inhibitor of COMT. Functions to increase the bioavailability of levodopa by inhibition of COMT, a levodopa metabolizing enzyme.",
15217,CHEMBL109,VALPROIC ACID,392,Succinate semialdehyde dehydrogenase inhibitor,INHIBITOR,283.0,CHEMBL1911,"Succinate-semialdehyde dehydrogenase, mitochondrial",1,1,1,,
149095,CHEMBL1090,VIDARABINE,1474,Human herpesvirus 1 DNA polymerase inhibitor,INHIBITOR,27.0,CHEMBL1872,DNA polymerase catalytic subunit,1,1,1,,
150313,CHEMBL1091,HYDROCORTISONE ACETATE,801,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
150389,CHEMBL1092,TRIHEXYPHENIDYL HYDROCHLORIDE,280,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Indicated for Parkinson's disease, M1 likely responsible",
150451,CHEMBL1094,FELBAMATE,1131,Glutamate [NMDA] receptor antagonist,ANTAGONIST,104706.0,CHEMBL2094124,Glutamate [NMDA] receptor,1,1,1,,
624225,CHEMBL1094636,NIRAPARIB,5681,Poly [ADP-ribose] polymerase 2 inhibitor,INHIBITOR,100933.0,CHEMBL5366,Poly [ADP-ribose] polymerase 2,1,1,1,,IC(50) inhibition PARP2 (2.1 nM)
624225,CHEMBL1094636,NIRAPARIB,5922,Poly [ADP-ribose] polymerase-1 inhibitor,INHIBITOR,11663.0,CHEMBL3105,Poly [ADP-ribose] polymerase 1,1,1,1,,IC(50) inhibition PARP1 (3.8 nM) 
150452,CHEMBL1095,ETHOTOIN,1961,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
626453,CHEMBL1095097,EPLERENONE,656,Mineralocorticoid receptor antagonist,ANTAGONIST,48.0,CHEMBL1994,Mineralocorticoid receptor,1,1,1,,
624251,CHEMBL1095292,BRETYLIUM TOSYLATE,883,Norepinephrine transporter substrate,SUBSTRATE,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,Taken up by transporter and displaces NE from vesicles,
624296,CHEMBL1095930,CEFUROXIME AXETIL,1688,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
150549,CHEMBL1096,AMLEXANOX,1060,Phosphodiesterase 4 inhibitor,INHIBITOR,104679.0,CHEMBL2093863,Phosphodiesterase 4,1,1,1,,
628156,CHEMBL1096146,PONESIMOD,5008,Sphingosine 1-phosphate receptor Edg-1 agonist,AGONIST,11631.0,CHEMBL4333,Sphingosine 1-phosphate receptor 1,1,1,1,,
624161,CHEMBL1096882,FLUDARABINE PHOSPHATE,1261,Ribonucleoside-diphosphate reductase RR1 inhibitor,INHIBITOR,104791.0,CHEMBL2095215,Ribonucleoside-diphosphate reductase RR1,1,1,1,,
624161,CHEMBL1096882,FLUDARABINE PHOSPHATE,1917,DNA polymerase (alpha/delta/epsilon) inhibitor,INHIBITOR,105737.0,CHEMBL2363042,DNA polymerase (alpha/delta/epsilon),1,1,1,,
624185,CHEMBL1096885,VALRUBICIN,104,DNA topoisomerase II alpha inhibitor,INHIBITOR,63.0,CHEMBL1806,DNA topoisomerase 2-alpha,1,1,1,,
624185,CHEMBL1096885,VALRUBICIN,1890,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
626138,CHEMBL1097279,CANGRELOR TETRASODIUM,2342,Purinergic receptor P2Y12 antagonist,ANTAGONIST,176.0,CHEMBL2001,P2Y purinoceptor 12,1,1,1,,
150882,CHEMBL1098,BUPIVACAINE,869,Sodium channel protein type IV alpha subunit blocker,BLOCKER,18043.0,CHEMBL2072,Sodium channel protein type 4 subunit alpha,1,1,1,,
150989,CHEMBL1100,PARAMETHADIONE,2097,Voltage-gated T-type calcium channel blocker,BLOCKER,105707.0,CHEMBL2362995,Voltage-gated T-type calcium channel,1,1,1,,
151300,CHEMBL1102,GLUTETHIMIDE,1605,GABA-A receptor; anion channel positive modulator,POSITIVE MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
151310,CHEMBL1103,FURAZOLIDONE,1829,DNA inhibitor,INHIBITOR,106020.0,CHEMBL2364041,DNA,1,1,1,Promotes inter-strand DNA cross-linking,
178290,CHEMBL110458,MIGALASTAT,6931,Alpha-galactosidase A stabiliser,STABILISER,10693.0,CHEMBL2524,Alpha-galactosidase A,1,1,1,"Migalastat binds to the active site of alpha-galactosidase A, deficient in Fabry disease, stabilising the protein or protein variant enabling trafficking to the lysosome and enzyme activity. ",Binds alpha-galactosidase A and variants.
182928,CHEMBL110691,CHLORMADINONE ACETATE,6219,Progesterone receptor modulator,MODULATOR,36.0,CHEMBL208,Progesterone receptor,1,1,1,"Chlormadinone acetate (CMA) shows high affinity and activity at the progesterone receptor. It has an anti-estrogenic effect and, in contrast to natural progesterone, shows moderate anti-androgenic properties. CMA acts by blocking androgen receptors in target organs and by reducing the activity of skin 5alpha-reductase. It suppresses gonadotropin secretion and thereby reduces ovarian and adrenal androgen production.","Chlormadinone acetate has a strong affinity for the progesterone receptor, one-third higher than natural progesterone."
152751,CHEMBL1108,DROPERIDOL,584,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
152751,CHEMBL1108,DROPERIDOL,2011,D2-like dopamine receptor antagonist,ANTAGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
153330,CHEMBL1109,SULFAPHENAZOLE,1655,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,Broad spectrum
16088,CHEMBL111,RIMONABANT,6296,Cannabinoid CB1 receptor antagonist,ANTAGONIST,87.0,CHEMBL218,Cannabinoid receptor 1,1,1,1,"Rimonabant, a selective cannabinoid CB1 receptor antagonist, given systemically reduces the increase of the concentration of dopamine in the dialysate from the shell of the nucleus accumbens, which occurs when rats are exposed to novel high palatable foods.",
154051,CHEMBL1111,AMBRISENTAN,1041,"Endothelin receptor, ET-A/ET-B antagonist",ANTAGONIST,104833.0,CHEMBL2096678,"Endothelin receptor, ET-A/ET-B",1,1,1,,
155006,CHEMBL1112,ARIPIPRAZOLE,205,Dopamine D2 receptor partial agonist,PARTIAL AGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
155006,CHEMBL1112,ARIPIPRAZOLE,472,Serotonin 1a (5-HT1a) receptor partial agonist,PARTIAL AGONIST,51.0,CHEMBL214,5-hydroxytryptamine receptor 1A,1,1,1,,
155006,CHEMBL1112,ARIPIPRAZOLE,585,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
155045,CHEMBL1113,AMOXAPINE,407,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
155045,CHEMBL1113,AMOXAPINE,899,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
155045,CHEMBL1113,AMOXAPINE,1152,Dopamine receptor antagonist,ANTAGONIST,104842.0,CHEMBL2096905,Dopamine receptor,1,1,1,,
158276,CHEMBL1116,RALOXIFENE HYDROCHLORIDE,649,Estrogen receptor beta modulator,MODULATOR,174.0,CHEMBL242,Estrogen receptor beta,1,1,1,Mixed agonist/antagonist,
161281,CHEMBL1118,DESVENLAFAXINE,393,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
161281,CHEMBL1118,DESVENLAFAXINE,876,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
16450,CHEMBL112,ACETAMINOPHEN,1172,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
16450,CHEMBL112,ACETAMINOPHEN,2226,Anandamide amidohydrolase inhibitor,INHIBITOR,11291.0,CHEMBL2243,Fatty-acid amide hydrolase 1,1,1,1,"FAAH converts acetaminophen into the active metabolite AM404, but this conversion also competes with degradation of anandamide increasing its concentration and effects",
16450,CHEMBL112,ACETAMINOPHEN,2227,Vanilloid receptor opener,OPENER,10260.0,CHEMBL4794,Transient receptor potential cation channel subfamily V member 1,1,1,1,"Active metabolite, AM404, activates vanilloid receptor (TRPV1)",
161649,CHEMBL1120,BISMUTH SUBSALICYLATE,1182,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
164064,CHEMBL1121,SINCALIDE,9406,Cholecystokinin A receptor agonist,AGONIST,10472.0,CHEMBL1901,Cholecystokinin receptor type A,1,1,1,,
167260,CHEMBL1126,PENICILLIN G SODIUM,1730,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
167875,CHEMBL1128,EDROPHONIUM CHLORIDE,743,Acetylcholinesterase inhibitor,INHIBITOR,93.0,CHEMBL220,Acetylcholinesterase,1,1,1,,
169321,CHEMBL1129,TRIFLURIDINE,1930,DNA inhibitor,INHIBITOR,106215.0,CHEMBL2366042,DNA,1,1,1,"Virustatic antimetabolites; recent studies indicate its role as an anti-cancer (pmid: 6436227, 18600528)",
16485,CHEMBL113,CAFFEINE,1214,Adenosine receptor antagonist,ANTAGONIST,105024.0,CHEMBL2111329,Adenosine receptor,1,1,1,,
169652,CHEMBL1131,ACITRETIN,1578,Retinoid receptor agonist,AGONIST,105766.0,CHEMBL2363071,Retinoid receptor,1,1,1,Precise mechanism uncertain. RARG/RXRA are predominant forms in skin,
170395,CHEMBL1133,OXYBUTYNIN CHLORIDE,49,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for overactive bladder, M3 likely responsible",
170395,CHEMBL1133,OXYBUTYNIN CHLORIDE,1514,Muscarinic acetylcholine receptor M2 antagonist,ANTAGONIST,47.0,CHEMBL211,Muscarinic acetylcholine receptor M2,1,1,1,"Indicated for overactive bladder, M2 likely responsible",
171062,CHEMBL1134,DECAMETHONIUM BROMIDE,1527,Muscle-type nicotinic acetylcholine receptor partial agonist,PARTIAL AGONIST,105709.0,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,1,1,1,depolarizing,
8633,CHEMBL11359,CISPLATIN,1872,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
171587,CHEMBL1136,TELITHROMYCIN,1766,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
175106,CHEMBL1138,EZETIMIBE,1377,Niemann-Pick C1-like protein 1 inhibitor,INHIBITOR,329.0,CHEMBL2027,NPC1-like intracellular cholesterol transporter 1,1,1,1,,
17169,CHEMBL114,SAQUINAVIR,1495,Human immunodeficiency virus type 1 protease inhibitor,INHIBITOR,191.0,CHEMBL243,Human immunodeficiency virus type 1 protease,1,1,1,,
180329,CHEMBL1148,TORSEMIDE,339,Sodium-(potassium)-chloride cotransporter 2 inhibitor,INHIBITOR,167.0,CHEMBL1874,Solute carrier family 12 member 1,1,1,1,,
182546,CHEMBL1152,PREDNISOLONE ACETATE,811,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
641189,CHEMBL1159650,CLOBETASOL PROPIONATE,768,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
17347,CHEMBL116,AMPRENAVIR,1493,Human immunodeficiency virus type 1 protease inhibitor,INHIBITOR,191.0,CHEMBL243,Human immunodeficiency virus type 1 protease,1,1,1,,
187696,CHEMBL1161,MOMETASONE FUROATE,802,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
187962,CHEMBL1162,NORETHINDRONE,1015,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,
647206,CHEMBL1164729,FEBUXOSTAT,438,Xanthine dehydrogenase inhibitor,INHIBITOR,149.0,CHEMBL1929,Xanthine dehydrogenase/oxidase,1,1,1,,
188815,CHEMBL1166,ARGATROBAN,78,Thrombin inhibitor,INHIBITOR,11.0,CHEMBL204,Prothrombin,1,1,1,,
9623,CHEMBL11662,OZAGREL,7616,Thromboxane-A synthase inhibitor,INHIBITOR,248.0,CHEMBL1835,Thromboxane-A synthase,1,1,1,,
189203,CHEMBL1168,RAMIPRIL,110,Angiotensin-converting enzyme inhibitor,INHIBITOR,69.0,CHEMBL1808,Angiotensin-converting enzyme,1,1,1,,
190484,CHEMBL1169,AMINOSALICYLIC ACID,5874,Dihydrofolate reductase inhibitor,INHIBITOR,102873.0,CHEMBL6065,Dihydrofolate reductase,1,1,1,"PAS is incorporated into the folate pathway by dihydropteroate synthase (DHPS) and dihydrofolate synthase (DHFS) to generate a hydroxyl dihydrofolate antimetabolite, which in turn inhibits DHFR enzymatic activity. Mechanism in Crohn's disease/ulcerative colitis may be through PPAR-gamma/NF-kappa-B inhibition",
190629,CHEMBL1170,TESTOSTERONE PROPIONATE,1324,Androgen Receptor agonist,AGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
191342,CHEMBL1172,DESLORATADINE,161,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
191172,CHEMBL117287,PRUCALOPRIDE,5624,Serotonin 4 (5-HT4) receptor agonist,AGONIST,168.0,CHEMBL1875,5-hydroxytryptamine receptor 4,1,1,1,Facilitates acetylcholine release and stimulates colonic peristalsis.,Selective for 5-HT4.
651088,CHEMBL1173055,RUCAPARIB,5674,"PARP 1, 2 and 3 inhibitor",INHIBITOR,109545.0,CHEMBL3390820,"PARP 1, 2 and 3",1,1,1,,
191902,CHEMBL1174,EPTIFIBATIDE,1078,Integrin alpha-IIb/beta-3 inhibitor,INHIBITOR,104685.0,CHEMBL2093869,Integrin alpha-IIb/beta-3,1,1,1,,
193281,CHEMBL117785,TETRABENAZINE,1481,Synaptic vesicular amine transporter inhibitor,INHIBITOR,162.0,CHEMBL1893,Synaptic vesicular amine transporter,1,1,1,,
18694,CHEMBL118,CELECOXIB,1462,Cyclooxygenase-2 inhibitor,INHIBITOR,126.0,CHEMBL230,Prostaglandin G/H synthase 2,1,1,1,,
195974,CHEMBL1184,ACETYLCHOLINE CHLORIDE,40,Muscarinic acetylcholine receptor M3 agonist,AGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for miosis, M3 likely involved (main form in iris)",
196215,CHEMBL1185,ZOLMITRIPTAN,364,Serotonin 1b (5-HT1b) receptor agonist,AGONIST,106.0,CHEMBL1898,5-hydroxytryptamine receptor 1B,1,1,1,,
196215,CHEMBL1185,ZOLMITRIPTAN,570,Serotonin 1d (5-HT1d) receptor agonist,AGONIST,105.0,CHEMBL1983,5-hydroxytryptamine receptor 1D,1,1,1,,
204115,CHEMBL1191,SULFAMETHIZOLE,1663,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,Broad spectrum
208749,CHEMBL1194,PRILOCAINE,1966,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
721,CHEMBL12,DIAZEPAM,1592,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
674272,CHEMBL1200321,SULFISOXAZOLE DIOLAMINE,1654,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,Broad spectrum
674273,CHEMBL1200322,ESCITALOPRAM OXALATE,395,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,reuptake inhibitor,
674274,CHEMBL1200323,LABETALOL HYDROCHLORIDE,1996,Adrenergic receptor antagonist,ANTAGONIST,105670.0,CHEMBL2331074,Adrenergic receptor,1,1,1,,
674277,CHEMBL1200326,NICARDIPINE HYDROCHLORIDE,1279,Voltage-gated L-type calcium channel blocker,BLOCKER,104801.0,CHEMBL2095229,Voltage-gated L-type calcium channel,1,1,1,,
674279,CHEMBL1200328,DULOXETINE HYDROCHLORIDE,409,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
674279,CHEMBL1200328,DULOXETINE HYDROCHLORIDE,901,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
674280,CHEMBL1200329,TIZANIDINE HYDROCHLORIDE,1140,Adrenergic receptor alpha-2 agonist,AGONIST,104743.0,CHEMBL2095158,Adrenergic receptor alpha-2,1,1,1,,
674281,CHEMBL1200330,PILOCARPINE HYDROCHLORIDE,43,Muscarinic acetylcholine receptor M3 agonist,AGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for miosis, M3 likely involved (main form in iris)",
674281,CHEMBL1200330,PILOCARPINE HYDROCHLORIDE,2368,Muscarinic acetylcholine receptor M1 agonist,AGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Indicated for dry mouth, M1 likely involved",
674282,CHEMBL1200331,FOSFOMYCIN TROMETHAMINE,636,UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor,INHIBITOR,109.0,CHEMBL1984,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,1,1,1,,
674283,CHEMBL1200332,PROTRIPTYLINE HYDROCHLORIDE,415,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
674283,CHEMBL1200332,PROTRIPTYLINE HYDROCHLORIDE,905,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
674285,CHEMBL1200334,MORICIZINE HYDROCHLORIDE,1977,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674286,CHEMBL1200335,TESTOSTERONE ENANTHATE,1325,Androgen Receptor agonist,AGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
674289,CHEMBL1200338,PINACIDIL,1230,"Sulfonylurea receptor 2, Kir6.2 opener",OPENER,104782.0,CHEMBL2095198,"Sulfonylurea receptor 2, Kir6.2",1,1,1,,
674290,CHEMBL1200339,PHENYLEPHRINE HYDROCHLORIDE,1167,Adrenergic receptor alpha-1 agonist,AGONIST,104723.0,CHEMBL2094251,Adrenergic receptor alpha-1,1,1,1,,
674291,CHEMBL1200340,OSELTAMIVIR PHOSPHATE,845,Neuraminidase inhibitor,INHIBITOR,21.0,CHEMBL2051,Neuraminidase,1,1,1,,
674291,CHEMBL1200340,OSELTAMIVIR PHOSPHATE,944,Neuraminidase inhibitor,INHIBITOR,10738.0,CHEMBL3377,Neuraminidase,1,1,1,,
674292,CHEMBL1200341,INDECAINIDE HYDROCHLORIDE,1990,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674293,CHEMBL1200342,PARAMETHASONE ACETATE,777,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674294,CHEMBL1200343,PERINDOPRIL ERBUMINE,115,Angiotensin-converting enzyme inhibitor,INHIBITOR,69.0,CHEMBL1808,Angiotensin-converting enzyme,1,1,1,,
674298,CHEMBL1200347,ISOPROPAMIDE IODIDE,52,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Role in regulating gastric secretion, M3 likely involved",
674298,CHEMBL1200347,ISOPROPAMIDE IODIDE,274,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Role in regulating gastric secretion, M1 likely involved",
674299,CHEMBL1200348,SULCONAZOLE NITRATE,1451,Cytochrome P450 51 inhibitor,INHIBITOR,58.0,CHEMBL1780,Lanosterol 14-alpha demethylase,1,1,1,,
674302,CHEMBL1200351,SULFADIAZINE SODIUM,1656,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,Broad spectrum
674307,CHEMBL1200356,CYCLACILLIN,1715,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674308,CHEMBL1200357,MOXALACTAM DISODIUM,1689,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674309,CHEMBL1200358,SODIUM PHENYLACETATE,2193,Glutamine sequestering agent,SEQUESTERING AGENT,106212.0,CHEMBL2366039,Glutamine,1,1,1,"Removes excess nitrogen, caused by enzyme deficiency",
674310,CHEMBL1200359,SULFAMETER,1661,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,Broad spectrum
674317,CHEMBL1200366,CEPHALEXIN HYDROCHLORIDE,1717,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674318,CHEMBL1200367,ECHOTHIOPHATE IODIDE,744,Acetylcholinesterase inhibitor,INHIBITOR,93.0,CHEMBL220,Acetylcholinesterase,1,1,1,,
674321,CHEMBL1200370,BENZOYL PEROXIDE,8409,Releases active oxygen,,,,,1,1,1,,
674325,CHEMBL1200374,EXEMESTANE,525,Cytochrome P450 19A1 inhibitor,INHIBITOR,65.0,CHEMBL1978,Aromatase,1,1,1,,
674327,CHEMBL1200376,BETAMETHASONE BENZOATE,795,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674328,CHEMBL1200377,AMPHETAMINE ASPARTATE,686,Dopamine transporter releasing agent,RELEASING AGENT,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
674328,CHEMBL1200377,AMPHETAMINE ASPARTATE,897,Norepinephrine transporter releasing agent,RELEASING AGENT,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
674330,CHEMBL1200379,APRACLONIDINE HYDROCHLORIDE,1146,Adrenergic receptor alpha-2 agonist,AGONIST,104743.0,CHEMBL2095158,Adrenergic receptor alpha-2,1,1,1,,
674331,CHEMBL1200380,ACYCLOVIR SODIUM,1475,Human herpesvirus 1 DNA polymerase inhibitor,INHIBITOR,27.0,CHEMBL1872,DNA polymerase catalytic subunit,1,1,1,Prodrug enzyme: Thymidine kinase,
674333,CHEMBL1200382,BEPRIDIL HYDROCHLORIDE,1919,Voltage-gated calcium channel blocker,BLOCKER,105734.0,CHEMBL2363032,Voltage-gated calcium channel,1,1,1,,
674334,CHEMBL1200383,BENZTROPINE MESYLATE,296,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Indicated for Parkinson's disease, M1 likely responsible",
674335,CHEMBL1200384,BETAMETHASONE DIPROPIONATE,778,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674337,CHEMBL1200386,PREDNICARBATE,783,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674338,CHEMBL1200387,AMPHETAMINE ADIPATE,692,Dopamine transporter releasing agent,RELEASING AGENT,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
674338,CHEMBL1200387,AMPHETAMINE ADIPATE,906,Norepinephrine transporter releasing agent,RELEASING AGENT,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
674339,CHEMBL1200388,CLOXACILLIN SODIUM,1425,Penicillin-binding protein inhibitor,INHIBITOR,105733.0,CHEMBL2363021,Penicillin-binding protein,1,1,1,Indicated for staphylococcal infections,
674340,CHEMBL1200389,BRIMONIDINE TARTRATE,1138,Adrenergic receptor alpha-2 agonist,AGONIST,104743.0,CHEMBL2095158,Adrenergic receptor alpha-2,1,1,1,,
674343,CHEMBL1200392,DOXYLAMINE SUCCINATE,164,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674344,CHEMBL1200393,GREPAFLOXACIN HYDROCHLORIDE,1910,DNA gyrase inhibitor,INHIBITOR,105578.0,CHEMBL2311225,DNA gyrase,1,1,1,,
674344,CHEMBL1200393,GREPAFLOXACIN HYDROCHLORIDE,2046,Topoisomerase IV inhibitor,INHIBITOR,105735.0,CHEMBL2363033,Topoisomerase IV,1,1,1,,
674346,CHEMBL1200395,ORPHENADRINE CITRATE,177,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674346,CHEMBL1200395,ORPHENADRINE CITRATE,914,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
674346,CHEMBL1200395,ORPHENADRINE CITRATE,1126,Glutamate [NMDA] receptor antagonist,ANTAGONIST,104706.0,CHEMBL2094124,Glutamate [NMDA] receptor,1,1,1,,
674346,CHEMBL1200395,ORPHENADRINE CITRATE,1980,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674347,CHEMBL1200396,BUPIVACAINE HYDROCHLORIDE,870,Sodium channel protein type IV alpha subunit blocker,BLOCKER,18043.0,CHEMBL2072,Sodium channel protein type 4 subunit alpha,1,1,1,,
674348,CHEMBL1200397,BUTENAFINE HYDROCHLORIDE,1401,Squalene monooxygenase inhibitor,INHIBITOR,106179.0,CHEMBL2364679,Squalene monooxygenase,1,1,1,,
674349,CHEMBL1200398,BUTOCONAZOLE NITRATE,1455,Cytochrome P450 51 inhibitor,INHIBITOR,58.0,CHEMBL1780,Lanosterol 14-alpha demethylase,1,1,1,,
674350,CHEMBL1200399,BUSPIRONE HYDROCHLORIDE,469,Serotonin 1a (5-HT1a) receptor partial agonist,PARTIAL AGONIST,51.0,CHEMBL214,5-hydroxytryptamine receptor 1A,1,1,1,,
674351,CHEMBL1200400,AZATHIOPRINE SODIUM,1746,Amidophosphoribosyltransferase inhibitor,INHIBITOR,105704.0,CHEMBL2362992,Amidophosphoribosyltransferase,1,1,1,Prodrug enzyme: hypoxanthine-guanine phosphoribosyl transferase (HGPRT; EC 2.4.2.8),
674351,CHEMBL1200400,AZATHIOPRINE SODIUM,1875,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,Prodrug enzyme: hypoxanthine-guanine phosphoribosyl transferase (HGPRT; EC 2.4.2.8),
674353,CHEMBL1200402,AMLODIPINE BESYLATE,1278,Voltage-gated L-type calcium channel blocker,BLOCKER,104801.0,CHEMBL2095229,Voltage-gated L-type calcium channel,1,1,1,,
674356,CHEMBL1200405,BITOLTEROL MESYLATE,1343,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
674357,CHEMBL1200406,DIMENHYDRINATE,172,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674360,CHEMBL1200409,LIDOCAINE HYDROCHLORIDE,1993,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674361,CHEMBL1200410,PROCARBAZINE HYDROCHLORIDE,1870,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
674362,CHEMBL1200411,ROPINIROLE HYDROCHLORIDE,2015,D2-like dopamine receptor agonist,AGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
674363,CHEMBL1200412,NANDROLONE PHENPROPIONATE,1332,Androgen Receptor agonist,AGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
674364,CHEMBL1200413,TETRAHYDROZOLINE HYDROCHLORIDE,1235,Adrenergic receptor alpha agonist,AGONIST,104787.0,CHEMBL2095203,Adrenergic receptor alpha,1,1,1,,
674369,CHEMBL1200418,DOBUTAMINE HYDROCHLORIDE,318,Beta-1 adrenergic receptor agonist,AGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
674369,CHEMBL1200418,DOBUTAMINE HYDROCHLORIDE,1366,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
674370,CHEMBL1200419,MOLINDONE HYDROCHLORIDE,210,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
674370,CHEMBL1200419,MOLINDONE HYDROCHLORIDE,592,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
674371,CHEMBL1200420,MIDAZOLAM HYDROCHLORIDE,1613,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
674375,CHEMBL1200424,PENTETATE ZINC TRISODIUM,1672,Radioactive metals chelating agent,CHELATING AGENT,106210.0,CHEMBL2366037,Radioactive metals,1,1,1,Chelates radioactive contaminants to increase elimination rate.,
674376,CHEMBL1200425,PARGYLINE HYDROCHLORIDE,1242,Monoamine oxidase inhibitor,INHIBITOR,104789.0,CHEMBL2095205,Monoamine oxidase,1,1,1,,
674377,CHEMBL1200426,METHIXENE HYDROCHLORIDE,292,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Indicated for Parkinson's disease, M1 likely responsible",
674377,CHEMBL1200426,METHIXENE HYDROCHLORIDE,616,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
674381,CHEMBL1200430,ESTRADIOL ACETATE,859,Estrogen receptor alpha agonist,AGONIST,19.0,CHEMBL206,Estrogen receptor,1,1,1,,
674383,CHEMBL1200432,METHYLDOPATE HYDROCHLORIDE,1143,Adrenergic receptor alpha-2 agonist,AGONIST,104743.0,CHEMBL2095158,Adrenergic receptor alpha-2,1,1,1,,
674385,CHEMBL1200434,OXTRIPHYLLINE,2388,Phosphodiesterase 4 inhibitor,INHIBITOR,104679.0,CHEMBL2093863,Phosphodiesterase 4,1,1,1,,
674385,CHEMBL1200434,OXTRIPHYLLINE,2389,Phosphodiesterase 3 inhibitor,INHIBITOR,104707.0,CHEMBL2094125,Phosphodiesterase 3,1,1,1,,
674385,CHEMBL1200434,OXTRIPHYLLINE,2390,Adenosine receptor antagonist,ANTAGONIST,105024.0,CHEMBL2111329,Adenosine receptor,1,1,1,,
674387,CHEMBL1200436,OXANDROLONE,1327,Androgen Receptor agonist,AGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
674388,CHEMBL1200437,QUINIDINE GLUCONATE,1959,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674389,CHEMBL1200438,TIOCONAZOLE,1452,Cytochrome P450 51 inhibitor,INHIBITOR,58.0,CHEMBL1780,Lanosterol 14-alpha demethylase,1,1,1,,
674391,CHEMBL1200440,MEPIVACAINE HYDROCHLORIDE,1976,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674394,CHEMBL1200443,MERETHOXYLLINE PROCAINE,1969,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674395,CHEMBL1200444,PIRBUTEROL ACETATE,1339,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
674397,CHEMBL1200446,TRIPELENNAMINE HYDROCHLORIDE,165,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674399,CHEMBL1200448,TILUDRONATE DISODIUM,1937,ATP inhibitor,INHIBITOR,106221.0,CHEMBL2366048,ATP,1,1,1,"Non N-containing biphosphonates, moa: its incorporated in ATP anologues, which accumulate in osteoclasts leading to its early apoptosis (specific to osteoclast, because it binds to hydropatite, and is then slowly released when the bone is reabsorded)",
674400,CHEMBL1200449,TRIAMCINOLONE DIACETATE,796,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674404,CHEMBL1200453,DOCOSANOL,1409,Envelope glycoprotein inhibitor,INHIBITOR,106196.0,CHEMBL2364696,Envelope glycoprotein,1,1,1,Seems to prevent the fusion between the host membrane and lipid-enveloped virus.,
674405,CHEMBL1200454,VALGANCICLOVIR HYDROCHLORIDE,1473,Human herpesvirus 1 DNA polymerase inhibitor,INHIBITOR,27.0,CHEMBL1872,DNA polymerase catalytic subunit,1,1,1,,
674412,CHEMBL1200461,MIDODRINE HYDROCHLORIDE,1166,Adrenergic receptor alpha-1 agonist,AGONIST,104723.0,CHEMBL2094251,Adrenergic receptor alpha-1,1,1,1,,
674414,CHEMBL1200463,OXAPROZIN POTASSIUM,1200,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
674415,CHEMBL1200464,PROPARACAINE HYDROCHLORIDE,1983,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674418,CHEMBL1200467,HYDROXYZINE PAMOATE,2387,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,Activity against other receptors such as 5HT2A and D2 may underlie efficacy of anxiolytic and antipsychotic effects ,
674419,CHEMBL1200468,MALATHION,1741,Acetylcholinesterase inhibitor,INHIBITOR,105700.0,CHEMBL2362988,Acetylcholinesterase,1,1,1,,
674420,CHEMBL1200469,PROMAZINE HYDROCHLORIDE,598,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
674420,CHEMBL1200469,PROMAZINE HYDROCHLORIDE,2014,D2-like dopamine receptor antagonist,ANTAGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
674421,CHEMBL1200470,ESOMEPRAZOLE SODIUM,1086,Potassium-transporting ATPase inhibitor,INHIBITOR,104758.0,CHEMBL2095173,Potassium-transporting ATPase,1,1,1,,
674423,CHEMBL1200472,QUAZEPAM,1617,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
674424,CHEMBL1200473,CYCLOPENTOLATE HYDROCHLORIDE,39,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for mydriasis, M3 likely involved (main form in iris)",
674425,CHEMBL1200474,DEMECLOCYCLINE HYDROCHLORIDE,1765,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
674426,CHEMBL1200475,DAUNORUBICIN CITRATE,100,DNA topoisomerase II alpha inhibitor,INHIBITOR,63.0,CHEMBL1806,DNA topoisomerase 2-alpha,1,1,1,,
674426,CHEMBL1200475,DAUNORUBICIN CITRATE,1876,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
674428,CHEMBL1200477,ALLOPURINOL SODIUM,437,Xanthine dehydrogenase inhibitor,INHIBITOR,149.0,CHEMBL1929,Xanthine dehydrogenase/oxidase,1,1,1,,
674429,CHEMBL1200478,DYCLONINE HYDROCHLORIDE,1964,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674430,CHEMBL1200479,DICYCLOMINE HYDROCHLORIDE,27,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated in irritable bowel, M3 likely involved",
674430,CHEMBL1200479,DICYCLOMINE HYDROCHLORIDE,285,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Indicated in irritable bowel, M3 likely involved",
674431,CHEMBL1200480,OCTREOTIDE ACETATE,1228,Somatostatin receptor agonist,AGONIST,104951.0,CHEMBL2111436,Somatostatin receptor,1,1,1,Long acting,"Selectivity for types 2, 3 and 5"
674433,CHEMBL1200482,CEFOPERAZONE SODIUM,1702,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674434,CHEMBL1200483,PHENMETRAZINE HYDROCHLORIDE,702,Dopamine transporter inhibitor,INHIBITOR,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
674434,CHEMBL1200483,PHENMETRAZINE HYDROCHLORIDE,896,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
674436,CHEMBL1200485,SORAFENIB TOSYLATE,388,Serine/threonine-protein kinase RAF inhibitor,INHIBITOR,10904.0,CHEMBL1906,RAF proto-oncogene serine/threonine-protein kinase,1,1,1,,
674436,CHEMBL1200485,SORAFENIB TOSYLATE,417,Platelet-derived growth factor receptor beta inhibitor,INHIBITOR,197.0,CHEMBL1913,Platelet-derived growth factor receptor beta,1,1,1,,
674436,CHEMBL1200485,SORAFENIB TOSYLATE,449,Stem cell growth factor receptor inhibitor,INHIBITOR,238.0,CHEMBL1936,Mast/stem cell growth factor receptor Kit,1,1,1,,
674436,CHEMBL1200485,SORAFENIB TOSYLATE,510,Tyrosine-protein kinase receptor FLT3 inhibitor,INHIBITOR,12670.0,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,1,1,1,,
674436,CHEMBL1200485,SORAFENIB TOSYLATE,994,Serine/threonine-protein kinase B-raf inhibitor,INHIBITOR,100126.0,CHEMBL5145,Serine/threonine-protein kinase B-raf,1,1,1,,
674436,CHEMBL1200485,SORAFENIB TOSYLATE,1266,Vascular endothelial growth factor receptor inhibitor,INHIBITOR,104799.0,CHEMBL2095227,Vascular endothelial growth factor receptor,1,1,1,,
674436,CHEMBL1200485,SORAFENIB TOSYLATE,1517,Tyrosine-protein kinase receptor RET inhibitor,INHIBITOR,100079.0,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,1,1,1,,
674438,CHEMBL1200487,ETHACRYNATE SODIUM,341,Sodium-(potassium)-chloride cotransporter 2 inhibitor,INHIBITOR,167.0,CHEMBL1874,Solute carrier family 12 member 1,1,1,1,,
674442,CHEMBL1200491,EPINASTINE HYDROCHLORIDE,133,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,413,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,593,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,619,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,911,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
674444,CHEMBL1200493,NAFTIFINE HYDROCHLORIDE,1404,Squalene monooxygenase inhibitor,INHIBITOR,106179.0,CHEMBL2364679,Squalene monooxygenase,1,1,1,,
674445,CHEMBL1200494,GUANFACINE HYDROCHLORIDE,1144,Adrenergic receptor alpha-2 agonist,AGONIST,104743.0,CHEMBL2095158,Adrenergic receptor alpha-2,1,1,1,,
674446,CHEMBL1200495,HYDROCORTISONE SODIUM SUCCINATE,769,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674448,CHEMBL1200497,CYCLIZINE LACTATE,134,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674449,CHEMBL1200498,ALATROFLOXACIN MESYLATE,1637,Topoisomerase IV inhibitor,INHIBITOR,105771.0,CHEMBL2363076,Topoisomerase IV,1,1,1,,Broad spectrum
674449,CHEMBL1200498,ALATROFLOXACIN MESYLATE,1898,Bacterial DNA gyrase inhibitor,INHIBITOR,105577.0,CHEMBL2311224,Bacterial DNA gyrase,1,1,1,,
674451,CHEMBL1200500,BECLOMETHASONE DIPROPIONATE,784,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674452,CHEMBL1200501,GOSERELIN ACETATE,260,Gonadotropin-releasing hormone receptor agonist,AGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,,
674454,CHEMBL1200503,BROMOCRIPTINE MESYLATE,2004,D2-like dopamine receptor agonist,AGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
674457,CHEMBL1200506,ERYTHROMYCIN LACTOBIONATE,1770,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
674460,CHEMBL1200509,HISTRELIN ACETATE,261,Gonadotropin-releasing hormone receptor agonist,AGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,,
674461,CHEMBL1200510,ERYTHROMYCIN STEARATE,1758,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
674462,CHEMBL1200511,GONADORELIN ACETATE,257,Gonadotropin-releasing hormone receptor agonist,AGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,,
674465,CHEMBL1200514,DEMECARIUM BROMIDE,745,Acetylcholinesterase inhibitor,INHIBITOR,93.0,CHEMBL220,Acetylcholinesterase,1,1,1,,
674466,CHEMBL1200515,DESERPIDINE,1480,Synaptic vesicular amine transporter inhibitor,INHIBITOR,162.0,CHEMBL1893,Synaptic vesicular amine transporter,1,1,1,,
674467,CHEMBL1200516,GONADORELIN HYDROCHLORIDE,262,Gonadotropin-releasing hormone receptor agonist,AGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,,
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,565,Serotonin 1d (5-HT1d) receptor agonist,AGONIST,105.0,CHEMBL1983,5-hydroxytryptamine receptor 1D,1,1,1,,
674472,CHEMBL1200521,ALMOTRIPTAN MALATE,97,Serotonin 1f (5-HT1f) receptor agonist,AGONIST,279.0,CHEMBL1805,5-hydroxytryptamine receptor 1F,1,1,1,,Selective
674472,CHEMBL1200521,ALMOTRIPTAN MALATE,368,Serotonin 1b (5-HT1b) receptor agonist,AGONIST,106.0,CHEMBL1898,5-hydroxytryptamine receptor 1B,1,1,1,,Selective
674472,CHEMBL1200521,ALMOTRIPTAN MALATE,571,Serotonin 1d (5-HT1d) receptor agonist,AGONIST,105.0,CHEMBL1983,5-hydroxytryptamine receptor 1D,1,1,1,,Selective
674474,CHEMBL1200523,CEFAZOLIN SODIUM,1699,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674478,CHEMBL1200527,ATRACURIUM BESYLATE,1534,Muscle-type nicotinic acetylcholine receptor antagonist,ANTAGONIST,105709.0,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,1,1,1,,
674481,CHEMBL1200530,CEFOXITIN SODIUM,1695,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674482,CHEMBL1200531,ALFENTANIL HYDROCHLORIDE,708,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
674483,CHEMBL1200532,METHDILAZINE HYDROCHLORIDE,145,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674485,CHEMBL1200534,MOEXIPRIL HYDROCHLORIDE,108,Angiotensin-converting enzyme inhibitor,INHIBITOR,69.0,CHEMBL1808,Angiotensin-converting enzyme,1,1,1,,
674489,CHEMBL1200538,BETAMETHASONE ACETATE,779,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674492,CHEMBL1200541,AMBENONIUM CHLORIDE,746,Acetylcholinesterase inhibitor,INHIBITOR,93.0,CHEMBL220,Acetylcholinesterase,1,1,1,,
674493,CHEMBL1200542,DESOXYCORTICOSTERONE ACETATE,657,Mineralocorticoid receptor agonist,AGONIST,48.0,CHEMBL1994,Mineralocorticoid receptor,1,1,1,,
674494,CHEMBL1200543,ANILERIDINE PHOSPHATE,730,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
674494,CHEMBL1200543,ANILERIDINE PHOSPHATE,1309,Kappa opioid receptor agonist,AGONIST,137.0,CHEMBL237,Kappa-type opioid receptor,1,1,1,,
674495,CHEMBL1200544,CEPHALEXIN,1698,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674496,CHEMBL1200545,DIFLORASONE DIACETATE,785,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674500,CHEMBL1200549,RAPACURONIUM BROMIDE,1532,Muscle-type nicotinic acetylcholine receptor antagonist,ANTAGONIST,105709.0,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,1,1,1,non-depolarizing,
674501,CHEMBL1200550,ANTAZOLINE PHOSPHATE,166,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674505,CHEMBL1200554,TRIPTORELIN PAMOATE,263,Gonadotropin-releasing hormone receptor agonist,AGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,,
674507,CHEMBL1200556,DESMOPRESSIN ACETATE,1643,Vasopressin receptor agonist,AGONIST,105773.0,CHEMBL2363078,Vasopressin receptor,1,1,1,,
674509,CHEMBL1200558,BACITRACIN,1818,C55-isoprenyl pyrophosphate inhibitor,INHIBITOR,106015.0,CHEMBL2364036,C55-isoprenyl pyrophosphate,1,1,1,,
674510,CHEMBL1200559,LACTIC ACID,2169,pH lowering agent,,,,,1,1,1,Antimicrobial activity,
674511,CHEMBL1200560,GUANABENZ ACETATE,1148,Adrenergic receptor alpha-2 agonist,AGONIST,104743.0,CHEMBL2095158,Adrenergic receptor alpha-2,1,1,1,,
674512,CHEMBL1200561,DOXAZOSIN MESYLATE,1162,Adrenergic receptor alpha-1 antagonist,ANTAGONIST,104723.0,CHEMBL2094251,Adrenergic receptor alpha-1,1,1,1,,
674513,CHEMBL1200562,HYDROCORTISONE VALERATE,797,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674514,CHEMBL1200563,CERIVASTATIN SODIUM,1053,HMG-CoA reductase inhibitor,INHIBITOR,24.0,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,1,1,1,,
674520,CHEMBL1200569,CAFFEINE CITRATE,1213,Adenosine receptor antagonist,ANTAGONIST,105024.0,CHEMBL2111329,Adenosine receptor,1,1,1,,
674528,CHEMBL1200577,CYSTEAMINE BITARTRATE,1822,Cystine reducing agent,REDUCING AGENT,106018.0,CHEMBL2364039,Cystine,1,1,1,,
674529,CHEMBL1200578,THEOPHYLLINE SODIUM GLYCINATE,1064,Phosphodiesterase 4 inhibitor,INHIBITOR,104679.0,CHEMBL2093863,Phosphodiesterase 4,1,1,1,,
674529,CHEMBL1200578,THEOPHYLLINE SODIUM GLYCINATE,1133,Phosphodiesterase 3 inhibitor,INHIBITOR,104707.0,CHEMBL2094125,Phosphodiesterase 3,1,1,1,,
674529,CHEMBL1200578,THEOPHYLLINE SODIUM GLYCINATE,1217,Adenosine receptor antagonist,ANTAGONIST,105024.0,CHEMBL2111329,Adenosine receptor,1,1,1,,
674531,CHEMBL1200580,SULFOXONE SODIUM,1748,Dihydropteroate synthase 1 inhibitor,INHIBITOR,105705.0,CHEMBL2362993,Dihydropteroate synthase,1,1,1,,
674533,CHEMBL1200582,AMINOLEVULINIC ACID HYDROCHLORIDE,2138,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,Photodynamic therapy,
674535,CHEMBL1200584,AMINOSALICYLATE POTASSIUM,7411,Dihydrofolate reductase inhibitor,INHIBITOR,102873.0,CHEMBL6065,Dihydrofolate reductase,1,1,1,"PAS is incorporated into the folate pathway by dihydropteroate synthase (DHPS) and dihydrofolate synthase (DHFS) to generate a hydroxyl dihydrofolate antimetabolite, which in turn inhibits DHFR enzymatic activity. Mechanism in Crohn's disease/ulcerative colitis may be through PPAR-gamma/NF-kappa-B inhibition",
674536,CHEMBL1200585,OXYMETHOLONE,1316,Androgen Receptor agonist,AGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
674537,CHEMBL1200586,PRILOCAINE HYDROCHLORIDE,1988,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674539,CHEMBL1200588,CLINDAMYCIN HYDROCHLORIDE,1763,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
674543,CHEMBL1200592,DESOXYCORTICOSTERONE PIVALATE,660,Mineralocorticoid receptor agonist,AGONIST,48.0,CHEMBL1994,Mineralocorticoid receptor,1,1,1,,
674546,CHEMBL1200595,CHLORPHENTERMINE HYDROCHLORIDE,402,Serotonin transporter substrate,SUBSTRATE,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
674547,CHEMBL1200596,CHLOROXINE,1830,DNA inhibitor,INHIBITOR,106020.0,CHEMBL2364041,DNA,1,1,1,Generates free radicals causing DNA damage.,
674548,CHEMBL1200597,ETIDOCAINE HYDROCHLORIDE,1978,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674549,CHEMBL1200598,DIETHYLSTILBESTROL DIPHOSPHATE,1073,Estrogen receptor agonist,AGONIST,104682.0,CHEMBL2093866,Estrogen receptor,1,1,1,,
674550,CHEMBL1200599,DIFENOXIN HYDROCHLORIDE,709,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
674551,CHEMBL1200600,FLUOROMETHOLONE,770,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674552,CHEMBL1200601,NARATRIPTAN HYDROCHLORIDE,369,Serotonin 1b (5-HT1b) receptor agonist,AGONIST,106.0,CHEMBL1898,5-hydroxytryptamine receptor 1B,1,1,1,,Selective
674552,CHEMBL1200601,NARATRIPTAN HYDROCHLORIDE,569,Serotonin 1d (5-HT1d) receptor agonist,AGONIST,105.0,CHEMBL1983,5-hydroxytryptamine receptor 1D,1,1,1,,Selective
674555,CHEMBL1200604,TROPICAMIDE,32,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for mydriasis, M3 likely involved (main form in iris)",
674557,CHEMBL1200606,MEXILETINE HYDROCHLORIDE,1955,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674558,CHEMBL1200607,PERFLEXANE,9299,Diagnostic,,,,,1,1,1,,
674560,CHEMBL1200609,PAROXETINE MESYLATE,400,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,reuptake inhibitor,
674561,CHEMBL1200610,LORACARBEF,1725,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674563,CHEMBL1200612,DIBUCAINE HYDROCHLORIDE,528,Sodium channel protein type V alpha subunit blocker,BLOCKER,11480.0,CHEMBL1980,Sodium channel protein type 5 subunit alpha,1,1,1,,
674563,CHEMBL1200612,DIBUCAINE HYDROCHLORIDE,1007,Sodium channel protein type X alpha subunit blocker,BLOCKER,18080.0,CHEMBL5451,Sodium channel protein type 10 subunit alpha,1,1,1,,
674564,CHEMBL1200613,TOLMETIN SODIUM,1188,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
674567,CHEMBL1200616,CHLOROTHIAZIDE SODIUM,347,Thiazide-sensitive sodium-chloride cotransporter inhibitor,INHIBITOR,151.0,CHEMBL1876,Solute carrier family 12 member 3,1,1,1,,
674568,CHEMBL1200617,RIMEXOLONE,816,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674569,CHEMBL1200618,FEXOFENADINE HYDROCHLORIDE,135,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674572,CHEMBL1200621,GEMIFLOXACIN MESYLATE,1912,DNA gyrase inhibitor,INHIBITOR,105578.0,CHEMBL2311225,DNA gyrase,1,1,1,,
674572,CHEMBL1200621,GEMIFLOXACIN MESYLATE,2044,Topoisomerase IV inhibitor,INHIBITOR,105735.0,CHEMBL2363033,Topoisomerase IV,1,1,1,,
674573,CHEMBL1200622,PARICALCITOL,518,Vitamin D receptor agonist,AGONIST,64.0,CHEMBL1977,Vitamin D3 receptor,1,1,1,,
674574,CHEMBL1200623,ETHYLESTRENOL,1322,Androgen Receptor agonist,AGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
674575,CHEMBL1200624,ETHYNODIOL DIACETATE,1025,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,
674579,CHEMBL1200628,VANCOMYCIN HYDROCHLORIDE,2262,Peptidoglycan inhibitor,INHIBITOR,107948.0,CHEMBL3041361,Peptidoglycan,1,1,1,,
674580,CHEMBL1200629,VECURONIUM BROMIDE,1540,Muscle-type nicotinic acetylcholine receptor antagonist,ANTAGONIST,105709.0,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,1,1,1,,
674583,CHEMBL1200632,CLINDAMYCIN PALMITATE HYDROCHLORIDE,1769,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
674586,CHEMBL1200635,HYDROCORTAMATE HYDROCHLORIDE,771,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674587,CHEMBL1200636,CYCLOBENZAPRINE HYDROCHLORIDE,580,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
674587,CHEMBL1200636,CYCLOBENZAPRINE HYDROCHLORIDE,633,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
674589,CHEMBL1200638,DEXBROMPHENIRAMINE MALEATE,138,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674591,CHEMBL1200640,FERROUS FUMARATE,8139,Supplement,,,,,1,1,1,,
674592,CHEMBL1200641,CISATRACURIUM BESYLATE,1529,Muscle-type nicotinic acetylcholine receptor antagonist,ANTAGONIST,105709.0,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,1,1,1,non-depolarizing,
674595,CHEMBL1200644,FONDAPARINUX SODIUM,482,Antithrombin-III activator,ACTIVATOR,16.0,CHEMBL1950,Antithrombin-III,1,1,1,ATIII then binds to F10,Selective
674596,CHEMBL1200645,ETOPOSIDE PHOSPHATE,99,DNA topoisomerase II alpha inhibitor,INHIBITOR,63.0,CHEMBL1806,DNA topoisomerase 2-alpha,1,1,1,,
674599,CHEMBL1200648,ROCURONIUM BROMIDE,1537,Muscle-type nicotinic acetylcholine receptor antagonist,ANTAGONIST,105709.0,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,1,1,1,,
674600,CHEMBL1200649,QUINUPRISTIN,1776,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
674605,CHEMBL1200654,BENOXINATE HYDROCHLORIDE,1953,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674607,CHEMBL1200656,NATAMYCIN,1806,Ergosterol sequestering agent,SEQUESTERING AGENT,106007.0,CHEMBL2364028,Ergosterol,1,1,1,,
674610,CHEMBL1200659,ENALAPRIL MALEATE,117,Angiotensin-converting enzyme inhibitor,INHIBITOR,69.0,CHEMBL1808,Angiotensin-converting enzyme,1,1,1,,
674611,CHEMBL1200660,ISOSORBIDE,2199,Osmotic agent,,,,,1,1,1,,
674616,CHEMBL1200665,DIPHENOXYLATE HYDROCHLORIDE,710,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
674617,CHEMBL1200666,CALCIPOTRIENE,517,Vitamin D receptor agonist,AGONIST,64.0,CHEMBL1977,Vitamin D3 receptor,1,1,1,,
674621,CHEMBL1200670,SARALASIN ACETATE,223,Type-1 angiotensin II receptor antagonist,ANTAGONIST,115.0,CHEMBL227,Type-1 angiotensin II receptor,1,1,1,,
674622,CHEMBL1200671,NAFARELIN ACETATE,256,Gonadotropin-releasing hormone receptor agonist,AGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,,
674623,CHEMBL1200672,CEFPIRAMIDE SODIUM,1703,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674626,CHEMBL1200675,TOREMIFENE CITRATE,1076,Estrogen receptor modulator,MODULATOR,104682.0,CHEMBL2093866,Estrogen receptor,1,1,1,Mixed agonist/antagonist,
674629,CHEMBL1200678,ATAZANAVIR SULFATE,1500,Human immunodeficiency virus type 1 protease inhibitor,INHIBITOR,191.0,CHEMBL243,Human immunodeficiency virus type 1 protease,1,1,1,,
674632,CHEMBL1200681,MONTELUKAST SODIUM,72,Cysteinyl leukotriene receptor 1 antagonist,ANTAGONIST,179.0,CHEMBL1798,Cysteinyl leukotriene receptor 1,1,1,1,,Selective
674633,CHEMBL1200682,SODIUM OXYBATE,1305,GABA-B receptor agonist,AGONIST,104988.0,CHEMBL2111463,GABA-B receptor,1,1,1,"Contains oxybate, a CNS depressant. Mechanism is not fully elucidated but proposed mechanism through GABAB.",
674637,CHEMBL1200686,PIMECROLIMUS,385,FK506-binding protein 1A inhibitor,INHIBITOR,80.0,CHEMBL1902,Peptidyl-prolyl cis-trans isomerase FKBP1A,1,1,1,,
674639,CHEMBL1200688,ERYTHROMYCIN ETHYLSUCCINATE,1786,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
674640,CHEMBL1200689,NITRIC OXIDE,1219,Soluble guanylate cyclase activator,ACTIVATOR,105048.0,CHEMBL2111348,Soluble guanylate cyclase,1,1,1,,
674641,CHEMBL1200690,LYPRESSIN,1644,Vasopressin receptor agonist,AGONIST,105773.0,CHEMBL2363078,Vasopressin receptor,1,1,1,,
674643,CHEMBL1200692,OLMESARTAN MEDOXOMIL,224,Type-1 angiotensin II receptor antagonist,ANTAGONIST,115.0,CHEMBL227,Type-1 angiotensin II receptor,1,1,1,,
674645,CHEMBL1200694,SEVOFLURANE,1552,Glycine receptor (alpha-1/beta) positive modulator,POSITIVE MODULATOR,105747.0,CHEMBL2363052,Glycine receptor (alpha-1/beta),1,1,1,alpha1/beta is main adult form,
674645,CHEMBL1200694,SEVOFLURANE,1621,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
674645,CHEMBL1200694,SEVOFLURANE,1941,Potassium channel subfamily K member 10 opener,OPENER,105637.0,CHEMBL2331041,Potassium channel subfamily K member 10,1,1,1,,
674645,CHEMBL1200694,SEVOFLURANE,1946,Potassium channel subfamily K member 18 opener,OPENER,105638.0,CHEMBL2331042,Potassium channel subfamily K member 18,1,1,1,,
674645,CHEMBL1200694,SEVOFLURANE,2050,Potassium channel subfamily K member 3 opener,OPENER,105602.0,CHEMBL2321613,Potassium channel subfamily K member 3,1,1,1,,
674645,CHEMBL1200694,SEVOFLURANE,2056,Potassium channel subfamily K member 9 opener,OPENER,105603.0,CHEMBL2321614,Potassium channel subfamily K member 9,1,1,1,,
674645,CHEMBL1200694,SEVOFLURANE,2062,Potassium channel subfamily K member 2 opener,OPENER,105604.0,CHEMBL2321615,Potassium channel subfamily K member 2,1,1,1,,
674646,CHEMBL1200695,PHENYLPROPANOLAMINE HYDROCHLORIDE,240,Alpha-1a adrenergic receptor agonist,AGONIST,125.0,CHEMBL229,Alpha-1A adrenergic receptor,1,1,1,,
674646,CHEMBL1200695,PHENYLPROPANOLAMINE HYDROCHLORIDE,917,Norepinephrine transporter releasing agent,RELEASING AGENT,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
674649,CHEMBL1200698,PENTETATE CALCIUM TRISODIUM YB-169,1673,Radioactive metals chelating agent,CHELATING AGENT,106210.0,CHEMBL2366037,Radioactive metals,1,1,1,,
674650,CHEMBL1200699,DOXYCYCLINE,966,Matrix metalloproteinase 7 inhibitor,INHIBITOR,12738.0,CHEMBL4073,Matrilysin,1,1,1,"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation",
674650,CHEMBL1200699,DOXYCYCLINE,978,Matrix metalloproteinase 8 inhibitor,INHIBITOR,11110.0,CHEMBL4588,Neutrophil collagenase,1,1,1,"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation",
674650,CHEMBL1200699,DOXYCYCLINE,981,Matrix metalloproteinase 13 inhibitor,INHIBITOR,11024.0,CHEMBL280,Collagenase 3,1,1,1,"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation",
674650,CHEMBL1200699,DOXYCYCLINE,987,Matrix metalloproteinase-1 inhibitor,INHIBITOR,13000.0,CHEMBL332,Interstitial collagenase,1,1,1,"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation",
674650,CHEMBL1200699,DOXYCYCLINE,7258,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
674652,CHEMBL1200701,DICLOXACILLIN SODIUM,1734,Penicillin-binding protein inhibitor,INHIBITOR,105685.0,CHEMBL2362972,Penicillin-binding protein,1,1,1,,
674654,CHEMBL1200703,CHLORDIAZEPOXIDE HYDROCHLORIDE,1591,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
674656,CHEMBL1200705,HYDROXYAMPHETAMINE HYDROBROMIDE,2002,Adrenergic receptor agonist,AGONIST,105670.0,CHEMBL2331074,Adrenergic receptor,1,1,1,,
674657,CHEMBL1200706,ALUMINUM HYDROXIDE,2180,Antacid,,,,,1,1,1,,
674658,CHEMBL1200707,BENZQUINAMIDE HYDROCHLORIDE,195,Dopamine D2 receptor modulator,MODULATOR,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,Antiemetic,
674661,CHEMBL1200710,CLOMIPRAMINE HYDROCHLORIDE,396,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,reuptake inhibitor,
674666,CHEMBL1200715,HEXYLCAINE HYDROCHLORIDE,1957,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674669,CHEMBL1200718,MAGNESIUM HYDROXIDE,9395,Saline laxative,,,,,1,1,1,,
674672,CHEMBL1200721,ESTRAMUSTINE PHOSPHATE SODIUM,647,Estrogen receptor beta modulator,MODULATOR,174.0,CHEMBL242,Estrogen receptor beta,1,1,1,Estrogen replacement therapy for prostate cancer,
674672,CHEMBL1200721,ESTRAMUSTINE PHOSPHATE SODIUM,2225,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,Nitogen mustard component is DNA alkylating agent,
674673,CHEMBL1200722,PIPECURONIUM BROMIDE,1533,Muscle-type nicotinic acetylcholine receptor antagonist,ANTAGONIST,105709.0,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,1,1,1,non-depolarizing,
674675,CHEMBL1200724,PSEUDOEPHEDRINE HYDROCHLORIDE,915,Norepinephrine transporter releasing agent,RELEASING AGENT,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
674676,CHEMBL1200725,SERTACONAZOLE NITRATE,1454,Cytochrome P450 51 inhibitor,INHIBITOR,58.0,CHEMBL1780,Lanosterol 14-alpha demethylase,1,1,1,,
674679,CHEMBL1200728,GUANIDINE HYDROCHLORIDE,2103,Voltage-gated potassium channel blocker,BLOCKER,105708.0,CHEMBL2362996,Voltage-gated potassium channel,1,1,1,,
674680,CHEMBL1200729,CHLORAMPHENICOL SODIUM SUCCINATE,1757,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
674682,CHEMBL1200731,POTASSIUM CHLORIDE,9191,Supplement,,,,,1,1,1,,
674683,CHEMBL1200732,AMCINONIDE,798,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674684,CHEMBL1200733,DESFLURANE,1550,Glycine receptor (alpha-1/beta) positive modulator,POSITIVE MODULATOR,105747.0,CHEMBL2363052,Glycine receptor (alpha-1/beta),1,1,1,alpha1/beta is main adult form,
674684,CHEMBL1200733,DESFLURANE,1601,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
674684,CHEMBL1200733,DESFLURANE,1940,Potassium channel subfamily K member 10 opener,OPENER,105637.0,CHEMBL2331041,Potassium channel subfamily K member 10,1,1,1,,
674684,CHEMBL1200733,DESFLURANE,1945,Potassium channel subfamily K member 18 opener,OPENER,105638.0,CHEMBL2331042,Potassium channel subfamily K member 18,1,1,1,,
674684,CHEMBL1200733,DESFLURANE,2048,Potassium channel subfamily K member 3 opener,OPENER,105602.0,CHEMBL2321613,Potassium channel subfamily K member 3,1,1,1,,
674684,CHEMBL1200733,DESFLURANE,2054,Potassium channel subfamily K member 9 opener,OPENER,105603.0,CHEMBL2321614,Potassium channel subfamily K member 9,1,1,1,,
674684,CHEMBL1200733,DESFLURANE,2060,Potassium channel subfamily K member 2 opener,OPENER,105604.0,CHEMBL2321615,Potassium channel subfamily K member 2,1,1,1,,
674685,CHEMBL1200734,FOSAMPRENAVIR CALCIUM,1494,Human immunodeficiency virus type 1 protease inhibitor,INHIBITOR,191.0,CHEMBL243,Human immunodeficiency virus type 1 protease,1,1,1,,
674686,CHEMBL1200735,MOXIFLOXACIN HYDROCHLORIDE,1638,Topoisomerase IV inhibitor,INHIBITOR,105771.0,CHEMBL2363076,Topoisomerase IV,1,1,1,,Broad spectrum
674686,CHEMBL1200735,MOXIFLOXACIN HYDROCHLORIDE,1906,Bacterial DNA gyrase inhibitor,INHIBITOR,105577.0,CHEMBL2311224,Bacterial DNA gyrase,1,1,1,,
674687,CHEMBL1200736,MAGNESIUM CARBONATE,8213,Neutralises acid,,,,,1,1,1,,
674688,CHEMBL1200737,COLFOSCERIL PALMITATE,8166,Lung surfactant,,,,,1,1,1,Replaces deficient surfactant,
674696,CHEMBL1200745,OXPRENOLOL HYDROCHLORIDE,313,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
674696,CHEMBL1200745,OXPRENOLOL HYDROCHLORIDE,1356,Beta-2 adrenergic receptor antagonist,ANTAGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
674699,CHEMBL1200748,CARBIDOPA,234,DOPA decarboxylase inhibitor,INHIBITOR,83.0,CHEMBL1843,Aromatic-L-amino-acid decarboxylase,1,1,1,,
674700,CHEMBL1200749,LEVOBUPIVACAINE HYDROCHLORIDE,868,Sodium channel protein type IV alpha subunit blocker,BLOCKER,18043.0,CHEMBL2072,Sodium channel protein type 4 subunit alpha,1,1,1,,
674701,CHEMBL1200750,PROMETHAZINE HYDROCHLORIDE,139,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674702,CHEMBL1200751,MERCAPTOPURINE,1745,Amidophosphoribosyltransferase inhibitor,INHIBITOR,105704.0,CHEMBL2362992,Amidophosphoribosyltransferase,1,1,1,Prodrug enzyme: hypoxanthine-guanine phosphoribosyl transferase (HGPRT; ec 2.4.2.8),
674702,CHEMBL1200751,MERCAPTOPURINE,1885,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,Prodrug enzyme: hypoxanthine-guanine phosphoribosyl transferase (HGPRT; ec 2.4.2.8),
674706,CHEMBL1200755,CERULETIDE DIETHYLAMINE,381,Cholecystokinin A receptor agonist,AGONIST,10472.0,CHEMBL1901,Cholecystokinin receptor type A,1,1,1,,
674707,CHEMBL1200756,PYRIDOXINE HYDROCHLORIDE,8259,Supplement,,,,,1,1,1,,
674708,CHEMBL1200757,PANCURONIUM BROMIDE,1528,Muscle-type nicotinic acetylcholine receptor antagonist,ANTAGONIST,105709.0,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,1,1,1,non-depolarizing,
674709,CHEMBL1200758,AMPICILLIN SODIUM,1719,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674710,CHEMBL1200759,ANAGRELIDE HYDROCHLORIDE,1134,Phosphodiesterase 3 inhibitor,INHIBITOR,104707.0,CHEMBL2094125,Phosphodiesterase 3,1,1,1,,
674711,CHEMBL1200760,BALSALAZIDE DISODIUM,268,Arachidonate 5-lipoxygenase inhibitor,INHIBITOR,55.0,CHEMBL215,Polyunsaturated fatty acid 5-lipoxygenase,1,1,1,,
674711,CHEMBL1200760,BALSALAZIDE DISODIUM,425,Peroxisome proliferator-activated receptor gamma agonist,AGONIST,133.0,CHEMBL235,Peroxisome proliferator-activated receptor gamma,1,1,1,,
674711,CHEMBL1200760,BALSALAZIDE DISODIUM,1191,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
674712,CHEMBL1200761,CHLOROTRIANISENE,648,Estrogen receptor beta modulator,MODULATOR,174.0,CHEMBL242,Estrogen receptor beta,1,1,1,Mixed agonist/antagonist,
674713,CHEMBL1200762,BETAMETHASONE SODIUM PHOSPHATE,772,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674715,CHEMBL1200764,METHACHOLINE CHLORIDE,36,Muscarinic acetylcholine receptor M3 agonist,AGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for diagnosis of broncoconstriction, M3 likely responsible",
674719,CHEMBL1200768,CEFTAZIDIME SODIUM,1707,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674720,CHEMBL1200769,TRIPELENNAMINE CITRATE,159,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674722,CHEMBL1200771,TRIDIHEXETHYL CHLORIDE,20,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Role in regulating gastric secretion, M3 likely involved",
674722,CHEMBL1200771,TRIDIHEXETHYL CHLORIDE,286,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Role in regulating gastric secretion, M1 likely involved",
674723,CHEMBL1200772,WARFARIN POTASSIUM,443,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,INHIBITOR,224.0,CHEMBL1930,Vitamin K epoxide reductase complex subunit 1,1,1,1,,
674724,CHEMBL1200773,TOCAINIDE HYDROCHLORIDE,1994,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674725,CHEMBL1200774,FLUPREDNISOLONE,805,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674726,CHEMBL1200775,LEUPROLIDE ACETATE,265,Gonadotropin-releasing hormone receptor agonist,AGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,,
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,357,Calcium sensing receptor positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,282.0,CHEMBL1878,Extracellular calcium-sensing receptor,1,1,1,,
674729,CHEMBL1200778,DEXRAZOXANE HYDROCHLORIDE,9812,DNA topoisomerase II inhibitor,INHIBITOR,104727.0,CHEMBL2094255,DNA topoisomerase II,1,1,1,Not fully elucidated,
674729,CHEMBL1200778,DEXRAZOXANE HYDROCHLORIDE,9813,Iron chelating agent,CHELATING AGENT,105753.0,CHEMBL2363058,Iron,1,1,1,Not fully elucidated,
674730,CHEMBL1200779,TROVAFLOXACIN MESYLATE,1641,Topoisomerase IV inhibitor,INHIBITOR,105771.0,CHEMBL2363076,Topoisomerase IV,1,1,1,,Broad spectrum
674730,CHEMBL1200779,TROVAFLOXACIN MESYLATE,1903,Bacterial DNA gyrase inhibitor,INHIBITOR,105577.0,CHEMBL2311224,Bacterial DNA gyrase,1,1,1,,
674732,CHEMBL1200781,CITALOPRAM HYDROBROMIDE,397,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,reuptake inhibitor,
674733,CHEMBL1200782,DEXTROAMPHETAMINE ADIPATE,694,Dopamine transporter releasing agent,RELEASING AGENT,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
674733,CHEMBL1200782,DEXTROAMPHETAMINE ADIPATE,892,Norepinephrine transporter releasing agent,RELEASING AGENT,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
674733,CHEMBL1200782,DEXTROAMPHETAMINE ADIPATE,1485,Synaptic vesicular amine transporter inhibitor,INHIBITOR,162.0,CHEMBL1893,Synaptic vesicular amine transporter,1,1,1,,
674738,CHEMBL1200787,PHENOXYBENZAMINE HYDROCHLORIDE,1239,Adrenergic receptor alpha antagonist,ANTAGONIST,104787.0,CHEMBL2095203,Adrenergic receptor alpha,1,1,1,,
674739,CHEMBL1200788,CISAPRIDE MONOHYDRATE,1335,Serotonin 4 (5-HT4) receptor agonist,AGONIST,168.0,CHEMBL1875,5-hydroxytryptamine receptor 4,1,1,1,,
674740,CHEMBL1200789,TRICLOFOS SODIUM,1631,GABA-A receptor; anion channel positive modulator,POSITIVE MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
674741,CHEMBL1200790,METHYPRYLON,1612,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
674742,CHEMBL1200791,OXYMETAZOLINE HYDROCHLORIDE,1237,Adrenergic receptor alpha agonist,AGONIST,104787.0,CHEMBL2095203,Adrenergic receptor alpha,1,1,1,"complex action type, partial agonist at alpha-2 receptors",
674745,CHEMBL1200794,OXYMORPHONE HYDROCHLORIDE,1091,Opioid receptors; mu/kappa/delta agonist,AGONIST,104765.0,CHEMBL2095181,Opioid receptors; mu/kappa/delta,1,1,1,,
674746,CHEMBL1200795,CLEMASTINE FUMARATE,149,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674747,CHEMBL1200796,CYCLOPHOSPHAMIDE,1846,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
674748,CHEMBL1200797,TECHNETIUM TC 99M SUCCIMER,9581,Alpha-2-macroglobulin binding agent,BINDING AGENT,117935.0,CHEMBL4295690,Alpha-2-macroglobulin,1,1,1,,
674749,CHEMBL1200798,TRAZODONE HYDROCHLORIDE,404,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
674749,CHEMBL1200798,TRAZODONE HYDROCHLORIDE,582,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
674749,CHEMBL1200798,TRAZODONE HYDROCHLORIDE,626,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
674750,CHEMBL1200799,TRAVOPROST,643,Prostanoid FP receptor agonist,AGONIST,140.0,CHEMBL1987,Prostaglandin F2-alpha receptor,1,1,1,,
674751,CHEMBL1200800,CALCIUM ACETATE,2357,Phosphate sequestering agent,SEQUESTERING AGENT,106163.0,CHEMBL2364184,Phosphate,1,1,1,,
674753,CHEMBL1200802,TALBUTAL,1603,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
674754,CHEMBL1200803,SOLIFENACIN SUCCINATE,33,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for overactive bladder, M3 likely responsible",
674754,CHEMBL1200803,SOLIFENACIN SUCCINATE,1505,Muscarinic acetylcholine receptor M2 antagonist,ANTAGONIST,47.0,CHEMBL211,Muscarinic acetylcholine receptor M2,1,1,1,"Indicated for overactive bladder, M2 likely responsible",
674755,CHEMBL1200804,DICLOFENAC POTASSIUM,1189,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
674756,CHEMBL1200805,DILTIAZEM MALATE,1277,Voltage-gated L-type calcium channel blocker,BLOCKER,104801.0,CHEMBL2095229,Voltage-gated L-type calcium channel,1,1,1,,
674757,CHEMBL1200806,NAPROXEN SODIUM,1174,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
674758,CHEMBL1200807,NORELGESTROMIN,1024,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,
674760,CHEMBL1200809,AZELASTINE HYDROCHLORIDE,140,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674761,CHEMBL1200810,DOXERCALCIFEROL,521,Vitamin D receptor agonist,AGONIST,64.0,CHEMBL1977,Vitamin D3 receptor,1,1,1,,
674764,CHEMBL1200813,ACEBUTOLOL HYDROCHLORIDE,311,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
674765,CHEMBL1200814,ACETAZOLAMIDE SODIUM,15,Carbonic anhydrase I inhibitor,INHIBITOR,10193.0,CHEMBL261,Carbonic anhydrase 1,1,1,1,Expressed in eye,
674765,CHEMBL1200814,ACETAZOLAMIDE SODIUM,93,Carbonic anhydrase II inhibitor,INHIBITOR,15.0,CHEMBL205,Carbonic anhydrase 2,1,1,1,Expressed in eye,
674765,CHEMBL1200814,ACETAZOLAMIDE SODIUM,929,Carbonic anhydrase XII inhibitor,INHIBITOR,12209.0,CHEMBL3242,Carbonic anhydrase 12,1,1,1,Expressed in eye,
674765,CHEMBL1200814,ACETAZOLAMIDE SODIUM,960,Carbonic anhydrase IV inhibitor,INHIBITOR,12896.0,CHEMBL3729,Carbonic anhydrase 4,1,1,1,Expressed in eye,
674768,CHEMBL1200817,LEVOMETHADYL ACETATE HYDROCHLORIDE,726,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
674770,CHEMBL1200819,ARTICAINE HYDROCHLORIDE,1973,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674771,CHEMBL1200820,PIPERACILLIN SODIUM,1731,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674773,CHEMBL1200822,FLECAINIDE ACETATE,527,Sodium channel protein type V alpha subunit blocker,BLOCKER,11480.0,CHEMBL1980,Sodium channel protein type 5 subunit alpha,1,1,1,,
674774,CHEMBL1200823,IRON SUCROSE,9396,Supplement,,,,,1,1,1,,
674776,CHEMBL1200825,METHADONE HYDROCHLORIDE,718,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
674777,CHEMBL1200826,LITHIUM CARBONATE,61,Inositol-1(or 4)-monophosphatase 1 inhibitor,INHIBITOR,111.0,CHEMBL1786,Inositol monophosphatase 1,1,1,1,,
674777,CHEMBL1200826,LITHIUM CARBONATE,1113,Glycogen synthase kinase-3 inhibitor,INHIBITOR,104772.0,CHEMBL2095188,Glycogen synthase kinase-3,1,1,1,,
674779,CHEMBL1200828,CYCRIMINE HYDROCHLORIDE,281,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Indicated for Parkinson's disease, M1 likely responsible",
674781,CHEMBL1200830,FERROUS SULFATE,8186,Supplement,,,,,1,1,1,,
674782,CHEMBL1200831,SPIRAPRIL HYDROCHLORIDE,118,Angiotensin-converting enzyme inhibitor,INHIBITOR,69.0,CHEMBL1808,Angiotensin-converting enzyme,1,1,1,,
674783,CHEMBL1200832,TERBINAFINE HYDROCHLORIDE,1402,Squalene monooxygenase inhibitor,INHIBITOR,106179.0,CHEMBL2364679,Squalene monooxygenase,1,1,1,,
674784,CHEMBL1200833,DIPIVEFRIN HYDROCHLORIDE,1997,Adrenergic receptor agonist,AGONIST,105670.0,CHEMBL2331074,Adrenergic receptor,1,1,1,,
674787,CHEMBL1200836,OXICONAZOLE NITRATE,1456,Cytochrome P450 51 inhibitor,INHIBITOR,58.0,CHEMBL1780,Lanosterol 14-alpha demethylase,1,1,1,,
674788,CHEMBL1200837,LEVOBETAXOLOL HYDROCHLORIDE,310,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
674792,CHEMBL1200841,PROCAINE HYDROCHLORIDE,1970,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674794,CHEMBL1200843,METHYLERGONOVINE MALEATE,228,Serotonin 2b (5-HT2b) receptor partial agonist,PARTIAL AGONIST,227.0,CHEMBL1833,5-hydroxytryptamine receptor 2B,1,1,1,,
674794,CHEMBL1200843,METHYLERGONOVINE MALEATE,852,Dopamine D1 receptor antagonist,ANTAGONIST,88.0,CHEMBL2056,D(1A) dopamine receptor,1,1,1,,
674796,CHEMBL1200845,HALCINONIDE,761,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674799,CHEMBL1200848,HYDROXYPROGESTERONE CAPROATE,1016,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,
674801,CHEMBL1200850,GANCICLOVIR SODIUM,1470,Human herpesvirus 1 DNA polymerase inhibitor,INHIBITOR,27.0,CHEMBL1872,DNA polymerase catalytic subunit,1,1,1,,
674803,CHEMBL1200852,PENICILLIN V POTASSIUM,1685,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,"Indicated for streptococcal, pneumococcal and staphylococcal infections",
674804,CHEMBL1200853,DYDROGESTERONE,1017,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,
674805,CHEMBL1200854,FLUPHENAZINE DECANOATE,200,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
674806,CHEMBL1200855,TICARCILLIN DISODIUM,1682,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674813,CHEMBL1200862,METYROSINE,499,Tyrosine 3-hydroxylase inhibitor,INHIBITOR,39.0,CHEMBL1969,Tyrosine 3-monooxygenase,1,1,1,,
674814,CHEMBL1200863,MELPHALAN HYDROCHLORIDE,1866,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
674816,CHEMBL1200865,LOTEPREDNOL ETABONATE,773,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674820,CHEMBL1200869,METRONIDAZOLE HYDROCHLORIDE,1826,DNA inhibitor,INHIBITOR,106020.0,CHEMBL2364041,DNA,1,1,1,Generates free radicals causing DNA damage in trichomonas + bacterial species.  In H. Pylori infections the oxygen-insensitive NADPH nitroreductase enzymes responsible for metabolite generation are normally found mutated in resistant strains (PMID: 10960092),
674821,CHEMBL1200870,TIMOLOL MALEATE,326,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
674821,CHEMBL1200870,TIMOLOL MALEATE,1364,Beta-2 adrenergic receptor antagonist,ANTAGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
674824,CHEMBL1200873,PHENTOLAMINE MESYLATE,1236,Adrenergic receptor alpha antagonist,ANTAGONIST,104787.0,CHEMBL2095203,Adrenergic receptor alpha,1,1,1,,
674825,CHEMBL1200874,TOLBUTAMIDE SODIUM,1248,"Sulfonylurea receptor 1, Kir6.2 blocker",BLOCKER,104852.0,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",1,1,1,,
674826,CHEMBL1200875,FLAVOXATE HYDROCHLORIDE,1065,Phosphodiesterase 4 inhibitor,INHIBITOR,104679.0,CHEMBL2093863,Phosphodiesterase 4,1,1,1,,
674826,CHEMBL1200875,FLAVOXATE HYDROCHLORIDE,1227,Phosphodiesterase 7 inhibitor,INHIBITOR,104918.0,CHEMBL2111411,Phosphodiesterase 7,1,1,1,,
674826,CHEMBL1200875,FLAVOXATE HYDROCHLORIDE,1572,Phosphodiesterase 8 inhibitor,INHIBITOR,105762.0,CHEMBL2363067,Phosphodiesterase 8,1,1,1,,
674828,CHEMBL1200877,FLUMETHASONE PIVALATE,786,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674829,CHEMBL1200878,TRIAMCINOLONE HEXACETONIDE,806,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674830,CHEMBL1200879,WARFARIN SODIUM,444,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,INHIBITOR,224.0,CHEMBL1930,Vitamin K epoxide reductase complex subunit 1,1,1,1,,
674831,CHEMBL1200880,DIPHEMANIL METHYLSULFATE,26,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Role in regulating gastric secretion, M3 likely involved",
674831,CHEMBL1200880,DIPHEMANIL METHYLSULFATE,276,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Role in regulating gastric secretion, M1 likely involved",
674832,CHEMBL1200881,MINOCYCLINE HYDROCHLORIDE,1779,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
674836,CHEMBL1200885,ALOSETRON HYDROCHLORIDE,379,Serotonin 3a (5-HT3a) receptor antagonist,ANTAGONIST,144.0,CHEMBL1899,5-hydroxytryptamine receptor 3A,1,1,1,,
674841,CHEMBL1200890,OXYCODONE HYDROCHLORIDE,713,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
674842,CHEMBL1200891,OXYPHENCYCLIMINE HYDROCHLORIDE,50,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Role in regulating gastric secretion, M3 likely involved",
674842,CHEMBL1200891,OXYPHENCYCLIMINE HYDROCHLORIDE,298,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Role in regulating gastric secretion, M1 likely involved",
674844,CHEMBL1200893,PROTOKYLOL HYDROCHLORIDE,1340,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
674846,CHEMBL1200895,PHENELZINE SULFATE,1241,Monoamine oxidase inhibitor,INHIBITOR,104789.0,CHEMBL2095205,Monoamine oxidase,1,1,1,,
674847,CHEMBL1200896,DINOPROST TROMETHAMINE,644,Prostanoid FP receptor agonist,AGONIST,140.0,CHEMBL1987,Prostaglandin F2-alpha receptor,1,1,1,,
674852,CHEMBL1200901,HALOFANTRINE HYDROCHLORIDE,998,Ferriprotoporphyrin IX inhibitor,INHIBITOR,100262.0,CHEMBL613897,Ferriprotoporphyrin IX,1,1,1,,
674854,CHEMBL1200903,SECOBARBITAL SODIUM,1620,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
674855,CHEMBL1200904,SELEGILINE HYDROCHLORIDE,836,Monoamine oxidase B inhibitor,INHIBITOR,104.0,CHEMBL2039,Amine oxidase [flavin-containing] B,1,1,1,Irreversible inhibitor,
674857,CHEMBL1200906,OXYPHENONIUM BROMIDE,23,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated in mydriasis and regulating gastric secretion, M3 likely involved (main form in iris)",
674857,CHEMBL1200906,OXYPHENONIUM BROMIDE,273,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Role in regulating gastric secretion, M1 likely involved",
674858,CHEMBL1200907,TRILOSTANE,952,3-beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type II inhibitor,INHIBITOR,11423.0,CHEMBL3670,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,1,1,1,,
674859,CHEMBL1200908,HALOBETASOL PROPIONATE,787,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674860,CHEMBL1200909,PREDNISOLONE TEBUTATE,774,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674861,CHEMBL1200910,SULFISOXAZOLE ACETYL,1651,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,Broad spectrum
674863,CHEMBL1200912,PHENTERMINE HYDROCHLORIDE,886,Norepinephrine transporter releasing agent,RELEASING AGENT,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
674865,CHEMBL1200914,TAMSULOSIN HYDROCHLORIDE,1169,Adrenergic receptor alpha-1 antagonist,ANTAGONIST,104723.0,CHEMBL2094251,Adrenergic receptor alpha-1,1,1,1,,
674867,CHEMBL1200916,THIORIDAZINE HYDROCHLORIDE,607,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
674867,CHEMBL1200916,THIORIDAZINE HYDROCHLORIDE,625,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
674867,CHEMBL1200916,THIORIDAZINE HYDROCHLORIDE,2018,D2-like dopamine receptor antagonist,ANTAGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
674871,CHEMBL1200920,ISOETHARINE HYDROCHLORIDE,1362,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
674878,CHEMBL1200927,DEXCHLORPHENIRAMINE MALEATE,146,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674881,CHEMBL1200930,RABEPRAZOLE SODIUM,1083,Potassium-transporting ATPase inhibitor,INHIBITOR,104758.0,CHEMBL2095173,Potassium-transporting ATPase,1,1,1,,
674884,CHEMBL1200933,HEXAFLUORENIUM BROMIDE,739,Acetylcholinesterase inhibitor,INHIBITOR,93.0,CHEMBL220,Acetylcholinesterase,1,1,1,,
674885,CHEMBL1200934,NORGESTIMATE,1020,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,
674886,CHEMBL1200935,DARIFENACIN HYDROBROMIDE,34,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,Indicated for overactive bladder,M3 selective
674886,CHEMBL1200935,DARIFENACIN HYDROBROMIDE,1509,Muscarinic acetylcholine receptor M2 antagonist,ANTAGONIST,47.0,CHEMBL211,Muscarinic acetylcholine receptor M2,1,1,1,"Indicated for overactive bladder, M2 likely responsible",
674888,CHEMBL1200937,DALFOPRISTIN,1761,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
674889,CHEMBL1200938,METHYSERGIDE MALEATE,229,Serotonin 2b (5-HT2b) receptor antagonist,ANTAGONIST,227.0,CHEMBL1833,5-hydroxytryptamine receptor 2B,1,1,1,,
674889,CHEMBL1200938,METHYSERGIDE MALEATE,471,Serotonin 1a (5-HT1a) receptor partial agonist,PARTIAL AGONIST,51.0,CHEMBL214,5-hydroxytryptamine receptor 1A,1,1,1,,
674889,CHEMBL1200938,METHYSERGIDE MALEATE,617,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
674891,CHEMBL1200940,METOCLOPRAMIDE HYDROCHLORIDE,209,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
674891,CHEMBL1200940,METOCLOPRAMIDE HYDROCHLORIDE,380,Serotonin 3a (5-HT3a) receptor antagonist,ANTAGONIST,144.0,CHEMBL1899,5-hydroxytryptamine receptor 3A,1,1,1,,
674891,CHEMBL1200940,METOCLOPRAMIDE HYDROCHLORIDE,1336,Serotonin 4 (5-HT4) receptor agonist,AGONIST,168.0,CHEMBL1875,5-hydroxytryptamine receptor 4,1,1,1,,
674892,CHEMBL1200941,THIAMINE HYDROCHLORIDE,8243,Supplement,,,,,1,1,1,,
674895,CHEMBL1200944,SULBACTAM SODIUM,1669,Bacterial beta-lactamase TEM inhibitor,INHIBITOR,106170.0,CHEMBL2364670,Beta-lactamase TEM,1,1,1,,Broad spectrum
674896,CHEMBL1200945,PENTETATE CALCIUM TRISODIUM,1674,Radioactive metals chelating agent,CHELATING AGENT,106210.0,CHEMBL2366037,Radioactive metals,1,1,1,Chelates radioactive contaminants to increase elimination rate.,
674897,CHEMBL1200946,NANDROLONE DECANOATE,1326,Androgen Receptor agonist,AGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
674898,CHEMBL1200947,METIPRANOLOL HYDROCHLORIDE,317,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
674898,CHEMBL1200947,METIPRANOLOL HYDROCHLORIDE,1353,Beta-2 adrenergic receptor antagonist,ANTAGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
674899,CHEMBL1200948,TRIMIPRAMINE MALEATE,179,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674899,CHEMBL1200948,TRIMIPRAMINE MALEATE,215,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
674899,CHEMBL1200948,TRIMIPRAMINE MALEATE,611,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
674899,CHEMBL1200948,TRIMIPRAMINE MALEATE,628,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
674899,CHEMBL1200948,TRIMIPRAMINE MALEATE,921,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
674899,CHEMBL1200948,TRIMIPRAMINE MALEATE,1158,Adrenergic receptor alpha-1 antagonist,ANTAGONIST,104723.0,CHEMBL2094251,Adrenergic receptor alpha-1,1,1,1,,
674900,CHEMBL1200949,BETAZOLE HYDROCHLORIDE,458,Histamine H2 receptor agonist,AGONIST,102.0,CHEMBL1941,Histamine H2 receptor,1,1,1,,
674901,CHEMBL1200950,CLIDINIUM BROMIDE,45,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Role in regulating gastric secretion, M3 likely involved",
674901,CHEMBL1200950,CLIDINIUM BROMIDE,294,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Role in regulating gastric secretion, M1 likely involved",
674902,CHEMBL1200951,FLUPHENAZINE ENANTHATE,193,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
674903,CHEMBL1200952,METHAMPHETAMINE HYDROCHLORIDE,1567,Monoamine transporter inhibitor,INHIBITOR,105759.0,CHEMBL2363064,Monoamine transporter,1,1,1,,
674904,CHEMBL1200953,HYDROCORTISONE PROBUTATE,818,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674906,CHEMBL1200955,MYCOPHENOLATE MOFETIL HYDROCHLORIDE,1225,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,INHIBITOR,105058.0,CHEMBL2111369,Inosine-5'-monophosphate dehydrogenase (IMPDH),1,1,1,,
674910,CHEMBL1200959,METHDILAZINE,174,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674912,CHEMBL1200961,BROMPHENIRAMINE MALEATE,141,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674913,CHEMBL1200962,CEFEPIME HYDROCHLORIDE,1720,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674914,CHEMBL1200963,BIMATOPROST,645,Prostanoid FP receptor agonist,AGONIST,140.0,CHEMBL1987,Prostaglandin F2-alpha receptor,1,1,1,,
674915,CHEMBL1200964,AMITRIPTYLINE HYDROCHLORIDE,406,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
674915,CHEMBL1200964,AMITRIPTYLINE HYDROCHLORIDE,904,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
674916,CHEMBL1200965,BACAMPICILLIN HYDROCHLORIDE,1691,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674918,CHEMBL1200967,BROMODIPHENHYDRAMINE HYDROCHLORIDE,151,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674919,CHEMBL1200968,HYDROCORTISONE SODIUM PHOSPHATE,788,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674920,CHEMBL1200969,DUTASTERIDE,1635,Steroid 5-alpha-reductase inhibitor,INHIBITOR,105770.0,CHEMBL2363075,Steroid 5-alpha-reductase,1,1,1,,
674921,CHEMBL1200970,ETHOPROPAZINE HYDROCHLORIDE,293,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Indicated for Parkinson's disease, M1 likely responsible",
674922,CHEMBL1200971,CEPHALOGLYCIN,1690,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674924,CHEMBL1200973,ESTRADIOL CYPIONATE,864,Estrogen receptor alpha agonist,AGONIST,19.0,CHEMBL206,Estrogen receptor,1,1,1,,
674925,CHEMBL1200974,CARBINOXAMINE MALEATE,155,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674926,CHEMBL1200975,CLOCORTOLONE PIVALATE,807,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674927,CHEMBL1200976,IDARUBICIN HYDROCHLORIDE,105,DNA topoisomerase II alpha inhibitor,INHIBITOR,63.0,CHEMBL1806,DNA topoisomerase 2-alpha,1,1,1,,
674927,CHEMBL1200976,IDARUBICIN HYDROCHLORIDE,1889,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
674928,CHEMBL1200977,MILRINONE LACTATE,1381,Phosphodiesterase 3A inhibitor,INHIBITOR,170.0,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",1,1,1,,
674931,CHEMBL1200980,ESTROPIPATE,865,Estrogen receptor alpha agonist,AGONIST,19.0,CHEMBL206,Estrogen receptor,1,1,1,,
674932,CHEMBL1200981,EPIRUBICIN HYDROCHLORIDE,1850,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
674933,CHEMBL1200982,BUTABARBITAL SODIUM,1604,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
674934,CHEMBL1200983,GALLIUM NITRATE,1262,Ribonucleoside-diphosphate reductase RR1 inhibitor,INHIBITOR,104791.0,CHEMBL2095215,Ribonucleoside-diphosphate reductase RR1,1,1,1,,
674934,CHEMBL1200983,GALLIUM NITRATE,1557,Hydroxyapatite sequestering agent,SEQUESTERING AGENT,105750.0,CHEMBL2363055,Hydroxyapatite,1,1,1,enhances crystal formation by binding to hydroxyapatite,
674935,CHEMBL1200984,AMLODIPINE MALEATE,1274,Voltage-gated L-type calcium channel blocker,BLOCKER,104801.0,CHEMBL2095229,Voltage-gated L-type calcium channel,1,1,1,,
674936,CHEMBL1200985,CEFTIBUTEN DIHYDRATE,9895,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674937,CHEMBL1200986,HALOPERIDOL DECANOATE,603,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
674937,CHEMBL1200986,HALOPERIDOL DECANOATE,2017,D2-like dopamine receptor inverse agonist,INVERSE AGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
674938,CHEMBL1200987,EPROSARTAN MESYLATE,226,Type-1 angiotensin II receptor antagonist,ANTAGONIST,115.0,CHEMBL227,Type-1 angiotensin II receptor,1,1,1,,
674939,CHEMBL1200988,METHANTHELINE BROMIDE,463,Histamine H2 receptor antagonist,ANTAGONIST,102.0,CHEMBL1941,Histamine H2 receptor,1,1,1,,
674940,CHEMBL1200989,ALCLOMETASONE DIPROPIONATE,799,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674942,CHEMBL1200991,CARBENICILLIN INDANYL SODIUM,1678,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674944,CHEMBL1200993,GALLAMINE TRIETHIODIDE,1530,Muscle-type nicotinic acetylcholine receptor antagonist,ANTAGONIST,105709.0,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,1,1,1,non-depolarizing,
209829,CHEMBL1201,THIOTHIXENE,212,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
209829,CHEMBL1201,THIOTHIXENE,608,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
674951,CHEMBL1201000,NITROFURANTOIN SODIUM,1831,DNA inhibitor,INHIBITOR,106020.0,CHEMBL2364041,DNA,1,1,1,Generates free radicals causing DNA damage.,
674952,CHEMBL1201001,MECHLORETHAMINE HYDROCHLORIDE,1847,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,Alkylating agent,
674953,CHEMBL1201002,CARTEOLOL HYDROCHLORIDE,1124,Adrenergic receptor beta antagonist,ANTAGONIST,104700.0,CHEMBL2094118,Adrenergic receptor beta,1,1,1,,
674954,CHEMBL1201003,ELETRIPTAN HYDROBROMIDE,96,Serotonin 1f (5-HT1f) receptor agonist,AGONIST,279.0,CHEMBL1805,5-hydroxytryptamine receptor 1F,1,1,1,,Selective
674954,CHEMBL1201003,ELETRIPTAN HYDROBROMIDE,365,Serotonin 1b (5-HT1b) receptor agonist,AGONIST,106.0,CHEMBL1898,5-hydroxytryptamine receptor 1B,1,1,1,,Selective
674954,CHEMBL1201003,ELETRIPTAN HYDROBROMIDE,567,Serotonin 1d (5-HT1d) receptor agonist,AGONIST,105.0,CHEMBL1983,5-hydroxytryptamine receptor 1D,1,1,1,,Selective
674956,CHEMBL1201005,CEFONICID SODIUM,1718,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674957,CHEMBL1201006,PYRILAMINE MALEATE,142,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674961,CHEMBL1201010,FLUDROCORTISONE ACETATE,658,Mineralocorticoid receptor agonist,AGONIST,48.0,CHEMBL1994,Mineralocorticoid receptor,1,1,1,,
674962,CHEMBL1201011,QUINAPRIL HYDROCHLORIDE,106,Angiotensin-converting enzyme inhibitor,INHIBITOR,69.0,CHEMBL1808,Angiotensin-converting enzyme,1,1,1,,
674963,CHEMBL1201012,FLURANDRENOLIDE,819,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674964,CHEMBL1201013,OLSALAZINE SODIUM,271,Arachidonate 5-lipoxygenase inhibitor,INHIBITOR,55.0,CHEMBL215,Polyunsaturated fatty acid 5-lipoxygenase,1,1,1,,
674964,CHEMBL1201013,OLSALAZINE SODIUM,427,Peroxisome proliferator-activated receptor gamma agonist,AGONIST,133.0,CHEMBL235,Peroxisome proliferator-activated receptor gamma,1,1,1,,
674964,CHEMBL1201013,OLSALAZINE SODIUM,1197,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
674965,CHEMBL1201014,PREDNISOLONE SODIUM PHOSPHATE,800,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
674966,CHEMBL1201015,ALUMINUM ACETATE,2146,Astringent,,,,,1,1,1,,
674967,CHEMBL1201016,CEFPODOXIME PROXETIL,1723,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674969,CHEMBL1201018,CEFACLOR,1680,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674970,CHEMBL1201019,CEFTIZOXIME SODIUM,1697,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674971,CHEMBL1201020,DISOPYRAMIDE PHOSPHATE,1962,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674973,CHEMBL1201022,PHENAZOPYRIDINE HYDROCHLORIDE,1958,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674974,CHEMBL1201023,ORPHENADRINE HYDROCHLORIDE,176,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
674974,CHEMBL1201023,ORPHENADRINE HYDROCHLORIDE,913,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
674974,CHEMBL1201023,ORPHENADRINE HYDROCHLORIDE,1130,Glutamate [NMDA] receptor antagonist,ANTAGONIST,104706.0,CHEMBL2094124,Glutamate [NMDA] receptor,1,1,1,,
674974,CHEMBL1201023,ORPHENADRINE HYDROCHLORIDE,1979,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
674978,CHEMBL1201027,GLYCOPYRRONIUM BROMIDE,51,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Role in regulating gastric secretion, M3 likely involved",
674978,CHEMBL1201027,GLYCOPYRRONIUM BROMIDE,297,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Role in regulating gastric secretion, M1 likely involved",
674983,CHEMBL1201032,RIZATRIPTAN BENZOATE,370,Serotonin 1b (5-HT1b) receptor agonist,AGONIST,106.0,CHEMBL1898,5-hydroxytryptamine receptor 1B,1,1,1,,Selective
674983,CHEMBL1201032,RIZATRIPTAN BENZOATE,573,Serotonin 1d (5-HT1d) receptor agonist,AGONIST,105.0,CHEMBL1983,5-hydroxytryptamine receptor 1D,1,1,1,,Selective
674986,CHEMBL1201035,BIPERIDEN HYDROCHLORIDE,282,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Indicated for Parkinson's disease, M1 likely responsible",
674988,CHEMBL1201037,EFLORNITHINE HYDROCHLORIDE,1315,Ornithine decarboxylase inhibitor,INHIBITOR,272.0,CHEMBL1869,Ornithine decarboxylase,1,1,1,,
674990,CHEMBL1201039,BENZTHIAZIDE,345,Thiazide-sensitive sodium-chloride cotransporter inhibitor,INHIBITOR,151.0,CHEMBL1876,Solute carrier family 12 member 3,1,1,1,,
674992,CHEMBL1201041,AZLOCILLIN SODIUM,1424,Penicillin-binding protein inhibitor,INHIBITOR,105732.0,CHEMBL2363020,Penicillin-binding protein,1,1,1,,
674993,CHEMBL1201042,ETIDRONATE DISODIUM,1938,ATP inhibitor,INHIBITOR,106221.0,CHEMBL2366048,ATP,1,1,1,"1st generation of biphosphonates, moa: its incorporated in ATP anologues, which accumulate in osteoclasts leading to its early apoptosis (specific to osteoclast, because it binds to hydropatite, and is then slowly released when the bone is reabsorded)",
674994,CHEMBL1201043,CEPHAPIRIN SODIUM,1677,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674995,CHEMBL1201044,DAPIPRAZOLE HYDROCHLORIDE,239,Alpha-1a adrenergic receptor antagonist,ANTAGONIST,125.0,CHEMBL229,Alpha-1A adrenergic receptor,1,1,1,,
674997,CHEMBL1201046,CEFORANIDE,1693,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
674998,CHEMBL1201047,ANILERIDINE HYDROCHLORIDE,728,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
674998,CHEMBL1201047,ANILERIDINE HYDROCHLORIDE,1310,Kappa opioid receptor agonist,AGONIST,137.0,CHEMBL237,Kappa-type opioid receptor,1,1,1,,
674999,CHEMBL1201048,DROMOSTANOLONE PROPIONATE,1319,Androgen Receptor agonist,AGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
675000,CHEMBL1201049,ECONAZOLE NITRATE,1443,Cytochrome P450 51 inhibitor,INHIBITOR,58.0,CHEMBL1780,Lanosterol 14-alpha demethylase,1,1,1,,
675002,CHEMBL1201051,CIMETIDINE HYDROCHLORIDE,457,Histamine H2 receptor antagonist,ANTAGONIST,102.0,CHEMBL1941,Histamine H2 receptor,1,1,1,,
675003,CHEMBL1201052,MESORIDAZINE BESYLATE,208,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
675003,CHEMBL1201052,MESORIDAZINE BESYLATE,590,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
675007,CHEMBL1201056,SULFACYTINE,681,Dihydropteroate synthetase inhibitor,INHIBITOR,325.0,CHEMBL2013,Dihydropteroate synthetase,1,1,1,,
675008,CHEMBL1201057,CILASTATIN SODIUM,651,Renal dipeptidase inhibitor,INHIBITOR,245.0,CHEMBL1989,Dipeptidase 1,1,1,1,,
675010,CHEMBL1201059,PROGUANIL HYDROCHLORIDE,455,Dihydrofolate reductase inhibitor,INHIBITOR,70.0,CHEMBL1939,Bifunctional dihydrofolate reductase-thymidylate synthase,1,1,1,,
675011,CHEMBL1201060,LOXAPINE HYDROCHLORIDE,587,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
675011,CHEMBL1201060,LOXAPINE HYDROCHLORIDE,635,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
675011,CHEMBL1201060,LOXAPINE HYDROCHLORIDE,2021,D2-like dopamine receptor antagonist,ANTAGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
675012,CHEMBL1201061,LEVALBUTEROL HYDROCHLORIDE,1341,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
675014,CHEMBL1201063,PROPAFENONE HYDROCHLORIDE,330,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
675014,CHEMBL1201063,PROPAFENONE HYDROCHLORIDE,1358,Beta-2 adrenergic receptor antagonist,ANTAGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
675014,CHEMBL1201063,PROPAFENONE HYDROCHLORIDE,1982,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
675015,CHEMBL1201064,FLUOROMETHOLONE ACETATE,789,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
675016,CHEMBL1201065,THIAMYLAL SODIUM,1623,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
675017,CHEMBL1201066,VENLAFAXINE HYDROCHLORIDE,405,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
675017,CHEMBL1201066,VENLAFAXINE HYDROCHLORIDE,922,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
675018,CHEMBL1201067,BIPERIDEN LACTATE,284,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Indicated for Parkinson's disease, M1 likely responsible",
675019,CHEMBL1201068,PROPIOMAZINE HYDROCHLORIDE,152,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
675022,CHEMBL1201071,TETRACYCLINE PHOSPHATE COMPLEX,1774,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
675024,CHEMBL1201073,SUCCIMER,1807,Lead chelating agent,CHELATING AGENT,106008.0,CHEMBL2364029,Lead,1,1,1,,
675031,CHEMBL1201080,TRIMETHOPRIM HYDROCHLORIDE,1666,Bacterial dihydrofolate reductase inhibitor,INHIBITOR,106169.0,CHEMBL2364669,Dihydrofolate reductase,1,1,1,,Broad spectrum
675032,CHEMBL1201081,METHYLPREDNISOLONE SODIUM SUCCINATE,781,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
675033,CHEMBL1201082,FLUOXETINE HYDROCHLORIDE,401,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,reuptake inhibitor,
675038,CHEMBL1201087,CABERGOLINE,198,Dopamine D2 receptor agonist,AGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,Long acting,
675040,CHEMBL1201089,DIPHENHYDRAMINE CITRATE,175,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
675043,CHEMBL1201092,RIVASTIGMINE TARTRATE,1285,Cholinesterases; ACHE & BCHE inhibitor,INHIBITOR,104805.0,CHEMBL2095233,Cholinesterases; ACHE & BCHE,1,1,1,,
675044,CHEMBL1201093,METHYL AMINOLEVULINATE HYDROCHLORIDE,2219,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,Photodynamic therapy,
675049,CHEMBL1201098,CEFOTETAN DISODIUM,1712,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
675052,CHEMBL1201101,TESTOSTERONE CYPIONATE,1328,Androgen Receptor agonist,AGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
675053,CHEMBL1201102,TRIFLUPROMAZINE HYDROCHLORIDE,203,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
675054,CHEMBL1201103,METHOXAMINE HYDROCHLORIDE,1163,Adrenergic receptor alpha-1 agonist,AGONIST,104723.0,CHEMBL2094251,Adrenergic receptor alpha-1,1,1,1,,
675055,CHEMBL1201104,METHENAMINE HIPPURATE,1827,DNA inhibitor,INHIBITOR,106020.0,CHEMBL2364041,DNA,1,1,1,Causes cross-linking of proteins and nucleic acids (PMID: 9880479).,
675059,CHEMBL1201108,CONIVAPTAN HYDROCHLORIDE,65,Vasopressin V2 receptor antagonist,ANTAGONIST,112.0,CHEMBL1790,Vasopressin V2 receptor,1,1,1,,
675059,CHEMBL1201108,CONIVAPTAN HYDROCHLORIDE,362,Vasopressin V1a receptor antagonist,ANTAGONIST,134.0,CHEMBL1889,Vasopressin V1a receptor,1,1,1,,
675060,CHEMBL1201109,DESONIDE,782,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
675061,CHEMBL1201110,VALACYCLOVIR HYDROCHLORIDE,1477,Human herpesvirus 1 DNA polymerase inhibitor,INHIBITOR,27.0,CHEMBL1872,DNA polymerase catalytic subunit,1,1,1,,
675063,CHEMBL1201112,NELARABINE,1849,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
675066,CHEMBL1201115,ESMOLOL HYDROCHLORIDE,312,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
675066,CHEMBL1201115,ESMOLOL HYDROCHLORIDE,1367,Beta-2 adrenergic receptor antagonist,ANTAGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
675067,CHEMBL1201116,HETACILLIN,1526,Penicillin-binding protein inhibitor,INHIBITOR,105686.0,CHEMBL2362973,Penicillin-binding protein,1,1,1,,
675068,CHEMBL1201117,METHOCARBAMOL,14,Carbonic anhydrase I inhibitor,INHIBITOR,10193.0,CHEMBL261,Carbonic anhydrase 1,1,1,1,,
675069,CHEMBL1201118,CEFMETAZOLE SODIUM,1692,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
675070,CHEMBL1201119,LIOTHYRONINE SODIUM,1301,Thyroid hormone receptor agonist,AGONIST,104987.0,CHEMBL2111462,Thyroid hormone receptor,1,1,1,,
675071,CHEMBL1201120,REMIFENTANIL HYDROCHLORIDE,722,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
675072,CHEMBL1201121,HETACILLIN POTASSIUM,1525,Penicillin-binding protein inhibitor,INHIBITOR,105686.0,CHEMBL2362973,Penicillin-binding protein,1,1,1,,
675075,CHEMBL1201124,KETOROLAC TROMETHAMINE,1195,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
675078,CHEMBL1201127,DARUNAVIR ETHANOLATE,1498,Human immunodeficiency virus type 1 protease inhibitor,INHIBITOR,191.0,CHEMBL243,Human immunodeficiency virus type 1 protease,1,1,1,,
675080,CHEMBL1201129,DECITABINE,653,DNA (cytosine-5)-methyltransferase 3A inhibitor,INHIBITOR,322.0,CHEMBL1992,DNA (cytosine-5)-methyltransferase 3A,1,1,1,,
675080,CHEMBL1201129,DECITABINE,655,DNA (cytosine-5)-methyltransferase 1 inhibitor,INHIBITOR,321.0,CHEMBL1993,DNA (cytosine-5)-methyltransferase 1,1,1,1,,
675080,CHEMBL1201129,DECITABINE,1880,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
675082,CHEMBL1201131,PIPERONYL BUTOXIDE,1432,Cytochrome P450 inhibitor,INHIBITOR,106198.0,CHEMBL2364702,Cytochrome P450,1,1,1,,
675083,CHEMBL1201132,NALBUPHINE HYDROCHLORIDE,1096,Opioid receptors; mu/kappa/delta agonist,AGONIST,104765.0,CHEMBL2095181,Opioid receptors; mu/kappa/delta,1,1,1,may actually be mixed mode of action,
675085,CHEMBL1201134,LUBIPROSTONE,1009,Chloride channel protein 2 opener,OPENER,103797.0,CHEMBL1628478,Chloride channel protein 2,1,1,1,,
675090,CHEMBL1201139,MEGESTROL ACETATE,1012,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,
675092,CHEMBL1201141,IBUPROFEN LYSINE,1203,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
675093,CHEMBL1201142,RASAGILINE MESYLATE,835,Monoamine oxidase B inhibitor,INHIBITOR,104.0,CHEMBL2039,Amine oxidase [flavin-containing] B,1,1,1,Irreversible inhibitor,
675097,CHEMBL1201146,NORETHINDRONE ACETATE,1013,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,
675098,CHEMBL1201147,OCTOCRYLENE,8755,Sunscreen,,,,,1,1,1,,
675099,CHEMBL1201148,MEPREDNISONE,808,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
675100,CHEMBL1201149,NALTREXONE HYDROCHLORIDE,1095,Opioid receptors; mu/kappa/delta antagonist,ANTAGONIST,104765.0,CHEMBL2095181,Opioid receptors; mu/kappa/delta,1,1,1,,
675101,CHEMBL1201150,SUMATRIPTAN SUCCINATE,372,Serotonin 1b (5-HT1b) receptor agonist,AGONIST,106.0,CHEMBL1898,5-hydroxytryptamine receptor 1B,1,1,1,,Selective
675101,CHEMBL1201150,SUMATRIPTAN SUCCINATE,574,Serotonin 1d (5-HT1d) receptor agonist,AGONIST,105.0,CHEMBL1983,5-hydroxytryptamine receptor 1D,1,1,1,,Selective
675102,CHEMBL1201151,MESTRANOL,866,Estrogen receptor alpha agonist,AGONIST,19.0,CHEMBL206,Estrogen receptor,1,1,1,,
675104,CHEMBL1201153,ISOETHARINE MESYLATE,1352,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
675105,CHEMBL1201154,PROCHLORPERAZINE EDISYLATE,2192,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
675106,CHEMBL1201155,LOXAPINE SUCCINATE,588,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
675106,CHEMBL1201155,LOXAPINE SUCCINATE,634,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
675106,CHEMBL1201155,LOXAPINE SUCCINATE,2013,D2-like dopamine receptor antagonist,ANTAGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
675107,CHEMBL1201156,NORTRIPTYLINE HYDROCHLORIDE,414,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
675107,CHEMBL1201156,NORTRIPTYLINE HYDROCHLORIDE,912,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
675110,CHEMBL1201159,FENTANYL HYDROCHLORIDE,711,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
675112,CHEMBL1201161,MAFENIDE ACETATE,1650,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,Broad spectrum
675113,CHEMBL1201162,DORZOLAMIDE HYDROCHLORIDE,88,Carbonic anhydrase II inhibitor,INHIBITOR,15.0,CHEMBL205,Carbonic anhydrase 2,1,1,1,,
675114,CHEMBL1201163,SUFENTANIL CITRATE,724,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
675116,CHEMBL1201165,QUINESTROL,1074,Estrogen receptor agonist,AGONIST,104682.0,CHEMBL2093866,Estrogen receptor,1,1,1,,
675118,CHEMBL1201167,CARVEDILOL PHOSPHATE,1121,Adrenergic receptor beta antagonist,ANTAGONIST,104700.0,CHEMBL2094118,Adrenergic receptor beta,1,1,1,,
675118,CHEMBL1201167,CARVEDILOL PHOSPHATE,1165,Adrenergic receptor alpha-1 antagonist,ANTAGONIST,104723.0,CHEMBL2094251,Adrenergic receptor alpha-1,1,1,1,,
675119,CHEMBL1201168,ISOCARBOXAZID,1243,Monoamine oxidase inhibitor,INHIBITOR,104789.0,CHEMBL2095205,Monoamine oxidase,1,1,1,,
675124,CHEMBL1201173,MEDRYSONE,762,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
675125,CHEMBL1201174,SITAGLIPTIN PHOSPHATE,466,Dipeptidyl peptidase IV inhibitor,INHIBITOR,11140.0,CHEMBL284,Dipeptidyl peptidase 4,1,1,1,,
675128,CHEMBL1201177,LEVOBUNOLOL HYDROCHLORIDE,315,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
675128,CHEMBL1201177,LEVOBUNOLOL HYDROCHLORIDE,1363,Beta-2 adrenergic receptor antagonist,ANTAGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
675129,CHEMBL1201178,LISDEXAMFETAMINE DIMESYLATE,698,Dopamine transporter releasing agent,RELEASING AGENT,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
675129,CHEMBL1201178,LISDEXAMFETAMINE DIMESYLATE,920,Norepinephrine transporter releasing agent,RELEASING AGENT,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
675129,CHEMBL1201178,LISDEXAMFETAMINE DIMESYLATE,1487,Synaptic vesicular amine transporter inhibitor,INHIBITOR,162.0,CHEMBL1893,Synaptic vesicular amine transporter,1,1,1,,
675130,CHEMBL1201179,LAPATINIB DITOSYLATE,130,Receptor protein-tyrosine kinase erbB-2 inhibitor,INHIBITOR,188.0,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,1,1,1,,
675130,CHEMBL1201179,LAPATINIB DITOSYLATE,245,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,,
675131,CHEMBL1201180,DICLOFENAC EPOLAMINE,1175,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
675133,CHEMBL1201182,TEMSIROLIMUS,382,FK506-binding protein 1A inhibitor,INHIBITOR,80.0,CHEMBL1902,Peptidyl-prolyl cis-trans isomerase FKBP1A,1,1,1,,
675135,CHEMBL1201184,LANREOTIDE ACETATE,67,Somatostatin receptor 5 agonist,AGONIST,11265.0,CHEMBL1792,Somatostatin receptor type 5,1,1,1,,
675135,CHEMBL1201184,LANREOTIDE ACETATE,95,Somatostatin receptor 2 agonist,AGONIST,117.0,CHEMBL1804,Somatostatin receptor type 2,1,1,1,,
675141,CHEMBL1201190,LEVOCETIRIZINE DIHYDROCHLORIDE,167,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
675143,CHEMBL1201192,ARMODAFINIL,685,Dopamine transporter inhibitor,INHIBITOR,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
675242,CHEMBL1201291,IOXAGLIC ACID,9445,Diagnostic,,,,,1,1,1,,
675252,CHEMBL1201301,MANGAFODIPIR,8796,Diagnostic,,,,,1,1,1,,
675292,CHEMBL1201341,ECHOTHIOPHATE,5522,Acetylcholinesterase inhibitor,INHIBITOR,93.0,CHEMBL220,Acetylcholinesterase,1,1,1,Irreversible,
675528,CHEMBL1201414,TINZAPARIN SODIUM,475,Antithrombin-III activator,ACTIVATOR,16.0,CHEMBL1950,Antithrombin-III,1,1,1,Inhibits coagulation by activating antithrombin III;  ATIII then binds to F10; It's a low-molecular-weight heparin,
675530,CHEMBL1201419,LUTROPIN ALFA,251,Luteinizing hormone/Choriogonadotropin receptor agonist,AGONIST,95.0,CHEMBL1854,Lutropin-choriogonadotropic hormone receptor,1,1,1,"It's LH, used to stimulate development of a potentially competent follicle and to indirectly prepare the reproductive tract for implantation and pregnancy",
675518,CHEMBL1201420,UROKINASE,82,Urokinase-type plasminogen activator exogenous protein,EXOGENOUS PROTEIN,11942.0,CHEMBL3286,Urokinase-type plasminogen activator,1,1,1,,
675418,CHEMBL1201421,PEGAPTANIB SODIUM,55,Vascular endothelial growth factor A antagonist,ANTAGONIST,187.0,CHEMBL1783,"Vascular endothelial growth factor A, long form",1,1,1,"It's an aptamer, a pegylated modified oligonucleotide",Selective
675570,CHEMBL1201431,DORNASE ALFA,1841,DNA hydrolytic enzyme,HYDROLYTIC ENZYME,105574.0,CHEMBL2311221,DNA,1,1,1,,
675456,CHEMBL1201438,ALDESLEUKIN,1789,Interleukin-2 receptor agonist,AGONIST,106146.0,CHEMBL2364167,Interleukin-2 receptor,1,1,1,,
675419,CHEMBL1201439,BASILIXIMAB,1792,Interleukin-2 receptor inhibitor,INHIBITOR,106146.0,CHEMBL2364167,Interleukin-2 receptor,1,1,1,,
675516,CHEMBL1201441,COLISTIMETHATE SODIUM,1809,Cell membrane inhibitor,INHIBITOR,106010.0,CHEMBL2364031,Cell membrane,1,1,1,Disrupts cell membrane,
675443,CHEMBL1201447,CALFACTANT,2127,Surfactant agent,,,,,1,1,1,Replaces endogenous surfactant in case of deficiency; endogenous pulmonary surfactant lower surface tension at the air-liquid of the alveolar surfaces,
675462,CHEMBL1201448,ARDEPARIN SODIUM,481,Antithrombin-III activator,ACTIVATOR,16.0,CHEMBL1950,Antithrombin-III,1,1,1,Inhibits coagulation by activating antithrombin III;  ATIII then binds to F10; It's a low-molecular-weight heparin,
675406,CHEMBL1201451,ALBUMIN HUMAN,2074,Bilirubin sequestering agent,SEQUESTERING AGENT,106153.0,CHEMBL2364174,Bilirubin,1,1,1,"To expand the circulating blood volume in case of shock or hemorrhage, but also used in liver failure to bind excessive plasma bilirubin",
675463,CHEMBL1201454,ALSEROXYLON,1231,Adrenergic receptor alpha antagonist,ANTAGONIST,104787.0,CHEMBL2095203,Adrenergic receptor alpha,1,1,1,,
675430,CHEMBL1201457,CELLULOSE SODIUM PHOSPHATE,8159,Calcium sequestering agent,SEQUESTERING AGENT,106009.0,CHEMBL2364030,Calcium,1,1,1,,
675539,CHEMBL1201459,DESOXYRIBONUCLEASE,1842,DNA hydrolytic enzyme,HYDROLYTIC ENZYME,105574.0,CHEMBL2311221,DNA,1,1,1,,
675574,CHEMBL1201460,DALTEPARIN SODIUM,477,Antithrombin-III activator,ACTIVATOR,16.0,CHEMBL1950,Antithrombin-III,1,1,1,Inhibits coagulation by activating antithrombin III;  ATIII then binds to F10; It's a low-molecular-weight heparin,
675464,CHEMBL1201461,DEXTROMETHORPHAN POLISTIREX,332,Sigma opioid receptor agonist,AGONIST,11272.0,CHEMBL287,Sigma non-opioid intracellular receptor 1,1,1,1,,
675464,CHEMBL1201461,DEXTROMETHORPHAN POLISTIREX,505,Glutamate [NMDA] receptor subunit epsilon 1 antagonist,ANTAGONIST,166.0,CHEMBL1972,"Glutamate receptor ionotropic, NMDA 2A",1,1,1,,
675465,CHEMBL1201463,CODEINE POLISTIREX,1090,Opioid receptors; mu/kappa/delta agonist,AGONIST,104765.0,CHEMBL2095181,Opioid receptors; mu/kappa/delta,1,1,1,,
675508,CHEMBL1201464,CHORIOGONADOTROPIN ALFA,252,Luteinizing hormone/Choriogonadotropin receptor agonist,AGONIST,95.0,CHEMBL1854,Lutropin-choriogonadotropic hormone receptor,1,1,1,,
675559,CHEMBL1201465,CHYMOTRYPSIN,2089,Polypeptides proteolytic enzyme,PROTEOLYTIC ENZYME,106160.0,CHEMBL2364181,Polypeptides,1,1,1,"To replace endogenous digestive enzyme chymotrypsin, which protects against pancreatitis, in cases where loss of function variants have been identified in the CTRC gene; preferential cleavage: leu-|-xaa, tyr-|-xaa, phe-|-xaa, met-|-xaa, trp-|-xaa, gln-|-xaa, asn-|-xaa.",
675552,CHEMBL1201466,"ESTROGENS, CONJUGATED SYNTHETIC A",1069,Estrogen receptor agonist,AGONIST,104682.0,CHEMBL2093866,Estrogen receptor,1,1,1,,
675596,CHEMBL1201467,"SYNTHETIC CONJUGATED ESTROGENS, B",1071,Estrogen receptor agonist,AGONIST,104682.0,CHEMBL2093866,Estrogen receptor,1,1,1,,
675571,CHEMBL1201468,"ESTROGENS, ESTERIFIED",1068,Estrogen receptor agonist,AGONIST,104682.0,CHEMBL2093866,Estrogen receptor,1,1,1,,
675500,CHEMBL1201469,GRAMICIDIN,1810,Cell membrane inhibitor,INHIBITOR,106010.0,CHEMBL2364031,Cell membrane,1,1,1,,
675466,CHEMBL1201470,HYDROCODONE POLISTIREX,1089,Opioid receptors; mu/kappa/delta agonist,AGONIST,104765.0,CHEMBL2095181,Opioid receptors; mu/kappa/delta,1,1,1,,
675492,CHEMBL1201472,ICODEXTRIN,8496,Osmotic agent,,,,,1,1,1,Peritoneal dialysis solution,
675572,CHEMBL1201473,COLESEVELAM HYDROCHLORIDE,2076,Bile acids sequestering agent,SEQUESTERING AGENT,106154.0,CHEMBL2364175,Bile acids,1,1,1,,
675562,CHEMBL1201474,COLESTIPOL HYDROCHLORIDE,2077,Bile acids sequestering agent,SEQUESTERING AGENT,106154.0,CHEMBL2364175,Bile acids,1,1,1,,
675454,CHEMBL1201476,ENOXAPARIN SODIUM,476,Antithrombin-III activator,ACTIVATOR,16.0,CHEMBL1950,Antithrombin-III,1,1,1,Inhibits coagulation by activating antithrombin III;  ATIII then binds to F10; It's a low-molecular-weight heparin,
675467,CHEMBL1201477,POLYESTRADIOL PHOSPHATE,855,Estrogen receptor alpha agonist,AGONIST,19.0,CHEMBL206,Estrogen receptor,1,1,1,,
675520,CHEMBL1201479,POLYETHYLENE GLYCOL 3350,8206,Osmotic laxative,,,,,1,1,1,,
675597,CHEMBL1201481,PORFIMER SODIUM,2115,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,Photodynamic therapy,
675598,CHEMBL1201482,PROTEASE (PANCRELIPASE),2090,Polypeptides hydrolytic enzyme,HYDROLYTIC ENZYME,106160.0,CHEMBL2364181,Polypeptides,1,1,1,,
675599,CHEMBL1201483,PSEUDOEPHEDRINE POLISTIREX,874,Norepinephrine transporter releasing agent,RELEASING AGENT,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
675556,CHEMBL1201484,SODIUM POLYSTYRENE SULFONATE,9540,Potassium sequestering agent,SEQUESTERING AGENT,109707.0,CHEMBL3545434,Potassium,1,1,1,,
675468,CHEMBL1201486,QUINIDINE POLYGALACTURONATE,1950,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
675600,CHEMBL1201487,SACROSIDASE,2091,Sucrose hydrolytic enzyme,HYDROLYTIC ENZYME,106161.0,CHEMBL2364182,Sucrose,1,1,1,Replaces endogenous human sucrase in case of congenital sucrase-isomaltase deficiency (CSIS),
675369,CHEMBL1201488,SECRETIN SYNTHETIC HUMAN,428,Secretin receptor agonist,AGONIST,147.0,CHEMBL1925,Secretin receptor,1,1,1,,
675424,CHEMBL1201489,SERACTIDE ACETATE,495,Melanocortin receptor 2 agonist,AGONIST,154.0,CHEMBL1965,Adrenocorticotropic hormone receptor,1,1,1,Is corticotropin,
675506,CHEMBL1201490,SERMORELIN ACETATE,756,Growth hormone-releasing hormone receptor agonist,AGONIST,158.0,CHEMBL2032,Growth hormone-releasing hormone receptor,1,1,1,"It's an analogue of GHRH, which seems to be used as diagnostic of growth hormone deficiency, but also as a replacement therapy in children",
675495,CHEMBL1201492,SEVELAMER HYDROCHLORIDE,2093,Phosphate sequestering agent,SEQUESTERING AGENT,106163.0,CHEMBL2364184,Phosphate,1,1,1,It's a non-absorbed binding crosslinked polymer which binds to phosphate and removes it from circulation in case of hyperphosphatemia,
675527,CHEMBL1201494,SODIUM FERRIC GLUCONATE COMPLEX,9193,Supplement,,,,,1,1,1,,
675441,CHEMBL1201496,INSULIN ASPART,559,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
675383,CHEMBL1201497,INSULIN GLARGINE,550,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
675522,CHEMBL1201505,"FIBRINOLYSIN, HUMAN",2038,Fibrinogen inhibitor,INHIBITOR,106205.0,CHEMBL2364709,Fibrinogen,1,1,1,,
675524,CHEMBL1201506,GEMTUZUMAB OZOGAMICIN,233,Myeloid cell surface antigen CD33 binding agent,BINDING AGENT,81.0,CHEMBL1842,Myeloid cell surface antigen CD33,1,1,1,targets ozogamicin to cell,
675524,CHEMBL1201506,GEMTUZUMAB OZOGAMICIN,1843,DNA disrupting agent,DISRUPTING AGENT,105574.0,CHEMBL2311221,DNA,1,1,1,intercalates DNA and causes double strand breakage,
675623,CHEMBL1201509,"GONADOTROPIN, CHORIONIC",253,Luteinizing hormone/Choriogonadotropin receptor agonist,AGONIST,95.0,CHEMBL1854,Lutropin-choriogonadotropic hormone receptor,1,1,1,,
675519,CHEMBL1201512,FOMIVIRSEN SODIUM,2095,Major intermediate early region 2 mRNA antisense inhibitor,ANTISENSE INHIBITOR,106165.0,CHEMBL2364186,Major intermediate early region 2 mRNA,1,1,1,Antisense therapy; It's a phosphorothioate oligonucleotide,
675473,CHEMBL1201513,HEPARIN CALCIUM,480,Antithrombin-III activator,ACTIVATOR,16.0,CHEMBL1950,Antithrombin-III,1,1,1,Inhibits coagulation by activating antithrombin III;  ATIII then binds to F10;,
675398,CHEMBL1201514,PEGADEMASE BOVINE,2082,2'-deoxyadenosine hydrolytic enzyme,HYDROLYTIC ENZYME,106156.0,CHEMBL2364177,2'-deoxyadenosine,1,1,1,"Replaces the ada enzyme in case of deficiency, and hydrolyses purine substrates",
675398,CHEMBL1201514,PEGADEMASE BOVINE,2083,Adenosine hydrolytic enzyme,HYDROLYTIC ENZYME,106157.0,CHEMBL2364178,Adenosine,1,1,1,"Replaces the ada enzyme in case of deficiency, and hydrolyses purine substrates",
675474,CHEMBL1201515,PEGVISOMANT,514,Growth hormone receptor antagonist,ANTAGONIST,60.0,CHEMBL1976,Growth hormone receptor,1,1,1,It's a recombinant protein which selectively binds to growth hormone receptor,
675507,CHEMBL1201520,UROFOLLITROPIN,750,Follicle stimulating hormone receptor agonist,AGONIST,99.0,CHEMBL2024,Follicle-stimulating hormone receptor,1,1,1,,
675414,CHEMBL1201522,TECHNETIUM TC 99M ALBUMIN AGGREGATED,9295,Diagnostic,,,,,1,1,1,,
675409,CHEMBL1201528,VASOPRESSIN TANNATE,63,Vasopressin V2 receptor agonist,AGONIST,112.0,CHEMBL1790,Vasopressin V2 receptor,1,1,1,,
675409,CHEMBL1201528,VASOPRESSIN TANNATE,361,Vasopressin V1a receptor agonist,AGONIST,134.0,CHEMBL1889,Vasopressin V1a receptor,1,1,1,,
675409,CHEMBL1201528,VASOPRESSIN TANNATE,420,Vasopressin V1b receptor agonist,AGONIST,148.0,CHEMBL1921,Vasopressin V1b receptor,1,1,1,,
675540,CHEMBL1201532,THYROTROPIN,491,Thyroid stimulating hormone receptor agonist,AGONIST,78.0,CHEMBL1963,Thyrotropin receptor,1,1,1,"It's purified bovine thyroid stimulating hormone approved for diagnosis of serum thyroglobulin levels, but also is indicated as an adjunctive treatment for radioiodine ablation of thyroid tissue remnants in cancer patients",
675607,CHEMBL1201533,THYROTROPIN ALFA,490,Thyroid stimulating hormone receptor agonist,AGONIST,78.0,CHEMBL1963,Thyrotropin receptor,1,1,1,"It's recombinant human thyroid stimulating hormone approved for diagnosis of serum thyroglobulin levels, but also is indicated as an adjunctive treatment for radioiodine ablation of thyroid tissue remnants in cancer patients",
675608,CHEMBL1201534,DANAPAROID SODIUM,478,Antithrombin-III activator,ACTIVATOR,16.0,CHEMBL1950,Antithrombin-III,1,1,1,Inhibits coagulation by activating antithrombin III;  ATIII then binds to F10;,
675476,CHEMBL1201535,PHENYLPROPANOLAMINE POLISTIREX,237,Alpha-1a adrenergic receptor agonist,AGONIST,125.0,CHEMBL229,Alpha-1A adrenergic receptor,1,1,1,,
675476,CHEMBL1201535,PHENYLPROPANOLAMINE POLISTIREX,877,Norepinephrine transporter releasing agent,RELEASING AGENT,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
675444,CHEMBL1201536,NICOTINE POLACRILEX,1043,Neuronal acetylcholine receptor; alpha4/beta2 agonist,AGONIST,104283.0,CHEMBL1907589,Neuronal acetylcholine receptor; alpha4/beta2,1,1,1,,
675366,CHEMBL1201538,INSULIN LISPRO,547,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
675478,CHEMBL1201539,INSULIN PORK,551,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
675609,CHEMBL1201540,INSULIN SUSP ISOPHANE RECOMBINANT HUMAN,531,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
675436,CHEMBL1201545,INSULIN SUSP ISOPHANE BEEF,543,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
675611,CHEMBL1201548,TYLOXAPOL,2125,Surfactant agent,,,,,1,1,1,Replaces endogenous surfactant in case of deficiency; endogenous pulmonary surfactant lower surface tension at the air-liquid of the alveolar surfaces,
675370,CHEMBL1201549,TERIPARATIDE ACETATE,69,Parathyroid hormone receptor agonist,AGONIST,160.0,CHEMBL1793,Parathyroid hormone/parathyroid hormone-related peptide receptor,1,1,1,,
675367,CHEMBL1201550,DENILEUKIN DIFTITOX,1257,Elongation factor 2 inhibitor,INHIBITOR,104188.0,CHEMBL1795108,Elongation factor 2,1,1,1,,
675367,CHEMBL1201550,DENILEUKIN DIFTITOX,1791,Interleukin-2 receptor binding agent,BINDING AGENT,106146.0,CHEMBL2364167,Interleukin-2 receptor,1,1,1,targets toxin to cell,
675404,CHEMBL1201554,ANTITHROMBIN ALFA,6754,Coagulation factor X inhibitor,INHIBITOR,194.0,CHEMBL244,Coagulation factor X,1,1,1,"Antithrombin (AT) is a serine protease inhibitor that is the principal inhibitor of the blood coagulation serine proteases thrombin and Factor Xa, and to a lesser extent, Factors IXa, XIa, XIIa, trypsin, plasmin, and kallikrein. AT neutralizes the activity of thrombin and other serine proteases by forming a complex between enzyme and inhibitor. This complex is rapidly cleared from the circulation by internalization into liver cells. In the absence of heparin, complex formation occurs at a relatively slow rate. When heparin or heparin sulfate on the vessel wall is present, however, it binds to lysyl residues on AT and dramatically accelerates the rate of complex formation.",
675404,CHEMBL1201554,ANTITHROMBIN ALFA,6893,Thrombin inhibitor,INHIBITOR,11.0,CHEMBL204,Prothrombin,1,1,1,"Antithrombin (AT) is a serine protease inhibitor that is the principal inhibitor of the blood coagulation serine proteases thrombin and Factor Xa, and to a lesser extent, Factors IXa, XIa, XIIa, trypsin, plasmin, and kallikrein. AT neutralizes the activity of thrombin and other serine proteases by forming a complex between enzyme and inhibitor. This complex is rapidly cleared from the circulation by internalization into liver cells. In the absence of heparin, complex formation occurs at a relatively slow rate. When heparin or heparin sulfate on the vessel wall is present, however, it binds to lysyl residues on AT and dramatically accelerates the rate of complex formation.",
675377,CHEMBL1201556,BECAPLERMIN,1115,Platelet-derived growth factor receptor agonist,AGONIST,104773.0,CHEMBL2095189,Platelet-derived growth factor receptor,1,1,1,,
675613,CHEMBL1201557,INTERFERON ALFACON-1,1802,Interferon alpha/beta receptor agonist,AGONIST,106149.0,CHEMBL2364170,Interferon alpha/beta receptor,1,1,1,,
675368,CHEMBL1201558,INTERFERON ALFA-2B,1797,Interferon alpha/beta receptor agonist,AGONIST,106149.0,CHEMBL2364170,Interferon alpha/beta receptor,1,1,1,,
675549,CHEMBL1201560,PEGINTERFERON ALFA-2A,1799,Interferon alpha/beta receptor agonist,AGONIST,106149.0,CHEMBL2364170,Interferon alpha/beta receptor,1,1,1,,
675616,CHEMBL1201561,PEGINTERFERON ALFA-2B,1800,Interferon alpha/beta receptor agonist,AGONIST,106149.0,CHEMBL2364170,Interferon alpha/beta receptor,1,1,1,,
675521,CHEMBL1201562,INTERFERON BETA-1A,1798,Interferon alpha/beta receptor agonist,AGONIST,106149.0,CHEMBL2364170,Interferon alpha/beta receptor,1,1,1,,
675558,CHEMBL1201563,INTERFERON BETA-1B,1801,Interferon alpha/beta receptor agonist,AGONIST,106149.0,CHEMBL2364170,Interferon alpha/beta receptor,1,1,1,,
675394,CHEMBL1201564,INTERFERON GAMMA-1B,1803,Interferon gamma receptor agonist,AGONIST,106150.0,CHEMBL2364171,Interferon gamma receptor,1,1,1,,
675361,CHEMBL1201565,EPOETIN ALFA,124,Erythropoietin receptor agonist,AGONIST,201.0,CHEMBL1817,Erythropoietin receptor,1,1,1,,
675493,CHEMBL1201566,DARBEPOETIN ALFA,125,Erythropoietin receptor agonist,AGONIST,201.0,CHEMBL1817,Erythropoietin receptor,1,1,1,,
675434,CHEMBL1201567,FILGRASTIM,669,Granulocyte colony stimulating factor receptor agonist,AGONIST,207.0,CHEMBL1996,Granulocyte colony-stimulating factor receptor,1,1,1,,
675363,CHEMBL1201568,PEGFILGRASTIM,670,Granulocyte colony stimulating factor receptor agonist,AGONIST,207.0,CHEMBL1996,Granulocyte colony-stimulating factor receptor,1,1,1,,
675387,CHEMBL1201569,RIMABOTULINUMTOXINB,1418,Vesicle-associated membrane protein 2 inhibitor,INHIBITOR,106139.0,CHEMBL2364160,Vesicle-associated membrane protein 2,1,1,1,Cleaves snare complex,
675577,CHEMBL1201570,ANAKINRA,489,Interleukin-1 receptor antagonist,ANTAGONIST,198.0,CHEMBL1959,Interleukin-1 receptor type 1,1,1,1,,
675480,CHEMBL1201571,ALEFACEPT,838,T-cell surface antigen CD2 inhibitor,INHIBITOR,196.0,CHEMBL2040,T-cell surface antigen CD2,1,1,1,,
675371,CHEMBL1201572,ETANERCEPT,183,TNF-alpha inhibitor,INHIBITOR,185.0,CHEMBL1825,Tumor necrosis factor,1,1,1,,
675548,CHEMBL1201573,OPRELVEKIN,1385,Interleukin 11 receptor alpha agonist,AGONIST,206.0,CHEMBL2050,Interleukin-11 receptor subunit alpha,1,1,1,complex with beta but only associcates on ligand binding so excluded,
675360,CHEMBL1201574,ONABOTULINUMTOXINA,1417,Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor,INHIBITOR,106138.0,CHEMBL2364159,Synaptosomal-associated protein 25,1,1,1,"BOTOX blocks neuromuscular transmission by binding to acceptor sites on motor or sympathetic nerve terminals, entering the nerve terminals, and inhibiting the release of acetylcholine. This inhibition occurs as the neurotoxin cleaves SNAP-25, a protein integral to the successful docking and release of acetylcholine from vesicles situated within nerve endings.",
675481,CHEMBL1201575,EFALIZUMAB,2042,Integrin alpha-L/beta-2 (LFA-1) inhibitor,INHIBITOR,106151.0,CHEMBL2364172,Integrin alpha-L/beta-2 (LFA-1),1,1,1,,
675578,CHEMBL1201576,RITUXIMAB,1521,B-lymphocyte antigen CD20 binding agent,BINDING AGENT,181.0,CHEMBL2058,B-lymphocyte antigen CD20,1,1,1,"Acts through engagement of immune effector cells, directly activating intracellular death signaling pathways and/or activation of the complement cascade.",
675579,CHEMBL1201577,CETUXIMAB,242,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,,
675482,CHEMBL1201580,ADALIMUMAB,182,TNF-alpha inhibitor,INHIBITOR,185.0,CHEMBL1825,Tumor necrosis factor,1,1,1,,
675617,CHEMBL1201581,INFLIXIMAB,180,TNF-alpha inhibitor,INHIBITOR,185.0,CHEMBL1825,Tumor necrosis factor,1,1,1,,
675483,CHEMBL1201583,BEVACIZUMAB,58,Vascular endothelial growth factor A inhibitor,INHIBITOR,187.0,CHEMBL1783,"Vascular endothelial growth factor A, long form",1,1,1,,
675576,CHEMBL1201584,ABCIXIMAB,1077,Integrin alpha-IIb/beta-3 inhibitor,INHIBITOR,104685.0,CHEMBL2093869,Integrin alpha-IIb/beta-3,1,1,1,,
675576,CHEMBL1201584,ABCIXIMAB,1294,Integrin alpha-V/beta-3 inhibitor,INHIBITOR,104292.0,CHEMBL1907598,Integrin alpha-V/beta-3,1,1,1,,
675581,CHEMBL1201585,TRASTUZUMAB,127,Receptor protein-tyrosine kinase erbB-2 inhibitor,INHIBITOR,188.0,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,1,1,1,,
675484,CHEMBL1201586,PALIVIZUMAB,1423,Fusion glycoprotein F0 inhibitor,INHIBITOR,106144.0,CHEMBL2364165,Fusion glycoprotein F0,1,1,1,Pathogen target,
675582,CHEMBL1201587,ALEMTUZUMAB,1370,CAMPATH-1 antigen inhibitor,INHIBITOR,203.0,CHEMBL1912,CAMPATH-1 antigen,1,1,1,,
675485,CHEMBL1201589,OMALIZUMAB,230,Ig epsilon chain C region inhibitor,INHIBITOR,229.0,CHEMBL1834,Immunoglobulin heavy constant epsilon,1,1,1,Should be protein complex but not trivial to define,
675431,CHEMBL1201593,ALTEPLASE,84,Tissue-type plasminogen activator exogenous protein,EXOGENOUS PROTEIN,11399.0,CHEMBL1873,Tissue-type plasminogen activator,1,1,1,"is TPA, cleaves plasminogen to plasmin",
675388,CHEMBL1201594,RASBURICASE,1675,Uric acid oxidative enzyme,OXIDATIVE ENZYME,106162.0,CHEMBL2364183,Uric acid,1,1,1,,
675399,CHEMBL1201595,LARONIDASE,1398,Heparan sulfate hydrolytic enzyme,HYDROLYTIC ENZYME,106177.0,CHEMBL2364677,Heparan sulfate,1,1,1,Replacement of alpha-L-iduronidase enzyme,
675399,CHEMBL1201595,LARONIDASE,2085,Dermatan sulfate hydrolytic enzyme,HYDROLYTIC ENZYME,106158.0,CHEMBL2364179,Dermatan sulfate,1,1,1,Replacement of alpha-L-iduronidase enzyme,
675486,CHEMBL1201599,HUMAN IMMUNOGLOBULIN G,9793,"Replacement therapy, immunomodulatory effects",,,,,1,1,1,,
675487,CHEMBL1201604,TOSITUMOMAB,1523,B-lymphocyte antigen CD20 binding agent,BINDING AGENT,181.0,CHEMBL2058,B-lymphocyte antigen CD20,1,1,1,,
675587,CHEMBL1201605,DACLIZUMAB,1790,Interleukin-2 receptor inhibitor,INHIBITOR,106146.0,CHEMBL2364167,Interleukin-2 receptor,1,1,1,,
675488,CHEMBL1201607,NATALIZUMAB,1112,Integrin alpha-4/beta-7 inhibitor,INHIBITOR,104768.0,CHEMBL2095184,Integrin alpha-4/beta-7,1,1,1,,
675488,CHEMBL1201607,NATALIZUMAB,1295,Integrin alpha-4/beta-1 inhibitor,INHIBITOR,104293.0,CHEMBL1907599,Integrin alpha-4/beta-1,1,1,1,,
675588,CHEMBL1201608,MUROMONAB-CD3,1793,T cell surface glycoprotein CD3 inhibitor,INHIBITOR,106147.0,CHEMBL2364168,T cell surface glycoprotein CD3,1,1,1,,
675376,CHEMBL1201609,CORTICOTROPIN ZINC HYDROXIDE,493,Melanocortin receptor 2 agonist,AGONIST,154.0,CHEMBL1965,Adrenocorticotropic hormone receptor,1,1,1,,
675393,CHEMBL1201610,CORTICOTROPIN,492,Melanocortin receptor 2 agonist,AGONIST,154.0,CHEMBL1965,Adrenocorticotropic hormone receptor,1,1,1,,
675446,CHEMBL1201611,INSULIN LISPRO PROTAMINE RECOMBINANT,545,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
675589,CHEMBL1201613,INSULIN GLULISINE,548,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
675494,CHEMBL1201616,SECRETIN SYNTHETIC PORCINE,429,Secretin receptor agonist,AGONIST,147.0,CHEMBL1925,Secretin receptor,1,1,1,,
675554,CHEMBL1201619,APROTININ,83,Plasminogen inhibitor,INHIBITOR,12.0,CHEMBL1801,Plasminogen,1,1,1,,
675554,CHEMBL1201619,APROTININ,674,Plasma kallikrein inhibitor,INHIBITOR,23.0,CHEMBL2000,Plasma kallikrein,1,1,1,,
675381,CHEMBL1201620,SOMATREM,512,Growth hormone receptor agonist,AGONIST,60.0,CHEMBL1976,Growth hormone receptor,1,1,1,It's a recombinant protein: methionyl growth hormone approved for the treatment of growth hormone deficiency,
675591,CHEMBL1201621,SOMATROPIN,513,Growth hormone receptor agonist,AGONIST,60.0,CHEMBL1976,Growth hormone receptor,1,1,1,It's a recombinant protein approved for the treatment of growth hormone deficiency,
675553,CHEMBL1201622,PORACTANT ALFA,2126,Surfactant agent,,,,,1,1,1,Replaces endogenous surfactant in case of deficiency; endogenous pulmonary surfactant lower surface tension at the air-liquid of the alveolar surfaces,
675546,CHEMBL1201624,BERACTANT,2116,Surfactant agent,,,,,1,1,1,Replaces endogenous surfactant in case of deficiency; endogenous pulmonary surfactant lower surface tension at the air-liquid of the alveolar surfaces,
675490,CHEMBL1201625,CHOLESTYRAMINE,2075,Bile acids sequestering agent,SEQUESTERING AGENT,106154.0,CHEMBL2364175,Bile acids,1,1,1,Removes bile acids from the enterohepatic circulation by adsorbing and combing with the bile acids in the intestine and forming an insoluble complex which is extrected in the feces,
675593,CHEMBL1201626,CHYMOPAPAIN,2088,Polypeptides proteolytic enzyme,PROTEOLYTIC ENZYME,106160.0,CHEMBL2364181,Polypeptides,1,1,1,"It's a proteolytic enzyme derived from papaya, which hydrolysis proteins in the nucleus pulposus, and helps to manage pain in disc herniations",
675386,CHEMBL1201627,INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN,556,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
675451,CHEMBL1201629,INSULIN PURIFIED BEEF,532,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
675594,CHEMBL1201630,INSULIN PURIFIED PORK,542,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
675534,CHEMBL1201631,INSULIN HUMAN,537,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
675396,CHEMBL1201632,IMIGLUCERASE,2080,Glucocerebroside hydrolytic enzyme,HYDROLYTIC ENZYME,106155.0,CHEMBL2364176,Glucocerebroside,1,1,1,Given in cases of gaucher disease to overcome a deficiency of beta-glucocerebrosidase activity. Imiglucerase catalyses the hydrolysis of glucocerebroside to glucose and ceramide,
675389,CHEMBL1201633,ALGLUCERASE,2081,Glucocerebroside hydrolytic enzyme,HYDROLYTIC ENZYME,106155.0,CHEMBL2364176,Glucocerebroside,1,1,1,,
675561,CHEMBL1201636,HYALURONIDASE,7983,Hyaluronic acid hydrolytic enzyme,HYDROLYTIC ENZYME,118784.0,CHEMBL4495554,Hyaluronic acid,1,1,1,Tissue permeability modifier,
675374,CHEMBL1201637,LIPASE (PANCRELIPASE),2040,Fatty acids hydrolytic enzyme,HYDROLYTIC ENZYME,106207.0,CHEMBL2364711,Fatty acids,1,1,1,,
675618,CHEMBL1201644,INSULIN ZINC SUSP RECOMBINANT HUMAN,533,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
675380,CHEMBL1201648,AMYLASE (PANCRELIPASE),2086,Starch hydrolytic enzyme,HYDROLYTIC ENZYME,106159.0,CHEMBL2364180,Starch,1,1,1,Replaces digestive enzymes when pancreas is not fully functional; hydrolyses starches to dextrins and short chain sugars such as maltose and maltriose,
675621,CHEMBL1201649,"ESTROGENS, CONJUGATED",1070,Estrogen receptor agonist,AGONIST,104682.0,CHEMBL2093866,Estrogen receptor,1,1,1,,
675537,CHEMBL1201650,THYROGLOBULIN,2113,Iodine storage agent,,,,,1,1,1,"It is a synthetic thyroglobulin, hence it works as an iodine storage, and when necessary it is degraded in lysossomes into T4 and T3 hormones",
675563,CHEMBL1201651,PROTAMINE SULFATE,2041,Heparin inhibitor,INHIBITOR,106208.0,CHEMBL2364712,Heparin,1,1,1,,
675515,CHEMBL1201657,HEPARIN SODIUM,479,Antithrombin-III activator,ACTIVATOR,16.0,CHEMBL1950,Antithrombin-III,1,1,1,Inhibits coagulation by activating antithrombin III;  ATIII then binds to F10;,
675544,CHEMBL1201659,CHLORPHENIRAMINE POLISTIREX,131,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
675525,CHEMBL1201662,DESIRUDIN,73,Thrombin inhibitor,INHIBITOR,11.0,CHEMBL204,Prothrombin,1,1,1,,Selective
675445,CHEMBL1201664,INSULIN ASPART PROTAMINE RECOMBINANT,560,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
675435,CHEMBL1201666,LEPIRUDIN,75,Thrombin inhibitor,INHIBITOR,11.0,CHEMBL204,Prothrombin,1,1,1,,
675413,CHEMBL1201668,NESIRITIDE,650,Atrial natriuretic peptide receptor A agonist,AGONIST,244.0,CHEMBL1988,Atrial natriuretic peptide receptor 1,1,1,1,,
675569,CHEMBL1201670,SARGRAMOSTIM,1794,Granulocyte-macrophage colony-stimulating factor receptor agonist,AGONIST,106148.0,CHEMBL2364169,Granulocyte-macrophage colony-stimulating factor receptor,1,1,1,,
675630,CHEMBL1201688,FOMIVIRSEN,7538,Major intermediate early region 2 mRNA antisense inhibitor,ANTISENSE INHIBITOR,106165.0,CHEMBL2364186,Major intermediate early region 2 mRNA,1,1,1,,
675667,CHEMBL1201692,FOLLITROPIN ALFA,9631,Follicle stimulating hormone receptor agonist,AGONIST,99.0,CHEMBL2024,Follicle-stimulating hormone receptor,1,1,1,"It's FSH, for the stimulation of ovarian follicular growth",
675639,CHEMBL1201697,LH (MENOTROPINS),254,Luteinizing hormone/Choriogonadotropin receptor agonist,AGONIST,95.0,CHEMBL1854,Lutropin-choriogonadotropic hormone receptor,1,1,1,,
675637,CHEMBL1201716,MECASERMIN,488,Insulin-like growth factor I receptor agonist,AGONIST,234.0,CHEMBL1957,Insulin-like growth factor 1 receptor,1,1,1,,
675627,CHEMBL1201717,MECASERMIN RINFABATE,487,Insulin-like growth factor I receptor agonist,AGONIST,234.0,CHEMBL1957,Insulin-like growth factor 1 receptor,1,1,1,,
675545,CHEMBL1201718,HYALURONIDASE (HUMAN RECOMBINANT),8564,Hyaluronic acid hydrolytic enzyme,HYDROLYTIC ENZYME,118784.0,CHEMBL4495554,Hyaluronic acid,1,1,1,Tissue permeability modifier,
675625,CHEMBL1201721,IODINE POVACRYLEX,8454,"Skin preparation/antiseptic, oxidising agent",,,,,1,1,1,,
675679,CHEMBL1201728,DESVENLAFAXINE SUCCINATE,408,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
675679,CHEMBL1201728,DESVENLAFAXINE SUCCINATE,889,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
675680,CHEMBL1201729,DRONEDARONE HYDROCHLORIDE,1273,Voltage-gated L-type calcium channel blocker,BLOCKER,104801.0,CHEMBL2095229,Voltage-gated L-type calcium channel,1,1,1,"Dronedarone reported to have antiarrhythmic properties belonging to all four Vaughan-Williams classes, importance of beta adrenergic receptors and calcium channels disputed in PMID: 23647933",
675680,CHEMBL1201729,DRONEDARONE HYDROCHLORIDE,1963,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,Dronedarone reported to have antiarrhythmic properties belonging to all four Vaughan-Williams classes,
675680,CHEMBL1201729,DRONEDARONE HYDROCHLORIDE,2366,Inward rectifier potassium channel 2 blocker,BLOCKER,104372.0,CHEMBL1914276,Inward rectifier potassium channel 2,1,1,1,,
675680,CHEMBL1201729,DRONEDARONE HYDROCHLORIDE,2367,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker,BLOCKER,103531.0,CHEMBL1250417,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,1,1,1,,HCN4 is predominant form in sinoatrial node and atrioventricular node
675682,CHEMBL1201731,NEBIVOLOL HYDROCHLORIDE,329,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
675682,CHEMBL1201731,NEBIVOLOL HYDROCHLORIDE,1355,Beta-2 adrenergic receptor antagonist,ANTAGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
675684,CHEMBL1201733,PAZOPANIB HYDROCHLORIDE,235,Macrophage colony stimulating factor receptor inhibitor,INHIBITOR,12840.0,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,1,1,1,,
675684,CHEMBL1201733,PAZOPANIB HYDROCHLORIDE,447,Stem cell growth factor receptor inhibitor,INHIBITOR,238.0,CHEMBL1936,Mast/stem cell growth factor receptor Kit,1,1,1,,
675684,CHEMBL1201733,PAZOPANIB HYDROCHLORIDE,840,Tyrosine-protein kinase LCK inhibitor,INHIBITOR,10140.0,CHEMBL258,Tyrosine-protein kinase Lck,1,1,1,,
675684,CHEMBL1201733,PAZOPANIB HYDROCHLORIDE,931,Fibroblast growth factor receptor 3 inhibitor,INHIBITOR,11926.0,CHEMBL2742,Fibroblast growth factor receptor 3,1,1,1,,
675684,CHEMBL1201733,PAZOPANIB HYDROCHLORIDE,950,Fibroblast growth factor receptor 1 inhibitor,INHIBITOR,10266.0,CHEMBL3650,Fibroblast growth factor receptor 1,1,1,1,,
675684,CHEMBL1201733,PAZOPANIB HYDROCHLORIDE,1116,Platelet-derived growth factor receptor inhibitor,INHIBITOR,104773.0,CHEMBL2095189,Platelet-derived growth factor receptor,1,1,1,,
675684,CHEMBL1201733,PAZOPANIB HYDROCHLORIDE,1267,Vascular endothelial growth factor receptor inhibitor,INHIBITOR,104799.0,CHEMBL2095227,Vascular endothelial growth factor receptor,1,1,1,,
675684,CHEMBL1201733,PAZOPANIB HYDROCHLORIDE,1524,Tyrosine-protein kinase ITK/TSK inhibitor,INHIBITOR,10918.0,CHEMBL2959,Tyrosine-protein kinase ITK/TSK,1,1,1,,
675685,CHEMBL1201734,BENDAMUSTINE HYDROCHLORIDE,1844,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
675686,CHEMBL1201735,BUPROPION HYDROBROMIDE,689,Dopamine transporter inhibitor,INHIBITOR,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
675686,CHEMBL1201735,BUPROPION HYDROBROMIDE,888,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
675691,CHEMBL1201740,NILOTINIB HYDROCHLORIDE MONOHYDRATE,300,Tyrosine-protein kinase ABL inhibitor,INHIBITOR,8.0,CHEMBL1862,Tyrosine-protein kinase ABL1,1,1,1,,
675691,CHEMBL1201740,NILOTINIB HYDROCHLORIDE MONOHYDRATE,8633,Bcr/Abl fusion protein inhibitor,INHIBITOR,104811.0,CHEMBL2096618,Bcr/Abl fusion protein,1,1,1,,
675694,CHEMBL1201743,SAXAGLIPTIN HYDROCHLORIDE,468,Dipeptidyl peptidase IV inhibitor,INHIBITOR,11140.0,CHEMBL284,Dipeptidyl peptidase 4,1,1,1,,
675696,CHEMBL1201745,CHOLINE FENOFIBRATE,431,Peroxisome proliferator-activated receptor alpha agonist,AGONIST,163.0,CHEMBL239,Peroxisome proliferator-activated receptor alpha,1,1,1,,
675697,CHEMBL1201746,PRALATREXATE,848,Dihydrofolate reductase inhibitor,INHIBITOR,6.0,CHEMBL202,Dihydrofolate reductase,1,1,1,,
675698,CHEMBL1201747,ALCAFTADINE,156,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
675699,CHEMBL1201748,CABAZITAXEL,1105,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,Stabilises microtubule assembly,
675700,CHEMBL1201749,DIFLUPREDNATE,763,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
675703,CHEMBL1201752,IXABEPILONE,1107,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,Stabilises microtubule assembly,
675705,CHEMBL1201754,RUFINAMIDE,1985,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
675710,CHEMBL1201759,BEPOTASTINE BESYLATE,168,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
675712,CHEMBL1201761,BESIFLOXACIN HYDROCHLORIDE,1636,Topoisomerase IV inhibitor,INHIBITOR,105771.0,CHEMBL2363076,Topoisomerase IV,1,1,1,,Broad spectrum
675712,CHEMBL1201761,BESIFLOXACIN HYDROCHLORIDE,1897,Bacterial DNA gyrase inhibitor,INHIBITOR,105577.0,CHEMBL2311224,Bacterial DNA gyrase,1,1,1,,
675716,CHEMBL1201765,FESOTERODINE FUMARATE,38,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for overactive bladder, M3 likely responsible",
675716,CHEMBL1201765,FESOTERODINE FUMARATE,1508,Muscarinic acetylcholine receptor M2 antagonist,ANTAGONIST,47.0,CHEMBL211,Muscarinic acetylcholine receptor M2,1,1,1,"Indicated for overactive bladder, M2 likely responsible",
675721,CHEMBL1201770,METHYLNALTREXONE BROMIDE,723,Mu opioid receptor antagonist,ANTAGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
675724,CHEMBL1201773,PRASUGREL HYDROCHLORIDE,1504,Purinergic receptor P2Y12 antagonist,ANTAGONIST,176.0,CHEMBL2001,P2Y purinoceptor 12,1,1,1,Irreversible inhibitor,
675726,CHEMBL1201775,SAPROPTERIN DIHYDROCHLORIDE,937,Phenylalanine-4-hydroxylase activator,ACTIVATOR,10744.0,CHEMBL3076,Phenylalanine-4-hydroxylase,1,1,1,,
675728,CHEMBL1201777,TAPENTADOL HYDROCHLORIDE,731,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
675728,CHEMBL1201777,TAPENTADOL HYDROCHLORIDE,918,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
675731,CHEMBL1201780,CARGLUMIC ACID,1743,"Carbamoyl-phosphate synthase [ammonia], mitochondrial positive allosteric modulator",POSITIVE ALLOSTERIC MODULATOR,105702.0,CHEMBL2362990,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",1,1,1,,
675733,CHEMBL1201782,FOSAPREPITANT DIMEGLUMINE,1372,Neurokinin 1 receptor antagonist,ANTAGONIST,250.0,CHEMBL249,Substance-P receptor,1,1,1,,
675772,CHEMBL1201821,PALIFERMIN,969,Fibroblast growth factor receptor 2 agonist,AGONIST,10264.0,CHEMBL4142,Fibroblast growth factor receptor 2,1,1,1,,
675773,CHEMBL1201822,GALSULFASE,2084,Dermatan sulfate hydrolytic enzyme,HYDROLYTIC ENZYME,106158.0,CHEMBL2364179,Dermatan sulfate,1,1,1,To replace endogenous lysosomal enzymes required for the catabollism of GAG in case of mucopolysaccharide storage disorders,
675774,CHEMBL1201823,ABATACEPT,1411,T-lymphocyte activation antigen CD86 inhibitor,INHIBITOR,106135.0,CHEMBL2364156,T-lymphocyte activation antigen CD86,1,1,1,,
675774,CHEMBL1201823,ABATACEPT,1412,T-lymphocyte activation antigen CD80 inhibitor,INHIBITOR,106136.0,CHEMBL2364157,T-lymphocyte activation antigen CD80,1,1,1,,
675775,CHEMBL1201824,ALGLUCOSIDASE ALFA,2087,Starch hydrolytic enzyme,HYDROLYTIC ENZYME,106159.0,CHEMBL2364180,Starch,1,1,1,"1,4-alpha glucose polysaccharides (substrate)",
675776,CHEMBL1201825,RANIBIZUMAB,56,Vascular endothelial growth factor A inhibitor,INHIBITOR,187.0,CHEMBL1783,"Vascular endothelial growth factor A, long form",1,1,1,,
675777,CHEMBL1201826,IDURSULFASE,1397,Heparan sulfate hydrolytic enzyme,HYDROLYTIC ENZYME,106177.0,CHEMBL2364677,Heparan sulfate,1,1,1,,
675778,CHEMBL1201827,PANITUMUMAB,241,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,,
675779,CHEMBL1201828,ECULIZUMAB,1421,Complement C5 inhibitor,INHIBITOR,106142.0,CHEMBL2364163,Complement C5,1,1,1,,
675781,CHEMBL1201830,RILONACEPT,1289,Interleukin-1 beta inhibitor,INHIBITOR,104335.0,CHEMBL1909490,Interleukin-1 beta,1,1,1,,
675782,CHEMBL1201831,CERTOLIZUMAB PEGOL,181,TNF-alpha inhibitor,INHIBITOR,185.0,CHEMBL1825,Tumor necrosis factor,1,1,1,,
675783,CHEMBL1201832,ROMIPLOSTIM,305,Thrombopoietin receptor agonist,AGONIST,265.0,CHEMBL1864,Thrombopoietin receptor,1,1,1,,
675784,CHEMBL1201833,GOLIMUMAB,184,TNF-alpha inhibitor,INHIBITOR,185.0,CHEMBL1825,Tumor necrosis factor,1,1,1,,
675785,CHEMBL1201834,CANAKINUMAB,1288,Interleukin-1 beta inhibitor,INHIBITOR,104335.0,CHEMBL1909490,Interleukin-1 beta,1,1,1,,
675786,CHEMBL1201835,USTEKINUMAB,1837,Interleukin-12 inhibitor,INHIBITOR,106132.0,CHEMBL2364153,Interleukin-12,1,1,1,,
675786,CHEMBL1201835,USTEKINUMAB,1838,Interleukin-23 inhibitor,INHIBITOR,106133.0,CHEMBL2364154,Interleukin-23,1,1,1,,
675787,CHEMBL1201836,OFATUMUMAB,1522,B-lymphocyte antigen CD20 binding agent,BINDING AGENT,181.0,CHEMBL2058,B-lymphocyte antigen CD20,1,1,1,,
675788,CHEMBL1201837,ECALLANTIDE,673,Plasma kallikrein inhibitor,INHIBITOR,23.0,CHEMBL2000,Plasma kallikrein,1,1,1,,
675812,CHEMBL1201863,DEXLANSOPRAZOLE,1081,Potassium-transporting ATPase inhibitor,INHIBITOR,104758.0,CHEMBL2095173,Potassium-transporting ATPase,1,1,1,,
675814,CHEMBL1201865,VELAGLUCERASE ALFA,2078,Glucocerebroside hydrolytic enzyme,HYDROLYTIC ENZYME,106155.0,CHEMBL2364176,Glucocerebroside,1,1,1,Given in cases of gaucher disease to overcome a deficiency of beta-glucocerebrosidase activity. Imiglucerase catalyses the hydrolysis of glucocerebroside to glucose and ceramide,
675842,CHEMBL1201891,DEFLAZACORT,6166,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,"Prodrug - activity due to metabolite, 21-desDFZ",
210388,CHEMBL1202,CIPROFLOXACIN HYDROCHLORIDE,1902,Bacterial DNA gyrase inhibitor,INHIBITOR,105577.0,CHEMBL2311224,Bacterial DNA gyrase,1,1,1,,
210388,CHEMBL1202,CIPROFLOXACIN HYDROCHLORIDE,8640,Topoisomerase IV inhibitor,INHIBITOR,105771.0,CHEMBL2363076,Topoisomerase IV,1,1,1,,
678116,CHEMBL1204165,DILEVALOL HYDROCHLORIDE,6237,Adrenergic receptor beta antagonist,ANTAGONIST,104700.0,CHEMBL2094118,Adrenergic receptor beta,1,1,1,"Dilevalol is a nonselective, Beta-adrenergic receptor antagonist with, Beta 2-adrenergic receptor agonist activity. It has three to six times the activity of labetalol at the Beta-receptor, but unlike labetalol, little activity at the Alpha 1-receptor. In animal studies, it causes vasodilation even in denervated limbs, which is blocked by propranolol, suggesting that these vasodilator effects are due to Beta 2-adrenergic receptor agonism. It lowers blood pressure, both in normal and hypertensive subjects. Because the fall in blood pressure correlates with a fall in peripheral vascular resistance rather than a decrease in cardiac index, it is thought to be due to the Beta 2-adrenergic receptor agonist induced vasodilation, rather than to non-specific, Beta-adrenergic receptor antagonist effects.",
678116,CHEMBL1204165,DILEVALOL HYDROCHLORIDE,6876,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,"Dilevalol is a nonselective, Beta-adrenergic receptor antagonist with, Beta 2-adrenergic receptor agonist activity. It has three to six times the activity of labetalol at the Beta-receptor, but unlike labetalol, little activity at the Alpha 1-receptor. In animal studies, it causes vasodilation even in denervated limbs, which is blocked by propranolol, suggesting that these vasodilator effects are due to Beta 2-adrenergic receptor agonism. It lowers blood pressure, both in normal and hypertensive subjects. Because the fall in blood pressure correlates with a fall in peripheral vascular resistance rather than a decrease in cardiac index, it is thought to be due to the Beta 2-adrenergic receptor agonist induced vasodilation, rather than to non-specific, Beta-adrenergic receptor antagonist effects.",
678138,CHEMBL1204187,GEPIRONE HYDROCHLORIDE,9993,Serotonin 1a (5-HT1a) receptor agonist,AGONIST,51.0,CHEMBL214,5-hydroxytryptamine receptor 1A,1,1,1,,
213505,CHEMBL1205,NELFINAVIR MESYLATE,1492,Human immunodeficiency virus type 1 protease inhibitor,INHIBITOR,191.0,CHEMBL243,Human immunodeficiency virus type 1 protease,1,1,1,,
680641,CHEMBL1206690,PARECOXIB,5912,Cyclooxygenase-2 inhibitor,INHIBITOR,126.0,CHEMBL230,Prostaglandin G/H synthase 2,1,1,1,"Parecoxib is hydrolyzed by hepatic carboxyesterases to its active form, valdecoxib. Valdecoxib selectively binds to and inhibits COX-2. This prevents the conversion of arachidonic acid into prostaglandins, which are involved in the regulation of pain, inflammation, and fever.  It does not inhibit COX-1 at therapeutic concentrations and, therefore, does not interfere with blood coagulation.",
214701,CHEMBL1208,CINOXACIN,1900,Bacterial DNA gyrase inhibitor,INHIBITOR,105577.0,CHEMBL2311224,Bacterial DNA gyrase,1,1,1,,
682106,CHEMBL1208155,ELAGOLIX,5343,Gonadotropin-releasing hormone receptor antagonist,ANTAGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,,
20027,CHEMBL121,ROSIGLITAZONE,9861,Peroxisome proliferator-activated receptor gamma agonist,AGONIST,133.0,CHEMBL235,Peroxisome proliferator-activated receptor gamma,1,1,1,,
685006,CHEMBL1213165,DOLUTEGRAVIR SODIUM,2235,Human immunodeficiency virus type 1 integrase inhibitor,INHIBITOR,12456.0,CHEMBL3471,Human immunodeficiency virus type 1 integrase,1,1,1,HIV-1 integrase strand transfer inhibitor,
685091,CHEMBL1213250,CEFTOLOZANE SULFATE,2355,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
685974,CHEMBL1214124,PERAMPANEL,1038,Glutamate receptor ionotropic AMPA antagonist,ANTAGONIST,104825.0,CHEMBL2096670,Glutamate receptor ionotropic AMPA,1,1,1,,
221962,CHEMBL1218,RAMELTEON,1137,Melatonin receptor agonist,AGONIST,104733.0,CHEMBL2094268,Melatonin receptor,1,1,1,,
21697,CHEMBL122,ROFECOXIB,1457,Cyclooxygenase-2 inhibitor,INHIBITOR,126.0,CHEMBL230,Prostaglandin G/H synthase 2,1,1,1,,
222633,CHEMBL1220,TINIDAZOLE,1934,DNA disrupting agent,DISRUPTING AGENT,106218.0,CHEMBL2366045,DNA,1,1,1,,
222633,CHEMBL1220,TINIDAZOLE,10114,DNA disrupting agent,DISRUPTING AGENT,106020.0,CHEMBL2364041,DNA,1,1,1,,
226400,CHEMBL1223,PENICILLIN G POTASSIUM,1729,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
226880,CHEMBL1224,ACRIVASTINE,157,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
691867,CHEMBL1229517,VEMURAFENIB,995,Serine/threonine-protein kinase B-raf inhibitor,INHIBITOR,100126.0,CHEMBL5145,Serine/threonine-protein kinase B-raf,1,1,1,Indicated for mutated form - V600E,
229058,CHEMBL1231,OXYBUTYNIN,48,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for overactive bladder, M3 likely responsible",
229058,CHEMBL1231,OXYBUTYNIN,1513,Muscarinic acetylcholine receptor M2 antagonist,ANTAGONIST,47.0,CHEMBL211,Muscarinic acetylcholine receptor M2,1,1,1,"Indicated for overactive bladder, M2 likely responsible",
229172,CHEMBL1232,ERTAPENEM SODIUM,1706,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
230444,CHEMBL1234,DEFEROXAMINE MESYLATE,1563,Iron chelating agent,CHELATING AGENT,105753.0,CHEMBL2363058,Iron,1,1,1,,
697236,CHEMBL1234886,OXYGEN,9809,Essential for cellular homeostasis,,,,,1,1,1,,
698665,CHEMBL1236315,TARTARIC ACID,9882,Radiographic contrast agent,,,,,1,1,1,Tartaric acid and sodium bicarbonate generate carbon dioxide following oral administration. Carbon dioxide extends the stomach and provides a negative contrast medium during double contrast radiography.,
699373,CHEMBL1237022,TOCILIZUMAB,1839,Interleukin-6 receptor alpha subunit inhibitor,INHIBITOR,106134.0,CHEMBL2364155,Interleukin-6 receptor subunit alpha,1,1,1,"Complex with beta subunit in membrane bound form, but binds to soluble (alpha only) form too",
699374,CHEMBL1237023,DENOSUMAB,1420,Tumor necrosis factor ligand superfamily member 11 inhibitor,INHIBITOR,106141.0,CHEMBL2364162,Tumor necrosis factor ligand superfamily member 11,1,1,1,,
699376,CHEMBL1237025,PEGLOTICASE,2092,Uric acid oxidative enzyme,OXIDATIVE ENZYME,106162.0,CHEMBL2364183,Uric acid,1,1,1,"It's a recombinant uricase, which catalysis the oxidation of uric acid to allantoin, approved for the treatment of chronic gout",
699405,CHEMBL1237054,PLICAMYCIN,1854,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
699406,CHEMBL1237055,HYDROMORPHONE HYDROCHLORIDE,704,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
699412,CHEMBL1237061,PITAVASTATIN CALCIUM,1054,HMG-CoA reductase inhibitor,INHIBITOR,24.0,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,1,1,1,,
699416,CHEMBL1237065,TRAMADOL HYDROCHLORIDE,707,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
699421,CHEMBL1237070,MICAFUNGIN SODIUM,1392,"1,3-beta-glucan synthase inhibitor",INHIBITOR,106173.0,CHEMBL2364673,"1,3-beta-glucan synthase",1,1,1,,
699423,CHEMBL1237072,DIRITHROMYCIN,1759,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
699431,CHEMBL1237080,GRANISETRON HYDROCHLORIDE,375,Serotonin 3a (5-HT3a) receptor antagonist,ANTAGONIST,144.0,CHEMBL1899,5-hydroxytryptamine receptor 3A,1,1,1,,
699433,CHEMBL1237082,MECAMYLAMINE HYDROCHLORIDE,1291,Neuronal acetylcholine receptor; alpha3/beta4 negative allosteric modulator,NEGATIVE ALLOSTERIC MODULATOR,104288.0,CHEMBL1907594,Neuronal acetylcholine receptor; alpha3/beta4,1,1,1,,
699450,CHEMBL1237099,DOXACURIUM CHLORIDE,1531,Muscle-type nicotinic acetylcholine receptor antagonist,ANTAGONIST,105709.0,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,1,1,1,non-depolarizing,
699453,CHEMBL1237102,LEVOCABASTINE HYDROCHLORIDE,150,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
699455,CHEMBL1237104,PROPOXYPHENE HYDROCHLORIDE,719,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
699456,CHEMBL1237105,CARBOPROST TROMETHAMINE,646,Prostanoid FP receptor agonist,AGONIST,140.0,CHEMBL1987,Prostaglandin F2-alpha receptor,1,1,1,,
699470,CHEMBL1237119,TREPROSTINIL,664,Prostanoid IP receptor agonist,AGONIST,143.0,CHEMBL1995,Prostacyclin receptor,1,1,1,,
699483,CHEMBL1237132,CLEVIDIPINE,1269,Voltage-gated L-type calcium channel blocker,BLOCKER,104801.0,CHEMBL2095229,Voltage-gated L-type calcium channel,1,1,1,,
699486,CHEMBL1237135,MAPROTILINE HYDROCHLORIDE,878,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,reuptake inhibitor,
230999,CHEMBL1240,PROPANTHELINE BROMIDE,22,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Role in regulating gastric secretion and overactive bladded, M3 likely involved",
230999,CHEMBL1240,PROPANTHELINE BROMIDE,277,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Role in regulating gastric secretion, M1 likely involved",
230999,CHEMBL1240,PROPANTHELINE BROMIDE,1506,Muscarinic acetylcholine receptor M2 antagonist,ANTAGONIST,47.0,CHEMBL211,Muscarinic acetylcholine receptor M2,1,1,1,"Indicated for overactive bladder, M2 likely responsible",
701175,CHEMBL1241951,LETERMOVIR,6910,DNA terminase inhibitor,INHIBITOR,117302.0,CHEMBL3991482,DNA terminase,1,1,1,,
235211,CHEMBL1245,TRIMETHAPHAN CAMSYLATE,1293,Neuronal acetylcholine receptor; alpha3/beta4 antagonist,ANTAGONIST,104288.0,CHEMBL1907594,Neuronal acetylcholine receptor; alpha3/beta4,1,1,1,,
236376,CHEMBL1251,GANIRELIX,9991,Gonadotropin-releasing hormone receptor antagonist,ANTAGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,,
237298,CHEMBL1252,ABARELIX,258,Gonadotropin-releasing hormone receptor antagonist,ANTAGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,,
704633,CHEMBL1255654,TETRACAINE HYDROCHLORIDE,5520,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
704719,CHEMBL1255739,METHAPYRILENE HYDROCHLORIDE,6264,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
704780,CHEMBL1255800,FIDAXOMICIN,2065,DNA-directed RNA polymerase inhibitor,INHIBITOR,105831.0,CHEMBL2363852,DNA-directed RNA polymerase,1,1,1,,
238127,CHEMBL1256,ISOFLURANE,1554,Glycine receptor (alpha-1/beta) positive modulator,POSITIVE MODULATOR,105747.0,CHEMBL2363052,Glycine receptor (alpha-1/beta),1,1,1,alpha1/beta is main adult form,
238127,CHEMBL1256,ISOFLURANE,1629,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
238127,CHEMBL1256,ISOFLURANE,1943,Potassium channel subfamily K member 10 opener,OPENER,105637.0,CHEMBL2331041,Potassium channel subfamily K member 10,1,1,1,,
238127,CHEMBL1256,ISOFLURANE,1948,Potassium channel subfamily K member 18 opener,OPENER,105638.0,CHEMBL2331042,Potassium channel subfamily K member 18,1,1,1,,
238127,CHEMBL1256,ISOFLURANE,2052,Potassium channel subfamily K member 3 opener,OPENER,105602.0,CHEMBL2321613,Potassium channel subfamily K member 3,1,1,1,,
238127,CHEMBL1256,ISOFLURANE,2058,Potassium channel subfamily K member 9 opener,OPENER,105603.0,CHEMBL2321614,Potassium channel subfamily K member 9,1,1,1,,
238127,CHEMBL1256,ISOFLURANE,2064,Potassium channel subfamily K member 2 opener,OPENER,105604.0,CHEMBL2321615,Potassium channel subfamily K member 2,1,1,1,,
705121,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,1823,Cystine reducing agent,REDUCING AGENT,106018.0,CHEMBL2364039,Cystine,1,1,1,,
705687,CHEMBL1256696,CARBETAPENTANE CITRATE,6218,Sigma opioid receptor agonist,AGONIST,11272.0,CHEMBL287,Sigma non-opioid intracellular receptor 1,1,1,1,"Carbetapentane suppresses the cough reflex in the central nervous system, but the exact mechanism of action is not known with certainty. The drug acts as an agonist at sigma receptors (subtype 1).","Binding affinity (determined by competitive binding to [3H]-pentazocine-labelled sites on guinea-pig brain membranes): 75+- 28 nM, n=3"
705811,CHEMBL1256818,DEXTROMETHORPHAN HYDROBROMIDE,335,Sigma opioid receptor agonist,AGONIST,11272.0,CHEMBL287,Sigma non-opioid intracellular receptor 1,1,1,1,,
705811,CHEMBL1256818,DEXTROMETHORPHAN HYDROBROMIDE,506,Glutamate [NMDA] receptor subunit epsilon 1 antagonist,ANTAGONIST,166.0,CHEMBL1972,"Glutamate receptor ionotropic, NMDA 2A",1,1,1,,
705834,CHEMBL1256841,NIALAMIDE,6273,Monoamine oxidase inhibitor,INHIBITOR,104789.0,CHEMBL2095205,Monoamine oxidase,1,1,1,"Monoamine oxidase (MAO) works by interfering with the MAO enzyme, therefore increasing the concentrations of various neurotransmitters, such as Serotonin, Epinephrine, Dopamine and Norepinephrine.",Inhibition of rat brain mono-amine oxidase in vitro (I50): 7.8+- 0.5 uM
705835,CHEMBL1256842,NOMIFENSINE MALEATE,6276,Monoamine transporter inhibitor,INHIBITOR,105759.0,CHEMBL2363064,Monoamine transporter,1,1,1,It strongly inhibits the re-uptake of dopamine as well as noradrenaline and it is a relatively weak inhibitor of serotonin uptake.,Nomifensine inhibition of norepinephrine (NA) uptake by synaptosomal fractions from rat hypothalamus (IC50 = 7.0  107 M) was similar to that of nortriptyline and protriptyline. It was found to be a powerful inhibitor of NA uptake in synaptosomes obtained from whole brain (IC50 = 9.0  108 M). Nomifensine had only a moderate effect on serotonin accumulation (IC50 = 2.8  105 M).
705952,CHEMBL1256958,EPINEPHRINE BITARTRATE,1998,Adrenergic receptor agonist,AGONIST,105670.0,CHEMBL2331074,Adrenergic receptor,1,1,1,,
238429,CHEMBL1257,ENFLURANE,1551,Glycine receptor (alpha-1/beta) positive modulator,POSITIVE MODULATOR,105747.0,CHEMBL2363052,Glycine receptor (alpha-1/beta),1,1,1,alpha1/beta is main adult form,
238429,CHEMBL1257,ENFLURANE,1608,GABA-A receptor; anion channel positive modulator,POSITIVE MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
238429,CHEMBL1257,ENFLURANE,1944,Potassium channel subfamily K member 10 opener,OPENER,105637.0,CHEMBL2331041,Potassium channel subfamily K member 10,1,1,1,,
238429,CHEMBL1257,ENFLURANE,1949,Potassium channel subfamily K member 18 opener,OPENER,105638.0,CHEMBL2331042,Potassium channel subfamily K member 18,1,1,1,,
238429,CHEMBL1257,ENFLURANE,2053,Potassium channel subfamily K member 3 opener,OPENER,105602.0,CHEMBL2321613,Potassium channel subfamily K member 3,1,1,1,,
238429,CHEMBL1257,ENFLURANE,2059,Potassium channel subfamily K member 9 opener,OPENER,105603.0,CHEMBL2321614,Potassium channel subfamily K member 9,1,1,1,,
238429,CHEMBL1257,ENFLURANE,2061,Potassium channel subfamily K member 2 opener,OPENER,105604.0,CHEMBL2321615,Potassium channel subfamily K member 2,1,1,1,,
706035,CHEMBL1257040,TRIFLUOPERAZINE HYDROCHLORIDE,610,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
706035,CHEMBL1257040,TRIFLUOPERAZINE HYDROCHLORIDE,627,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
706035,CHEMBL1257040,TRIFLUOPERAZINE HYDROCHLORIDE,2028,D2-like dopamine receptor antagonist,ANTAGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
706068,CHEMBL1257073,TECOVIRIMAT,9794,Envelope phospholipase OPG057 inhibitor,INHIBITOR,121143.0,CHEMBL5308522,Envelope phospholipase OPG057,1,1,1,Antiviral inhibiting the orthopoxvirus envelope wrapping protein VP37 and preventing its interaction with cellular components and the subsequent production of virion particles.,
708075,CHEMBL1259059,SOFOSBUVIR,2247,RNA-directed RNA polymerase inhibitor,INHIBITOR,118447.0,CHEMBL4296320,RNA-directed RNA polymerase,1,1,1,,
26280,CHEMBL126,LINEZOLID,2067,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,"Indicated for Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus agalactiae, Enterococcus faecium",
244450,CHEMBL1265,ADAPALENE,677,Retinoic acid receptor agonist,AGONIST,105764.0,CHEMBL2363069,Retinoic acid receptor,1,1,1,RARG/RXRA are predominant forms in skin,Binds with higher affinity to RARB+RARG
26386,CHEMBL127,MEROPENEM,1726,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
10813,CHEMBL12713,SERTINDOLE,6297,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,"Sertindole was developed as an antipsychotic drug. It is a potent antagonist at dopamine D2, serotonin 5-HT2, and 1-adrenergic receptors with high affinity. Additionally, Sertindole suppresses potassium channel in the brain and heart. It also induces both autophagy and ROS generation in neuroblastoma cells.","It has high affinity for dopamine D2, serotonin 5-HT2, and 1-adrenergic receptors."
10813,CHEMBL12713,SERTINDOLE,6865,Adrenergic receptor alpha-1 antagonist,ANTAGONIST,104723.0,CHEMBL2094251,Adrenergic receptor alpha-1,1,1,1,"Sertindole was developed as an antipsychotic drug. It is a potent antagonist at dopamine D2, serotonin 5-HT2, and 1-adrenergic receptors with high affinity. Additionally, Sertindole suppresses potassium channel in the brain and heart. It also induces both autophagy and ROS generation in neuroblastoma cells.","It has high affinity for dopamine D2, serotonin 5-HT2, and 1-adrenergic receptors."
10813,CHEMBL12713,SERTINDOLE,6866,Serotonin 2 receptors; 5-HT2a & 5-HT2c antagonist,ANTAGONIST,104817.0,CHEMBL2096662,Serotonin 2 receptors; 5-HT2a & 5-HT2c,1,1,1,"Sertindole was developed as an antipsychotic drug. It is a potent antagonist at dopamine D2, serotonin 5-HT2, and 1-adrenergic receptors with high affinity. Additionally, Sertindole suppresses potassium channel in the brain and heart. It also induces both autophagy and ROS generation in neuroblastoma cells.","It has high affinity for dopamine D2, serotonin 5-HT2, and 1-adrenergic receptors."
248669,CHEMBL1272,REPAGLINIDE,1252,"Sulfonylurea receptor 1, Kir6.2 blocker",BLOCKER,104852.0,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",1,1,1,,
249414,CHEMBL1274,NILUTAMIDE,1318,Androgen Receptor antagonist,ANTAGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
249814,CHEMBL1275,PERGOLIDE MESYLATE,1151,Dopamine receptor agonist,AGONIST,104842.0,CHEMBL2096905,Dopamine receptor,1,1,1,,
209964,CHEMBL127516,BUTAMBEN,6215,Transient receptor potential cation channel subfamily V member 4 inhibitor,INHIBITOR,11847.0,CHEMBL3119,Transient receptor potential cation channel subfamily V member 4,1,1,1,"Butamben is a pain-relieving local anesthetic. It inhibits voltage-gated channels in the sensory neurons (T-type calcium channels, Cav1.2/L-type channels, Kv4 channels). It also inhibits Transient Receptor Potential A1 (TRPA1) and Transient Receptor Potential V4 (TRPV4).",
209964,CHEMBL127516,BUTAMBEN,6856,Transient receptor potential cation channel subfamily A member 1 inhibitor,INHIBITOR,101412.0,CHEMBL6007,Transient receptor potential cation channel subfamily A member 1,1,1,1,"Butamben is a pain-relieving local anesthetic. It inhibits voltage-gated channels in the sensory neurons (T-type calcium channels, Cav1.2/L-type channels, Kv4 channels). It also inhibits Transient Receptor Potential A1 (TRPA1) and Transient Receptor Potential V4 (TRPV4).",
712273,CHEMBL1276308,MIFEPRISTONE,821,Glucocorticoid receptor antagonist,ANTAGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,Selective
712273,CHEMBL1276308,MIFEPRISTONE,1026,Progesterone receptor antagonist,ANTAGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,Selective
27111,CHEMBL128,SUMATRIPTAN,371,Serotonin 1b (5-HT1b) receptor agonist,AGONIST,106.0,CHEMBL1898,5-hydroxytryptamine receptor 1B,1,1,1,,Selective
27111,CHEMBL128,SUMATRIPTAN,575,Serotonin 1d (5-HT1d) receptor agonist,AGONIST,105.0,CHEMBL1983,5-hydroxytryptamine receptor 1D,1,1,1,,Selective
250508,CHEMBL1280,VERAPAMIL HYDROCHLORIDE,1275,Voltage-gated L-type calcium channel blocker,BLOCKER,104801.0,CHEMBL2095229,Voltage-gated L-type calcium channel,1,1,1,,
250908,CHEMBL1282,IMIQUIMOD,1440,Toll-like receptor 7 agonist,AGONIST,101608.0,CHEMBL5936,Toll-like receptor 7,1,1,1,,
252155,CHEMBL1286,LEVETIRACETAM,672,Synaptic vesicle glycoprotein 2A modulator,MODULATOR,31000.0,CHEMBL1998,Synaptic vesicle glycoprotein 2A,1,1,1,,
252155,CHEMBL1286,LEVETIRACETAM,990,Voltage-gated N-type calcium channel alpha-1B subunit blocker,BLOCKER,10511.0,CHEMBL4478,Voltage-dependent N-type calcium channel subunit alpha-1B,1,1,1,,
714243,CHEMBL1287853,FEDRATINIB,5326,Tyrosine-protein kinase receptor FLT3 inhibitor,INHIBITOR,12670.0,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,1,1,1,Potent inhibitor of BRD4 (PMID: 24584101).,
714243,CHEMBL1287853,FEDRATINIB,5327,Tyrosine-protein kinase JAK2 inhibitor,INHIBITOR,10938.0,CHEMBL2971,Tyrosine-protein kinase JAK2,1,1,1,Potent inhibitor of BRD4 (PMID: 24584101).,
253862,CHEMBL1289,HALOPROGIN,1816,Cell membrane inhibitor,INHIBITOR,106012.0,CHEMBL2364033,Cell membrane,1,1,1,Disrupts cell membrane,
715901,CHEMBL1289494,TIVOZANIB,5295,Vascular endothelial growth factor receptor inhibitor,INHIBITOR,104799.0,CHEMBL2095227,Vascular endothelial growth factor receptor,1,1,1,,
716337,CHEMBL1289926,AXITINIB,1264,Vascular endothelial growth factor receptor inhibitor,INHIBITOR,104799.0,CHEMBL2095227,Vascular endothelial growth factor receptor,1,1,1,,
27307,CHEMBL129,ZIDOVUDINE,828,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,,
255347,CHEMBL1292,CLOFAZIMINE,1928,DNA inhibitor,INHIBITOR,106214.0,CHEMBL2366041,DNA,1,1,1,Direct DNA binding,
27340,CHEMBL130,CHLORAMPHENICOL,1751,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
258371,CHEMBL1303,ROTIGOTINE,2025,D2-like dopamine receptor agonist,AGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
261343,CHEMBL1308,FOMEPIZOLE,1542,Alcohol dehydrogenase class I inhibitor,INHIBITOR,105739.0,CHEMBL2363044,Alcohol dehydrogenase class I,1,1,1,Competitive inhibitor,
27370,CHEMBL131,PREDNISOLONE,775,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
263453,CHEMBL1311,ISOSORBIDE MONONITRATE,1221,Soluble guanylate cyclase activator,ACTIVATOR,105048.0,CHEMBL2111348,Soluble guanylate cyclase,1,1,1,,
264400,CHEMBL1314,TIOPRONIN,2175,Reducing agent,,,,,1,1,1,Prevents cysteine excretion,
738635,CHEMBL1314751,PROCHLORPERAZINE MALEATE,199,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
739751,CHEMBL1315867,TERBUTALINE SULFATE,1347,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
264453,CHEMBL1316,CARPROFEN,1458,Cyclooxygenase-2 inhibitor,INHIBITOR,126.0,CHEMBL230,Prostaglandin G/H synthase 2,1,1,1,,Selective
742171,CHEMBL1318287,PENTOLINIUM TARTRATE,1292,Neuronal acetylcholine receptor; alpha3/beta4 antagonist,ANTAGONIST,104288.0,CHEMBL1907594,Neuronal acetylcholine receptor; alpha3/beta4,1,1,1,,
267163,CHEMBL1323,DARUNAVIR,7641,Human immunodeficiency virus type 1 protease inhibitor,INHIBITOR,191.0,CHEMBL243,Human immunodeficiency virus type 1 protease,1,1,1,,"Active against laboratory strains and clinical isolates of HIV-1 and laboratory strains of HIV-2. Active against a broad panel of HIV-1 group M (A, B, C, D, E, F, G), and group O primary isolates."
267825,CHEMBL1324,TOLCAPONE,735,Catechol O-methyltransferase inhibitor,INHIBITOR,91.0,CHEMBL2023,Catechol O-methyltransferase,1,1,1,,
11715,CHEMBL13280,FLUNITRAZEPAM,6251,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,"It binds to a specific part of the GABA-A receptor, called the benzodiazepine site, which is distinct from the GABA binding site. When bound, it enhances the effect of GABA so they shut down brain activity more effectively, which broadens their spectrum of tranquillising actions.",
757917,CHEMBL1334033,PERHEXILINE MALEATE,6278,"Carnitine O-palmitoyltransferase 1, muscle isoform inhibitor",INHIBITOR,105495.0,CHEMBL2216739,"Carnitine O-palmitoyltransferase 1, muscle isoform",1,1,1,"It inhibits the mitochondrial enzyme carnitine palmitoyltransferase 1 (CPT-1) and to a lesser extent CPT-2. This causes a shift in myocardial substrate utilisation from long chain fatty acids to carbohydrates, resulting in increased glucose and lactate utilization and increased ATP production for the same O2 consumption as before and consequently increases myocardial efficiency. Perhexiline maleate was also found to inhibit the activity of Mammalian target of rapamycin complex 1 (mTORC1).","It inhibits rat heart and liver carnitine palmitoyltransferase 1 (CPT1) (IC50 = 77 and 148 M, respectively) and rat heart CPT2 (IC50 = 79 M). It reversibly inhibits Mammalian target of rapamycin complex 1 (mTORC1) at micromolar concentrations."
757917,CHEMBL1334033,PERHEXILINE MALEATE,6860,Carnitine palmitoyltransferase 2 inhibitor,INHIBITOR,10765.0,CHEMBL3238,"Carnitine O-palmitoyltransferase 2, mitochondrial",1,1,1,"It inhibits the mitochondrial enzyme carnitine palmitoyltransferase 1 (CPT-1) and to a lesser extent CPT-2. This causes a shift in myocardial substrate utilisation from long chain fatty acids to carbohydrates, resulting in increased glucose and lactate utilization and increased ATP production for the same O2 consumption as before and consequently increases myocardial efficiency. Perhexiline maleate was also found to inhibit the activity of Mammalian target of rapamycin complex 1 (mTORC1).","It inhibits rat heart and liver carnitine palmitoyltransferase 1 (CPT1) (IC50 = 77 and 148 M, respectively) and rat heart CPT2 (IC50 = 79 M). It reversibly inhibits Mammalian target of rapamycin complex 1 (mTORC1) at micromolar concentrations."
757917,CHEMBL1334033,PERHEXILINE MALEATE,6861,Serine/threonine-protein kinase mTOR inhibitor,INHIBITOR,11400.0,CHEMBL2842,Serine/threonine-protein kinase mTOR,1,1,1,"It inhibits the mitochondrial enzyme carnitine palmitoyltransferase 1 (CPT-1) and to a lesser extent CPT-2. This causes a shift in myocardial substrate utilisation from long chain fatty acids to carbohydrates, resulting in increased glucose and lactate utilization and increased ATP production for the same O2 consumption as before and consequently increases myocardial efficiency. Perhexiline maleate was also found to inhibit the activity of Mammalian target of rapamycin complex 1 (mTORC1).","It inhibits rat heart and liver carnitine palmitoyltransferase 1 (CPT1) (IC50 = 77 and 148 M, respectively) and rat heart CPT2 (IC50 = 79 M). It reversibly inhibits Mammalian target of rapamycin complex 1 (mTORC1) at micromolar concentrations."
281549,CHEMBL1337,NITISINONE,1307,4-hydroxyphenylpyruvate dioxygenase inhibitor,INHIBITOR,123.0,CHEMBL1861,4-hydroxyphenylpyruvate dioxygenase,1,1,1,,
11685,CHEMBL13376,CLOMETACIN,6227,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,Non steroidal antiinflamatory drug.,
283529,CHEMBL1339,VARDENAFIL HYDROCHLORIDE,186,Phosphodiesterase 5A inhibitor,INHIBITOR,3.0,CHEMBL1827,"cGMP-specific 3',5'-cyclic phosphodiesterase",1,1,1,,Selective
27609,CHEMBL134,CLONIDINE,1145,Adrenergic receptor alpha-2 agonist,AGONIST,104743.0,CHEMBL2095158,Adrenergic receptor alpha-2,1,1,1,,
284208,CHEMBL1341,METHOXYFLURANE,1549,Glycine receptor (alpha-1/beta) agonist,AGONIST,105747.0,CHEMBL2363052,Glycine receptor (alpha-1/beta),1,1,1,,
284208,CHEMBL1341,METHOXYFLURANE,1587,GABA-A receptor; anion channel positive modulator,POSITIVE MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
289505,CHEMBL1345,GUANETHIDINE MONOSULFATE,884,Norepinephrine transporter substrate,SUBSTRATE,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,Taken up by transporter and displaces NE from vesicles,
27626,CHEMBL135,ESTRADIOL,858,Estrogen receptor alpha agonist,AGONIST,19.0,CHEMBL206,Estrogen receptor,1,1,1,,
300022,CHEMBL1351,CARBOPLATIN,1855,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
224263,CHEMBL135400,ZOPICLONE,8463,GABA-A receptor; agonist GABA site positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104905.0,CHEMBL2109244,GABA-A receptor; agonist GABA site,1,1,1,,
778083,CHEMBL1354199,METHSCOPOLAMINE BROMIDE,47,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Role in regulating gastric secretion, M3 likely involved",
778083,CHEMBL1354199,METHSCOPOLAMINE BROMIDE,295,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Role in regulating gastric secretion, M1 likely involved",
779620,CHEMBL1355736,THEOPHYLLINE,1063,Phosphodiesterase 4 inhibitor,INHIBITOR,104679.0,CHEMBL2093863,Phosphodiesterase 4,1,1,1,,
779620,CHEMBL1355736,THEOPHYLLINE,1136,Phosphodiesterase 3 inhibitor,INHIBITOR,104707.0,CHEMBL2094125,Phosphodiesterase 3,1,1,1,,
779620,CHEMBL1355736,THEOPHYLLINE,1216,Adenosine receptor antagonist,ANTAGONIST,105024.0,CHEMBL2111329,Adenosine receptor,1,1,1,,
781532,CHEMBL1357648,AMODIAQUINE HYDROCHLORIDE,999,Ferriprotoporphyrin IX inhibitor,INHIBITOR,100262.0,CHEMBL613897,Ferriprotoporphyrin IX,1,1,1,prevents crystallisation,
304798,CHEMBL1358,FULVESTRANT,1075,Estrogen receptor alpha antagonist,ANTAGONIST,19.0,CHEMBL206,Estrogen receptor,1,1,1,,
304798,CHEMBL1358,FULVESTRANT,10100,Estrogen receptor degrader,DEGRADER,19.0,CHEMBL206,Estrogen receptor,1,1,1,,
304903,CHEMBL1359,ERTAPENEM,9965,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
304903,CHEMBL1359,ERTAPENEM,10009,"Peptidoglycan D,D-transpeptidase FtsI inhibitor",INHIBITOR,121574.0,CHEMBL5500282,"Peptidoglycan D,D-transpeptidase FtsI",1,1,1,,
304903,CHEMBL1359,ERTAPENEM,10030,Cell shape peptidoglycan synthetase penicillin-binding protein 2 inhibitor,INHIBITOR,109175.0,CHEMBL3309036,Cell shape peptidoglycan synthetase penicillin-binding protein 2,1,1,1,,
788028,CHEMBL1364144,METHYLPREDNISOLONE ACETATE,817,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
788435,CHEMBL1364551,MINAPRINE HYDROCHLORIDE,6868,Acetylcholinesterase inhibitor,INHIBITOR,93.0,CHEMBL220,Acetylcholinesterase,1,1,1,"Minaprine binds to serotonin type 2 receptors and to dopamine D1 and D2 type receptors. It also binds to the serotonin reuptake pump. Therefore, minaprine blocks the reuptake of both dopamine and serotonin. It is also, to a slight degree, cholinomimetic. Thus it may exhibit both mood-brightening and nootropic properties. It also acts as a reversible inhibitor of monoamine oxidase. It has also been found to inhibit acetylcholinesterase in a reversible and competitive way.",IC50= 85M on homogenized rat striatum acetylcholinesterase.
788435,CHEMBL1364551,MINAPRINE HYDROCHLORIDE,6869,Dopamine D1 and D2 receptor agonist,AGONIST,105040.0,CHEMBL2111341,Dopamine D1 and D2 receptor,1,1,1,"Minaprine binds to serotonin type 2 receptors and to dopamine D1 and D2 type receptors. It also binds to the serotonin reuptake pump. Therefore, minaprine blocks the reuptake of both dopamine and serotonin. It is also, to a slight degree, cholinomimetic. Thus it may exhibit both mood-brightening and nootropic properties. It also acts as a reversible inhibitor of monoamine oxidase. It has also been found to inhibit acetylcholinesterase in a reversible and competitive way.",IC50= 85M on homogenized rat striatum acetylcholinesterase.
788435,CHEMBL1364551,MINAPRINE HYDROCHLORIDE,6870,Monoamine oxidase A inhibitor,INHIBITOR,86.0,CHEMBL1951,Amine oxidase [flavin-containing] A,1,1,1,"Minaprine binds to serotonin type 2 receptors and to dopamine D1 and D2 type receptors. It also binds to the serotonin reuptake pump. Therefore, minaprine blocks the reuptake of both dopamine and serotonin. It is also, to a slight degree, cholinomimetic. Thus it may exhibit both mood-brightening and nootropic properties. It also acts as a reversible inhibitor of monoamine oxidase. It has also been found to inhibit acetylcholinesterase in a reversible and competitive way.",IC50= 85M on homogenized rat striatum acetylcholinesterase.
788435,CHEMBL1364551,MINAPRINE HYDROCHLORIDE,6871,Muscarinic acetylcholine receptor M1 agonist,AGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Minaprine binds to serotonin type 2 receptors and to dopamine D1 and D2 type receptors. It also binds to the serotonin reuptake pump. Therefore, minaprine blocks the reuptake of both dopamine and serotonin. It is also, to a slight degree, cholinomimetic. Thus it may exhibit both mood-brightening and nootropic properties. It also acts as a reversible inhibitor of monoamine oxidase. It has also been found to inhibit acetylcholinesterase in a reversible and competitive way.",IC50= 85M on homogenized rat striatum acetylcholinesterase.
788435,CHEMBL1364551,MINAPRINE HYDROCHLORIDE,8642,Serotonin 2 (5-HT2) receptor antagonist,ANTAGONIST,104784.0,CHEMBL2095200,Serotonin 2 (5-HT2) receptor,1,1,1,,
226851,CHEMBL136478,SODIUM NITROPRUSSIDE,1220,Soluble guanylate cyclase activator,ACTIVATOR,105048.0,CHEMBL2111348,Soluble guanylate cyclase,1,1,1,,
791489,CHEMBL1367605,RITODRINE HYDROCHLORIDE,1345,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
27912,CHEMBL137,METRONIDAZOLE,1824,DNA inhibitor,INHIBITOR,106020.0,CHEMBL2364041,DNA,1,1,1,Generates free radicals causing DNA damage in trichomonas + bacterial species.  In H. Pylori infections the oxygen-insensitive NADPH nitroreductase enzymes responsible for metabolite generation are normally found mutated in resistant strains (PMID: 10960092),
313314,CHEMBL1370,BUDESONIDE,812,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
794445,CHEMBL1370561,AMINOPHYLLINE,1066,Phosphodiesterase 4 inhibitor,INHIBITOR,104679.0,CHEMBL2093863,Phosphodiesterase 4,1,1,1,,
794445,CHEMBL1370561,AMINOPHYLLINE,1135,Phosphodiesterase 3 inhibitor,INHIBITOR,104707.0,CHEMBL2094125,Phosphodiesterase 3,1,1,1,,
794445,CHEMBL1370561,AMINOPHYLLINE,1212,Adenosine receptor antagonist,ANTAGONIST,105024.0,CHEMBL2111329,Adenosine receptor,1,1,1,,
315123,CHEMBL1371,CHLORZOXAZONE,974,Intermediate conductance calcium-activated potassium channel protein 4 opener,OPENER,10992.0,CHEMBL4305,Intermediate conductance calcium-activated potassium channel protein 4,1,1,1,,
316787,CHEMBL1372,OXIGLUTATIONE,932,Glutathione reductase other,OTHER,12642.0,CHEMBL2755,"Glutathione reductase, mitochondrial",1,1,1,,
317124,CHEMBL1373,MODAFINIL,684,Dopamine transporter inhibitor,INHIBITOR,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
798263,CHEMBL1374379,BENZONATATE,1407,Slowly adapting pulmonary stretch receptor inhibitor,INHIBITOR,106182.0,CHEMBL2364682,Slowly adapting pulmonary stretch receptor,1,1,1,,
799627,CHEMBL1375743,ZIPRASIDONE HYDROCHLORIDE,612,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
799627,CHEMBL1375743,ZIPRASIDONE HYDROCHLORIDE,629,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
799627,CHEMBL1375743,ZIPRASIDONE HYDROCHLORIDE,2029,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
806511,CHEMBL1382627,"SULFADIAZINE, SILVER",1646,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,Broad spectrum
328153,CHEMBL1387,NORETHYNODREL,1010,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,
328158,CHEMBL1388,MONOBENZONE,508,Tyrosinase inhibitor,INHIBITOR,73.0,CHEMBL1973,Tyrosinase,1,1,1,,
328164,CHEMBL1389,LEVONORGESTREL,1021,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,
29890,CHEMBL139,DICLOFENAC,2254,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
328201,CHEMBL1393,SPIRONOLACTONE,659,Mineralocorticoid receptor antagonist,ANTAGONIST,48.0,CHEMBL1994,Mineralocorticoid receptor,1,1,1,,
328400,CHEMBL1395,METHYLTESTOSTERONE,1321,Androgen Receptor agonist,AGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
334337,CHEMBL1397,POSACONAZOLE,1453,Cytochrome P450 51 inhibitor,INHIBITOR,58.0,CHEMBL1780,Lanosterol 14-alpha demethylase,1,1,1,,
822010,CHEMBL1398126,AMILORIDE HYDROCHLORIDE,1256,"Amiloride-sensitive sodium channel, ENaC blocker",BLOCKER,104888.0,CHEMBL2107836,"Amiloride-sensitive sodium channel, ENaC",1,1,1,,
337366,CHEMBL1399,ANASTROZOLE,523,Cytochrome P450 19A1 inhibitor,INHIBITOR,65.0,CHEMBL1978,Aromatase,1,1,1,,
892,CHEMBL14,CARBACHOL,41,Muscarinic acetylcholine receptor M3 agonist,AGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for miosis, M3 likely involved (main form in iris)",
338934,CHEMBL1401,NITAZOXANIDE,2033,Pyruvate:ferredoxin oxidoreductase inhibitor,INHIBITOR,106005.0,CHEMBL2364026,Pyruvate dehydrogenase [NADP(+)],1,1,1,,
338934,CHEMBL1401,NITAZOXANIDE,2034,Pyruvate:ferredoxin oxidoreductase inhibitor,INHIBITOR,106006.0,CHEMBL2364027,Pyruvate:ferredoxin oxidoreductase,1,1,1,,
341382,CHEMBL1404,RANOLAZINE,529,Sodium channel protein type V alpha subunit blocker,BLOCKER,11480.0,CHEMBL1980,Sodium channel protein type 5 subunit alpha,1,1,1,,
341382,CHEMBL1404,RANOLAZINE,871,Sodium channel protein type IV alpha subunit blocker,BLOCKER,18043.0,CHEMBL2072,Sodium channel protein type 4 subunit alpha,1,1,1,Competitive reversible inhibitor,
342897,CHEMBL1405,ESTRONE,857,Estrogen receptor alpha agonist,AGONIST,19.0,CHEMBL206,Estrogen receptor,1,1,1,,
345595,CHEMBL1409,FLUVOXAMINE MALEATE,398,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,reuptake inhibitor,
33986,CHEMBL141,LAMIVUDINE,834,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,"When monophosporylated is incorporates into the DNA, when triphosporylated inhibits the enzymes",
33986,CHEMBL141,LAMIVUDINE,1543,DNA inhibitor,INHIBITOR,105743.0,CHEMBL2363048,DNA,1,1,1,"When monophosporylated is incorporates into the DNA, when triphosporylated inhibits the enzymes",
33986,CHEMBL141,LAMIVUDINE,1544,DNA inhibitor,INHIBITOR,105741.0,CHEMBL2363046,DNA,1,1,1,"When monophosporylated is incorporates into the DNA, when triphosporylated inhibits the enzymes",
33986,CHEMBL141,LAMIVUDINE,1545,DNA inhibitor,INHIBITOR,105742.0,CHEMBL2363047,DNA,1,1,1,"When monophosporylated is incorporates into the DNA, when triphosporylated inhibits the enzymes",
33986,CHEMBL141,LAMIVUDINE,1926,DNA polymerase/reverse transcriptase inhibitor,INHIBITOR,105706.0,CHEMBL2362994,DNA polymerase/reverse transcriptase,1,1,1,"When monophosporylated is incorporates into the DNA, when triphosporylated inhibits the enzymes",
345872,CHEMBL1410,NONOXYNOL 9,8920,Cell membrane disrupting agent,DISRUPTING AGENT,109551.0,CHEMBL3390826,Cell membrane,1,1,1,,
353011,CHEMBL1413,CICLOPIROX,2200,Iron chelating agent,CHELATING AGENT,105753.0,CHEMBL2363058,Iron,1,1,1,Trivalent metal cations chelating agent; inhibition of the metal-dependent enzymes that are responsible for the degradation of peroxides within the fungal cell,
353011,CHEMBL1413,CICLOPIROX,2224,Aluminium chelating agent,CHELATING AGENT,106544.0,CHEMBL2366381,Aluminium,1,1,1,Trivalent metal cations chelating agent; inhibition of the metal-dependent enzymes that are responsible for the degradation of peroxides within the fungal cell,
231925,CHEMBL141305,CYCLOFENIL,6230,Estrogen receptor modulator,MODULATOR,104682.0,CHEMBL2093866,Estrogen receptor,1,1,1,"Cyclofenil is a weak non-steroidal oestrogen which has been used to induce ovulation, and more recently to treat systemic sclerosis. It is metabolized in rats, rabbits and man to cyclofenil diphenol (bis(p-hydroxyphenyl)cyclohexylidenemethane). Both of them bind to oestrogen receptors, although with a rather lower affinity than 17 beta-oestradiol.",
840903,CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE,103,DNA topoisomerase II alpha inhibitor,INHIBITOR,63.0,CHEMBL1806,DNA topoisomerase 2-alpha,1,1,1,,
840903,CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE,1886,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
842060,CHEMBL1418176,METHANDROSTENOLONE,6262,Androgen Receptor agonist,AGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,"Methandrostenolone binds to and activates the androgen receptor (AR) causing dramatic increases in protein synthesis, glycogenolysis, and muscle strength over a short space of time.",
361469,CHEMBL1421,DASATINIB ANHYDROUS,301,Tyrosine-protein kinase ABL inhibitor,INHIBITOR,8.0,CHEMBL1862,Tyrosine-protein kinase ABL1,1,1,1,,
361469,CHEMBL1421,DASATINIB ANHYDROUS,416,Platelet-derived growth factor receptor beta inhibitor,INHIBITOR,197.0,CHEMBL1913,Platelet-derived growth factor receptor beta,1,1,1,,
361469,CHEMBL1421,DASATINIB ANHYDROUS,446,Stem cell growth factor receptor inhibitor,INHIBITOR,238.0,CHEMBL1936,Mast/stem cell growth factor receptor Kit,1,1,1,,
361469,CHEMBL1421,DASATINIB ANHYDROUS,854,Ephrin type-A receptor 2 inhibitor,INHIBITOR,30008.0,CHEMBL2068,Ephrin type-A receptor 2,1,1,1,,
361469,CHEMBL1421,DASATINIB ANHYDROUS,1634,SRC inhibitor,INHIBITOR,105769.0,CHEMBL2363074,SRC,1,1,1,,
361469,CHEMBL1421,DASATINIB ANHYDROUS,8631,Bcr/Abl fusion protein inhibitor,INHIBITOR,104811.0,CHEMBL2096618,Bcr/Abl fusion protein,1,1,1,,
364141,CHEMBL1423,PIMOZIDE,600,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
364141,CHEMBL1423,PIMOZIDE,1153,Dopamine receptor antagonist,ANTAGONIST,104842.0,CHEMBL2096905,Dopamine receptor,1,1,1,,
237007,CHEMBL142635,NAFTOPIDIL,7571,Alpha-1d adrenergic receptor antagonist,ANTAGONIST,103.0,CHEMBL223,Alpha-1D adrenergic receptor,1,1,1,,Higher selectivity for the alpha 1D subtype over the alpha 1A type (3-fold) and alpha 1B type (17-fold). 
234541,CHEMBL142703,VILDAGLIPTIN,5734,Dipeptidyl peptidase IV inhibitor,INHIBITOR,11140.0,CHEMBL284,Dipeptidyl peptidase 4,1,1,1,,
365248,CHEMBL1428,NIMODIPINE,662,Mineralocorticoid receptor antagonist,ANTAGONIST,48.0,CHEMBL1994,Mineralocorticoid receptor,1,1,1,,
365248,CHEMBL1428,NIMODIPINE,1280,Voltage-gated L-type calcium channel blocker,BLOCKER,104801.0,CHEMBL2095229,Voltage-gated L-type calcium channel,1,1,1,,
369179,CHEMBL1430,PENICILLAMINE,1559,Copper chelating agent,CHELATING AGENT,105752.0,CHEMBL2363057,Copper,1,1,1,,
858397,CHEMBL1434513,NOREPINEPHRINE BITARTRATE,2001,Adrenergic receptor agonist,AGONIST,105670.0,CHEMBL2331074,Adrenergic receptor,1,1,1,,
14263,CHEMBL14370,REBOXETINE,5901,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,"It acts by binding to the norepinephrine transporter and blocking reuptake of extracellular norepinephrine (noradrenaline) back into the terminals. A meta-analysis showed that reboxetine (marketed by Pfizer in Europe, but not in the U.S. ) lacks efficacy.",High selectivity for NET over SERT/DAT. Low affinity for monoamine/histamine/ACh receptors
13949,CHEMBL14376,ILOPERIDONE,207,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
13949,CHEMBL14376,ILOPERIDONE,605,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
373856,CHEMBL1439,TAZOBACTAM SODIUM,1668,Bacterial beta-lactamase TEM inhibitor,INHIBITOR,106170.0,CHEMBL2364670,Beta-lactamase TEM,1,1,1,,Broad spectrum
373985,CHEMBL1440,TETRACYCLINE,1771,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
374005,CHEMBL1441,ETHIONAMIDE,250,Enoyl-[acyl-carrier-protein] reductase inhibitor,INHIBITOR,145.0,CHEMBL1849,Enoyl-[acyl-carrier-protein] reductase [NADH],1,1,1,Prodrug enzyme: FAD-containing monooxygenase (EthA),
864943,CHEMBL1441059,ALBUTEROL SULFATE,1351,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
866306,CHEMBL1442422,DIBENZEPIN,6695,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,"Dibenzepin is a tricyclic antidepressant (TCA). It acts as a selective norepinephrine reuptake inhibitor (NRI). It is also a potent antihistamine (H1 receptor). The drug has weak or negligible effects on serotonin and dopamine reuptake. Unlike many other TCAs, dibenzepin has no antiadrenergic (1, 2), antiserotonergic (5-HT1A, 5-HT2A), or antidopaminergic effects and has few or no anticholinergic (mACh) effects.",Inhibitory effect on the uptake of noradrenaline (59 nM) by the perfused rabbit heart: 44.8 mM (ID50) Ki = 23 nM for H1 receptors.
866306,CHEMBL1442422,DIBENZEPIN,6877,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,"Dibenzepin is a tricyclic antidepressant (TCA). It acts as a selective norepinephrine reuptake inhibitor (NRI). It is also a potent antihistamine (H1 receptor). The drug has weak or negligible effects on serotonin and dopamine reuptake. Unlike many other TCAs, dibenzepin has no antiadrenergic (1, 2), antiserotonergic (5-HT1A, 5-HT2A), or antidopaminergic effects and has few or no anticholinergic (mACh) effects.",Inhibitory effect on the uptake of noradrenaline (59 nM) by the perfused rabbit heart: 44.8 mM (ID50) Ki = 23 nM for H1 receptors.
374548,CHEMBL1444,LETROZOLE,524,Cytochrome P450 19A1 inhibitor,INHIBITOR,65.0,CHEMBL1978,Aromatase,1,1,1,,
377718,CHEMBL1445,FLUOXYMESTERONE,1330,Androgen Receptor agonist,AGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
378124,CHEMBL1446,KANAMYCIN SULFATE,1762,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
378207,CHEMBL1447,LINCOMYCIN,9435,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
378218,CHEMBL1448,NICLOSAMIDE,1931,DNA inhibitor,INHIBITOR,106216.0,CHEMBL2366043,DNA,1,1,1,,
378218,CHEMBL1448,NICLOSAMIDE,1933,DNA inhibitor,INHIBITOR,106217.0,CHEMBL2366044,DNA,1,1,1,,
872071,CHEMBL1448187,FLUPHENAZINE HYDROCHLORIDE,197,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
378315,CHEMBL1450,ATOVAQUONE,19,Cytochrome b inhibitor,INHIBITOR,159.0,CHEMBL1777,Cytochrome b,1,1,1,,
381691,CHEMBL1451,TRIAMCINOLONE,791,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
386327,CHEMBL1455,ALTRETAMINE,1857,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
386457,CHEMBL1456,MYCOPHENOLATE MOFETIL,1223,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,INHIBITOR,105058.0,CHEMBL2111369,Inosine-5'-monophosphate dehydrogenase (IMPDH),1,1,1,,
390877,CHEMBL1460,DIDANOSINE,824,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,,
244737,CHEMBL146095,GLAFENINE,6252,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,Glafenine is a nonsteroidal anti-inflammatory drug that inhibits both COX isoforms.,
393942,CHEMBL1463,FLUCYTOSINE,975,Thymidylate synthase inhibitor,INHIBITOR,100829.0,CHEMBL4665,Thymidylate synthase,1,1,1,,
393942,CHEMBL1463,FLUCYTOSINE,1405,Thymidylate synthase inhibitor,INHIBITOR,106180.0,CHEMBL2364680,Thymidylate synthase,1,1,1,,
887229,CHEMBL1463345,CANRENONE,6217,Mineralocorticoid receptor antagonist,ANTAGONIST,48.0,CHEMBL1994,Mineralocorticoid receptor,1,1,1,"Canrenone specifically antagonizes aldosterone at the mineralocorticoid receptor in the kidneys, thereby increasing sodium excretion and inhibiting potassium excretion.",
394229,CHEMBL1465,PHENPROCOUMON,440,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,INHIBITOR,224.0,CHEMBL1930,Vitamin K epoxide reductase complex subunit 1,1,1,1,,
394231,CHEMBL1466,DICUMAROL,442,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,INHIBITOR,224.0,CHEMBL1930,Vitamin K epoxide reductase complex subunit 1,1,1,1,,
395607,CHEMBL1467,ALLOPURINOL,439,Xanthine dehydrogenase inhibitor,INHIBITOR,149.0,CHEMBL1929,Xanthine dehydrogenase/oxidase,1,1,1,,
399361,CHEMBL1471,APREPITANT,1371,Neurokinin 1 receptor antagonist,ANTAGONIST,250.0,CHEMBL249,Substance-P receptor,1,1,1,,
400344,CHEMBL1472,PROTIRELIN,119,Thyrotropin-releasing hormone receptor agonist,AGONIST,260.0,CHEMBL1810,Thyrotropin-releasing hormone receptor,1,1,1,,
896873,CHEMBL1472989,BISOPROLOL FUMARATE,314,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
401141,CHEMBL1473,FLUTICASONE PROPIONATE,820,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
402531,CHEMBL1475,TRIOXSALEN,1871,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,Photodynamic therapy,
405364,CHEMBL1479,DANAZOL,1028,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,
405364,CHEMBL1479,DANAZOL,1333,Androgen Receptor agonist,AGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
405365,CHEMBL1480,FELODIPINE,663,Mineralocorticoid receptor antagonist,ANTAGONIST,48.0,CHEMBL1994,Mineralocorticoid receptor,1,1,1,,
405365,CHEMBL1480,FELODIPINE,1282,Voltage-gated L-type calcium channel blocker,BLOCKER,104801.0,CHEMBL2095229,Voltage-gated L-type calcium channel,1,1,1,,
405366,CHEMBL1481,GLIMEPIRIDE,1245,"Sulfonylurea receptor 1, Kir6.2 blocker",BLOCKER,104852.0,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",1,1,1,,
406787,CHEMBL1483,ALBENDAZOLE,1436,Tubulin inhibitor,INHIBITOR,106200.0,CHEMBL2364704,Tubulin,1,1,1,,
406787,CHEMBL1483,ALBENDAZOLE,1437,Tubulin inhibitor,INHIBITOR,106201.0,CHEMBL2364705,Tubulin,1,1,1,,
417163,CHEMBL1486,TENOFOVIR DISOPROXIL FUMARATE,825,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,,
418344,CHEMBL1488,URACIL MUSTARD,1856,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,Alkylating agent,
418401,CHEMBL1489,AZACITIDINE,652,DNA (cytosine-5)-methyltransferase 3A inhibitor,INHIBITOR,322.0,CHEMBL1992,DNA (cytosine-5)-methyltransferase 3A,1,1,1,,
418401,CHEMBL1489,AZACITIDINE,654,DNA (cytosine-5)-methyltransferase 1 inhibitor,INHIBITOR,321.0,CHEMBL1993,DNA (cytosine-5)-methyltransferase 1,1,1,1,,
418401,CHEMBL1489,AZACITIDINE,1873,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
418401,CHEMBL1489,AZACITIDINE,1894,RNA inhibitor,INHIBITOR,105575.0,CHEMBL2311222,RNA,1,1,1,,
419410,CHEMBL1497,BETAMETHASONE VALERATE,814,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
419542,CHEMBL1501,FLUOCINONIDE,792,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
419601,CHEMBL1503,OMEPRAZOLE,1080,Potassium-transporting ATPase inhibitor,INHIBITOR,104758.0,CHEMBL2095173,Potassium-transporting ATPase,1,1,1,,
419622,CHEMBL1504,TRIAMCINOLONE ACETONIDE,766,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
421032,CHEMBL1509,DROSPIRENONE,661,Mineralocorticoid receptor antagonist,ANTAGONIST,48.0,CHEMBL1994,Mineralocorticoid receptor,1,1,1,,
421032,CHEMBL1509,DROSPIRENONE,1027,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,
421038,CHEMBL1511,ESTRADIOL VALERATE,860,Estrogen receptor alpha agonist,AGONIST,19.0,CHEMBL206,Estrogen receptor,1,1,1,,
421058,CHEMBL1512,FLUNISOLIDE,776,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
421066,CHEMBL1513,IRBESARTAN,221,Type-1 angiotensin II receptor antagonist,ANTAGONIST,115.0,CHEMBL227,Type-1 angiotensin II receptor,1,1,1,,
421070,CHEMBL1514,LEVOMETHADYL ACETATE,9846,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
421089,CHEMBL1515,METHIMAZOLE,231,Thyroid peroxidase inhibitor,INHIBITOR,40.0,CHEMBL1839,Thyroid peroxidase,1,1,1,,
940358,CHEMBL1516474,TEGASEROD MALEATE,1334,Serotonin 4 (5-HT4) receptor partial agonist,PARTIAL AGONIST,168.0,CHEMBL1875,5-hydroxytryptamine receptor 4,1,1,1,,
421157,CHEMBL1517,OXYTETRACYCLINE,1753,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
421208,CHEMBL1518,PROPYLTHIOURACIL,232,Thyroid peroxidase inhibitor,INHIBITOR,40.0,CHEMBL1839,Thyroid peroxidase,1,1,1,,
421208,CHEMBL1518,PROPYLTHIOURACIL,1376,Type I iodothyronine deiodinase (Type-I 5'-deiodinase) (DIOI) (Type 1 DI) (5DI) inhibitor,INHIBITOR,19914.0,CHEMBL2019,Type I iodothyronine deiodinase,1,1,1,,
421317,CHEMBL1519,TRANDOLAPRIL,107,Angiotensin-converting enzyme inhibitor,INHIBITOR,69.0,CHEMBL1808,Angiotensin-converting enzyme,1,1,1,,
421332,CHEMBL1521,ZALEPLON,1633,GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,105087.0,CHEMBL2111392,GABA A receptor alpha-1/beta-1/gamma-2,1,1,1,,"Selective for the brain omega-1 receptor (i.e. BZ1-type, i.e. alpha1/beta1/gamma2-GABA receptor)"
421334,CHEMBL1522,ESZOPICLONE,1593,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
947848,CHEMBL1523964,EPHEDRINE SULFATE,7494,Adrenergic receptor agonist,AGONIST,105670.0,CHEMBL2331074,Adrenergic receptor,1,1,1,"Alpha and beta-adrenergic receptor agonist with direct effects that increase arterial pressures, cardiac output, and peripheral resistance. Indirectly causes release of norepinephrine from sympathetic neurons.",
421902,CHEMBL1525,PERMETHRIN,1738,Voltage-sensitive sodium channel blocker,BLOCKER,105697.0,CHEMBL2362985,Voltage-sensitive sodium channel,1,1,1,,
426067,CHEMBL1529,DIPHENIDOL HYDROCHLORIDE,290,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,antiemetic,
954312,CHEMBL1530428,DEXAMETHASONE ACETATE,803,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
428747,CHEMBL1531,ETONOGESTREL,1011,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,
428791,CHEMBL1532,QUINETHAZONE,348,Thiazide-sensitive sodium-chloride cotransporter inhibitor,INHIBITOR,151.0,CHEMBL1876,Solute carrier family 12 member 3,1,1,1,,
429174,CHEMBL1533,DESOGESTREL,1022,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,
957194,CHEMBL1533310,HISTAMINE DIHYDROCHLORIDE,10123,Topical analgesic,,,,,1,1,1,Mechanism_for_indication: Minor aches and pains.,
957194,CHEMBL1533310,HISTAMINE DIHYDROCHLORIDE,10129,Immunoprotectant,,,,,1,1,1,Mechanism_for_indication: Acute myeloid leukemia.,
958409,CHEMBL1534525,MIBEFRADIL DIHYDROCHLORIDE,2363,Voltage-gated T-type calcium channel blocker,BLOCKER,105707.0,CHEMBL2362995,Voltage-gated T-type calcium channel,1,1,1,,
430124,CHEMBL1536,ERGOCALCIFEROL,516,Vitamin D receptor agonist,AGONIST,64.0,CHEMBL1977,Vitamin D3 receptor,1,1,1,,
430546,CHEMBL1539,SULFADOXINE,680,Dihydropteroate synthetase inhibitor,INHIBITOR,325.0,CHEMBL2013,Dihydropteroate synthetase,1,1,1,,
51056,CHEMBL154,NAPROXEN,1173,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
430597,CHEMBL1540,PENCICLOVIR,6175,Human herpesvirus 1 DNA polymerase inhibitor,INHIBITOR,27.0,CHEMBL1872,DNA polymerase catalytic subunit,1,1,1,,
430642,CHEMBL1541,CEFIXIME,1713,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
431141,CHEMBL1542,AZATHIOPRINE,1744,Amidophosphoribosyltransferase inhibitor,INHIBITOR,105704.0,CHEMBL2362992,Amidophosphoribosyltransferase,1,1,1,Prodrug enzyme: hypoxanthine-guanine phosphoribosyl transferase (HGPRT; EC 2.4.2.8),
431141,CHEMBL1542,AZATHIOPRINE,1874,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,Prodrug enzyme: hypoxanthine-guanine phosphoribosyl transferase (HGPRT; EC 2.4.2.8),
433015,CHEMBL1544,LIOTHYRONINE,1303,Thyroid hormone receptor agonist,AGONIST,104987.0,CHEMBL2111462,Thyroid hormone receptor,1,1,1,,
439720,CHEMBL1549,HYDROCORTISONE CYPIONATE,767,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
442013,CHEMBL1551,URSODIOL,842,Bile acid receptor FXR agonist,AGONIST,11180.0,CHEMBL2047,Bile acid receptor,1,1,1,,
442943,CHEMBL1554,DACTINOMYCIN,1845,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
443255,CHEMBL1555,GALANTAMINE HYDROBROMIDE,741,Acetylcholinesterase inhibitor,INHIBITOR,93.0,CHEMBL220,Acetylcholinesterase,1,1,1,,
444077,CHEMBL1557,DOPAMINE HYDROCHLORIDE,319,Beta-1 adrenergic receptor agonist,AGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
444191,CHEMBL1558,PRAZOSIN HYDROCHLORIDE,1168,Adrenergic receptor alpha-1 antagonist,ANTAGONIST,104723.0,CHEMBL2094251,Adrenergic receptor alpha-1,1,1,1,,
444419,CHEMBL1559,MICONAZOLE NITRATE,1449,Cytochrome P450 51 inhibitor,INHIBITOR,58.0,CHEMBL1780,Lanosterol 14-alpha demethylase,1,1,1,,
444750,CHEMBL1560,CAPTOPRIL,114,Angiotensin-converting enzyme inhibitor,INHIBITOR,69.0,CHEMBL1808,Angiotensin-converting enzyme,1,1,1,,
445681,CHEMBL1561,MIGLITOL,872,Maltase-glucoamylase inhibitor,INHIBITOR,1.0,CHEMBL2074,Maltase-glucoamylase,1,1,1,,
445681,CHEMBL1561,MIGLITOL,930,Lysosomal alpha-glucosidase inhibitor,INHIBITOR,10977.0,CHEMBL2608,Lysosomal alpha-glucosidase,1,1,1,,
986494,CHEMBL1562610,MECLOFENAMATE SODIUM,269,Arachidonate 5-lipoxygenase inhibitor,INHIBITOR,55.0,CHEMBL215,Polyunsaturated fatty acid 5-lipoxygenase,1,1,1,,
986494,CHEMBL1562610,MECLOFENAMATE SODIUM,1181,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
446279,CHEMBL1563,DAUNORUBICIN HYDROCHLORIDE,101,DNA topoisomerase II alpha inhibitor,INHIBITOR,63.0,CHEMBL1806,DNA topoisomerase 2-alpha,1,1,1,,
446279,CHEMBL1563,DAUNORUBICIN HYDROCHLORIDE,1877,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
447448,CHEMBL1564,DIPHENYLPYRALINE HYDROCHLORIDE,169,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
450864,CHEMBL1567,SUNITINIB MALATE,236,Macrophage colony stimulating factor receptor inhibitor,INHIBITOR,12840.0,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,1,1,1,,
450864,CHEMBL1567,SUNITINIB MALATE,450,Stem cell growth factor receptor inhibitor,INHIBITOR,238.0,CHEMBL1936,Mast/stem cell growth factor receptor Kit,1,1,1,,
450864,CHEMBL1567,SUNITINIB MALATE,511,Tyrosine-protein kinase receptor FLT3 inhibitor,INHIBITOR,12670.0,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,1,1,1,,
450864,CHEMBL1567,SUNITINIB MALATE,1118,Platelet-derived growth factor receptor inhibitor,INHIBITOR,104773.0,CHEMBL2095189,Platelet-derived growth factor receptor,1,1,1,,
450864,CHEMBL1567,SUNITINIB MALATE,1263,Vascular endothelial growth factor receptor inhibitor,INHIBITOR,104799.0,CHEMBL2095227,Vascular endothelial growth factor receptor,1,1,1,,
450864,CHEMBL1567,SUNITINIB MALATE,1518,Tyrosine-protein kinase receptor RET inhibitor,INHIBITOR,100079.0,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,1,1,1,,
991212,CHEMBL1567328,OMEPRAZOLE MAGNESIUM,1082,Potassium-transporting ATPase inhibitor,INHIBITOR,104758.0,CHEMBL2095173,Potassium-transporting ATPase,1,1,1,,
16521,CHEMBL15677,FENCLOFENAC,6244,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,"It acts by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions.",
991941,CHEMBL1568057,METAPROTERENOL SULFATE,1350,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
992160,CHEMBL1568276,NAFCILLIN SODIUM,1735,Penicillin-binding protein inhibitor,INHIBITOR,105685.0,CHEMBL2362972,Penicillin-binding protein,1,1,1,,
992582,CHEMBL1568698,GANAXOLONE,5887,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,"It binds to both, synaptic and extrasynaptic GABA A receptors and acts most potently and effectively at GABA A receptors containing the delta-subunits, potentiating both tonic and phasic inhibition.",
452635,CHEMBL1569,AMANTADINE HYDROCHLORIDE,1128,Glutamate [NMDA] receptor antagonist,ANTAGONIST,104706.0,CHEMBL2094124,Glutamate [NMDA] receptor,1,1,1,Indicated for Parkinson's disease,
452635,CHEMBL1569,AMANTADINE HYDROCHLORIDE,1290,Matrix protein 2 inhibitor,INHIBITOR,104398.0,CHEMBL1932894,Matrix protein 2,1,1,1,Antiviral activity,
453121,CHEMBL1571,TESTOLACTONE,522,Cytochrome P450 19A1 inhibitor,INHIBITOR,65.0,CHEMBL1978,Aromatase,1,1,1,,
255904,CHEMBL157101,KETOCONAZOLE,1445,Cytochrome P450 51 inhibitor,INHIBITOR,58.0,CHEMBL1780,Lanosterol 14-alpha demethylase,1,1,1,,
453532,CHEMBL1574,PHENTERMINE,880,Norepinephrine transporter releasing agent,RELEASING AGENT,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
453564,CHEMBL1577,METHYCLOTHIAZIDE,349,Thiazide-sensitive sodium-chloride cotransporter inhibitor,INHIBITOR,151.0,CHEMBL1876,Solute carrier family 12 member 3,1,1,1,,
16510,CHEMBL15770,SULINDAC,1196,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
453573,CHEMBL1578,ANISOTROPINE METHYLBROMIDE,29,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Role in regulating gastric secretion, M3 likely involved",
453573,CHEMBL1578,ANISOTROPINE METHYLBROMIDE,279,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Role in regulating gastric secretion, M1 likely involved",
61680,CHEMBL158,AZTREONAM,1686,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
453578,CHEMBL1580,PENTOSTATIN,389,Adenosine deaminase inhibitor,INHIBITOR,14.0,CHEMBL1910,Adenosine deaminase,1,1,1,,
453721,CHEMBL1584,PIPERACETAZINE,9857,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
453722,CHEMBL1585,PIPOBROMAN,1863,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,Alkylating agent,
453832,CHEMBL1587,POLYTHIAZIDE,355,Thiazide-sensitive sodium-chloride cotransporter inhibitor,INHIBITOR,151.0,CHEMBL1876,Solute carrier family 12 member 3,1,1,1,,
16599,CHEMBL15870,INDOPROFEN,6255,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,"It is a cyclooxygenase inhibitor. This prevents the conversion of arachidonic acid into prostaglandins, which are involved in the regulation of pain, inflammation, and fever.",
454070,CHEMBL1589,ACETOHEXAMIDE,1250,"Sulfonylurea receptor 1, Kir6.2 blocker",BLOCKER,104852.0,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",1,1,1,,
16654,CHEMBL15891,LINDANE,2031,GABA-A receptor negative allosteric modulator,NEGATIVE ALLOSTERIC MODULATOR,106003.0,CHEMBL2364024,GABA-A receptor,1,1,1,"mode not clear, but seems negative and likely allosteric, binds at picrotoxin site?",
16654,CHEMBL15891,LINDANE,2032,GABA-A receptor negative allosteric modulator,NEGATIVE ALLOSTERIC MODULATOR,106004.0,CHEMBL2364025,GABA-A receptor,1,1,1,"mode not clear, but seems negative and likely allosteric, binds at picrotoxin site?",
1015985,CHEMBL1592101,BISMUTH SUBGALLATE,6483,Coagulation factor XII activator,ACTIVATOR,11288.0,CHEMBL2821,Coagulation factor XII,1,1,1,Bismuth subgallate activates factor XII (Hageman factor) and therefore accelerates the coagulation cascade thus promoting rapid haemostasis.,
265957,CHEMBL159226,MOXISYLYTE,6270,Adrenergic receptor alpha antagonist,ANTAGONIST,104787.0,CHEMBL2095203,Adrenergic receptor alpha,1,1,1,"Moxisylyte reduces or blocks the response to adrenaline. Because of its alpha-blocking properties, it competitively inhibits the effects of noradrenaline without effect on beta and 5-hydroxytriptamine receptors.","Moderate specificity for alpha-1 receptors. IC50 value of 86 nM was obtained for native alpha 1A subtypes from rat submaxillary gland and an IC50 value of 39 nM for native alpha-1B subtypes from rat liver. No affinity for beta adrenoceptors, D1, 5HT1A and 5HT2 receptors and moderate affinity for H1 receptors. On the native receptor subtypes also, deacetylmoxisylyte (DAM), the main active metabolite, had the same affinity as moxisylyte (IC50=25 nM for alpha1A subtypes and 34nM for alpha1B subtypes)"
454382,CHEMBL1597,DIMERCAPROL,1555,Heavy metals chelating agent,CHELATING AGENT,105748.0,CHEMBL2363053,Heavy metals,1,1,1,gold/arsenic/mercury,
921,CHEMBL16,PHENYTOIN,1987,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
72873,CHEMBL160,CYCLOSPORINE,474,Cyclophilin A modulator,MODULATOR,180.0,CHEMBL1949,Peptidyl-prolyl cis-trans isomerase A,1,1,1,,
454576,CHEMBL1604,CEPHRADINE,1681,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
454578,CHEMBL1605,CEFTIBUTEN,1709,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
456266,CHEMBL1607,TOPOTECAN HYDROCHLORIDE,1742,DNA topoisomerase I inhibitor,INHIBITOR,62.0,CHEMBL1781,DNA topoisomerase 1,1,1,1,,
1031157,CHEMBL1607273,CETIRIZINE HYDROCHLORIDE,143,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
1031364,CHEMBL1607480,OXYTETRACYCLINE HYDROCHLORIDE,1777,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
458912,CHEMBL1611,PHENYTOIN SODIUM,1967,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
465356,CHEMBL1614,DESLANOSIDE,1583,Sodium/potassium-transporting ATPase inhibitor,INHIBITOR,104770.0,CHEMBL2095186,Sodium/potassium-transporting ATPase,1,1,1,,
1037712,CHEMBL1614701,SELUMETINIB,4647,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,INHIBITOR,11409.0,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,1,1,1,Non-adenosine-5'-triphosphate (ATP) competitive inhibitor,
1037712,CHEMBL1614701,SELUMETINIB,4648,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,INHIBITOR,11046.0,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,1,1,1,Non-adenosine-5'-triphosphate (ATP) competitive inhibitor,
1038352,CHEMBL1615369,DABIGATRAN ETEXILATE MESYLATE,77,Thrombin inhibitor,INHIBITOR,11.0,CHEMBL204,Prothrombin,1,1,1,,
1038355,CHEMBL1615372,LURASIDONE HYDROCHLORIDE,589,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
1038355,CHEMBL1615372,LURASIDONE HYDROCHLORIDE,2022,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,403,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,473,Serotonin 1a (5-HT1a) receptor partial agonist,PARTIAL AGONIST,51.0,CHEMBL214,5-hydroxytryptamine receptor 1A,1,1,1,,
1038730,CHEMBL1615779,IOBENGUANE I 131,7593,Norepinephrine transporter substrate,SUBSTRATE,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,"Is similar in structure to the neurotransmitter norepinephrine (NE) and is taken up by the NE transporter and accumulates in adrenergically innervated tissues, including tumors of neural crest origin that express high levels of surface NE transporter. Radiation causes cell death.",
466768,CHEMBL1617,RIFAXIMIN,1389,Bacterial DNA-directed RNA polymerase inhibitor,INHIBITOR,106172.0,CHEMBL2364672,Bacterial DNA-directed RNA polymerase,1,1,1,,
466810,CHEMBL1618,CEFAMANDOLE NAFATE,1679,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
467361,CHEMBL1619,CLADRIBINE,1867,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,"Activated by the deoxycytidine kinase to a toxic compound, which then gets incorporated into DNA",
468199,CHEMBL1620,DIPHENHYDRAMINE HYDROCHLORIDE,162,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
468656,CHEMBL1621,PALIPERIDONE,211,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
468656,CHEMBL1621,PALIPERIDONE,596,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
469732,CHEMBL1625,OXYBENZONE,8941,Sunscreen,,,,,1,1,1,,
1049461,CHEMBL1626570,HEXOCYCLIUM METHYLSULFATE,25,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Role in regulating gastric secretion, M3 likely involved",
1049461,CHEMBL1626570,HEXOCYCLIUM METHYLSULFATE,283,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Role in regulating gastric secretion, M1 likely involved",
1051118,CHEMBL1628227,DOXEPIN,10124,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,"Mechanism_for_indication: pruritis, insomnia",
1051124,CHEMBL1628233,FLUORESCEIN SODIUM,8850,Disclosing agent,,,,,1,1,1,,
1051125,CHEMBL1628234,DOXEPIN HYDROCHLORIDE,881,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,reuptake inhibitor,
1051353,CHEMBL1628502,GABAPENTIN ENACARBIL,1922,Voltage-gated calcium channel modulator,MODULATOR,105734.0,CHEMBL2363032,Voltage-gated calcium channel,1,1,1,,
1051355,CHEMBL1628504,RILPIVIRINE HYDROCHLORIDE,832,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,,
88100,CHEMBL163,RITONAVIR,1491,Human immunodeficiency virus type 1 protease inhibitor,INHIBITOR,191.0,CHEMBL243,Human immunodeficiency virus type 1 protease,1,1,1,,
88100,CHEMBL163,RITONAVIR,8613,Cytochrome P450 3A inhibitor,INHIBITOR,106175.0,CHEMBL2364675,Cytochrome P450 3A,1,1,1,This drug is a viral protease inhibitor but in new co-formulations is used to inhibit cytochrome P450s and boost concentration of co-administered antivirals.,
1054485,CHEMBL1631694,FEXINIDAZOLE,8442,Cytotoxic,,,,,1,1,1,Nitro pro-drug that is reduced to form cytotoxic species,Potential in leishmaniasis and trypanosomiasis
478059,CHEMBL1632,CEPHALOTHIN SODIUM,1687,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
479129,CHEMBL1633,KETOTIFEN FUMARATE,170,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
480382,CHEMBL1637,GEMCITABINE HYDROCHLORIDE,1260,Ribonucleoside-diphosphate reductase RR1 inhibitor,INHIBITOR,104791.0,CHEMBL2095215,Ribonucleoside-diphosphate reductase RR1,1,1,1,,
480382,CHEMBL1637,GEMCITABINE HYDROCHLORIDE,1918,DNA polymerase (alpha/delta/epsilon) inhibitor,INHIBITOR,105737.0,CHEMBL2363042,DNA polymerase (alpha/delta/epsilon),1,1,1,,
482031,CHEMBL1640,TRYPAN BLUE,9548,Diagnostic,,,,,1,1,1,,
485100,CHEMBL1642,IMATINIB MESYLATE,304,Tyrosine-protein kinase ABL inhibitor,INHIBITOR,8.0,CHEMBL1862,Tyrosine-protein kinase ABL1,1,1,1,,
485100,CHEMBL1642,IMATINIB MESYLATE,418,Platelet-derived growth factor receptor beta inhibitor,INHIBITOR,197.0,CHEMBL1913,Platelet-derived growth factor receptor beta,1,1,1,,
485100,CHEMBL1642,IMATINIB MESYLATE,451,Stem cell growth factor receptor inhibitor,INHIBITOR,238.0,CHEMBL1936,Mast/stem cell growth factor receptor Kit,1,1,1,,
485100,CHEMBL1642,IMATINIB MESYLATE,8630,Bcr/Abl fusion protein inhibitor,INHIBITOR,104811.0,CHEMBL2096618,Bcr/Abl fusion protein,1,1,1,,
485738,CHEMBL1643,RIBAVIRIN,126,Inosine-5'-monophosphate dehydrogenase 1 inhibitor,INHIBITOR,84.0,CHEMBL1822,Inosine-5'-monophosphate dehydrogenase 1,1,1,1,,
485738,CHEMBL1643,RIBAVIRIN,1006,RNA-directed RNA polymerase inhibitor,INHIBITOR,118447.0,CHEMBL4296320,RNA-directed RNA polymerase,1,1,1,,
485738,CHEMBL1643,RIBAVIRIN,1580,RNA inhibitor,INHIBITOR,105768.0,CHEMBL2363073,RNA,1,1,1,,
485902,CHEMBL1644,CEFADROXIL,1705,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
18271,CHEMBL16476,PRONETALOL,6290,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,Non-selective beta blocker clinical candidate. It was never used clinically.,
18271,CHEMBL16476,PRONETALOL,6897,Beta-2 adrenergic receptor antagonist,ANTAGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,Non-selective beta blocker clinical candidate. It was never used clinically.,
486789,CHEMBL1648,ISRADIPINE,1271,Voltage-gated L-type calcium channel blocker,BLOCKER,104801.0,CHEMBL2095229,Voltage-gated L-type calcium channel,1,1,1,,
487711,CHEMBL1650,CORTISONE ACETATE,815,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
1062842,CHEMBL1650818,AMDINOCILLIN PIVOXIL,9985,Bacterial penicillin-binding protein 2 inhibitor,INHIBITOR,105684.0,CHEMBL2354313,"Peptidoglycan D,D-transpeptidase MrdA",1,1,1,,
490981,CHEMBL1653,PHENIRAMINE MALEATE,163,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
494630,CHEMBL1654,RISEDRONATE SODIUM,1048,Farnesyl diphosphate synthase inhibitor,INHIBITOR,71.0,CHEMBL1782,Farnesyl pyrophosphate synthase,1,1,1,"Binds to the bone matrix (hydroxyapatite), and when the bone starts to be reabsorbed the compound is released and taken up by osteoclasts, inhibiting protein prenylation of the GTPases involved in the formation of the ruffled border",
495572,CHEMBL1657,TAZAROTENE,1574,Retinoic acid receptor agonist,AGONIST,105764.0,CHEMBL2363069,Retinoic acid receptor,1,1,1,,
496769,CHEMBL1658,RETAPAMULIN,1833,70S ribosome inhibitor,INHIBITOR,106075.0,CHEMBL2364096,70S ribosome,1,1,1,Indicated for staph aur and strep pyogenes.,
496769,CHEMBL1658,RETAPAMULIN,1834,70S ribosome inhibitor,INHIBITOR,106082.0,CHEMBL2364103,70S ribosome,1,1,1,Indicated for staph aur and strep pyogenes.,
496910,CHEMBL1659,CHLORPHENIRAMINE MALEATE,148,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
497291,CHEMBL1660,RIFAPENTINE,1388,Bacterial DNA-directed RNA polymerase inhibitor,INHIBITOR,106172.0,CHEMBL2364672,Bacterial DNA-directed RNA polymerase,1,1,1,,
497330,CHEMBL1661,LACTITOL,7485,Osmotic agent,,,,,1,1,1,Osmotic agent with a laxative effect in the colon. ,
503213,CHEMBL1668,RESCINNAMINE,1478,Synaptic vesicular amine transporter inhibitor,INHIBITOR,162.0,CHEMBL1893,Synaptic vesicular amine transporter,1,1,1,,
504310,CHEMBL1670,MITOTANE,759,Cytochrome P450 11A1 inhibitor,INHIBITOR,32.0,CHEMBL2033,"Cholesterol side-chain cleavage enzyme, mitochondrial",1,1,1,,
504310,CHEMBL1670,MITOTANE,1369,Cytochrome P450 11B1 inhibitor,INHIBITOR,76.0,CHEMBL1908,"Cytochrome P450 11B1, mitochondrial",1,1,1,,
505776,CHEMBL1671,PROPRANOLOL HYDROCHLORIDE,321,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
505776,CHEMBL1671,PROPRANOLOL HYDROCHLORIDE,1359,Beta-2 adrenergic receptor antagonist,ANTAGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
508532,CHEMBL1676,FLUTICASONE FUROATE,793,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
508604,CHEMBL1677,TACRINE HYDROCHLORIDE,1287,Cholinesterases; ACHE & BCHE inhibitor,INHIBITOR,104805.0,CHEMBL2095233,Cholinesterases; ACHE & BCHE,1,1,1,,
280181,CHEMBL167731,PIXANTRONE,5730,DNA cross-linking agent,CROSS-LINKING AGENT,105574.0,CHEMBL2311221,DNA,1,1,1,Forms formaldehyde-mediated adducts with DNA (favours the CpG motif) and stimulates topoisomerase II-mediated DNA cleavage,
508667,CHEMBL1678,DONEPEZIL HYDROCHLORIDE,738,Acetylcholinesterase inhibitor,INHIBITOR,93.0,CHEMBL220,Acetylcholinesterase,1,1,1,,
515027,CHEMBL1683,HYDROCORTISONE BUTYRATE,804,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
1073669,CHEMBL1683544,ERIBULIN MESYLATE,1104,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,,
515239,CHEMBL1684,BENDROFLUMETHIAZIDE,351,Thiazide-sensitive sodium-chloride cotransporter inhibitor,INHIBITOR,151.0,CHEMBL1876,Solute carrier family 12 member 3,1,1,1,,
518361,CHEMBL1685,DEZOCINE,729,Mu opioid receptor partial agonist,PARTIAL AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
518361,CHEMBL1685,DEZOCINE,1308,Kappa opioid receptor antagonist,ANTAGONIST,137.0,CHEMBL237,Kappa-type opioid receptor,1,1,1,,
524710,CHEMBL1689,TOLAZOLINE HYDROCHLORIDE,178,Histamine H1 receptor agonist,AGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
524710,CHEMBL1689,TOLAZOLINE HYDROCHLORIDE,464,Histamine H2 receptor agonist,AGONIST,102.0,CHEMBL1941,Histamine H2 receptor,1,1,1,,
524710,CHEMBL1689,TOLAZOLINE HYDROCHLORIDE,1240,Adrenergic receptor alpha antagonist,ANTAGONIST,104787.0,CHEMBL2095203,Adrenergic receptor alpha,1,1,1,,
529987,CHEMBL1690,HYDROXYCHLOROQUINE SULFATE,1005,Ferriprotoporphyrin IX inhibitor,INHIBITOR,100262.0,CHEMBL613897,Ferriprotoporphyrin IX,1,1,1,inhibits polymerisation,
529987,CHEMBL1690,HYDROXYCHLOROQUINE SULFATE,1441,Toll-like receptor 7 antagonist,ANTAGONIST,101608.0,CHEMBL5936,Toll-like receptor 7,1,1,1,,
529987,CHEMBL1690,HYDROXYCHLOROQUINE SULFATE,1582,Toll-like receptor 9 antagonist,ANTAGONIST,101567.0,CHEMBL5804,Toll-like receptor 9,1,1,1,,
543228,CHEMBL1691,BETAXOLOL HYDROCHLORIDE,325,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,Selective
543658,CHEMBL1692,IMIPRAMINE HYDROCHLORIDE,410,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
543658,CHEMBL1692,IMIPRAMINE HYDROCHLORIDE,919,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
543703,CHEMBL1693,DIETHYLPROPION HYDROCHLORIDE,697,Dopamine transporter inhibitor,INHIBITOR,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
543703,CHEMBL1693,DIETHYLPROPION HYDROCHLORIDE,895,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
544432,CHEMBL1694,BENAZEPRIL HYDROCHLORIDE,113,Angiotensin-converting enzyme inhibitor,INHIBITOR,69.0,CHEMBL1808,Angiotensin-converting enzyme,1,1,1,,
544765,CHEMBL1695,TIAGABINE HYDROCHLORIDE,1368,GABA transporter 1 inhibitor,INHIBITOR,113.0,CHEMBL1903,Sodium- and chloride-dependent GABA transporter 1,1,1,1,reuptake inhibitor,
545075,CHEMBL1696,DESIPRAMINE HYDROCHLORIDE,882,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,"Mechanism_for_indication: depression. Higher activity against the norepinephrine transporter, weaker binding against the serotonin transporter. Reuptake inhibitor.",
545509,CHEMBL1697,DILTIAZEM HYDROCHLORIDE,1272,Voltage-gated L-type calcium channel blocker,BLOCKER,104801.0,CHEMBL2095229,Voltage-gated L-type calcium channel,1,1,1,,
1078476,CHEMBL1697708,MEZLOCILLIN SODIUM,1727,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
1078532,CHEMBL1697768,SODIUM PICOSULFATE,7834,Stimulant laxative,,,,,1,1,1,,
545956,CHEMBL1698,BUPROPION HYDROCHLORIDE,690,Dopamine transporter inhibitor,INHIBITOR,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
545956,CHEMBL1698,BUPROPION HYDROCHLORIDE,907,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
545974,CHEMBL1699,MEMANTINE HYDROCHLORIDE,1129,Glutamate [NMDA] receptor negative allosteric modulator,NEGATIVE ALLOSTERIC MODULATOR,104706.0,CHEMBL2094124,Glutamate [NMDA] receptor,1,1,1,,
1085,CHEMBL17,DICHLORPHENAMIDE,16,Carbonic anhydrase I inhibitor,INHIBITOR,10193.0,CHEMBL261,Carbonic anhydrase 1,1,1,1,,
1085,CHEMBL17,DICHLORPHENAMIDE,89,Carbonic anhydrase II inhibitor,INHIBITOR,15.0,CHEMBL205,Carbonic anhydrase 2,1,1,1,,
1085,CHEMBL17,DICHLORPHENAMIDE,927,Carbonic anhydrase XII inhibitor,INHIBITOR,12209.0,CHEMBL3242,Carbonic anhydrase 12,1,1,1,,
1085,CHEMBL17,DICHLORPHENAMIDE,956,Carbonic anhydrase IV inhibitor,INHIBITOR,12896.0,CHEMBL3729,Carbonic anhydrase 4,1,1,1,,
546564,CHEMBL1700,SOTALOL HYDROCHLORIDE,323,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
546564,CHEMBL1700,SOTALOL HYDROCHLORIDE,504,HERG blocker,BLOCKER,165.0,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,1,1,1,,
546564,CHEMBL1700,SOTALOL HYDROCHLORIDE,1361,Beta-2 adrenergic receptor antagonist,ANTAGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
547402,CHEMBL1701,MEPERIDINE HYDROCHLORIDE,717,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
547576,CHEMBL1702,ATOMOXETINE HYDROCHLORIDE,885,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,reuptake inhibitor,
547681,CHEMBL1703,METFORMIN HYDROCHLORIDE,1570,Mitochondrial complex I (NADH dehydrogenase) inhibitor,INHIBITOR,105760.0,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),1,1,1,May not be direct target,
547681,CHEMBL1703,METFORMIN HYDROCHLORIDE,2370,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,INHIBITOR,109555.0,CHEMBL3391681,"Glycerol-3-phosphate dehydrogenase, mitochondrial",1,1,1,,
548124,CHEMBL1705,CLONIDINE HYDROCHLORIDE,1142,Adrenergic receptor alpha-2 agonist,AGONIST,104743.0,CHEMBL2095158,Adrenergic receptor alpha-2,1,1,1,,
548594,CHEMBL1706,NAPHAZOLINE HYDROCHLORIDE,1234,Adrenergic receptor alpha agonist,AGONIST,104787.0,CHEMBL2095203,Adrenergic receptor alpha,1,1,1,,
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,706,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
549372,CHEMBL1709,SERTRALINE HYDROCHLORIDE,399,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,reuptake inhibitor,
550053,CHEMBL1711,ISOPROTERENOL HYDROCHLORIDE,1125,Adrenergic receptor beta agonist,AGONIST,104700.0,CHEMBL2094118,Adrenergic receptor beta,1,1,1,,
1093573,CHEMBL1712842,MEPAZINE ACETATE,6260,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 inhibitor,INHIBITOR,109917.0,CHEMBL3632452,Mucosa-associated lymphoid tissue lymphoma translocation protein 1,1,1,1,"Mepazine is a small molecule inhibitor of the mucosa-associated lymphoid tissue lymphoma translocation protein-1 (MALT1). It selectively inhibits the cleavage activity of recombinant and cellular MALT1 by a noncompetitive mechanism. Consequently, it inhibits anti-apoptotic NF-kB signaling and elicits toxic effects selectively on MALT1-dependent ABC-DLBCL cells in vitro and in vivo.",
550303,CHEMBL1713,CHLORPROMAZINE HYDROCHLORIDE,578,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
550303,CHEMBL1713,CHLORPROMAZINE HYDROCHLORIDE,2006,D2-like dopamine receptor antagonist,ANTAGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
550657,CHEMBL1714,KETAMINE HYDROCHLORIDE,1132,Glutamate [NMDA] receptor negative allosteric modulator,NEGATIVE ALLOSTERIC MODULATOR,104706.0,CHEMBL2094124,Glutamate [NMDA] receptor,1,1,1,,
1095305,CHEMBL1714574,TERCONAZOLE,1448,Cytochrome P450 51 inhibitor,INHIBITOR,58.0,CHEMBL1780,Lanosterol 14-alpha demethylase,1,1,1,,
550857,CHEMBL1715,PIOGLITAZONE HYDROCHLORIDE,422,Peroxisome proliferator-activated receptor gamma agonist,AGONIST,133.0,CHEMBL235,Peroxisome proliferator-activated receptor gamma,1,1,1,,
19569,CHEMBL17157,TERFENADINE,6308,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,"In humans, terfenadine is well absorbed and it is metabolized by two routes, i.e. N-dealkylation to azacyclonol and hydroxylation of the t-butyl group to form hydroxyterfenadine. Hydroxyterfenadine undergoes subsequent oxidation to the corresponding carboxylic acid, which is thought to be the biologically active antihistamine.",
550917,CHEMBL1716,CYPROHEPTADINE HYDROCHLORIDE,136,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
551003,CHEMBL1717,TICLOPIDINE HYDROCHLORIDE,1502,Purinergic receptor P2Y12 antagonist,ANTAGONIST,176.0,CHEMBL2001,P2Y purinoceptor 12,1,1,1,,
551147,CHEMBL1718,NALOXONE HYDROCHLORIDE,1098,Opioid receptors; mu/kappa/delta antagonist,ANTAGONIST,104765.0,CHEMBL2095181,Opioid receptors; mu/kappa/delta,1,1,1,,
551224,CHEMBL1719,OLOPATADINE HYDROCHLORIDE,144,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
551486,CHEMBL1720,PALONOSETRON HYDROCHLORIDE,377,Serotonin 3a (5-HT3a) receptor antagonist,ANTAGONIST,144.0,CHEMBL1899,5-hydroxytryptamine receptor 3A,1,1,1,,
552883,CHEMBL1722,METHYLPHENIDATE HYDROCHLORIDE,699,Dopamine transporter inhibitor,INHIBITOR,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
552883,CHEMBL1722,METHYLPHENIDATE HYDROCHLORIDE,910,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
1102940,CHEMBL1722209,TOLTERODINE TARTRATE,21,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for overactive bladder, M3 likely responsible",
1102940,CHEMBL1722209,TOLTERODINE TARTRATE,1515,Muscarinic acetylcholine receptor M2 antagonist,ANTAGONIST,47.0,CHEMBL211,Muscarinic acetylcholine receptor M2,1,1,1,"Indicated for overactive bladder, M2 likely responsible",
553490,CHEMBL1723,ALFUZOSIN HYDROCHLORIDE,1161,Adrenergic receptor alpha-1 agonist,AGONIST,104723.0,CHEMBL2094251,Adrenergic receptor alpha-1,1,1,1,,
1103972,CHEMBL1723241,SULFACETAMIDE SODIUM,1652,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,Broad spectrum
554127,CHEMBL1724,MEPENZOLATE BROMIDE,24,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Role in regulating gastric secretion, M3 likely involved",
554127,CHEMBL1724,MEPENZOLATE BROMIDE,278,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Role in regulating gastric secretion, M1 likely involved",
554892,CHEMBL1726,NISOLDIPINE,1281,Voltage-gated L-type calcium channel blocker,BLOCKER,104801.0,CHEMBL2095229,Voltage-gated L-type calcium channel,1,1,1,,
557467,CHEMBL1728,LOMEFLOXACIN HYDROCHLORIDE,1908,Bacterial DNA gyrase inhibitor,INHIBITOR,105577.0,CHEMBL2311224,Bacterial DNA gyrase,1,1,1,,
563318,CHEMBL1735,INDINAVIR SULFATE,1499,Human immunodeficiency virus type 1 protease inhibitor,INHIBITOR,191.0,CHEMBL243,Human immunodeficiency virus type 1 protease,1,1,1,,
563318,CHEMBL1735,INDINAVIR SULFATE,9851,Human immunodeficiency virus type 1 protease inhibitor,INHIBITOR,191.0,CHEMBL243,Human immunodeficiency virus type 1 protease,1,1,1,,Approximately tenfold selectivity for HIV1 over HIV2 proteinase.
564291,CHEMBL1737,SILDENAFIL CITRATE,187,Phosphodiesterase 5A inhibitor,INHIBITOR,3.0,CHEMBL1827,"cGMP-specific 3',5'-cyclic phosphodiesterase",1,1,1,,
567195,CHEMBL1738,DEXRAZOXANE,9066,Iron sequestering agent,SEQUESTERING AGENT,105753.0,CHEMBL2363058,Iron,1,1,1,Detoxifying agents for antineoplastic agents. Chelation of iron by the hydrolysis products of dexrazoxane is thought to be the primary mechanism (PMID: 17652819).,
567195,CHEMBL1738,DEXRAZOXANE,9076,DNA topoisomerase II inhibitor,INHIBITOR,104727.0,CHEMBL2094255,DNA topoisomerase II,1,1,1,Detoxifying agents for antineoplastic agents. Chelation of iron by the hydrolysis products of dexrazoxane is thought to be the primary mechanism (PMID: 17652819).,
567201,CHEMBL1739,METOCURINE IODIDE,1535,Muscle-type nicotinic acetylcholine receptor antagonist,ANTAGONIST,105709.0,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,1,1,1,,
305519,CHEMBL174,AMPICILLIN,1711,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
570147,CHEMBL1741,CLARITHROMYCIN,1787,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,Broad spectrum
1121337,CHEMBL1742466,LANDIOLOL,7753,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,The selectivity for beta-1-receptor blockade is 255 times higher than for beta-2-receptor.
1121342,CHEMBL1742471,EBROTIDINE,6240,Histamine H2 receptor antagonist,ANTAGONIST,102.0,CHEMBL1941,Histamine H2 receptor,1,1,1,"Ebrotidine is the first of a new generation of H2 receptor antagonists with gastroprotective activity. It stimulates epithelial cell proliferative activity and produces beneficial physicochemical changes in the gastric mucus that contribute to its gastro-protective action against ethanol-, aspirin- or stress-induced gastric mucosal damage. The antisecretory properties of ebrotidine are similar to those of ranitidine and approximately 10-fold greater than those of cimetidine. This drug exhibits anti-Helicobacter pylori activity that is synergistic with a number of antibacterial agents; it inhibits the urease enzyme and the proteolytic and mucolytic activities of H. pylori, and counteracts the inhibitory effects of H. pylori lipo-polysaccharide.",
1121342,CHEMBL1742471,EBROTIDINE,6863,Urease inhibitor,INHIBITOR,100923.0,CHEMBL5325,Urease,1,1,1,"Ebrotidine is the first of a new generation of H2 receptor antagonists with gastroprotective activity. It stimulates epithelial cell proliferative activity and produces beneficial physicochemical changes in the gastric mucus that contribute to its gastro-protective action against ethanol-, aspirin- or stress-induced gastric mucosal damage. The antisecretory properties of ebrotidine are similar to those of ranitidine and approximately 10-fold greater than those of cimetidine. This drug exhibits anti-Helicobacter pylori activity that is synergistic with a number of antibacterial agents; it inhibits the urease enzyme and the proteolytic and mucolytic activities of H. pylori, and counteracts the inhibitory effects of H. pylori lipo-polysaccharide.",
1121853,CHEMBL1742982,AFLIBERCEPT,57,Vascular endothelial growth factor A inhibitor,INHIBITOR,187.0,CHEMBL1783,"Vascular endothelial growth factor A, long form",1,1,1,,
1121853,CHEMBL1742982,AFLIBERCEPT,1035,Placenta growth factor inhibitor,INHIBITOR,103950.0,CHEMBL1697671,Placenta growth factor,1,1,1,,
1121861,CHEMBL1742990,BELATACEPT,1410,T-lymphocyte activation antigen CD86 inhibitor,INHIBITOR,106135.0,CHEMBL2364156,T-lymphocyte activation antigen CD86,1,1,1,,
1121861,CHEMBL1742990,BELATACEPT,1413,T-lymphocyte activation antigen CD80 inhibitor,INHIBITOR,106136.0,CHEMBL2364157,T-lymphocyte activation antigen CD80,1,1,1,,
1121862,CHEMBL1742991,BENRALIZUMAB,5444,Interleukin-5 receptor subunit alpha inhibitor,INHIBITOR,109779.0,CHEMBL3580483,Interleukin-5 receptor subunit alpha,1,1,1,"Binds to an epitope on IL5RA which is in close proximity to the IL-5 binding site and thus inhibits IL-5 receptor signaling, independent of ligand.",
1121863,CHEMBL1742992,BLINATUMOMAB,2322,T cell surface glycoprotein CD3 cross-linking agent,CROSS-LINKING AGENT,106147.0,CHEMBL2364168,T cell surface glycoprotein CD3,1,1,1,,
1121863,CHEMBL1742992,BLINATUMOMAB,2323,B-lymphocyte antigen CD19 cross-linking agent,CROSS-LINKING AGENT,109546.0,CHEMBL3390821,B-lymphocyte antigen CD19,1,1,1,,
1121865,CHEMBL1742994,BRENTUXIMAB VEDOTIN,1101,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,,
1121865,CHEMBL1742994,BRENTUXIMAB VEDOTIN,1419,Tumor necrosis factor receptor superfamily member 8 binding agent,BINDING AGENT,106140.0,CHEMBL2364161,Tumor necrosis factor receptor superfamily member 8,1,1,1,,
1121867,CHEMBL1742996,BRODALUMAB,5448,Interleukin-17 receptor A antagonist,ANTAGONIST,109781.0,CHEMBL3580485,Interleukin-17 receptor A,1,1,1,,
1121878,CHEMBL1743007,DARATUMUMAB,2425,Lymphocyte differentiation antigen CD38 inhibitor,INHIBITOR,100622.0,CHEMBL4660,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1,1,1,,
1121881,CHEMBL1743010,ELOTUZUMAB,2428,SLAM family member 7 inhibitor,INHIBITOR,109709.0,CHEMBL3559386,SLAM family member 7,1,1,1,,
1121900,CHEMBL1743029,IBALIZUMAB,6004,T-cell surface antigen CD4 inhibitor,INHIBITOR,10476.0,CHEMBL2754,T-cell surface glycoprotein CD4,1,1,1,"Binds CD4, the primary receptor for human immunodeficiency virus type 1 (HIV-1), and inhibits the viral entry process.",
1121905,CHEMBL1743034,IXEKIZUMAB,5514,Interleukin 17A inhibitor,INHIBITOR,109547.0,CHEMBL3390822,Interleukin-17A,1,1,1,,
1121906,CHEMBL1743035,LEBRIKIZUMAB,5458,Interleukin-13 inhibitor,INHIBITOR,109782.0,CHEMBL3580486,Interleukin-13,1,1,1,,
1121906,CHEMBL1743035,LEBRIKIZUMAB,6376,Interleukin-13 inhibitor,INHIBITOR,109782.0,CHEMBL3580486,Interleukin-13,1,1,1,,
1121912,CHEMBL1743041,MOGAMULIZUMAB,6359,C-C chemokine receptor type 4 cross-linking agent,CROSS-LINKING AGENT,10579.0,CHEMBL2414,C-C chemokine receptor type 4,1,1,1,,
1121914,CHEMBL1743043,MOXETUMOMAB PASUDOTOX,5460,CD22 binding agent,BINDING AGENT,11695.0,CHEMBL3218,B-cell receptor CD22,1,1,1,"The Fv at the amino terminus binds to CD22 present on the B-cell malignancy being targeted, and the carboxyl terminal lysine residue at position 613 is rapidly removed by plasma carboxypeptidase, generating a protein ending in REDL. Very soon after binding, the recombinant immunotoxin-CD22 complex is internalized through clathrin-coated pits into the endocytic compartment, where 2 steps occur: (i) reduction of the disulfide bond in domain II, and (ii) a furin-catalyzed cleavage in the middle of ",
1121914,CHEMBL1743043,MOXETUMOMAB PASUDOTOX,7409,Elongation factor 2 inhibitor,INHIBITOR,104188.0,CHEMBL1795108,Elongation factor 2,1,1,1,"The Fv at the amino terminus binds to CD22 present on the B-cell malignancy being targeted, and the carboxyl terminal lysine residue at position 613 is rapidly removed by plasma carboxypeptidase, generating a protein ending in REDL. Very soon after binding, the recombinant immunotoxin-CD22 complex is internalized through clathrin-coated pits into the endocytic compartment, where 2 steps occur: (i) reduction of the disulfide bond in domain II, and (ii) a furin-catalyzed cleavage in the middle of ",
1121918,CHEMBL1743047,NECITUMUMAB,2427,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,,
1121919,CHEMBL1743048,OBINUTUZUMAB,2241,B-lymphocyte antigen CD20 binding agent,BINDING AGENT,181.0,CHEMBL2058,B-lymphocyte antigen CD20,1,1,1,"Obinutuzumab mediates B-cell lysis through engagement of immune effector cells, directly activating intracellular death signaling pathways and/or activation of the complement cascade.",
1121920,CHEMBL1743049,OLARATUMAB,6014,Platelet-derived growth factor receptor alpha antagonist,ANTAGONIST,12627.0,CHEMBL2007,Platelet-derived growth factor receptor alpha,1,1,1,"Human immunoglobulin G subclass 1 (IgG1) monoclonal antibody that binds to PDGFRalpha and blocks the PDGF-AA, PDGF-BB, and PDGF-CC ligands from binding to the receptor. ",
1121933,CHEMBL1743062,RAMUCIRUMAB,2273,Vascular endothelial growth factor receptor 2 inhibitor,INHIBITOR,10980.0,CHEMBL279,Vascular endothelial growth factor receptor 2,1,1,1,,
1121939,CHEMBL1743068,SECUKINUMAB,2327,Interleukin 17A inhibitor,INHIBITOR,109547.0,CHEMBL3390822,Interleukin-17A,1,1,1,,
1121941,CHEMBL1743070,SILTUXIMAB,2274,Interleukin-6 antagonist,ANTAGONIST,104209.0,CHEMBL1795129,Interleukin-6,1,1,1,,
1121944,CHEMBL1743073,SOTATERCEPT,6024,Inhibin beta A chain inhibitor,INHIBITOR,109824.0,CHEMBL3588735,Inhibin beta A chain,1,1,1,"By binding activin, Sotatercept prevents activin from binding endogenous receptors and thus acts as a decoy.",
1121949,CHEMBL1743078,TEPLIZUMAB,5467,T-cell surface glycoprotein CD3 epsilon chain other,OTHER,233.0,CHEMBL1975,T-cell surface glycoprotein CD3 epsilon chain,1,1,1,It binds to an epitope of the CD3-epsilon chain expressed on mature T cells. Modulates the T-cell receptor (TCR)CD3 complex resulting in the cells becoming 'blind' to antigen (antigenic immunomodulation of the TCR complex).,
1121950,CHEMBL1743079,TEPROTUMUMAB,5977,Insulin-like growth factor I receptor antagonist,ANTAGONIST,234.0,CHEMBL1957,Insulin-like growth factor 1 receptor,1,1,1,Antibody binding results in endosomal degradation of IGF-1R and inhibition of receptor-mediated signaling.,
1121952,CHEMBL1743081,TRALOKINUMAB,5469,Interleukin-13 inhibitor,INHIBITOR,109782.0,CHEMBL3580486,Interleukin-13,1,1,1,IL-13-neutralizing IgG4 monoclonal antibody.,
1121953,CHEMBL1743082,TRASTUZUMAB EMTANSINE,129,Receptor protein-tyrosine kinase erbB-2 binding agent,BINDING AGENT,188.0,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,1,1,1,,
1121953,CHEMBL1743082,TRASTUZUMAB EMTANSINE,1100,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,inhibits polymerisation,
1121953,CHEMBL1743082,TRASTUZUMAB EMTANSINE,6331,Receptor protein-tyrosine kinase erbB-2 binding agent,BINDING AGENT,188.0,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,1,1,1,,
1121958,CHEMBL1743087,VEDOLIZUMAB,2310,Integrin alpha-4/beta-7 inhibitor,INHIBITOR,104768.0,CHEMBL2095184,Integrin alpha-4/beta-7,1,1,1,,
1123018,CHEMBL1744447,ROSUVASTATIN CALCIUM,1056,HMG-CoA reductase inhibitor,INHIBITOR,24.0,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,1,1,1,,
575670,CHEMBL1746,SODIUM PHENYLBUTYRATE,2151,Glutamine sequestering agent,SEQUESTERING AGENT,106212.0,CHEMBL2366039,Glutamine,1,1,1,"Removes excess nitrogen, caused by enzyme deficiency",
577488,CHEMBL1747,TOBRAMYCIN,2073,70S ribosome inhibitor,INHIBITOR,106001.0,CHEMBL2364022,70S ribosome,1,1,1,,
317909,CHEMBL175,DEXIBUPROFEN,5900,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,"Dexibuprofen works by blocking the cyclo-oxygenase (COX-1, COX2) enzymes. These enzymes are involved in the production of prostaglandins. Some prostaglandins are produced at sites of injury or damage, and cause pain and inflammation. By blocking the effect of COX enzymes, fewer prostaglandins are produced, which means pain and inflammation are eased.",
581569,CHEMBL1750,CLOFARABINE,1259,Ribonucleoside-diphosphate reductase RR1 inhibitor,INHIBITOR,104791.0,CHEMBL2095215,Ribonucleoside-diphosphate reductase RR1,1,1,1,,
581569,CHEMBL1750,CLOFARABINE,1879,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
581569,CHEMBL1750,CLOFARABINE,1915,DNA polymerase (alpha/delta/epsilon) inhibitor,INHIBITOR,105737.0,CHEMBL2363042,DNA polymerase (alpha/delta/epsilon),1,1,1,,
581814,CHEMBL1751,DIGOXIN,1585,Sodium/potassium-transporting ATPase inhibitor,INHIBITOR,104770.0,CHEMBL2095186,Sodium/potassium-transporting ATPase,1,1,1,,
581819,CHEMBL1752,DYPHYLLINE,1061,Phosphodiesterase 4 inhibitor,INHIBITOR,104679.0,CHEMBL2093863,Phosphodiesterase 4,1,1,1,,
581819,CHEMBL1752,DYPHYLLINE,1382,Phosphodiesterase 3A inhibitor,INHIBITOR,170.0,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",1,1,1,,
293438,CHEMBL175247,ORLISTAT,70,Gastric lipase inhibitor,INHIBITOR,10073.0,CHEMBL1796,Gastric triacylglycerol lipase,1,1,1,,
293438,CHEMBL175247,ORLISTAT,122,Pancreatic lipase inhibitor,INHIBITOR,77.0,CHEMBL1812,Pancreatic triacylglycerol lipase,1,1,1,,
296388,CHEMBL175691,RILPIVIRINE,8815,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,,
583519,CHEMBL1761,PROCYCLIDINE HYDROCHLORIDE,288,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Indicated for Parkinson's disease, M1 likely responsible",
583522,CHEMBL1763,HYDROFLUMETHIAZIDE,352,Thiazide-sensitive sodium-chloride cotransporter inhibitor,INHIBITOR,151.0,CHEMBL1876,Solute carrier family 12 member 3,1,1,1,,
583530,CHEMBL1764,LEVOMEPROMAZINE,2016,D2-like dopamine receptor antagonist,ANTAGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
591037,CHEMBL1766,DESOXIMETASONE,794,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
1142451,CHEMBL1767408,DIQUAFOSOL TETRASODIUM,7528,Purinergic receptor P2Y2 agonist,AGONIST,11907.0,CHEMBL4398,P2Y purinoceptor 2,1,1,1,,"Selective for P2Y receptors. Purinergic receptor P2Y2 is the proposed target but the drug is active against P2Y1, P2Y2, P2Y4 and P2Y4 which could also contribute to activity (order of binding affinity; P2Y2 = P2Y4 > P2Y6 > P2Y1)."
1142451,CHEMBL1767408,DIQUAFOSOL TETRASODIUM,7529,Purinergic receptor P2Y1 agonist,AGONIST,10544.0,CHEMBL4315,P2Y purinoceptor 1,1,1,1,,"Selective for P2Y receptors. Purinergic receptor P2Y2 is the proposed target but the drug is active against P2Y1, P2Y2, P2Y4 and P2Y4 which could also contribute to activity (order of binding affinity; P2Y2 = P2Y4 > P2Y6 > P2Y1)."
1142451,CHEMBL1767408,DIQUAFOSOL TETRASODIUM,7577,Pyrimidinergic receptor P2Y6 agonist,AGONIST,10012.0,CHEMBL4714,P2Y purinoceptor 6,1,1,1,,"Selective for P2Y receptors. Purinergic receptor P2Y2 is the proposed target but the drug is active against P2Y1, P2Y2, P2Y4 and P2Y4 which could also contribute to activity (order of binding affinity; P2Y2 = P2Y4 > P2Y6 > P2Y1)."
1142451,CHEMBL1767408,DIQUAFOSOL TETRASODIUM,7578,Pyrimidinergic receptor P2Y4 agonist,AGONIST,10541.0,CHEMBL2123,P2Y purinoceptor 4,1,1,1,,"Selective for P2Y receptors. Purinergic receptor P2Y2 is the proposed target but the drug is active against P2Y1, P2Y2, P2Y4 and P2Y4 which could also contribute to activity (order of binding affinity; P2Y2 = P2Y4 > P2Y6 > P2Y1)."
594843,CHEMBL1768,BETHANECHOL CHLORIDE,28,Muscarinic acetylcholine receptor M3 agonist,AGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for urinary retention, M3 likely responsible",
594843,CHEMBL1768,BETHANECHOL CHLORIDE,1507,Muscarinic acetylcholine receptor M2 agonist,AGONIST,47.0,CHEMBL211,Muscarinic acetylcholine receptor M2,1,1,1,"Indicated for urinary retention, M2 likely responsible",
595277,CHEMBL1769,PROPOXYCAINE HYDROCHLORIDE,1984,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
596044,CHEMBL1770,LEVAMISOLE HYDROCHLORIDE,359,Nicotinic acetylcholine receptor alpha subunit agonist,AGONIST,5.0,CHEMBL1884,Nicotinic acetylcholine receptor alpha subunit,1,1,1,,
1142547,CHEMBL1770248,ERTUGLIFLOZIN,5683,Sodium/glucose cotransporter 2 inhibitor,INHIBITOR,20092.0,CHEMBL3884,Sodium/glucose cotransporter 2,1,1,1,,It shows >2000-fold selectivity for SGLT2 inhibition (relative to SGLT1) in vitro
1143222,CHEMBL1770916,NIROGACESTAT,9221,Gamma-secretase inhibitor,INHIBITOR,104717.0,CHEMBL2094135,Gamma-secretase,1,1,1,,
598447,CHEMBL1773,CAPECITABINE,485,Thymidylate synthase inhibitor,INHIBITOR,28.0,CHEMBL1952,Thymidylate synthase,1,1,1,,
598447,CHEMBL1773,CAPECITABINE,1881,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
598447,CHEMBL1773,CAPECITABINE,1891,RNA inhibitor,INHIBITOR,105575.0,CHEMBL2311222,RNA,1,1,1,,
1148185,CHEMBL1779710,EVOGLIPTIN,7601,Dipeptidyl peptidase IV inhibitor,INHIBITOR,11140.0,CHEMBL284,Dipeptidyl peptidase 4,1,1,1,,
336913,CHEMBL178,DAUNORUBICIN,6903,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
336913,CHEMBL178,DAUNORUBICIN,7252,DNA topoisomerase II alpha inhibitor,INHIBITOR,63.0,CHEMBL1806,DNA topoisomerase 2-alpha,1,1,1,,
20100,CHEMBL17879,MARALIXIBAT CHLORIDE,8902,Ileal bile acid transporter inhibitor,INHIBITOR,12909.0,CHEMBL2778,Ileal sodium/bile acid cotransporter,1,1,1,,
300585,CHEMBL178803,BLONANSERIN,7559,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,"Also has high affinity for 5-HT6 receptors. Low affinity for 5-HT2C, adrenergic 1, histamine H1, muscarinic (M1) receptors and 5-HT1A receptors. Blonanserin has lower affinity for 5-HT2 receptors (Ki = 0.812 nM) compared to D2 receptors (Ki = 0.142 nM), its active metabolite, AD-6048, has highest affinity for D3 receptors."
300585,CHEMBL178803,BLONANSERIN,7560,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,"Also has high affinity for 5-HT6 receptors. Low affinity for 5-HT2C, adrenergic 1, histamine H1, muscarinic (M1) receptors and 5-HT1A receptors. Blonanserin has lower affinity for 5-HT2 receptors (Ki = 0.812 nM) compared to D2 receptors (Ki = 0.142 nM), its active metabolite, AD-6048, has highest affinity for D3 receptors."
300585,CHEMBL178803,BLONANSERIN,7573,Dopamine D3 receptor antagonist,ANTAGONIST,130.0,CHEMBL234,D(3) dopamine receptor,1,1,1,,"Also has high affinity for 5-HT6 receptors. Low affinity for 5-HT2C, adrenergic 1, histamine H1, muscarinic (M1) receptors and 5-HT1A receptors. Blonanserin has lower affinity for 5-HT2 receptors (Ki = 0.812 nM) compared to D2 receptors (Ki = 0.142 nM), its active metabolite, AD-6048, has highest affinity for D3 receptors."
1151796,CHEMBL1788132,LOFEXIDINE HYDROCHLORIDE,7368,Adrenergic receptor alpha-2 agonist,AGONIST,104743.0,CHEMBL2095158,Adrenergic receptor alpha-2,1,1,1,Reduces norepinephrine release and decreases synmpathetic tone.,
1153493,CHEMBL1789842,INDACATEROL MALEATE,1346,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,Long acting,
1153494,CHEMBL1789843,BELIMUMAB,1414,Tumor necrosis factor ligand superfamily member 13B inhibitor,INHIBITOR,106137.0,CHEMBL2364158,Tumor necrosis factor ligand superfamily member 13B,1,1,1,,
1153495,CHEMBL1789844,IPILIMUMAB,1422,Cytotoxic T-lymphocyte protein 4 inhibitor,INHIBITOR,106143.0,CHEMBL2364164,Cytotoxic T-lymphocyte protein 4,1,1,1,,
1153672,CHEMBL1790041,RANITIDINE,7279,Histamine H2 receptor antagonist,ANTAGONIST,102.0,CHEMBL1941,Histamine H2 receptor,1,1,1,,
1158402,CHEMBL1795071,RUXOLITINIB PHOSPHATE,934,Tyrosine-protein kinase JAK1 inhibitor,INHIBITOR,10919.0,CHEMBL2835,Tyrosine-protein kinase JAK1,1,1,1,,
1158402,CHEMBL1795071,RUXOLITINIB PHOSPHATE,936,Tyrosine-protein kinase JAK2 inhibitor,INHIBITOR,10938.0,CHEMBL2971,Tyrosine-protein kinase JAK2,1,1,1,,
1158403,CHEMBL1795072,ZICONOTIDE ACETATE,976,Voltage-gated N-type calcium channel alpha-1B subunit blocker,BLOCKER,10511.0,CHEMBL4478,Voltage-dependent N-type calcium channel subunit alpha-1B,1,1,1,,
1096,CHEMBL18,ETHOXZOLAMIDE,1088,Carbonic anhydrase inhibitor,INHIBITOR,104764.0,CHEMBL2095180,Carbonic anhydrase,1,1,1,,
1161221,CHEMBL1800159,RELUGOLIX,5010,Gonadotropin-releasing hormone receptor antagonist,ANTAGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,,
299120,CHEMBL180022,NERATINIB,5285,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,
299120,CHEMBL180022,NERATINIB,5286,Receptor protein-tyrosine kinase erbB-2 inhibitor,INHIBITOR,188.0,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,1,1,1,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,
299120,CHEMBL180022,NERATINIB,7420,Receptor protein-tyrosine kinase erbB-4 inhibitor,INHIBITOR,12699.0,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,1,1,1,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,
1166082,CHEMBL1808388,BEXAGLIFLOZIN,5826,Sodium/glucose cotransporter 2 inhibitor,INHIBITOR,20092.0,CHEMBL3884,Sodium/glucose cotransporter 2,1,1,1,,
364859,CHEMBL181,DIAZOXIDE,360,"Potassium channel, inwardly rectifying, subfamily J, member 11 opener",OPENER,285.0,CHEMBL1886,ATP-sensitive inward rectifier potassium channel 11,1,1,1,,
364859,CHEMBL181,DIAZOXIDE,985,"Potassium channel, inwardly rectifying, subfamily J, member 8 opener",OPENER,10891.0,CHEMBL4770,ATP-sensitive inward rectifier potassium channel 8,1,1,1,,
20372,CHEMBL18116,TOLOXATONE,7563,Monoamine oxidase A inhibitor,INHIBITOR,86.0,CHEMBL1951,Amine oxidase [flavin-containing] A,1,1,1,Reversible inhibitor.,
365284,CHEMBL182,GANCICLOVIR,1471,Human herpesvirus 1 DNA polymerase inhibitor,INHIBITOR,27.0,CHEMBL1872,DNA polymerase catalytic subunit,1,1,1,,
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,8673,Fibroblast growth factor receptor inhibitor,INHIBITOR,104793.0,CHEMBL2095217,Fibroblast growth factor receptor,1,1,1,Indicated for FGFR2-mutated cancers and therefore FGFR2 is the primary target for this indication.,Higher activity against FGFR 1-3 vs. 4
365538,CHEMBL184,ACYCLOVIR,1472,Human herpesvirus 1 DNA polymerase inhibitor,INHIBITOR,27.0,CHEMBL1872,DNA polymerase catalytic subunit,1,1,1,Prodrug enzyme: Thymidine kinase,
20346,CHEMBL18442,PLERIXAFOR,923,C-X-C chemokine receptor type 4 partial agonist,PARTIAL AGONIST,10473.0,CHEMBL2107,C-X-C chemokine receptor type 4,1,1,1,,
368538,CHEMBL185,FLUOROURACIL,486,Thymidylate synthase inhibitor,INHIBITOR,28.0,CHEMBL1952,Thymidylate synthase,1,1,1,,
368538,CHEMBL185,FLUOROURACIL,1888,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
368538,CHEMBL185,FLUOROURACIL,1895,RNA inhibitor,INHIBITOR,105575.0,CHEMBL2311222,RNA,1,1,1,,
1193367,CHEMBL1852688,INFIGRATINIB,4864,Fibroblast growth factor receptor inhibitor,INHIBITOR,104793.0,CHEMBL2095217,Fibroblast growth factor receptor,1,1,1,Indicated for FGFR2-mutated cancers and therefore FGFR2 is the primary target for this indication.,
1204085,CHEMBL1863514,ASPARAGINASE ERWINIA CHRYSANTHEMI,2228,Asparagine hydrolytic enzyme,HYDROLYTIC ENZYME,106202.0,CHEMBL2364706,Asparagine,1,1,1,,
1204086,CHEMBL1863515,GLUCARPIDASE,2039,Methotrexate hydrolytic enzyme,HYDROLYTIC ENZYME,106206.0,CHEMBL2364710,Methotrexate,1,1,1,,
1214046,CHEMBL1873475,IBRUTINIB,2242,Tyrosine-protein kinase BTK inhibitor,INHIBITOR,100097.0,CHEMBL5251,Tyrosine-protein kinase BTK,1,1,1,Irreversible inhibitor,
316600,CHEMBL187709,TRIPARANOL,6317,Delta(24)-sterol reductase inhibitor,INHIBITOR,105655.0,CHEMBL2331059,Delta(24)-sterol reductase,1,1,1,"Inhibits 24-dehydrocholesterol reductase, which catalyzes the final step of cholesterol biosynthesis, the conversion of desmosterol into cholesterol. This results in tissue accumulation of desmosterol, which in turn is responsible for the side effects of triparanol.",
1228462,CHEMBL1887891,DEXFENFLURAMINE HYDROCHLORIDE,6232,Serotonin (5-HT) receptor agonist,AGONIST,104841.0,CHEMBL2096904,Serotonin (5-HT) receptor,1,1,1,"It reduces appetite by increasing the amount of extracellular serotonin in the brain. Dexfenfluramine is an anorectic agent that acts by enhancing serotonergic transmission through inhibition of 5-HT reuptake by the parent compound, and through its major circulating des-ethylated metabolite, dexnorfenfluramine, which is a 5-HT reuptake inhibitor, a 5-HT and noradrenaline releasing agent, and a potent agonist at postsynaptic 5-HT2 receptors.",
1229711,CHEMBL1889140,ROPIVACAINE HYDROCHLORIDE,1951,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
314827,CHEMBL188952,PIRPROFEN,6284,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,Inhibits the conversion of arachidonic acid into prostaglandin E2 by prostaglandin synthase in a competitive and reversible way.,
319858,CHEMBL189963,PALBOCICLIB,2316,CDK6/cyclin D1 inhibitor,INHIBITOR,104977.0,CHEMBL2111455,CDK6/cyclin D1,1,1,1,,
319858,CHEMBL189963,PALBOCICLIB,2317,Cyclin-dependent kinase 4/cyclin D1 inhibitor,INHIBITOR,104295.0,CHEMBL1907601,Cyclin-dependent kinase 4/cyclin D1,1,1,1,,
1240372,CHEMBL1899801,PERFLENAPENT,9845,Ultrasound contrast agent,,,,,1,1,1,,
1124,CHEMBL19,METHAZOLAMIDE,13,Carbonic anhydrase VII inhibitor,INHIBITOR,11060.0,CHEMBL2326,Carbonic anhydrase 7,1,1,1,,
1124,CHEMBL19,METHAZOLAMIDE,18,Carbonic anhydrase I inhibitor,INHIBITOR,10193.0,CHEMBL261,Carbonic anhydrase 1,1,1,1,,
1124,CHEMBL19,METHAZOLAMIDE,90,Carbonic anhydrase II inhibitor,INHIBITOR,15.0,CHEMBL205,Carbonic anhydrase 2,1,1,1,,
1124,CHEMBL19,METHAZOLAMIDE,957,Carbonic anhydrase IV inhibitor,INHIBITOR,12896.0,CHEMBL3729,Carbonic anhydrase 4,1,1,1,,
21459,CHEMBL19019,NALTREXONE,1092,Opioid receptors; mu/kappa/delta antagonist,ANTAGONIST,104765.0,CHEMBL2095181,Opioid receptors; mu/kappa/delta,1,1,1,,
318390,CHEMBL190461,CANNABIDIOL,5822,Cannabinoid CB1 receptor negative allosteric modulator,NEGATIVE ALLOSTERIC MODULATOR,87.0,CHEMBL218,Cannabinoid receptor 1,1,1,1,,
1248731,CHEMBL1908360,EVEROLIMUS,384,FK506-binding protein 1A inhibitor,INHIBITOR,80.0,CHEMBL1902,Peptidyl-prolyl cis-trans isomerase FKBP1A,1,1,1,,
1248741,CHEMBL1908370,FINAFLOXACIN,2336,Topoisomerase IV inhibitor,INHIBITOR,107934.0,CHEMBL3038508,Topoisomerase IV,1,1,1,,
1248741,CHEMBL1908370,FINAFLOXACIN,2337,Topoisomerase IV inhibitor,INHIBITOR,109552.0,CHEMBL3390827,Topoisomerase IV,1,1,1,,
1248741,CHEMBL1908370,FINAFLOXACIN,2338,DNA gyrase inhibitor,INHIBITOR,107908.0,CHEMBL3038482,DNA gyrase,1,1,1,,
1248741,CHEMBL1908370,FINAFLOXACIN,2339,DNA gyrase inhibitor,INHIBITOR,109553.0,CHEMBL3390828,DNA gyrase,1,1,1,,
1249053,CHEMBL1909283,MEBANAZINE,6259,Monoamine oxidase inhibitor,INHIBITOR,104789.0,CHEMBL2095205,Monoamine oxidase,1,1,1,"Mebanazine, a monoamine oxidase inhibitor, when injected in vivo, reduces pituitary weight, STH and LH production, DNA, RNA and alkaline phosphatase activity.",
1249055,CHEMBL1909285,NITREFAZOLE,6275,Alcohol dehydrogenase inhibitor,INHIBITOR,104823.0,CHEMBL2096668,Alcohol dehydrogenase,1,1,1,,
1249056,CHEMBL1909286,PHENOXYPROPAZINE,6281,Monoamine oxidase inhibitor,INHIBITOR,104789.0,CHEMBL2095205,Monoamine oxidase,1,1,1,Phenoxypropazine is an irreversible and non-selective monoamine oxidase inhibitor.,
21698,CHEMBL19236,MOXONIDINE,5894,Nischarin agonist,AGONIST,11684.0,CHEMBL3923,Nischarin,1,1,1,"Activates I1 imidazoline receptors in the rostal ventrolateral medulla (RVLM). The result is the inhibition of peripheral alpha-adrenergic tone, and the decrease of blood pressure, due to a fall in systemic vascular resistant.",
1270372,CHEMBL1929396,ANAGLIPTIN,7548,Dipeptidyl peptidase IV inhibitor,INHIBITOR,11140.0,CHEMBL284,Dipeptidyl peptidase 4,1,1,1,,
22873,CHEMBL19299,LOXOPROFEN,7568,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,Activated in vivo.,Non-selective: active against COX-1 and COX-2.
419596,CHEMBL193,NIFEDIPINE,1276,Voltage-gated L-type calcium channel blocker,BLOCKER,104801.0,CHEMBL2095229,Voltage-gated L-type calcium channel,1,1,1,,
321696,CHEMBL193240,ROFLUMILAST,1062,Phosphodiesterase 4 inhibitor,INHIBITOR,104679.0,CHEMBL2093863,Phosphodiesterase 4,1,1,1,,Selective
328137,CHEMBL193482,ESTRIOL,7533,Estrogen receptor modulator,MODULATOR,104682.0,CHEMBL2093866,Estrogen receptor,1,1,1,,
23745,CHEMBL19449,IBUDILAST,7569,Phosphodiesterase 4 inhibitor,INHIBITOR,104679.0,CHEMBL2093863,Phosphodiesterase 4,1,1,1,,Also active against PDE11.
23745,CHEMBL19449,IBUDILAST,7572,Phosphodiesterase 3A inhibitor,INHIBITOR,170.0,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",1,1,1,,Also active against PDE11.
23745,CHEMBL19449,IBUDILAST,7583,Phosphodiesterase 10A inhibitor,INHIBITOR,100010.0,CHEMBL4409,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",1,1,1,,Also active against PDE11.
23745,CHEMBL19449,IBUDILAST,7584,Phosphodiesterase 5A inhibitor,INHIBITOR,3.0,CHEMBL1827,"cGMP-specific 3',5'-cyclic phosphodiesterase",1,1,1,,Also active against PDE11.
1277553,CHEMBL1946170,REGORAFENIB,303,Tyrosine-protein kinase ABL inhibitor,INHIBITOR,8.0,CHEMBL1862,Tyrosine-protein kinase ABL1,1,1,1,,
1277553,CHEMBL1946170,REGORAFENIB,387,Serine/threonine-protein kinase RAF inhibitor,INHIBITOR,10904.0,CHEMBL1906,RAF proto-oncogene serine/threonine-protein kinase,1,1,1,,
1277553,CHEMBL1946170,REGORAFENIB,448,Stem cell growth factor receptor inhibitor,INHIBITOR,238.0,CHEMBL1936,Mast/stem cell growth factor receptor Kit,1,1,1,,
1277553,CHEMBL1946170,REGORAFENIB,951,Fibroblast growth factor receptor 1 inhibitor,INHIBITOR,10266.0,CHEMBL3650,Fibroblast growth factor receptor 1,1,1,1,,
1277553,CHEMBL1946170,REGORAFENIB,962,MAP kinase p38 beta inhibitor,INHIBITOR,10120.0,CHEMBL3961,Mitogen-activated protein kinase 11,1,1,1,,
1277553,CHEMBL1946170,REGORAFENIB,970,Fibroblast growth factor receptor 2 inhibitor,INHIBITOR,10264.0,CHEMBL4142,Fibroblast growth factor receptor 2,1,1,1,,
1277553,CHEMBL1946170,REGORAFENIB,972,Tyrosine-protein kinase FRK inhibitor,INHIBITOR,30012.0,CHEMBL4223,Tyrosine-protein kinase FRK,1,1,1,,
1277553,CHEMBL1946170,REGORAFENIB,991,Discoidin domain-containing receptor 2 inhibitor,INHIBITOR,101079.0,CHEMBL5122,Discoidin domain-containing receptor 2,1,1,1,,
1277553,CHEMBL1946170,REGORAFENIB,993,Serine/threonine-protein kinase B-raf inhibitor,INHIBITOR,100126.0,CHEMBL5145,Serine/threonine-protein kinase B-raf,1,1,1,,Also active against BRAFV600E
1277553,CHEMBL1946170,REGORAFENIB,1033,Tyrosine-protein kinase TIE-2 inhibitor,INHIBITOR,12913.0,CHEMBL4128,Angiopoietin-1 receptor,1,1,1,,
1277553,CHEMBL1946170,REGORAFENIB,1117,Platelet-derived growth factor receptor inhibitor,INHIBITOR,104773.0,CHEMBL2095189,Platelet-derived growth factor receptor,1,1,1,,
1277553,CHEMBL1946170,REGORAFENIB,1268,Vascular endothelial growth factor receptor inhibitor,INHIBITOR,104799.0,CHEMBL2095227,Vascular endothelial growth factor receptor,1,1,1,,
1277553,CHEMBL1946170,REGORAFENIB,1516,Tyrosine-protein kinase receptor RET inhibitor,INHIBITOR,100079.0,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,1,1,1,,
1277553,CHEMBL1946170,REGORAFENIB,8645,Ephrin type-A receptor 2 inhibitor,INHIBITOR,30008.0,CHEMBL2068,Ephrin type-A receptor 2,1,1,1,,
1277553,CHEMBL1946170,REGORAFENIB,8646,Nerve growth factor receptor Trk-A inhibitor,INHIBITOR,11902.0,CHEMBL2815,High affinity nerve growth factor receptor,1,1,1,,
1280054,CHEMBL1951071,ARFORMOTEROL TARTRATE,1342,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,Long acting,
1280078,CHEMBL1951095,ERAVACYCLINE,9810,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,Inhibits bacterial protein synthesis.,"Indicated for infections caused by Escherichia coli, Klebsiella pneumoniae, Citrobacter freundii, Enterobacter cloacae, Klebsiella oxytoca, Enterococcus faecalis, Enterococcus faecium, Staphylococcus aureus, Streptococcus anginosus group, Clostridium perfringens, Bacteroides species and Parabacteroides distasonis. Active in vitro against additional organisms but clinical signficance unknown. "
443348,CHEMBL196,ASCORBIC ACID,7472,Supplement,,,,,1,1,1,Provides a source of ascorbic acid and restores depleted ascorbic acid resources.,
1285392,CHEMBL1963681,AVANAFIL,188,Phosphodiesterase 5A inhibitor,INHIBITOR,3.0,CHEMBL1827,"cGMP-specific 3',5'-cyclic phosphodiesterase",1,1,1,,
1285394,CHEMBL1963683,TAFLUPROST,641,Prostanoid FP receptor agonist,AGONIST,140.0,CHEMBL1987,Prostaglandin F2-alpha receptor,1,1,1,,
1285395,CHEMBL1963684,PEGINESATIDE ACETATE,123,Erythropoietin receptor agonist,AGONIST,201.0,CHEMBL1817,Erythropoietin receptor,1,1,1,,
1285396,CHEMBL1963685,LUCINACTANT,2112,Surfactant agent,,,,,1,1,1,Replaces endogenous surfactant in case of deficiency; endogenous pulmonary surfactant lower surface tension at the air-liquid of the alveolar surfaces,
1285397,CHEMBL1964120,TALIGLUCERASE ALFA,2079,Glucocerebroside hydrolytic enzyme,HYDROLYTIC ENZYME,106155.0,CHEMBL2364176,Glucocerebroside,1,1,1,Given in cases of gaucher disease to overcome a deficiency of beta-glucocerebrosidase activity. Imiglucerase catalyses the hydrolysis of glucocerebroside to glucose and ceramide,
1298870,CHEMBL1977579,STREPTOZOCIN,1848,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
1304559,CHEMBL1983268,ENTRECTINIB,7454,Neurotrophic tyrosine kinase receptor inhibitor,INHIBITOR,109739.0,CHEMBL3559684,Neurotrophic tyrosine kinase receptor,1,1,1,"TRK, ROS1, or ALK kinase fusion proteins can cause abherrent signalling and cell proliferation. 
Entrectinib demonstrated in vitro and in vivo inhibition of cancer cell lines harboring NTRK, ROS1, and ALK fusion genes. ","Inhibits the TRK, ROS1 and ALK kinases at 0.1 to 2 nM. Active against the JAK2 and TNK2 kinases with IC50 values > 5 nM."
1304559,CHEMBL1983268,ENTRECTINIB,7455,Proto-oncogene tyrosine-protein kinase ROS inhibitor,INHIBITOR,101019.0,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,1,1,1,"TRK, ROS1, or ALK kinase fusion proteins can cause abherrent signalling and cell proliferation. 
Entrectinib demonstrated in vitro and in vivo inhibition of cancer cell lines harboring NTRK, ROS1, and ALK fusion genes. ","Inhibits the TRK, ROS1 and ALK kinases at 0.1 to 2 nM. Active against the JAK2 and TNK2 kinases with IC50 values > 5 nM."
1304559,CHEMBL1983268,ENTRECTINIB,7456,ALK tyrosine kinase receptor inhibitor,INHIBITOR,100417.0,CHEMBL4247,ALK tyrosine kinase receptor,1,1,1,"TRK, ROS1, or ALK kinase fusion proteins can cause abherrent signalling and cell proliferation. 
Entrectinib demonstrated in vitro and in vivo inhibition of cancer cell lines harboring NTRK, ROS1, and ALK fusion genes. ","Inhibits the TRK, ROS1 and ALK kinases at 0.1 to 2 nM. Active against the JAK2 and TNK2 kinases with IC50 values > 5 nM."
328601,CHEMBL198362,RIVAROXABAN,1375,Coagulation factor X inhibitor,INHIBITOR,194.0,CHEMBL244,Coagulation factor X,1,1,1,,
1125,CHEMBL20,ACETAZOLAMIDE,17,Carbonic anhydrase I inhibitor,INHIBITOR,10193.0,CHEMBL261,Carbonic anhydrase 1,1,1,1,Expressed in eye,
1125,CHEMBL20,ACETAZOLAMIDE,92,Carbonic anhydrase II inhibitor,INHIBITOR,15.0,CHEMBL205,Carbonic anhydrase 2,1,1,1,Expressed in eye,
1125,CHEMBL20,ACETAZOLAMIDE,928,Carbonic anhydrase XII inhibitor,INHIBITOR,12209.0,CHEMBL3242,Carbonic anhydrase 12,1,1,1,Expressed in eye,
1125,CHEMBL20,ACETAZOLAMIDE,959,Carbonic anhydrase IV inhibitor,INHIBITOR,12896.0,CHEMBL3729,Carbonic anhydrase 4,1,1,1,Expressed in eye,
1326477,CHEMBL2005186,BELUMOSUDIL,8779,Rho-associated protein kinase 2 inhibitor,INHIBITOR,11149.0,CHEMBL2973,Rho-associated protein kinase 2,1,1,1,,Also active against ROCK1 but higher potency against ROCK2
1328912,CHEMBL2007641,PERTUZUMAB,128,Receptor protein-tyrosine kinase erbB-2 inhibitor,INHIBITOR,188.0,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,1,1,1,,
1330340,CHEMBL2009089,SELENIOUS ACID,7756,Supplement,,,,,1,1,1,Nutritional supplement.,
1331852,CHEMBL2010601,IVACAFTOR,965,Cystic fibrosis transmembrane conductance regulator positive modulator,POSITIVE MODULATOR,11540.0,CHEMBL4051,Cystic fibrosis transmembrane conductance regulator,1,1,1,,
1335827,CHEMBL2018096,IPRAGLIFLOZIN,8219,Sodium/glucose cotransporter 2 inhibitor,INHIBITOR,20092.0,CHEMBL3884,Sodium/glucose cotransporter 2,1,1,1,,
1337005,CHEMBL2021430,DEXAMETHASONE SODIUM PHOSPHATE,780,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
1339278,CHEMBL2023895,HYDROXYSTILBAMIDINE ISETHIONATE,1884,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
1339278,CHEMBL2023895,HYDROXYSTILBAMIDINE ISETHIONATE,1896,RNA inhibitor,INHIBITOR,105575.0,CHEMBL2311222,RNA,1,1,1,,
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,2402,Dopamine D3 receptor modulator,MODULATOR,130.0,CHEMBL234,D(3) dopamine receptor,1,1,1,Mixed antagonist/partial agonist,
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,2403,Dopamine D2 receptor modulator,MODULATOR,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,Mixed antagonist/partial agonist,
1341084,CHEMBL2028852,ICATIBANT ACETATE,925,Bradykinin B2 receptor antagonist,ANTAGONIST,10034.0,CHEMBL3157,B2 bradykinin receptor,1,1,1,,
1341219,CHEMBL2028987,DEGARELIX ACETATE,259,Gonadotropin-releasing hormone receptor antagonist,ANTAGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,,
341064,CHEMBL203321,BRINCIDOFOVIR,8890,DNA polymerase inhibitor,INHIBITOR,117246.0,CHEMBL3988586,DNA polymerase,1,1,1,,
1344709,CHEMBL2035187,PACRITINIB,5328,Tyrosine-protein kinase JAK2 inhibitor,INHIBITOR,10938.0,CHEMBL2971,Tyrosine-protein kinase JAK2,1,1,1,,
1344709,CHEMBL2035187,PACRITINIB,5329,Tyrosine-protein kinase receptor FLT3 inhibitor,INHIBITOR,12670.0,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,1,1,1,,
1347273,CHEMBL2040682,CICLESONIDE,809,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
1349878,CHEMBL2043437,GLASDEGIB,4887,Smoothened homolog antagonist,ANTAGONIST,101400.0,CHEMBL5971,Protein smoothened,1,1,1,Inhibits smoothened which is involved in hedgehog pathway signalling and inhibited tumor growth in a mouse model.,
340684,CHEMBL204656,ELVITEGRAVIR,945,Human immunodeficiency virus type 1 integrase inhibitor,INHIBITOR,12456.0,CHEMBL3471,Human immunodeficiency virus type 1 integrase,1,1,1,HIV-1 integrase strand transfer inhibitor,
1351456,CHEMBL2048028,LIFITEGRAST,5769,Integrin alpha-L/beta-2 (LFA-1) antagonist,ANTAGONIST,106151.0,CHEMBL2364172,Integrin alpha-L/beta-2 (LFA-1),1,1,1,,
1355754,CHEMBL2062163,PHENDIMETRAZINE TARTRATE,701,Dopamine transporter inhibitor,INHIBITOR,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
1355754,CHEMBL2062163,PHENDIMETRAZINE TARTRATE,916,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
1355853,CHEMBL2062262,METARAMINOL BITARTRATE,1164,Adrenergic receptor alpha-1 agonist,AGONIST,104723.0,CHEMBL2094251,Adrenergic receptor alpha-1,1,1,1,,
1355855,CHEMBL2062264,PHENYLEPHRINE BITARTRATE,1159,Adrenergic receptor alpha-1 agonist,AGONIST,104723.0,CHEMBL2094251,Adrenergic receptor alpha-1,1,1,1,,
1355857,CHEMBL2062266,DIHYDROCODEINE BITARTRATE,721,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
1355867,CHEMBL2062276,LEVALLORPHAN TARTRATE,734,Mu opioid receptor antagonist,ANTAGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
1355867,CHEMBL2062276,LEVALLORPHAN TARTRATE,1314,Kappa opioid receptor partial agonist,PARTIAL AGONIST,137.0,CHEMBL237,Kappa-type opioid receptor,1,1,1,,
1355926,CHEMBL2062335,METOPROLOL TARTRATE,328,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
341603,CHEMBL206253,NETUPITANT,2312,Neurokinin 1 receptor antagonist,ANTAGONIST,250.0,CHEMBL249,Substance-P receptor,1,1,1,,
1356484,CHEMBL2063090,GRAZOPREVIR ANHYDROUS,5511,"Hepatitis C virus serine protease, NS3/NS4A inhibitor",INHIBITOR,104803.0,CHEMBL2095231,"Hepatitis C virus serine protease, NS3/NS4A",1,1,1,,
1357436,CHEMBL2064032,VONOPRAZAN FUMARATE,7615,Potassium-transporting ATPase inhibitor,INHIBITOR,104758.0,CHEMBL2095173,Potassium-transporting ATPase,1,1,1,,"Inhibits human muscarine M1, M2, and M3 receptors, rat L-type calcium channel, rat sodium channel, rat serotonin 5-HT2 receptor, and guinea-pig sigma receptor by 50% but at concentrations higher than the Cmax."
1359038,CHEMBL2068724,ACAMPROSATE CALCIUM,1127,Glutamate [NMDA] receptor antagonist,ANTAGONIST,104706.0,CHEMBL2094124,Glutamate [NMDA] receptor,1,1,1,,
1359038,CHEMBL2068724,ACAMPROSATE CALCIUM,1606,GABA-A receptor; anion channel positive modulator,POSITIVE MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
1360388,CHEMBL2070241,BREMELANOTIDE,5407,Melanocortin receptor 4 agonist,AGONIST,10142.0,CHEMBL259,Melanocortin receptor 4,1,1,1,"Alpha-MSH analogue. Binds MC1R, MC3R, MC4R and MC5R but most potent against MC1R and MC4R. MC4R is expressed on neurons in the central nervous system and likely to be involved in efficacy. MC3R may also be involved, but role poorly understood.",
348726,CHEMBL207538,BREXANOLONE,7366,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,"Mechanism of action not fully elucidated. Activity against alpha-1/beta-2/gamma-2, alpha-4/beta-3/delta and alpha-6/beta-3/delta in vitro.",
1363818,CHEMBL2079587,STANOZOLOL,1323,Androgen Receptor agonist,AGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
1364024,CHEMBL2079793,PENCICLOVIR SODIUM,1469,Human herpesvirus 1 DNA polymerase inhibitor,INHIBITOR,27.0,CHEMBL1872,DNA polymerase catalytic subunit,1,1,1,,
1369602,CHEMBL2095206,BOSUTINIB MONOHYDRATE,8632,Bcr/Abl fusion protein inhibitor,INHIBITOR,104811.0,CHEMBL2096618,Bcr/Abl fusion protein,1,1,1,,
1369604,CHEMBL2095208,COBICISTAT,1394,Cytochrome P450 3A inhibitor,INHIBITOR,106175.0,CHEMBL2364675,Cytochrome P450 3A,1,1,1,,
1369607,CHEMBL2095211,LORCASERIN HYDROCHLORIDE,615,Serotonin 2c (5-HT2c) receptor agonist,AGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
1369608,CHEMBL2095212,MIRABEGRON,961,Beta-3 adrenergic receptor agonist,AGONIST,226.0,CHEMBL246,Beta-3 adrenergic receptor,1,1,1,,
1369610,CHEMBL2095222,OCRIPLASMIN,938,Fibronectin proteolytic enzyme,PROTEOLYTIC ENZYME,17040.0,CHEMBL3810,Fibronectin,1,1,1,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,
1369610,CHEMBL2095222,OCRIPLASMIN,1427,Laminin hydrolytic enzyme,HYDROLYTIC ENZYME,106166.0,CHEMBL2364187,Laminin,1,1,1,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,
1369610,CHEMBL2095222,OCRIPLASMIN,1429,Collagen hydrolytic enzyme,HYDROLYTIC ENZYME,106167.0,CHEMBL2364188,Collagen,1,1,1,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,
1369638,CHEMBL2096629,PRUSSIAN BLUE INSOLUBLE,2203,Radioactive metals chelating agent,CHELATING AGENT,106210.0,CHEMBL2366037,Radioactive metals,1,1,1,Scavenge of radioactive and non-radioactive cesium and thalium,
1369640,CHEMBL2096631,CLORAZEPATE DIPOTASSIUM,1589,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
1369642,CHEMBL2096633,MAGNESIUM TRISILICATE,8214,Neutralises acid,,,,,1,1,1,,
1369643,CHEMBL2096634,SODIUM CHROMATE CR 51,8477,Radiopharmaceutical,,,,,1,1,1,,
1369648,CHEMBL2096639,BACITRACIN ZINC,1819,C55-isoprenyl pyrophosphate inhibitor,INHIBITOR,106015.0,CHEMBL2364036,C55-isoprenyl pyrophosphate,1,1,1,,
1369651,CHEMBL2096642,INAMRINONE LACTATE,1379,Phosphodiesterase 3A inhibitor,INHIBITOR,170.0,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",1,1,1,,
1369655,CHEMBL2096646,AMINOSALICYLATE SODIUM,7410,Dihydrofolate reductase inhibitor,INHIBITOR,102873.0,CHEMBL6065,Dihydrofolate reductase,1,1,1,"PAS is incorporated into the folate pathway by dihydropteroate synthase (DHPS) and dihydrofolate synthase (DHFS) to generate a hydroxyl dihydrofolate antimetabolite, which in turn inhibits DHFR enzymatic activity. Mechanism in Crohn's disease/ulcerative colitis may be through PPAR-gamma/NF-kappa-B inhibition",
1369656,CHEMBL2096647,LANTHANUM CARBONATE,2391,Phosphate sequestering agent,SEQUESTERING AGENT,106163.0,CHEMBL2364184,Phosphate,1,1,1,,
1369660,CHEMBL2096651,MANGAFODIPIR TRISODIUM,9849,Diagnostic,,,,,1,1,1,,
1159,CHEMBL21,SULFANILAMIDE,1648,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,Broad spectrum
1376005,CHEMBL2103735,CETRORELIX ACETATE,255,Gonadotropin-releasing hormone receptor antagonist,ANTAGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,,
1376006,CHEMBL2103736,FENOPROFEN CALCIUM,1177,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
1376007,CHEMBL2103737,HYDROXOCOBALAMIN,9702,Cyanide sequestering agent,SEQUESTERING AGENT,120005.0,CHEMBL4632347,Cyanide,1,1,1,,
1376008,CHEMBL2103738,LITHIUM CITRATE,62,Inositol-1(or 4)-monophosphatase 1 inhibitor,INHIBITOR,111.0,CHEMBL1786,Inositol monophosphatase 1,1,1,1,,
1376008,CHEMBL2103738,LITHIUM CITRATE,1114,Glycogen synthase kinase-3 inhibitor,INHIBITOR,104772.0,CHEMBL2095188,Glycogen synthase kinase-3,1,1,1,,
1376009,CHEMBL2103739,EMEDASTINE DIFUMARATE,173,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
1376011,CHEMBL2103741,LEVOTHYROXINE SODIUM,1304,Thyroid hormone receptor agonist,AGONIST,104987.0,CHEMBL2111462,Thyroid hormone receptor,1,1,1,,
1376012,CHEMBL2103742,MANGANESE SULFATE,9194,Supplement,,,,,1,1,1,,
1376013,CHEMBL2103743,TOFACITINIB CITRATE,1565,Janus Kinase (JAK) inhibitor,INHIBITOR,105757.0,CHEMBL2363062,Janus Kinase (JAK),1,1,1,,
1376014,CHEMBL2103744,MORPHINE SULFATE,714,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
1376054,CHEMBL2103784,COSYNTROPIN,494,Melanocortin receptor 2 agonist,AGONIST,154.0,CHEMBL1965,Adrenocorticotropic hormone receptor,1,1,1,,
1376065,CHEMBL2103795,AZILSARTAN KAMEDOXOMIL,219,Type-1 angiotensin II receptor antagonist,ANTAGONIST,115.0,CHEMBL227,Type-1 angiotensin II receptor,1,1,1,,Selective
1376070,CHEMBL2103800,COLESTILAN CHLORIDE,5587,Phosphate sequestering agent,SEQUESTERING AGENT,106163.0,CHEMBL2364184,Phosphate,1,1,1,"Acts in the GI tract as a non-calcium, non-metallic phosphate binder",
1376072,CHEMBL2103802,DAPAGLIFLOZIN PROPANEDIOL,2394,Sodium/glucose cotransporter 2 inhibitor,INHIBITOR,20092.0,CHEMBL3884,Sodium/glucose cotransporter 2,1,1,1,,
1376092,CHEMBL2103822,TASIMELTEON,2269,Melatonin receptor agonist,AGONIST,104733.0,CHEMBL2094268,Melatonin receptor,1,1,1,,
1376097,CHEMBL2103827,DROXIDOPA,2267,Adrenergic receptor agonist,AGONIST,105670.0,CHEMBL2331074,Adrenergic receptor,1,1,1,,
1376100,CHEMBL2103830,FOSTAMATINIB,5323,Tyrosine-protein kinase SYK inhibitor,INHIBITOR,10906.0,CHEMBL2599,Tyrosine-protein kinase SYK,1,1,1,Prodrug - active metabolite is R-406,
1376107,CHEMBL2103837,TAFAMIDIS,5605,Transthyretin stabiliser,STABILISER,12704.0,CHEMBL3194,Transthyretin,1,1,1,"Binds TTR with negative cooperativity and kinetically stabilizes WT-TTR and amyloidogenic mutant homotetramers under denaturing and physiologic conditions, inhibiting amyloidogenesis.",
1376114,CHEMBL2103844,PIXANTRONE DIMALEATE,5608,DNA cross-linking agent,CROSS-LINKING AGENT,105574.0,CHEMBL2311221,DNA,1,1,1,Forms formaldehyde-mediated adducts with DNA (favours the CpG motif) and stimulates topoisomerase II-mediated DNA cleavage,
1376124,CHEMBL2103854,OMADACYCLINE TOSYLATE,7393,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,Inhibits bacterial protein synthesis.,"Active against gram-positives expressing tetracycline resistance proteins tetK, tetL, tetM."
1376137,CHEMBL2103867,PLECANATIDE,5620,Heat-stable enterotoxin receptor agonist,AGONIST,104277.0,CHEMBL1795197,Guanylyl cyclase C,1,1,1,,
1376138,CHEMBL2103868,CABOZANTINIB S-MALATE,753,Vascular endothelial growth factor receptor 2 inhibitor,INHIBITOR,10980.0,CHEMBL279,Vascular endothelial growth factor receptor 2,1,1,1,"Multi-kinase inhibitor; Cabozantinib (XL184) is a potent inhibitor of MET and VEGFR2 that also inhibits RET, KIT, AXL, and FLT3, all of which have been implicated in tumor pathogenesis (PMID: 21926191)",
1376138,CHEMBL2103868,CABOZANTINIB S-MALATE,954,Hepatocyte growth factor receptor inhibitor,INHIBITOR,11451.0,CHEMBL3717,Hepatocyte growth factor receptor,1,1,1,"Multi-kinase inhibitor; Cabozantinib (XL184) is a potent inhibitor of MET and VEGFR2 that also inhibits RET, KIT, AXL, and FLT3, all of which have been implicated in tumor pathogenesis (PMID: 21926191)",
1376140,CHEMBL2103870,LUMACAFTOR,2346,Cystic fibrosis transmembrane conductance regulator stabiliser,STABILISER,11540.0,CHEMBL4051,Cystic fibrosis transmembrane conductance regulator,1,1,1,Modulates the folding and trafficking of CFTR protein in patients with one or two copies of the F508del mutation. Acts on the membrane-spanning domain 1 of the CFTR protein.,
1376143,CHEMBL2103873,MACITENTAN,2240,"Endothelin receptor, ET-A/ET-B antagonist",ANTAGONIST,104833.0,CHEMBL2096678,"Endothelin receptor, ET-A/ET-B",1,1,1,,
1376145,CHEMBL2103875,TRAMETINIB,7580,Dual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor,INHIBITOR,104912.0,CHEMBL2111289,Dual specificity mitogen-activated protein kinase kinase; MEK1/2,1,1,1,Reversible inhibitor of MEK1/2. BRAF mutations activate the BRAF pathway that includes MEK1/2 (regulators of cell proliferation). Dabrafenib inhibits a different kinase in the pathway and drug combination has a greater inhibitory effect on tumour growth.,Indicated for cancers with BRAF V600E or V600K mutations.
1376147,CHEMBL2103877,EFINACONAZOLE,2284,Lanosterol 14-alpha demethylase inhibitor,INHIBITOR,108435.0,CHEMBL3307221,Lanosterol 14-alpha demethylase,1,1,1,,
1376153,CHEMBL2103883,AVATROMBOPAG,5625,Thrombopoietin receptor agonist,AGONIST,265.0,CHEMBL1864,Thrombopoietin receptor,1,1,1,,
1376661,CHEMBL2104391,INSULIN DETEMIR,561,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
1377063,CHEMBL2104793,PYROVALERONE HYDROCHLORIDE,6293,Monoamine transporters; Norepinephrine & dopamine inhibitor,INHIBITOR,104870.0,CHEMBL2096990,Monoamine transporters; Norepinephrine & dopamine,1,1,1,"It is an inhibitor of the transporters for certain monoamine neurotransmitters, including dopamine and norepinephrine, preventing their uptake.",
1377257,CHEMBL2104987,TEDUGLUTIDE,1008,Glucagon-like peptide 2 receptor agonist,AGONIST,102687.0,CHEMBL5844,Glucagon-like peptide 2 receptor,1,1,1,,
1377293,CHEMBL2105023,INDIGOTINDISULFONATE SODIUM,9605,Diagnostic,,,,,1,1,1,Renal dye for visualization of the ureteral orifices,
1377503,CHEMBL2105233,PROXIBARBAL,6292,Diamine oxidase activator,ACTIVATOR,10664.0,CHEMBL2118,Diamine oxidase [copper-containing],1,1,1,"Proxibarbal is a non-sedative barbiturate with a specific anti-serotonin and anti-histamine effect, due to enzyme induction of serotoninase and histaminase. Its lack of unpleasant side-effects permits its use for the preventive treatment of migraine.",
1377503,CHEMBL2105233,PROXIBARBAL,6864,Monoamine oxidase A activator,ACTIVATOR,86.0,CHEMBL1951,Amine oxidase [flavin-containing] A,1,1,1,"Proxibarbal is a non-sedative barbiturate with a specific anti-serotonin and anti-histamine effect, due to enzyme induction of serotoninase and histaminase. Its lack of unpleasant side-effects permits its use for the preventive treatment of migraine.",
1377615,CHEMBL2105345,PROPANIDID,6291,Butyrylcholinesterase inhibitor,INHIBITOR,10532.0,CHEMBL1914,Cholinesterase,1,1,1,"Propanidid is a competitive inhibitor of serum cholinesterase, and neuromuscular plaque and brain acetylcholinesterase.  It is an intravenous anesthetic that has been used for rapid induction of anesthesia and for maintenance of anesthesia of short duration.",
1377615,CHEMBL2105345,PROPANIDID,6859,Acetylcholinesterase inhibitor,INHIBITOR,93.0,CHEMBL220,Acetylcholinesterase,1,1,1,"Propanidid is a competitive inhibitor of serum cholinesterase, and neuromuscular plaque and brain acetylcholinesterase.  It is an intravenous anesthetic that has been used for rapid induction of anesthesia and for maintenance of anesthesia of short duration.",
1377665,CHEMBL2105395,OSPEMIFENE,1072,Estrogen receptor modulator,MODULATOR,104682.0,CHEMBL2093866,Estrogen receptor,1,1,1,Mixed agonist/antagonist,
1377690,CHEMBL2105420,TAUROLIDINE,9727,Cell wall disrupting agent,DISRUPTING AGENT,121127.0,CHEMBL5303716,Cell wall,1,1,1,Interacts with bacterial cell wall and also disrupts adhesion to surfaces.,
1377728,CHEMBL2105458,THENALIDINE,6311,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
1377797,CHEMBL2105527,TETRAZEPAM,6310,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,Tetrazepam is a benzodiazepine site agonist and binds unselectively to type 1 and type 2 benzodiazepine site types as well as to peripheral benzodiazepine receptors. The muscle relaxant properties of tetrazepam are most likely due to a reduction of calcium influx.,"Tetrazepam was approximately one-seventh as potent as diazepam at the central receptor and as potent as diazepam at the peripheral binding site. Tetrazepam did not distinguish type I from type II central benzodiazepine receptors, as evidenced by comparable affinities for the cerebellar and hippocampal receptors."
1377851,CHEMBL2105581,VERALIPRIDE,6320,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,Induces prolactin secretion without any estrogenic or progestagenic effects.,
1377883,CHEMBL2105613,DIVALPROEX SODIUM,390,Succinate semialdehyde dehydrogenase inhibitor,INHIBITOR,283.0,CHEMBL1911,"Succinate-semialdehyde dehydrogenase, mitochondrial",1,1,1,,
1377899,CHEMBL2105629,VINFLUNINE DITARTRATE,9808,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,,
1377908,CHEMBL2105638,DELAFLOXACIN MEGLUMINE,6904,Bacterial DNA gyrase inhibitor,INHIBITOR,105577.0,CHEMBL2311224,Bacterial DNA gyrase,1,1,1,,
1377908,CHEMBL2105638,DELAFLOXACIN MEGLUMINE,7254,Topoisomerase IV inhibitor,INHIBITOR,105771.0,CHEMBL2363076,Topoisomerase IV,1,1,1,,
1377918,CHEMBL2105648,PALOVAROTENE,4602,Retinoic acid receptor gamma agonist,AGONIST,240.0,CHEMBL2003,Retinoic acid receptor gamma,1,1,1,,
1377932,CHEMBL2105662,LOMITAPIDE MESYLATE,1406,Microsomal triglyceride transfer protein inhibitor,INHIBITOR,106181.0,CHEMBL2364681,Microsomal triglyceride transfer protein,1,1,1,,
1377939,CHEMBL2105669,TEDIZOLID PHOSPHATE,2282,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
1377945,CHEMBL2105675,TAFAMIDIS MEGLUMINE,5664,Transthyretin stabiliser,STABILISER,12704.0,CHEMBL3194,Transthyretin,1,1,1,"Binds TTR with negative cooperativity and kinetically stabilizes WT-TTR and amyloidogenic mutant homotetramers under denaturing and physiologic conditions, inhibiting amyloidogenesis.",
1377950,CHEMBL2105680,RIFAMYCIN SODIUM,7377,DNA-directed RNA polymerase inhibitor,INHIBITOR,118390.0,CHEMBL4296169,DNA-directed RNA polymerase,1,1,1,Binds to the beta subunit of RNA polymerase inhibiting bacterial RNA synthesis.,Active against enterotoxigenic and enteroaggregative E coli involved in traveller's diarrhea.
1377952,CHEMBL2105682,EDOXABAN TOSYLATE,2318,Coagulation factor X inhibitor,INHIBITOR,194.0,CHEMBL244,Coagulation factor X,1,1,1,,
1377954,CHEMBL2105684,SELUMETINIB SULFATE,7761,Dual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor,INHIBITOR,104912.0,CHEMBL2111289,Dual specificity mitogen-activated protein kinase kinase; MEK1/2,1,1,1,"Inhibits MEK1/2 which are involved in the RAS-regulated RAF-MEK-ERK pathway, often activated in cancers.",
1377959,CHEMBL2105689,LULICONAZOLE,2245,Cytochrome P450 51 inhibitor,INHIBITOR,58.0,CHEMBL1780,Lanosterol 14-alpha demethylase,1,1,1,,
1377965,CHEMBL2105695,TELOTRISTAT ETHYL,6165,Tryptophan 5-hydroxylase inhibitor,INHIBITOR,116867.0,CHEMBL3831287,Tryptophan 5-hydroxylase,1,1,1,"Prodrug, in vitro inhibitory potency of telotristat towards tryptophan hydroxylase is 29 times higher than that of telotristat ethyl",
1377970,CHEMBL2105700,BEDAQUILINE FUMARATE,1840,ATP synthase inhibitor,INHIBITOR,106145.0,CHEMBL2364166,ATP synthase,1,1,1,"It has been shown that mutation in the atpE gene, which encodes the c subunit, of the mycobacterial ATP synthase, confers resistant to Bedaquiline, suggesting that Bedaquiline binds crucially to this target, inhibiting the proton pump of M. tuberculosis and therefore interfering with the rotation properties of the transmembrane disk, leading to ATP depletion (PMID: 15591164)",
1377974,CHEMBL2105704,LENVATINIB MESYLATE,2314,Vascular endothelial growth factor receptor inhibitor,INHIBITOR,104799.0,CHEMBL2095227,Vascular endothelial growth factor receptor,1,1,1,,
1377978,CHEMBL2105708,PONATINIB HYDROCHLORIDE,1119,Bcr/Abl fusion protein inhibitor,INHIBITOR,104811.0,CHEMBL2096618,Bcr/Abl fusion protein,1,1,1,,
1377979,CHEMBL2105709,QUIZARTINIB DIHYDROCHLORIDE,9862,Tyrosine-protein kinase receptor FLT3 inhibitor,INHIBITOR,12670.0,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,1,1,1,,
1377981,CHEMBL2105711,TOFOGLIFLOZIN,5672,Sodium/glucose cotransporter 2 inhibitor,INHIBITOR,20092.0,CHEMBL3884,Sodium/glucose cotransporter 2,1,1,1,,"SGLT2 selective. IC50 rSGLT2= 14.5nM; mSGLT2= 5.0 nM vs IC50 rSGLT1=8200 nM; IC50 mSGLT1, 1800 nM."
1377982,CHEMBL2105712,AFATINIB DIMALEATE,2234,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,"Afatinib covalently binds to the kinase domains of EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4) and irreversibly inhibits tyrosine kinase autophosphorylation, resulting in downregulation of ErbB signaling",
1377982,CHEMBL2105712,AFATINIB DIMALEATE,2257,Receptor protein-tyrosine kinase erbB-2 inhibitor,INHIBITOR,188.0,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,1,1,1,"Afatinib covalently binds to the kinase domains of EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4) and irreversibly inhibits tyrosine kinase autophosphorylation, resulting in downregulation of ErbB signaling",
1377982,CHEMBL2105712,AFATINIB DIMALEATE,2258,Receptor protein-tyrosine kinase erbB-4 inhibitor,INHIBITOR,12699.0,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,1,1,1,"Afatinib covalently binds to the kinase domains of EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4) and irreversibly inhibits tyrosine kinase autophosphorylation, resulting in downregulation of ErbB signaling",
1377989,CHEMBL2105719,DACOMITINIB,5311,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,Dacomitinib is an irreversible pan-ERBB inhibitor.,
1377989,CHEMBL2105719,DACOMITINIB,5312,Receptor protein-tyrosine kinase erbB-2 inhibitor,INHIBITOR,188.0,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,1,1,1,Dacomitinib is an irreversible pan-ERBB inhibitor.,
1377989,CHEMBL2105719,DACOMITINIB,5313,Receptor protein-tyrosine kinase erbB-4 inhibitor,INHIBITOR,12699.0,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,1,1,1,Dacomitinib is an irreversible pan-ERBB inhibitor.,
1377990,CHEMBL2105720,LESINURAD,2436,Solute carrier family 22 member 12 inhibitor,INHIBITOR,102767.0,CHEMBL6120,Solute carrier family 22 member 12,1,1,1,,
1377999,CHEMBL2105729,DABRAFENIB MESYLATE,992,Serine/threonine-protein kinase B-raf inhibitor,INHIBITOR,100126.0,CHEMBL5145,Serine/threonine-protein kinase B-raf,1,1,1,,
1378002,CHEMBL2105732,LEVOMILNACIPRAN HYDROCHLORIDE,2252,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
1378002,CHEMBL2105732,LEVOMILNACIPRAN HYDROCHLORIDE,2253,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
1378005,CHEMBL2105735,ASUNAPREVIR,7504,"Hepatitis C virus serine protease, NS3/NS4A inhibitor",INHIBITOR,104803.0,CHEMBL2095231,"Hepatitis C virus serine protease, NS3/NS4A",1,1,1,,
1378010,CHEMBL2105740,SITAXENTAN SODIUM,6299,"Endothelin receptor, ET-A/ET-B antagonist",ANTAGONIST,104833.0,CHEMBL2096678,"Endothelin receptor, ET-A/ET-B",1,1,1,"Sitaxentan is a competitive antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors. Under normal conditions, endothelin-1 binding of ET-A or ET-B receptors causes pulmonary vasoconstriction. By blocking this interaction, Sitaxentan decreases pulmonary vascular resistance",
1378011,CHEMBL2105741,TRAMETINIB DIMETHYL SULFOXIDE,935,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,INHIBITOR,11046.0,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,1,1,1,,
1378011,CHEMBL2105741,TRAMETINIB DIMETHYL SULFOXIDE,948,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,INHIBITOR,11409.0,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,1,1,1,,
1378013,CHEMBL2105743,OLODATEROL HYDROCHLORIDE,2281,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,Long-acting,
1378015,CHEMBL2105745,GLYCEROL PHENYLBUTYRATE,1676,Glutamine sequestering agent,SEQUESTERING AGENT,106212.0,CHEMBL2366039,Glutamine,1,1,1,"Removes excess nitrogen, caused by enzyme deficiency",
1378018,CHEMBL2105748,PRUCALOPRIDE SUCCINATE,7355,Serotonin 4 (5-HT4) receptor agonist,AGONIST,168.0,CHEMBL1875,5-hydroxytryptamine receptor 4,1,1,1,Facilitates acetylcholine release and stimulates colonic peristalsis.,Selective for 5-HT4.
1378019,CHEMBL2105749,SAMIDORPHAN L-MALATE,8781,Kappa opioid receptor partial agonist,PARTIAL AGONIST,137.0,CHEMBL237,Kappa-type opioid receptor,1,1,1,,Increased potency at the mu receptor
1378019,CHEMBL2105749,SAMIDORPHAN L-MALATE,8812,Delta opioid receptor partial agonist,PARTIAL AGONIST,136.0,CHEMBL236,Delta-type opioid receptor,1,1,1,,Increased potency at the mu receptor
1378019,CHEMBL2105749,SAMIDORPHAN L-MALATE,9004,Mu opioid receptor antagonist,ANTAGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,Increased potency at the mu receptor
1378024,CHEMBL2105754,TRELAGLIPTIN SUCCINATE,5682,Dipeptidyl peptidase IV inhibitor,INHIBITOR,11140.0,CHEMBL284,Dipeptidyl peptidase 4,1,1,1,,
1378025,CHEMBL2105755,NALDEMEDINE,5356,Mu opioid receptor antagonist,ANTAGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,"Nalmedine is also an antagonist at delta and kappa opioid receptors but functions as a peripherally-acting mu-opioid receptor antagonist in constipation, so the mu receptor is the therapeutic target for this indication.",
1378026,CHEMBL2105756,TIVOZANIB HYDROCHLORIDE,8674,Vascular endothelial growth factor receptor inhibitor,INHIBITOR,104799.0,CHEMBL2095227,Vascular endothelial growth factor receptor,1,1,1,,More potent against VEGFR vs. c-KIT/PDGFR-beta
1378026,CHEMBL2105756,TIVOZANIB HYDROCHLORIDE,8711,Stem cell growth factor receptor inhibitor,INHIBITOR,238.0,CHEMBL1936,Mast/stem cell growth factor receptor Kit,1,1,1,,More potent against VEGFR vs. c-KIT/PDGFR-beta
1378026,CHEMBL2105756,TIVOZANIB HYDROCHLORIDE,8944,Platelet-derived growth factor receptor beta inhibitor,INHIBITOR,197.0,CHEMBL1913,Platelet-derived growth factor receptor beta,1,1,1,,More potent against VEGFR vs. c-KIT/PDGFR-beta
1378028,CHEMBL2105758,AVATROMBOPAG MALEATE,7347,Thrombopoietin receptor agonist,AGONIST,265.0,CHEMBL1864,Thrombopoietin receptor,1,1,1,Stimulates megakaryocyte production resulting in increased platelets.,
1378029,CHEMBL2105759,BARICITINIB,5293,Tyrosine-protein kinase JAK1 inhibitor,INHIBITOR,10919.0,CHEMBL2835,Tyrosine-protein kinase JAK1,1,1,1,,
1378029,CHEMBL2105759,BARICITINIB,5294,Tyrosine-protein kinase JAK2 inhibitor,INHIBITOR,10938.0,CHEMBL2971,Tyrosine-protein kinase JAK2,1,1,1,,
1378030,CHEMBL2105760,BREXPIPRAZOLE,2348,Dopamine D2 receptor partial agonist,PARTIAL AGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
1378030,CHEMBL2105760,BREXPIPRAZOLE,2349,Serotonin 1a (5-HT1a) receptor partial agonist,PARTIAL AGONIST,51.0,CHEMBL214,5-hydroxytryptamine receptor 1A,1,1,1,,
1378030,CHEMBL2105760,BREXPIPRAZOLE,2350,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
1378032,CHEMBL2105762,OMARIGLIPTIN,5684,Dipeptidyl peptidase IV inhibitor,INHIBITOR,11140.0,CHEMBL284,Dipeptidyl peptidase 4,1,1,1,,
1378389,CHEMBL2106119,CALCIUM GLUCONATE,6901,Mineral supplement,,,,,1,1,1,Mechanism_for_indication: hypocalcemia. Increases calcium level.,
1378425,CHEMBL2106155,ENCAINIDE HYDROCHLORIDE,6241,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,"Encainide is a class IC antiarrhythmic agent having little or no effect on action-potential duration or maximum diastolic potential but decreasing the maximum rate of phase O depolarization as well as increasing atrial and ventricular effective refractory periods. In intact animals or humans, encainide increases the AH, PR, QRS, and H-V intervals while not affecting the sinus node cycle length or JT interval. It is metabolized to O-demethyl encainide (ODE) and 3-methoxy-ODE (MODE), both of which are also antiarrhythmics with similar pharmacology to encainide.",
1378465,CHEMBL2106195,DEXMEDETOMIDINE HYDROCHLORIDE,1139,Adrenergic receptor alpha-2 agonist,AGONIST,104743.0,CHEMBL2095158,Adrenergic receptor alpha-2,1,1,1,,Selective
1378487,CHEMBL2106217,FENFLURAMINE HYDROCHLORIDE,6246,Serotonin 1d (5-HT1d) receptor agonist,AGONIST,105.0,CHEMBL1983,5-hydroxytryptamine receptor 1D,1,1,1,"Fenfluramine (FA) reduces epileptiform activity by stimulating 5-HT2C and 5-HT1D receptors, leading to enhanced GABAergic neurotransmission, and by a 1-antagonistic action that can reduce the excitatory neurotransmission by modulating N-methyl-D-aspartate (NMDA) responses. In addition, FA also significantly decreases the noradrenaline (NAD) brain content that might contribute to its anti-epileptic effects. Fenfluramine causes the release of serotonin (5-HT) by disrupting vesicular storage of the neurotransmitter and inhibiting its reuptake. The increased 5-HT availability in the brain results in a loss of appetite.",
1378487,CHEMBL2106217,FENFLURAMINE HYDROCHLORIDE,6857,Serotonin 2c (5-HT2c) receptor agonist,AGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,"Fenfluramine (FA) reduces epileptiform activity by stimulating 5-HT2C and 5-HT1D receptors, leading to enhanced GABAergic neurotransmission, and by a 1-antagonistic action that can reduce the excitatory neurotransmission by modulating N-methyl-D-aspartate (NMDA) responses. In addition, FA also significantly decreases the noradrenaline (NAD) brain content that might contribute to its anti-epileptic effects. Fenfluramine causes the release of serotonin (5-HT) by disrupting vesicular storage of the neurotransmitter and inhibiting its reuptake. The increased 5-HT availability in the brain results in a loss of appetite.",
1378487,CHEMBL2106217,FENFLURAMINE HYDROCHLORIDE,6858,Sigma opioid receptor antagonist,ANTAGONIST,11272.0,CHEMBL287,Sigma non-opioid intracellular receptor 1,1,1,1,"Fenfluramine (FA) reduces epileptiform activity by stimulating 5-HT2C and 5-HT1D receptors, leading to enhanced GABAergic neurotransmission, and by a 1-antagonistic action that can reduce the excitatory neurotransmission by modulating N-methyl-D-aspartate (NMDA) responses. In addition, FA also significantly decreases the noradrenaline (NAD) brain content that might contribute to its anti-epileptic effects. Fenfluramine causes the release of serotonin (5-HT) by disrupting vesicular storage of the neurotransmitter and inhibiting its reuptake. The increased 5-HT availability in the brain results in a loss of appetite.",
1378753,CHEMBL2106483,VILOXAZINE HYDROCHLORIDE,8574,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
1378885,CHEMBL2106615,BAZEDOXIFENE ACETATE,2248,Estrogen receptor modulator,MODULATOR,104682.0,CHEMBL2093866,Estrogen receptor,1,1,1,"Bazedoxifene profile is antagonistic in breast and endometrial tissue, while an estrogen agonist in bone tissue;  Bazedoxifene in combination with conjugated estrogens is the first approved tissue-selective estrogen receptor complex (TSEC)",
1378913,CHEMBL2106643,MYCOPHENOLATE SODIUM,9269,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,INHIBITOR,105058.0,CHEMBL2111369,Inosine-5'-monophosphate dehydrogenase (IMPDH),1,1,1,,
1379099,CHEMBL2106829,METHAQUALONE HYDROCHLORIDE,6266,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,"Methaqualone was demonstrated to be a positive allosteric modulator at human Alpha 1,2,3,5 Beta 2,3 Gamma 2S GABA A receptors (GABAARs) expressed in Xenopus oocytes, whereas it displayed highly diverse functionalities at the Alpha 4,6 Beta 1,2,3 Delta GABAAR subtypes, ranging from inactivity (Alpha4 Beta1 Delta), through negative (Alpha 6 Beta 1 Delta) or positive allosteric modulation (Alpha 4 Beta 2 Delta, Alpha 6 Beta 2,3 Delta), to superagonism (Alpha 4 Beta 3 Delta).",
1379209,CHEMBL2106939,POLIHEXANIDE,9476,Cell membrane disrupting agent,DISRUPTING AGENT,120340.0,CHEMBL4804260,Cell membrane,1,1,1,,
1379209,CHEMBL2106939,POLIHEXANIDE,9481,Cell membrane disrupting agent,DISRUPTING AGENT,106010.0,CHEMBL2364031,Cell membrane,1,1,1,,
1379337,CHEMBL2107067,TESTOSTERONE UNDECANOATE,2270,Androgen Receptor agonist,AGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
1379484,CHEMBL2107214,IOMEPROL,9246,Diagnostic,,,,,1,1,1,,
1379523,CHEMBL2107253,SULFADIMETHOXINE SODIUM,6304,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,"Bacteria and some protozoa are unable to obtain folic acid from the environment, and must synthesize it by converting PABA (para-aminobenzoate) to dihydropteroate using the enzyme dihydropteroate synthase. Sulfadimethoxine, being structurally similar to PABA, acts as a competitive inhibitor. It binds to the enzyme's active site and prevents the synthesis of folic acid from progressing. Folic acid is necessary for these organisms to produce nucleic acids, which are required for cell division. Thus, it has a microbiostatic effect rather than a microbiocidal one, and has the strongest effect in the beginning stages of an infection, when the pathogen is rapidly dividing.",
1379603,CHEMBL2107333,DIMETHYL FUMARATE,1298,Kelch-like ECH-associated protein 1 inhibitor,INHIBITOR,104593.0,CHEMBL2069156,Kelch-like ECH-associated protein 1,1,1,1,"Alykylates Keap1 to prevent interaction with Nrf2 (PMID: 22732183, PMID: 23709213, PMID: 18618599)",
1379624,CHEMBL2107354,MIFAMURTIDE,5702,Nucleotide-binding oligomerization domain-containing protein 2 other,OTHER,103699.0,CHEMBL1293266,Nucleotide-binding oligomerization domain-containing protein 2,1,1,1,Immunostimulant,
1379625,CHEMBL2107355,MIGALASTAT HYDROCHLORIDE,7392,Alpha-galactosidase A stabiliser,STABILISER,10693.0,CHEMBL2524,Alpha-galactosidase A,1,1,1,"Migalastat binds to the active site of alpha-galactosidase A, deficient in Fabry disease, stabilising the protein or protein variant enabling trafficking to the lysosome and enzyme activity. ",Binds alpha-galactosidase A and variants.
1379630,CHEMBL2107360,PALIPERIDONE PALMITATE,206,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
1379630,CHEMBL2107360,PALIPERIDONE PALMITATE,597,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
1379644,CHEMBL2107374,SUGAMMADEX SODIUM,2433,Rocuronium sequestering agent,SEQUESTERING AGENT,109713.0,CHEMBL3559390,Rocuronium,1,1,1,,
1379644,CHEMBL2107374,SUGAMMADEX SODIUM,2434,Vecuronium sequestering agent,SEQUESTERING AGENT,109714.0,CHEMBL3559391,Vecuronium,1,1,1,,
1379653,CHEMBL2107383,VERNAKALANT HYDROCHLORIDE,7678,Kir3.1/Kir3.4 blocker,BLOCKER,107914.0,CHEMBL3038488,Kir3.1/Kir3.4,1,1,1,Also partially blocks the hERG channel.,
1379653,CHEMBL2107383,VERNAKALANT HYDROCHLORIDE,7679,Voltage-gated potassium channel subunit Kv1.5 blocker,BLOCKER,10198.0,CHEMBL4306,Potassium voltage-gated channel subfamily A member 5,1,1,1,Also partially blocks the hERG channel.,
1379653,CHEMBL2107383,VERNAKALANT HYDROCHLORIDE,7680,HERG blocker,BLOCKER,165.0,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,1,1,1,Also partially blocks the hERG channel.,
1379653,CHEMBL2107383,VERNAKALANT HYDROCHLORIDE,7710,Voltage-gated potassium channel subunit Kv4.3 blocker,BLOCKER,11153.0,CHEMBL1964,A-type voltage-gated potassium channel KCND3,1,1,1,Also partially blocks the hERG channel.,
1379653,CHEMBL2107383,VERNAKALANT HYDROCHLORIDE,7711,Sodium channel protein type V alpha subunit blocker,BLOCKER,11480.0,CHEMBL1980,Sodium channel protein type 5 subunit alpha,1,1,1,Also partially blocks the hERG channel.,
1379656,CHEMBL2107386,VORAPAXAR SULFATE,2289,Proteinase-activated receptor 1 antagonist,ANTAGONIST,10653.0,CHEMBL3974,Proteinase-activated receptor 1,1,1,1,,
1379657,CHEMBL2107387,VORTIOXETINE HYDROBROMIDE,2236,Serotonin 1a (5-HT1a) receptor agonist,AGONIST,51.0,CHEMBL214,5-hydroxytryptamine receptor 1A,1,1,1,,
1379657,CHEMBL2107387,VORTIOXETINE HYDROBROMIDE,2237,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,reuptake inhibitor,
1379657,CHEMBL2107387,VORTIOXETINE HYDROBROMIDE,2238,Serotonin 3a (5-HT3a) receptor antagonist,ANTAGONIST,144.0,CHEMBL1899,5-hydroxytryptamine receptor 3A,1,1,1,,
1379765,CHEMBL2107495,TEMAFLOXACIN HYDROCHLORIDE,6307,Bacterial DNA gyrase inhibitor,INHIBITOR,105577.0,CHEMBL2311224,Bacterial DNA gyrase,1,1,1,"The bactericidal activity of temafloxacin and other fluoroquinolones is attributed to inhibition of bacterial DNA gyrase (topoisomerase II), an enzyme that regulates supercoiling and uncoiling of DNA.",
1379795,CHEMBL2107525,SODIUM PHOSPHATE P 32,2207,Radiopharmaceutical,,,,,1,1,1,Mechanism for sodium phosphate P32,
1380067,CHEMBL2107797,NORGESTREL,1019,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,
1380076,CHEMBL2107806,TALAPORFIN SODIUM,7542,Photosensitizing agent,,,,,0,0,1,"Photosensitizing agent. Talaporfin sodium-mediated PDT has an antiproliferative effect, potentially through low-density lipoprotein (LDL) receptor-mediated uptake into cancer cells (PMID: 30867758) and subsequent cell damage upon light activation.",
1380085,CHEMBL2107815,TREPROSTINIL DIOLAMINE,2294,Prostanoid IP receptor agonist,AGONIST,143.0,CHEMBL1995,Prostacyclin receptor,1,1,1,,
1380086,CHEMBL2107816,RADIUM RA 223 DICHLORIDE,2111,Radiotherapy agent,,,,,1,1,1,"Radiotherapy agent, binds to hydroxyapatite in bone, where alpha radiation results in double strand DNA breaks.",
1380087,CHEMBL2107817,AVIBACTAM SODIUM,2324,Bacterial beta-lactamase TEM inhibitor,INHIBITOR,106170.0,CHEMBL2364670,Beta-lactamase TEM,1,1,1,,
1380095,CHEMBL2107825,TENOFOVIR ALAFENAMIDE,6930,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,Prodrug of tenofovir; active metabolite tenofovir diphosphate,
1380096,CHEMBL2107826,VIBEGRON,4911,Beta-3 adrenergic receptor agonist,AGONIST,226.0,CHEMBL246,Beta-3 adrenergic receptor,1,1,1,,
1380100,CHEMBL2107830,EMPAGLIFLOZIN,2291,Sodium/glucose cotransporter 2 inhibitor,INHIBITOR,20092.0,CHEMBL3884,Sodium/glucose cotransporter 2,1,1,1,,
1380101,CHEMBL2107831,LUSUTROMBOPAG,7353,Thrombopoietin receptor agonist,AGONIST,265.0,CHEMBL1864,Thrombopoietin receptor,1,1,1,Interacts with TPO receptors on megakaryocytes inducing proliferation and differentiation of megakaryocyte progenitor cells. Upregulates platelet production.,
1380104,CHEMBL2107834,RIOCIGUAT,2239,Soluble guanylate cyclase positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,105048.0,CHEMBL2111348,Soluble guanylate cyclase,1,1,1,"Riociguat has a dual mode of action. It sensitizes sGC to endogenous NO by stabilizing the NO-sGC binding and it also directly stimulates sGC via a different binding site, independently of NO. Recent studies have suggested that sCG stimulators bind to an allosteric nucleotide-binding site in the catalytic domains of sCG. The exact molecular mechanism of sCG stimulation remains a matter of debate.",
1380106,CHEMBL2107840,PATIROMER CALCIUM,2414,Potassium chelating agent,CHELATING AGENT,109707.0,CHEMBL3545434,Potassium,1,1,1,,
1380107,CHEMBL2107841,ALBIGLUTIDE,2276,Glucagon-like peptide 1 receptor agonist,AGONIST,11758.0,CHEMBL1784,Glucagon-like peptide 1 receptor,1,1,1,,
1380123,CHEMBL2107857,METRELEPTIN,2272,Leptin receptor agonist,AGONIST,102709.0,CHEMBL5913,Leptin receptor,1,1,1,,
1380132,CHEMBL2107866,PEGINESATIDE,5545,Erythropoietin receptor agonist,AGONIST,201.0,CHEMBL1817,Erythropoietin receptor,1,1,1,,
1380135,CHEMBL2107869,INSULIN DEGLUDEC,2409,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
1380139,CHEMBL2107873,VONICOG ALFA,9271,von Willebrand factor exogenous protein,EXOGENOUS PROTEIN,104515.0,CHEMBL2021748,von Willebrand factor,1,1,1,,
1380140,CHEMBL2107874,ROMOSOZUMAB,5471,Sclerostin inhibitor,INHIBITOR,109783.0,CHEMBL3580487,Sclerostin,1,1,1,"Inhibits the protein sclerostin, and has a dual effect on bone, both increasing bone formation and decreasing bone breakdown.",
1380150,CHEMBL2107884,RESLIZUMAB,5515,Interleukin-5 inhibitor,INHIBITOR,103470.0,CHEMBL1169600,Interleukin-5,1,1,1,,
1380151,CHEMBL2107885,RETEPLASE,81,Tissue-type plasminogen activator exogenous protein,EXOGENOUS PROTEIN,11399.0,CHEMBL1873,Tissue-type plasminogen activator,1,1,1,,
1380168,CHEMBL2107902,TECHNETIUM TC 99M FANOLESOMAB,9244,Diagnostic,,,,,1,1,1,,
1380209,CHEMBL2107943,POLIDEXIDE SULFATE,6285,Bile acids sequestering agent,SEQUESTERING AGENT,106154.0,CHEMBL2364175,Bile acids,1,1,1,Polidexide is an anion exchange resin that forms a non-absorbable complex with bile acids in the intestine thus removing the latter from the entero-hepatic circulation and facilitating their excretion in the faeces.,
1380293,CHEMBL2108027,DULAGLUTIDE,2308,Glucagon-like peptide 1 receptor agonist,AGONIST,11758.0,CHEMBL1784,Glucagon-like peptide 1 receptor,1,1,1,,
1380301,CHEMBL2108035,INCOBOTULINUMTOXINA,1415,Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor,INHIBITOR,106138.0,CHEMBL2364159,Synaptosomal-associated protein 25,1,1,1,"BOTOX blocks neuromuscular transmission by binding to acceptor sites on motor or sympathetic nerve terminals, entering the nerve terminals, and inhibiting the release of acetylcholine. This inhibition occurs as the neurotoxin cleaves SNAP-25, a protein integral to the successful docking and release of acetylcholine from vesicles situated within nerve endings.",
1380307,CHEMBL2108041,OCRELIZUMAB,5474,B-lymphocyte antigen CD20 binding agent,BINDING AGENT,181.0,CHEMBL2058,B-lymphocyte antigen CD20,1,1,1,"Humanized monoclonal antibody designed to target CD20-positive B cells, which are implicated in the inflammatory and neurodegenerative processes of multiple sclerosis.  By targeting CD20-positive B cells, this molecule depletes  (antibody-dependent cell-mediated cytotoxicity) pre-B cells and mature B cells without affecting plasma cells or progenitor cells in the bone marrow.",
1380340,CHEMBL2108074,PANCRELIPASE,2229,Fatty acids hydrolytic enzyme,HYDROLYTIC ENZYME,106207.0,CHEMBL2364711,Fatty acids,1,1,1,,
1380340,CHEMBL2108074,PANCRELIPASE,2230,Starch hydrolytic enzyme,HYDROLYTIC ENZYME,106159.0,CHEMBL2364180,Starch,1,1,1,,
1380340,CHEMBL2108074,PANCRELIPASE,2231,Polypeptides hydrolytic enzyme,HYDROLYTIC ENZYME,106160.0,CHEMBL2364181,Polypeptides,1,1,1,,
1380344,CHEMBL2108078,PARATHYROID HORMONE,2319,Parathyroid hormone receptor agonist,AGONIST,160.0,CHEMBL1793,Parathyroid hormone/parathyroid hormone-related peptide receptor,1,1,1,,
1380347,CHEMBL2108081,TRAFERMIN,5879,Fibroblast growth factor receptor 2 agonist,AGONIST,10264.0,CHEMBL4142,Fibroblast growth factor receptor 2,1,1,1,"It binds to the FGF2 receptor and stimulates the proliferation of fibroblasts, epithelial cells, vascular smooth muscle cells, vascular endothelial cells, peridontal and bone tissues. ",
1380372,CHEMBL2108106,TOCOFERSOLAN,9787,Nutritional support,,,,,1,1,1,,
1380413,CHEMBL2108147,STREPTOKINASE,80,Plasminogen activator,ACTIVATOR,12.0,CHEMBL1801,Plasminogen,1,1,1,,
1380441,CHEMBL2108175,HUMAN COAGULATION FACTOR VIII,9648,Coagulation factor VIII exogenous protein,EXOGENOUS PROTEIN,10210.0,CHEMBL3143,Coagulation factor VIII,1,1,1,,
1380450,CHEMBL2108184,CROFELEMER,964,Cystic fibrosis transmembrane conductance regulator inhibitor,INHIBITOR,11540.0,CHEMBL4051,Cystic fibrosis transmembrane conductance regulator,1,1,1,,
1380450,CHEMBL2108184,CROFELEMER,2386,Anoctamin-1 blocker,BLOCKER,104568.0,CHEMBL2046267,Anoctamin-1,1,1,1,,
1380451,CHEMBL2108185,CORIFOLLITROPIN ALFA,6682,Follicle stimulating hormone receptor agonist,AGONIST,99.0,CHEMBL2024,Follicle-stimulating hormone receptor,1,1,1,"Corifollitropin alfa is a recombinant long-acting follicle-stimulating hormone (FSH) agonist for the treatment of infertility. It is similar to FSH, a natural hormone in the body that stimulates the production of eggs in the ovaries. The  subunit of clorifollitropin alfa contains the carboxy-terminal peptide of human chorionic gonadotropin to prolong its activity in the body. As a result a single dose of the medicine can be given to stimulate egg production for seven days, thereby replacing daily injections that would be required with other FSH medicines.",
1380480,CHEMBL2108214,AGALSIDASE ALFA,8644,Globotriosylceramide hydrolytic enzyme,HYDROLYTIC ENZYME,106213.0,CHEMBL2366040,Globotriosylceramide,1,1,1,,
1380519,CHEMBL2108253,ARCITUMOMAB,7172,Carcinoembryonic antigen-related cell adhesion molecule 5 binding agent,BINDING AGENT,114842.0,CHEMBL3712881,Carcinoembryonic antigen-related cell adhesion molecule 5,1,1,1,,
1380544,CHEMBL2108278,ETEPLIRSEN,5565,Dystrophin pre-mRNA positive modulator,POSITIVE MODULATOR,116818.0,CHEMBL3826826,Dystrophin pre-mRNA,1,1,1,"Phosphorodiamidate morpholino oligomer (PMO) that selectively binds to exon 51 of dystrophin pre-mRNA, restoring the open reading frame and ena-
bling production of functional truncated in-frame dystrophin protein. ",
1380548,CHEMBL2108282,CATRIDECACOG,9517,Coagulation factor XIII exogenous protein,EXOGENOUS PROTEIN,100151.0,CHEMBL4530,Coagulation factor XIII A chain,1,1,1,,
1380552,CHEMBL2108286,TUROCTOCOG ALFA,9650,Coagulation factor VIII exogenous protein,EXOGENOUS PROTEIN,10210.0,CHEMBL3143,Coagulation factor VIII,1,1,1,,
1380556,CHEMBL2108290,EPOETIN THETA,7579,Erythropoietin receptor agonist,AGONIST,201.0,CHEMBL1817,Erythropoietin receptor,1,1,1,Supplements levels of the natural hormone erythropoietin and stimulates the production of red blood cells. Anemia is caused by a deficiency of red blood cells. ,
1380570,CHEMBL2108304,ALIPOGENE TIPARVOVEC,7667,Triglyceride hydrolytic enzyme,HYDROLYTIC ENZYME,109712.0,CHEMBL3559389,Triglyceride,1,1,1,Hydrolyses plasma triglycerides and triglyceride-lipoproteins.,
1380577,CHEMBL2108311,ASFOTASE ALFA,2416,Pyrophosphate hydrolytic enzyme,HYDROLYTIC ENZYME,109708.0,CHEMBL3545435,Pyrophosphate,1,1,1,First-in-class enzyme replacement therapy of TNSALP in case of hypophosphatasia (HPP),
1380585,CHEMBL2108319,SIMOCTOCOG ALFA,9646,Coagulation factor VIII exogenous protein,EXOGENOUS PROTEIN,10210.0,CHEMBL3143,Coagulation factor VIII,1,1,1,,
1380598,CHEMBL2108332,BEPERMINOGENE PERPLASMID,7627,Hepatocyte growth factor receptor agonist,AGONIST,11451.0,CHEMBL3717,Hepatocyte growth factor receptor,1,1,1,Induces angiogenesis.,
1380600,CHEMBL2108334,EPTACOG ALFA (ACTIVATED),9512,Coagulation factor VII exogenous protein,EXOGENOUS PROTEIN,12000.0,CHEMBL3991,Coagulation factor VII,1,1,1,,
1380602,CHEMBL2108336,LIXISENATIDE,6157,Glucagon-like peptide 1 receptor agonist,AGONIST,11758.0,CHEMBL1784,Glucagon-like peptide 1 receptor,1,1,1,,
1380614,CHEMBL2108348,NONACOG BETA PEGOL,9209,Coagulation factor IX exogenous protein,EXOGENOUS PROTEIN,193.0,CHEMBL2016,Coagulation factor IX,1,1,1,,
1380616,CHEMBL2108350,CONESTAT ALFA,9807,Plasma protease C1 inhibitor exogenous protein,EXOGENOUS PROTEIN,121134.0,CHEMBL5305024,Plasma protease C1 inhibitor,1,1,1,,
1380620,CHEMBL2108354,UBLITUXIMAB,5945,B-lymphocyte antigen CD20 binding agent,BINDING AGENT,181.0,CHEMBL2058,B-lymphocyte antigen CD20,1,1,1,High affinity for Fc gamma RIIIa (CD16) receptors and therefore greater antibody-dependent cellular cytotoxicity (ADCC) activity.,
1380693,CHEMBL2108427,MENOTROPINS,2232,Luteinizing hormone/Choriogonadotropin receptor agonist,AGONIST,95.0,CHEMBL1854,Lutropin-choriogonadotropic hormone receptor,1,1,1,,
1380693,CHEMBL2108427,MENOTROPINS,2233,Follicle stimulating hormone receptor agonist,AGONIST,99.0,CHEMBL2024,Follicle-stimulating hormone receptor,1,1,1,,
1380695,CHEMBL2108429,MEPOLIZUMAB,2420,Interleukin-5 inhibitor,INHIBITOR,103470.0,CHEMBL1169600,Interleukin-5,1,1,1,,
1380774,CHEMBL2108508,INTERFERON ALFA-2A,1796,Interferon alpha/beta receptor agonist,AGONIST,106149.0,CHEMBL2364170,Interferon alpha/beta receptor,1,1,1,,
1380778,CHEMBL2108512,HEPATITIS B IMMUNE GLOBULIN,9847,Surface antigen (HBsAg) binding agent,BINDING AGENT,121142.0,CHEMBL5308521,Surface antigen (HBsAg),1,1,1,,
1380812,CHEMBL2108546,PEGASPARGASE,2035,Asparagine hydrolytic enzyme,HYDROLYTIC ENZYME,106202.0,CHEMBL2364706,Asparagine,1,1,1,,
1380836,CHEMBL2108570,ABOBOTULINUMTOXINA,1416,Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor,INHIBITOR,106138.0,CHEMBL2364159,Synaptosomal-associated protein 25,1,1,1,"BOTOX blocks neuromuscular transmission by binding to acceptor sites on motor or sympathetic nerve terminals, entering the nerve terminals, and inhibiting the release of acetylcholine. This inhibition occurs as the neurotoxin cleaves SNAP-25, a protein integral to the successful docking and release of acetylcholine from vesicles situated within nerve endings.",
1380847,CHEMBL2108581,CATUMAXOMAB,6656,T cell surface glycoprotein CD3 cross-linking agent,CROSS-LINKING AGENT,106147.0,CHEMBL2364168,T cell surface glycoprotein CD3,1,1,1,"Catumaxomab is a trifunctional bispecific monoclonal antibody with potential antineoplastic activity. Catumaxomab has two antigen-recognition sites: one for human CD3, a T cell surface antigen; and one for human epithelial cell adhesion molecule (EpCAM), a cell surface antigen expressed by a variety of epithelial tumor cells. In addition, the modified Fc portion of this antibody binds Fc receptors on antingen presenting cells (APCs) such as macrophages and dendritic cells (DCs). Catumaxomab brings T cells, EpCAM-expressing epithelial tumor cells and APCs together into tricellular complexes, which may result in a potent cytotoxic T-lymphocyte (CTL) response against EpCAM-expressing epithelial tumor cells. Fc-mediated binding of APCs in the tricellular complex potentiates EpCAM antigen presentation to T cells and the activation of anti-tumor cytotoxic T cell functions.",
1380847,CHEMBL2108581,CATUMAXOMAB,6882,Epithelial cell adhesion molecule cross-linking agent,CROSS-LINKING AGENT,109789.0,CHEMBL3580493,Epithelial cell adhesion molecule,1,1,1,"Catumaxomab is a trifunctional bispecific monoclonal antibody with potential antineoplastic activity. Catumaxomab has two antigen-recognition sites: one for human CD3, a T cell surface antigen; and one for human epithelial cell adhesion molecule (EpCAM), a cell surface antigen expressed by a variety of epithelial tumor cells. In addition, the modified Fc portion of this antibody binds Fc receptors on antingen presenting cells (APCs) such as macrophages and dendritic cells (DCs). Catumaxomab brings T cells, EpCAM-expressing epithelial tumor cells and APCs together into tricellular complexes, which may result in a potent cytotoxic T-lymphocyte (CTL) response against EpCAM-expressing epithelial tumor cells. Fc-mediated binding of APCs in the tricellular complex potentiates EpCAM antigen presentation to T cells and the activation of anti-tumor cytotoxic T cell functions.",
1380859,CHEMBL2108593,EPOETIN ZETA,7534,Erythropoietin receptor agonist,AGONIST,201.0,CHEMBL1817,Erythropoietin receptor,1,1,1,Supplements levels of the natural hormone erythropoietin and stimulates the production of red blood cells. Anemia is caused by a deficiency of red blood cells. ,
1380860,CHEMBL2108594,EPTOTERMIN ALFA,9670,Bone morphogenetic protein receptor type-1A agonist,AGONIST,100907.0,CHEMBL5275,Bone morphogenetic protein receptor type-1A,1,1,1,,
1380860,CHEMBL2108594,EPTOTERMIN ALFA,9673,Bone morphogenetic protein receptor type-2 agonist,AGONIST,100993.0,CHEMBL5467,Bone morphogenetic protein receptor type-2,1,1,1,,
1380860,CHEMBL2108594,EPTOTERMIN ALFA,9676,Bone morphogenetic protein receptor type-1B agonist,AGONIST,101204.0,CHEMBL5476,Bone morphogenetic protein receptor type-1B,1,1,1,,
1380860,CHEMBL2108594,EPTOTERMIN ALFA,9679,Activin receptor type-1 agonist,AGONIST,101598.0,CHEMBL5903,Activin receptor type-1,1,1,1,,
1380863,CHEMBL2108597,FERRIC CARBOXYMALTOSE,8075,Supplement,,,,,1,1,1,,
1380877,CHEMBL2108611,INOTUZUMAB OZOGAMICIN,5484,CD22 binding agent,BINDING AGENT,11695.0,CHEMBL3218,B-cell receptor CD22,1,1,1,"Whenit binds to the CD22 antigen on malignant B-cells, it is internalized into the cell, where the cytotoxic agent calicheamicin is released to destroy the cell.",
1380877,CHEMBL2108611,INOTUZUMAB OZOGAMICIN,10069,DNA disrupting agent,DISRUPTING AGENT,105574.0,CHEMBL2311221,DNA,1,1,1,,
1380904,CHEMBL2108638,RAXIBACUMAB,2106,Protective antigen binding agent,BINDING AGENT,101164.0,CHEMBL5352,Protective antigen,1,1,1,"It's a monoclonal antibody that binds free PA, preventing the intracellular entry of anthrax",
1380924,CHEMBL2108658,TREMELIMUMAB,5485,Cytotoxic T-lymphocyte protein 4 inhibitor,INHIBITOR,106143.0,CHEMBL2364164,Cytotoxic T-lymphocyte protein 4,1,1,1,"Blocks the binding of the antigen-presenting cell ligands B7.1 and B7.2 to CTLA-4, resulting in inhibition of B7-CTLA-4-mediated downregulation of T-cell activation.",
1380933,CHEMBL2108667,YTTRIUM Y 90 IBRITUMOMAB TIUXETAN,1520,B-lymphocyte antigen CD20 binding agent,BINDING AGENT,181.0,CHEMBL2058,B-lymphocyte antigen CD20,1,1,1,targets radiotherapy to cell(via tiuxetan),
1380933,CHEMBL2108667,YTTRIUM Y 90 IBRITUMOMAB TIUXETAN,6562,B-lymphocyte antigen CD20 binding agent,BINDING AGENT,181.0,CHEMBL2058,B-lymphocyte antigen CD20,1,1,1,"One way to enhance the effectiveness of monoclonal antibodies is to chelate radionuclides, such as yttrium-90 ((90)Y), to the antibody. (90)Y is a high-energy, beta-emitting radioisotope that delivers most of its radiation over a path length of 2 to 5 mm. Therefore, the antibody, Ibritumomab, binds to the CD20 antigen, found on the surface of normal and malignant B cells, and delivers or targets the radiation only to CD20+ cells, sparing normal cells (and B cell precursors) from the radiation.",
1380936,CHEMBL2108670,BEZLOTOXUMAB,6158,Toxin B inhibitor,INHIBITOR,109801.0,CHEMBL3580505,Toxin B,1,1,1,,
1380941,CHEMBL2108675,DUPILUMAB,5486,Interleukin-4 receptor subunit alpha antagonist,ANTAGONIST,109786.0,CHEMBL3580490,Interleukin-4 receptor subunit alpha,1,1,1,,
1380942,CHEMBL2108676,ELOSULFASE ALFA,2277,Keratan sulfate hydrolytic enzyme,HYDROLYTIC ENZYME,108157.0,CHEMBL3140341,Keratan sulfate,1,1,1,,
1380942,CHEMBL2108676,ELOSULFASE ALFA,2278,Chondroitin-6-sulfate hydrolytic enzyme,HYDROLYTIC ENZYME,108158.0,CHEMBL3140342,Chondroitin-6-sulfate,1,1,1,,
1380943,CHEMBL2108677,PEGINTERFERON BETA-1A,2309,Interferon alpha/beta receptor agonist,AGONIST,106149.0,CHEMBL2364170,Interferon alpha/beta receptor,1,1,1,,
1380947,CHEMBL2108681,TILDRAKIZUMAB,5952,Interleukin-23 inhibitor,INHIBITOR,106133.0,CHEMBL2364154,Interleukin-23,1,1,1,,
1380968,CHEMBL2108702,IMETELSTAT SODIUM,5553,Telomerase reverse transcriptase inhibitor,INHIBITOR,12622.0,CHEMBL2916,Telomerase reverse transcriptase,1,1,1,"Competitive telomerase inhibitor, which binds directly to the active site of the enzyme, thus inhibiting its activity.",
1380975,CHEMBL2108709,COLLAGENASE CLOSTRIDIUM HISTOLYTICUM,1428,Collagen hydrolytic enzyme,HYDROLYTIC ENZYME,106167.0,CHEMBL2364188,Collagen,1,1,1,,
1380990,CHEMBL2108724,SEMAGLUTIDE,5413,Glucagon-like peptide 1 receptor agonist,AGONIST,11758.0,CHEMBL1784,Glucagon-like peptide 1 receptor,1,1,1,"Peptide, GLP-1 analogue.",
1380992,CHEMBL2108726,TECHNETIUM TC 99M TILMANOCEPT,9297,Diagnostic,,,,,1,1,1,,
1380993,CHEMBL2108727,TALIMOGENE LAHERPAREPVEC,5559,Melanoma cell disrupting agent,DISRUPTING AGENT,81258.0,CHEMBL614126,Melanoma cell,1,1,1,Causes lysis of tumour cells.,
1380994,CHEMBL2108728,CALASPARGASE PEGOL,7401,Asparagine hydrolytic enzyme,HYDROLYTIC ENZYME,106202.0,CHEMBL2364706,Asparagine,1,1,1,Hydrolyses L-asparagine which is required by leukemic cells which have low level expression of L-asparagine synthetase.,
1380996,CHEMBL2108730,SARILUMAB,5487,Interleukin-6 receptor alpha subunit antagonist,ANTAGONIST,106134.0,CHEMBL2364155,Interleukin-6 receptor subunit alpha,1,1,1,,
1381004,CHEMBL2108738,NIVOLUMAB,2326,Programmed cell death protein 1 inhibitor,INHIBITOR,108437.0,CHEMBL3307223,Programmed cell death protein 1,1,1,1,,
1381032,CHEMBL2108766,PYRETHRUM EXTRACT,1737,Voltage-sensitive sodium channel alpha-subunit blocker,BLOCKER,105696.0,CHEMBL2362984,Voltage-sensitive sodium channel alpha-subunit,1,1,1,,
1381057,CHEMBL2108791,TENECTEPLASE,79,Tissue-type plasminogen activator exogenous protein,EXOGENOUS PROTEIN,11399.0,CHEMBL1873,Tissue-type plasminogen activator,1,1,1,,
1381141,CHEMBL2108875,TETANUS TOXOID,9920,Tetanus toxoid vaccine antigen,VACCINE ANTIGEN,121587.0,CHEMBL5500295,Tetanus toxoid,1,1,1,,
1381154,CHEMBL2108888,AGALSIDASE BETA,1927,Globotriosylceramide hydrolytic enzyme,HYDROLYTIC ENZYME,106213.0,CHEMBL2366040,Globotriosylceramide,1,1,1,,
1381197,CHEMBL2108931,CRISANTASPASE,6787,Asparagine hydrolytic enzyme,HYDROLYTIC ENZYME,106202.0,CHEMBL2364706,Asparagine,1,1,1,"Crisantaspase (or Asparaginase) takes advantage of the fact that acute lymphoblastic leukemia cells and some other suspected tumor cells are unable to synthesize the non-essential amino acid asparagine, whereas normal cells are able to make their own asparagine; thus leukemic cells require high amount of asparagine. These leukemic cells depend on circulating asparagine. Asparaginase, however, catalyzes the conversion of L-asparagine to aspartic acid and ammonia. This deprives the leukemic cell of circulating asparagine, which leads to cell death.",
1381205,CHEMBL2108939,"VIBRIO CHOLERAE, LIVE ATTENUATED",9186,Biological vaccine - induces immune response,,,,,1,1,1,,
1381232,CHEMBL2108966,"INSULIN, NEUTRAL",9863,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
1381239,CHEMBL2108973,"INSULIN HUMAN, ISOPHANE",9359,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
1381240,CHEMBL2108974,INSULIN HUMAN ZINC,9976,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
1381255,CHEMBL2108989,ASPARAGINASE,2036,Asparagine hydrolytic enzyme,HYDROLYTIC ENZYME,106202.0,CHEMBL2364706,Asparagine,1,1,1,,
1381302,CHEMBL2109036,IGOVOMAB,6375,Mucin-16 binding agent,BINDING AGENT,109778.0,CHEMBL3580482,Mucin-16,1,1,1,,
1381304,CHEMBL2109038,IMCIROMAB PENTETATE,9492,Diagnostic (monoclonal antibody that is labelled with Indium (111In) for imaging),,,,,1,1,1,,
1381312,CHEMBL2109046,"INSULIN, PROTAMINE ZINC",9206,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
1381313,CHEMBL2109047,INTERFERON ALFA-N3,1795,Interferon alpha/beta receptor agonist,AGONIST,106149.0,CHEMBL2364170,Interferon alpha/beta receptor,1,1,1,,
1381331,CHEMBL2109065,DROTRECOGIN ALFA (ACTIVATED),924,Coagulation factor VIII inhibitor,INHIBITOR,10210.0,CHEMBL3143,Coagulation factor VIII,1,1,1,Activated protein c cleaves clotting factors to inactivate,
1381331,CHEMBL2109065,DROTRECOGIN ALFA (ACTIVATED),949,Coagulation factor V inhibitor,INHIBITOR,11387.0,CHEMBL3618,Coagulation factor V,1,1,1,Activated protein c cleaves clotting factors to inactivate,
1381358,CHEMBL2109092,EPOETIN BETA,7535,Erythropoietin receptor agonist,AGONIST,201.0,CHEMBL1817,Erythropoietin receptor,1,1,1,Supplements levels of the natural hormone erythropoietin and stimulates the production of red blood cells. Anemia is caused by a deficiency of red blood cells. ,
1381359,CHEMBL2109093,EPOETIN DELTA,7536,Erythropoietin receptor agonist,AGONIST,201.0,CHEMBL1817,Erythropoietin receptor,1,1,1,Supplements levels of the natural hormone erythropoietin and stimulates the production of red blood cells. Anemia is caused by a deficiency of red blood cells. ,
1381387,CHEMBL2109121,DIPHTHERIA TOXOID,9919,Diphtheria toxoid vaccine antigen,VACCINE ANTIGEN,121586.0,CHEMBL5500294,Diphtheria toxoid,1,1,1,,
1381403,CHEMBL2109137,MOROCTOCOG ALFA,9651,Coagulation factor VIII exogenous protein,EXOGENOUS PROTEIN,10210.0,CHEMBL3143,Coagulation factor VIII,1,1,1,,
1381437,CHEMBL2109171,DIBOTERMIN ALFA,9669,Bone morphogenetic protein receptor type-1A agonist,AGONIST,100907.0,CHEMBL5275,Bone morphogenetic protein receptor type-1A,1,1,1,,
1381437,CHEMBL2109171,DIBOTERMIN ALFA,9671,Activin receptor type-2B agonist,AGONIST,100992.0,CHEMBL5466,Activin receptor type-2B,1,1,1,,
1381437,CHEMBL2109171,DIBOTERMIN ALFA,9672,Bone morphogenetic protein receptor type-2 agonist,AGONIST,100993.0,CHEMBL5467,Bone morphogenetic protein receptor type-2,1,1,1,,
1381437,CHEMBL2109171,DIBOTERMIN ALFA,9677,Bone morphogenetic protein receptor type-1B agonist,AGONIST,101204.0,CHEMBL5476,Bone morphogenetic protein receptor type-1B,1,1,1,,
1381437,CHEMBL2109171,DIBOTERMIN ALFA,9678,Activin receptor type-2A agonist,AGONIST,101473.0,CHEMBL5616,Activin receptor type-2A,1,1,1,,
1381437,CHEMBL2109171,DIBOTERMIN ALFA,9680,Activin receptor type-1 agonist,AGONIST,101598.0,CHEMBL5903,Activin receptor type-1,1,1,1,,
1381447,CHEMBL2109181,NEBACUMAB,6272,Lipopolysaccharide (LPS) inhibitor,INHIBITOR,109804.0,CHEMBL3580508,Lipopolysaccharide (LPS),1,1,1,"It binds the lipid A moiety of endotoxin, the lipopolysaccharide (LPS) component of the gram-negative bacterial cell wall.",
1381470,CHEMBL2109204,NADROPARIN CALCIUM,9458,Antithrombin-III activator,ACTIVATOR,16.0,CHEMBL1950,Antithrombin-III,1,1,1,,
1381471,CHEMBL2109205,COAGULATION FACTOR IX RECOMBINANT HUMAN,9505,Coagulation factor IX exogenous protein,EXOGENOUS PROTEIN,193.0,CHEMBL2016,Coagulation factor IX,1,1,1,,
1381774,CHEMBL2109334,INEBILIZUMAB,6078,B-lymphocyte antigen CD19 binding agent,BINDING AGENT,109546.0,CHEMBL3390821,B-lymphocyte antigen CD19,1,1,1,MEDI-551 binds directly to CD19 protein on the surface of the plasmablasts (produce autoantibodies called AQP4-Ab (or NMO-IgG) to the protein aquaporin-4 ) and depletes them.,
1381867,CHEMBL2109427,ZOLBETUXIMAB,6105,Claudin-18 binding agent,BINDING AGENT,114820.0,CHEMBL3712859,Claudin-18,1,1,1,"Antibody drug conjugates (ADCs), coupled to a cytotoxic agent.",Against isoform 2 of Claudin-18.
1381980,CHEMBL2109540,ALIROCUMAB,2401,Subtilisin/kexin type 9 inhibitor,INHIBITOR,12353.0,CHEMBL2929,Proprotein convertase subtilisin/kexin type 9,1,1,1,,
1382064,CHEMBL2109624,CAPLACIZUMAB,5933,von Willebrand factor inhibitor,INHIBITOR,104515.0,CHEMBL2021748,von Willebrand factor,1,1,1,Inhibits the interaction between ultralarge von Willebrand factor (ULvWF) multimers and platelets by targeting the A1 domain of vWF and thus has the potential to immediately block the ULvWF mediated platelet interactions and the formation of the string-like clots in the blood of patients with acquired  thrombotic thrombocytopenic purpura (TTP).,
1382807,CHEMBL2110367,TRIMETHOPRIM SULFATE,1665,Bacterial dihydrofolate reductase inhibitor,INHIBITOR,106169.0,CHEMBL2364669,Dihydrofolate reductase,1,1,1,,Broad spectrum
1382808,CHEMBL2110368,BETHANIDINE SULFATE,875,Norepinephrine transporter substrate,SUBSTRATE,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,accumulates and displaces NE,
1382812,CHEMBL2110372,RANITIDINE HYDROCHLORIDE,460,Histamine H2 receptor antagonist,ANTAGONIST,102.0,CHEMBL1941,Histamine H2 receptor,1,1,1,,
1383003,CHEMBL2110563,CYANOCOBALAMIN,8271,Supplement,,,,,1,1,1,,
1383165,CHEMBL2110725,VINFLUNINE,5639,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,VFL bound to tubulin induces structural changes favoring an inhibition of GTP hydrolysis and inhibition of microtubule assembly,
1383172,CHEMBL2110732,DACOMITINIB ANHYDROUS,7415,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,Dacomitinib is an irreversible pan-ERBB inhibitor.,
1383172,CHEMBL2110732,DACOMITINIB ANHYDROUS,7416,Receptor protein-tyrosine kinase erbB-2 inhibitor,INHIBITOR,188.0,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,1,1,1,Dacomitinib is an irreversible pan-ERBB inhibitor.,
1383172,CHEMBL2110732,DACOMITINIB ANHYDROUS,7417,Receptor protein-tyrosine kinase erbB-4 inhibitor,INHIBITOR,12699.0,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,1,1,1,Dacomitinib is an irreversible pan-ERBB inhibitor.,
1383722,CHEMBL2111286,RANITIDINE BISMUTH CITRATE,462,Histamine H2 receptor antagonist,ANTAGONIST,102.0,CHEMBL1941,Histamine H2 receptor,1,1,1,,
1383724,CHEMBL2111290,TESAMORELIN ACETATE,757,Growth hormone-releasing hormone receptor agonist,AGONIST,158.0,CHEMBL2032,Growth hormone-releasing hormone receptor,1,1,1,,
353902,CHEMBL211471,NEOSTIGMINE METHYLSULFATE,737,Acetylcholinesterase inhibitor,INHIBITOR,93.0,CHEMBL220,Acetylcholinesterase,1,1,1,,
26451,CHEMBL21333,PRANLUKAST,7574,Cysteinyl leukotriene receptor 1 antagonist,ANTAGONIST,179.0,CHEMBL1798,Cysteinyl leukotriene receptor 1,1,1,1,,Selective for CysLT1R over CysLT2R. 
1406675,CHEMBL2134724,IPRATROPIUM BROMIDE,46,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Role in regulating nasal secretion, M3 likely involved",
1407411,CHEMBL2135460,TERLIPRESSIN,9598,Vasopressin V1 receptor binding agent,BINDING AGENT,104978.0,CHEMBL2111456,Vasopressin V1 receptor,1,1,1,,
1407411,CHEMBL2135460,TERLIPRESSIN,9599,Vasopressin V2 receptor binding agent,BINDING AGENT,112.0,CHEMBL1790,Vasopressin V2 receptor,1,1,1,,
1410635,CHEMBL2138684,FROVATRIPTAN SUCCINATE,366,Serotonin 1b (5-HT1b) receptor agonist,AGONIST,106.0,CHEMBL1898,5-hydroxytryptamine receptor 1B,1,1,1,,Selective
1410635,CHEMBL2138684,FROVATRIPTAN SUCCINATE,572,Serotonin 1d (5-HT1d) receptor agonist,AGONIST,105.0,CHEMBL1983,5-hydroxytryptamine receptor 1D,1,1,1,,Selective
1417028,CHEMBL2145077,IVABRADINE HYDROCHLORIDE,2313,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker,BLOCKER,103531.0,CHEMBL1250417,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,1,1,1,,
1418014,CHEMBL2146063,CHLORTETRACYCLINE HYDROCHLORIDE,1773,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
1418053,CHEMBL2146102,EPHEDRINE HYDROCHLORIDE,8978,Adrenergic receptor agonist,AGONIST,105670.0,CHEMBL2331074,Adrenergic receptor,1,1,1,"Alpha and beta-adrenergic receptor agonist with direct effects that increase arterial pressures, cardiac output, and peripheral resistance. Indirectly causes release of norepinephrine from sympathetic neurons.",
1418074,CHEMBL2146123,METHACYCLINE HYDROCHLORIDE,1755,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
1418075,CHEMBL2146124,CEFUROXIME SODIUM,1683,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
1418091,CHEMBL2146140,ESOMEPRAZOLE STRONTIUM,2251,Potassium-transporting ATPase inhibitor,INHIBITOR,104758.0,CHEMBL2095173,Potassium-transporting ATPase,1,1,1,,
1418097,CHEMBL2146146,ATROPINE SULFATE,30,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for mydriasis and regulating gastric secretion, M3 likely involved (main form in iris)",
1418097,CHEMBL2146146,ATROPINE SULFATE,287,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Role in regulating gastric secretion, M1 likely involved",
1418097,CHEMBL2146146,ATROPINE SULFATE,1511,Muscarinic acetylcholine receptor M2 antagonist,ANTAGONIST,47.0,CHEMBL211,Muscarinic acetylcholine receptor M2,1,1,1,"Indicated for bradycardia, M2 likely responsible",
1420377,CHEMBL2146883,COBIMETINIB,5324,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,INHIBITOR,11409.0,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,1,1,1,Approved in Switzerland 2015 for use in combination with vemurafenib as a treatment for patients with advanced melanoma.,
1420377,CHEMBL2146883,COBIMETINIB,5325,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,INHIBITOR,11046.0,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,1,1,1,Approved in Switzerland 2015 for use in combination with vemurafenib as a treatment for patients with advanced melanoma.,
1421280,CHEMBL2147777,TENELIGLIPTIN,7541,Dipeptidyl peptidase IV inhibitor,INHIBITOR,11140.0,CHEMBL284,Dipeptidyl peptidase 4,1,1,1,,
26653,CHEMBL21536,XANOMELINE,8758,Muscarinic acetylcholine receptor M4 agonist,AGONIST,214.0,CHEMBL1821,Muscarinic acetylcholine receptor M4,1,1,1,,
26653,CHEMBL21536,XANOMELINE,8761,Muscarinic acetylcholine receptor M1 agonist,AGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,,
1425665,CHEMBL2159122,ELUXADOLINE,2315,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
1428762,CHEMBL2165326,APROCITENTAN,8240,"Endothelin receptor, ET-A/ET-B antagonist",ANTAGONIST,104833.0,CHEMBL2096678,"Endothelin receptor, ET-A/ET-B",1,1,1,,
1439217,CHEMBL2178422,RIMEGEPANT,4919,Calcitonin gene-related peptide type 1 receptor antagonist,ANTAGONIST,19904.0,CHEMBL3798,Calcitonin gene-related peptide type 1 receptor,1,1,1,Therapeutic mechanism not fully elucidated.,
1442757,CHEMBL2181927,FINERENONE,4578,Mineralocorticoid receptor antagonist,ANTAGONIST,48.0,CHEMBL1994,Mineralocorticoid receptor,1,1,1,,
360720,CHEMBL218394,BOCEPREVIR,1283,"Hepatitis C virus serine protease, NS3/NS4A inhibitor",INHIBITOR,104803.0,CHEMBL2095231,"Hepatitis C virus serine protease, NS3/NS4A",1,1,1,,
365195,CHEMBL218650,DELAMANID,5617,Mycobacterium tuberculosis H37Rv inhibitor,INHIBITOR,104907.0,CHEMBL2111188,Mycobacterium tuberculosis H37Rv,1,1,1,"Inhibits the synthesis of mycobacterial cell wall components, methoxy mycolic acid and ketomycolic acid. Pro-drug activated by the enzyme deazaflavin dependent nitroreductase",
1216,CHEMBL22,TRIMETHOPRIM,1664,Bacterial dihydrofolate reductase inhibitor,INHIBITOR,106169.0,CHEMBL2364669,Dihydrofolate reductase,1,1,1,,Broad spectrum
366278,CHEMBL220491,BRINZOLAMIDE,87,Carbonic anhydrase II inhibitor,INHIBITOR,15.0,CHEMBL205,Carbonic anhydrase 2,1,1,1,,
366279,CHEMBL220492,TOPIRAMATE,91,Carbonic anhydrase II inhibitor,INHIBITOR,15.0,CHEMBL205,Carbonic anhydrase 2,1,1,1,,
366279,CHEMBL220492,TOPIRAMATE,958,Carbonic anhydrase IV inhibitor,INHIBITOR,12896.0,CHEMBL3729,Carbonic anhydrase 4,1,1,1,,
366279,CHEMBL220492,TOPIRAMATE,1039,Glutamate receptor ionotropic AMPA antagonist,ANTAGONIST,104825.0,CHEMBL2096670,Glutamate receptor ionotropic AMPA,1,1,1,,
366279,CHEMBL220492,TOPIRAMATE,1155,Glutamate receptor ionotropic kainate antagonist,ANTAGONIST,104902.0,CHEMBL2109241,Glutamate receptor ionotropic kainate,1,1,1,,
366279,CHEMBL220492,TOPIRAMATE,1630,GABA-A receptor; anion channel positive modulator,POSITIVE MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
366279,CHEMBL220492,TOPIRAMATE,1968,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
1445435,CHEMBL2205807,ABAMETAPIR,7595,Metalloproteinase inhibitor,INHIBITOR,118782.0,CHEMBL4495552,Metalloproteinase,1,1,1,Metalloproteases are essential for egg hatching. Abametapir chelates metal ions required for metalloprotease activity and inhibits metalloproteases.,
1445435,CHEMBL2205807,ABAMETAPIR,7596,Iron sequestering agent,SEQUESTERING AGENT,105753.0,CHEMBL2363058,Iron,1,1,1,Metalloproteases are essential for egg hatching. Abametapir chelates metal ions required for metalloprotease activity and inhibits metalloproteases.,
1445435,CHEMBL2205807,ABAMETAPIR,7619,Copper sequestering agent,SEQUESTERING AGENT,105752.0,CHEMBL2363057,Copper,1,1,1,Metalloproteases are essential for egg hatching. Abametapir chelates metal ions required for metalloprotease activity and inhibits metalloproteases.,
1445435,CHEMBL2205807,ABAMETAPIR,7719,Zinc sequestering agent,SEQUESTERING AGENT,105751.0,CHEMBL2363056,Zinc,1,1,1,Metalloproteases are essential for egg hatching. Abametapir chelates metal ions required for metalloprotease activity and inhibits metalloproteases.,
1445828,CHEMBL2206196,PAROMOMYCIN SULFATE,1778,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
1448219,CHEMBL2216870,IDELALISIB,2297,PI3-kinase p110-delta subunit inhibitor,INHIBITOR,11177.0,CHEMBL3130,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",1,1,1,,
373798,CHEMBL221722,FAVIPIRAVIR,7743,RNA-directed RNA polymerase inhibitor,INHIBITOR,119393.0,CHEMBL4523676,RNA-directed RNA polymerase,1,1,1,,Active against influenza A and B infections.
1449134,CHEMBL2218861,QUINAGOLIDE,8942,Dopamine D2 receptor agonist,AGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
1449150,CHEMBL2218877,ERYTHROMYCIN ESTOLATE,1781,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
1449151,CHEMBL2218878,TRIMETREXATE GLUCURONATE,1488,Dihydrofolate reductase inhibitor,INHIBITOR,10460.0,CHEMBL1926,Dihydrofolate reductase,1,1,1,,
1449167,CHEMBL2218894,FLUVASTATIN SODIUM,1055,HMG-CoA reductase inhibitor,INHIBITOR,24.0,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,1,1,1,,
1449169,CHEMBL2218896,NABILONE,1465,Cannabinoid CB1 receptor agonist,AGONIST,87.0,CHEMBL218,Cannabinoid receptor 1,1,1,1,,
1449186,CHEMBL2218913,CAPREOMYCIN SULFATE,2070,70S ribosome inhibitor,INHIBITOR,105944.0,CHEMBL2363965,70S ribosome,1,1,1,,
1449190,CHEMBL2218917,CEVIMELINE HYDROCHLORIDE,44,Muscarinic acetylcholine receptor M3 agonist,AGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Role in regulating gastric secretion, M3 likely involved",
1449190,CHEMBL2218917,CEVIMELINE HYDROCHLORIDE,275,Muscarinic acetylcholine receptor M1 agonist,AGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Role in regulating gastric secretion, M1 likely involved",
1449218,CHEMBL2219414,ERAVACYCLINE DIHYDROCHLORIDE,7373,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,Inhibits bacterial protein synthesis.,"Indicated for infections caused by Escherichia coli, Klebsiella pneumoniae, Citrobacter freundii, Enterobacter cloacae, Klebsiella oxytoca, Enterococcus faecalis, Enterococcus faecium, Staphylococcus aureus, Streptococcus anginosus group, Clostridium perfringens, Bacteroides species and Parabacteroides distasonis. Active in vitro against additional organisms but clinical signficance unknown. "
1449220,CHEMBL2219416,NALOXEGOL OXALATE,2306,Mu opioid receptor antagonist,ANTAGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
1449229,CHEMBL2219425,ARIPIPRAZOLE LAUROXIL,2410,Dopamine D2 receptor partial agonist,PARTIAL AGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,Prodrug of aripiprazole,
1449229,CHEMBL2219425,ARIPIPRAZOLE LAUROXIL,2411,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,Prodrug of aripiprazole,
1449229,CHEMBL2219425,ARIPIPRAZOLE LAUROXIL,2412,Serotonin 1a (5-HT1a) receptor partial agonist,PARTIAL AGONIST,51.0,CHEMBL214,5-hydroxytryptamine receptor 1A,1,1,1,Prodrug of aripiprazole,
27616,CHEMBL22242,REMOXIPRIDE,6294,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,"Remoxipride binds specifically to the D2 receptor and has little affinity for other central receptors e.g. adrenergic, muscarinic and 5-HT receptors. Therefore, the incidence of adverse effects is less than with other antipsychotics. Dopamine binding to the D2 receptor inhibits the prolactin release from the pituitary into plasma, and therefore, D2 antagonism induces its release.",
372438,CHEMBL222559,TIPRANAVIR,1497,Human immunodeficiency virus type 1 protease inhibitor,INHIBITOR,191.0,CHEMBL243,Human immunodeficiency virus type 1 protease,1,1,1,,
373806,CHEMBL222813,ZANAMIVIR,846,Neuraminidase inhibitor,INHIBITOR,21.0,CHEMBL2051,Neuraminidase,1,1,1,,
373806,CHEMBL222813,ZANAMIVIR,943,Neuraminidase inhibitor,INHIBITOR,10738.0,CHEMBL3377,Neuraminidase,1,1,1,,
374719,CHEMBL223228,EFAVIRENZ,827,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,,
374007,CHEMBL225071,RALTITREXED,5908,Thymidylate synthase inhibitor,INHIBITOR,28.0,CHEMBL1952,Thymidylate synthase,1,1,1,Also leads to an enhanced local production of antithrombotic prostaglandins. This mechanism provides potent antithrombotic action without affecting systemic haemostasis.,
374008,CHEMBL225072,PEMETREXED,9635,Dihydrofolate reductase inhibitor,INHIBITOR,6.0,CHEMBL202,Dihydrofolate reductase,1,1,1,,
374008,CHEMBL225072,PEMETREXED,9637,Thymidylate synthase inhibitor,INHIBITOR,28.0,CHEMBL1952,Thymidylate synthase,1,1,1,,
374008,CHEMBL225072,PEMETREXED,9666,GAR transformylase inhibitor,INHIBITOR,12291.0,CHEMBL3972,Trifunctional purine biosynthetic protein adenosine-3,1,1,1,,
377715,CHEMBL227529,ALOGLIPTIN BENZOATE,465,Dipeptidyl peptidase IV inhibitor,INHIBITOR,11140.0,CHEMBL284,Dipeptidyl peptidase 4,1,1,1,,
384165,CHEMBL230158,SELADELPAR,4592,Peroxisome proliferator-activated receptor delta agonist,AGONIST,12227.0,CHEMBL3979,Peroxisome proliferator-activated receptor delta,1,1,1,,
1503092,CHEMBL2303621,DACLATASVIR DIHYDROCHLORIDE,2393,Nonstructural protein 5A inhibitor,INHIBITOR,108438.0,CHEMBL3307224,Nonstructural protein 5A,1,1,1,,
1510461,CHEMBL2311030,ERGOLOID MESYLATES,363,Serotonin 1b (5-HT1b) receptor agonist,AGONIST,106.0,CHEMBL1898,5-hydroxytryptamine receptor 1B,1,1,1,,
1510461,CHEMBL2311030,ERGOLOID MESYLATES,470,Serotonin 1a (5-HT1a) receptor agonist,AGONIST,51.0,CHEMBL214,5-hydroxytryptamine receptor 1A,1,1,1,,
1510461,CHEMBL2311030,ERGOLOID MESYLATES,1150,Dopamine receptor agonist,AGONIST,104842.0,CHEMBL2096905,Dopamine receptor,1,1,1,,
1510461,CHEMBL2311030,ERGOLOID MESYLATES,1232,Adrenergic receptor alpha antagonist,ANTAGONIST,104787.0,CHEMBL2095203,Adrenergic receptor alpha,1,1,1,,
397524,CHEMBL231779,APIXABAN,1373,Coagulation factor X inhibitor,INHIBITOR,194.0,CHEMBL244,Coagulation factor X,1,1,1,,
394996,CHEMBL231813,TELAPREVIR,1284,"Hepatitis C virus serine protease, NS3/NS4A inhibitor",INHIBITOR,104803.0,CHEMBL2095231,"Hepatitis C virus serine protease, NS3/NS4A",1,1,1,,
395946,CHEMBL232201,BENZIODARONE,6210,Calmodulin inhibitor,INHIBITOR,101444.0,CHEMBL6093,Calmodulin-1,1,1,1,"Coronary vasodilator, uricosuric agent.",
1519923,CHEMBL2325741,CAPIVASERTIB,7260,Serine/threonine-protein kinase AKT inhibitor,INHIBITOR,105106.0,CHEMBL2111353,Serine/threonine-protein kinase AKT,1,1,1,Part of Astra Zeneca's Open Innovation program,
394539,CHEMBL233406,SODIUM SULFATE ANHYDROUS,10013,Laxative,,,,,1,1,1,Induces catharsis by the osmotic effects of the unabsorbed sulfate salts and polyethylene glycol (PEG) in the GI tract.,
1525716,CHEMBL2336050,XANOMELINE TARTRATE,9906,Muscarinic acetylcholine receptor M4 agonist,AGONIST,214.0,CHEMBL1821,Muscarinic acetylcholine receptor M4,1,1,1,"The mechanism of action of xanomeline in the treatment of schizophrenia is unclear; however, its efficacy is thought to be due to its agonist activity at M1 and M4 muscarinic acetylcholine receptors in the central nervous system.",
1525716,CHEMBL2336050,XANOMELINE TARTRATE,9992,Muscarinic acetylcholine receptor M1 agonist,AGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"The mechanism of action of xanomeline in the treatment of schizophrenia is unclear; however, its efficacy is thought to be due to its agonist activity at M1 and M4 muscarinic acetylcholine receptors in the central nervous system.",
1525737,CHEMBL2336071,SIPONIMOD,5371,Sphingosine 1-phosphate receptor Edg-1 agonist,AGONIST,11631.0,CHEMBL4333,Sphingosine 1-phosphate receptor 1,1,1,1,Siponimod reduces lymphocyte numbers in peripheral blood by blocking their release from the lymph nodes. The mechanism of theraputic effects in MS are unknown.,High binding affinity for S1P receptors 1 and 5. 
1528018,CHEMBL2338329,ROXADUSTAT,5785,Hypoxia-inducible factor prolyl hydroxylase inhibitor,INHIBITOR,116860.0,CHEMBL3831261,Hypoxia-inducible factor prolyl hydroxylase,1,1,1,,
1530622,CHEMBL2348780,VAMOROLONE,9636,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,Mechanism is not fully elucidated,
1530622,CHEMBL2348780,VAMOROLONE,9638,Mineralocorticoid receptor antagonist,ANTAGONIST,48.0,CHEMBL1994,Mineralocorticoid receptor,1,1,1,Mechanism is not fully elucidated,
1532522,CHEMBL2355333,ZIMELDINE HYDROCHLORIDE,6324,Serotonin (5-HT) receptor antagonist,ANTAGONIST,104841.0,CHEMBL2096904,Serotonin (5-HT) receptor,1,1,1,"Zimelidine (ZIM) and its main active metabolite norzimelidine (NZIM) have been shown to preferentially inhibit 5-hydroxytryptamine (5-HT, serotonin) neuronal uptake both in vitro and in vivo while having much less effect on noradrenaline (NA) uptake. ZIM in vivo blocked the 5-HT uptake mechanism in the cerebral cortex, hippocampus, striatum, hypothalamus and spinal cord, thus indicating effects on both the ascending and descending 5-HT pathways. ZIM is devoid of a 5-HT releasing action, MAO-inhibitory properties and effects on dopamine (DA) uptake",
1532645,CHEMBL2355456,IBUTILIDE FUMARATE,501,HERG blocker,BLOCKER,165.0,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,1,1,1,,
1533286,CHEMBL2356097,METOPROLOL SUCCINATE,327,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
1535336,CHEMBL2358147,CARPHENAZINE MALEATE,583,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
1535336,CHEMBL2358147,CARPHENAZINE MALEATE,631,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
1535336,CHEMBL2358147,CARPHENAZINE MALEATE,2010,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
1536859,CHEMBL2359670,THIETHYLPERAZINE MALATE,191,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
1537155,CHEMBL2359966,QUININE SULFATE,1002,Ferriprotoporphyrin IX inhibitor,INHIBITOR,100262.0,CHEMBL613897,Ferriprotoporphyrin IX,1,1,1,,
1537268,CHEMBL2360079,ACETOPHENAZINE MALEATE,201,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
1537653,CHEMBL2360464,PEMETREXED DISODIUM,484,Thymidylate synthase inhibitor,INHIBITOR,28.0,CHEMBL1952,Thymidylate synthase,1,1,1,,
1537653,CHEMBL2360464,PEMETREXED DISODIUM,850,Dihydrofolate reductase inhibitor,INHIBITOR,6.0,CHEMBL202,Dihydrofolate reductase,1,1,1,,
1537653,CHEMBL2360464,PEMETREXED DISODIUM,963,GAR transformylase inhibitor,INHIBITOR,12291.0,CHEMBL3972,Trifunctional purine biosynthetic protein adenosine-3,1,1,1,,
1537769,CHEMBL2360580,BUCLIZINE HYDROCHLORIDE,171,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
1538559,CHEMBL2361370,PENBUTOLOL SULFATE,322,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
1538559,CHEMBL2361370,PENBUTOLOL SULFATE,1357,Beta-2 adrenergic receptor antagonist,ANTAGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
1539599,CHEMBL2362410,LANDIOLOL HYDROCHLORIDE,9886,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
1540465,CHEMBL2364574,DOXYCYCLINE CALCIUM,967,Matrix metalloproteinase 7 inhibitor,INHIBITOR,12738.0,CHEMBL4073,Matrilysin,1,1,1,"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation",
1540465,CHEMBL2364574,DOXYCYCLINE CALCIUM,979,Matrix metalloproteinase 8 inhibitor,INHIBITOR,11110.0,CHEMBL4588,Neutrophil collagenase,1,1,1,"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation",
1540465,CHEMBL2364574,DOXYCYCLINE CALCIUM,982,Matrix metalloproteinase 13 inhibitor,INHIBITOR,11024.0,CHEMBL280,Collagenase 3,1,1,1,"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation",
1540465,CHEMBL2364574,DOXYCYCLINE CALCIUM,989,Matrix metalloproteinase-1 inhibitor,INHIBITOR,13000.0,CHEMBL332,Interstitial collagenase,1,1,1,"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation",
1540479,CHEMBL2364607,COBIMETINIB FUMARATE,2422,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,INHIBITOR,11409.0,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,1,1,1,Reversible inhibitor of mitogen-activated protein kinase (MAPK)/extracellular signal regulated kinase 1 (MEK1) and MEK2,
1540479,CHEMBL2364607,COBIMETINIB FUMARATE,2423,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,INHIBITOR,11046.0,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,1,1,1,Reversible inhibitor of mitogen-activated protein kinase (MAPK)/extracellular signal regulated kinase 1 (MEK1) and MEK2,
1540480,CHEMBL2364608,DORAVIRINE,7348,Human immunodeficiency virus type 1 reverse transcriptase negative allosteric modulator,NEGATIVE ALLOSTERIC MODULATOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,Inhibits reverse transcriptase and viral replication.,Does not inhibit human cellular DNA polymerases alpha and beta or mitochondrial DNA polymerase gamma. Active against a range of HIV-1 isolates from different groups. 
1540481,CHEMBL2364609,ESKETAMINE HYDROCHLORIDE,5758,Glutamate [NMDA] receptor negative allosteric modulator,NEGATIVE ALLOSTERIC MODULATOR,104706.0,CHEMBL2094124,Glutamate [NMDA] receptor,1,1,1,Noncompetitive binding to NMDA glutamate receptors,NMDA subtype non-selective 
1540484,CHEMBL2364612,LATANOPROSTENE BUNOD,5373,Prostanoid FP receptor agonist,AGONIST,140.0,CHEMBL1987,Prostaglandin F2-alpha receptor,1,1,1,Prodrug of latanoprost acid and butanediol mononitrate. Nitric oxide (NO)-donating prostaglandin F2-alpha analog,
1540489,CHEMBL2364617,MACIMORELIN ACETATE,6923,Ghrelin receptor agonist,AGONIST,11536.0,CHEMBL4616,Growth hormone secretagogue receptor type 1,1,1,1,,
1540495,CHEMBL2364623,PLAZOMICIN SULFATE,7394,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,Inhibits bacterial protein synthesis.,"Indicated for Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterobacter cloacae. Activity against (but not indicated for) Pseudomonas aeruginosa, Citrobacter freundii, Citrobacter koseri, Enterobacter aerogenes, Klebsiella oxytoca, Morganella morganii, Proteus vulgaris, Providencia stuartii and Serratia marcescens."
1540501,CHEMBL2364629,RIMEGEPANT SULFATE,7486,Calcitonin gene-related peptide type 1 receptor antagonist,ANTAGONIST,19904.0,CHEMBL3798,Calcitonin gene-related peptide type 1 receptor,1,1,1,Therapeutic mechanism not fully elucidated.,
1540509,CHEMBL2364637,TENOFOVIR ALAFENAMIDE FUMARATE,2421,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,Prodrug of tenofovir; active metabolite tenofovir diphosphate,
1540510,CHEMBL2364638,UBROGEPANT,4923,Calcitonin gene-related peptide type 1 receptor antagonist,ANTAGONIST,19904.0,CHEMBL3798,Calcitonin gene-related peptide type 1 receptor,1,1,1,,
1540511,CHEMBL2364639,VALBENAZINE,5766,Synaptic vesicular amine transporter inhibitor,INHIBITOR,162.0,CHEMBL1893,Synaptic vesicular amine transporter,1,1,1,,
1540520,CHEMBL2364648,GUSELKUMAB,5950,Interleukin-23 inhibitor,INHIBITOR,106133.0,CHEMBL2364154,Interleukin-23,1,1,1,,
1540521,CHEMBL2364649,MARGETUXIMAB,5944,Receptor protein-tyrosine kinase erbB-2 inhibitor,INHIBITOR,188.0,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,1,1,1,Antibody-dependent cell-mediated cytotoxicity (ADCC).,
1540525,CHEMBL2364653,ANIFROLUMAB,6335,Interferon-alpha/beta receptor alpha chain antagonist,ANTAGONIST,200.0,CHEMBL1887,Interferon alpha/beta receptor 1,1,1,1,,
1540527,CHEMBL2364655,EVOLOCUMAB,2404,Subtilisin/kexin type 9 inhibitor,INHIBITOR,12353.0,CHEMBL2929,Proprotein convertase subtilisin/kexin type 9,1,1,1,,
1543312,CHEMBL2368861,BUPRENORPHINE HYDROCHLORIDE,727,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
1543312,CHEMBL2368861,BUPRENORPHINE HYDROCHLORIDE,1312,Kappa opioid receptor agonist,AGONIST,137.0,CHEMBL237,Kappa-type opioid receptor,1,1,1,,
1543375,CHEMBL2368924,DOLASETRON MESYLATE,373,Serotonin 3a (5-HT3a) receptor antagonist,ANTAGONIST,144.0,CHEMBL1899,5-hydroxytryptamine receptor 3A,1,1,1,,Selective
1548671,CHEMBL2374220,LEDIPASVIR,2307,Nonstructural protein 5A inhibitor,INHIBITOR,108438.0,CHEMBL3307224,Nonstructural protein 5A,1,1,1,,
399873,CHEMBL237500,LINAGLIPTIN,467,Dipeptidyl peptidase IV inhibitor,INHIBITOR,11140.0,CHEMBL284,Dipeptidyl peptidase 4,1,1,1,,
406189,CHEMBL238804,SELEXIPAG,2435,Prostanoid IP receptor agonist,AGONIST,143.0,CHEMBL1995,Prostacyclin receptor,1,1,1,,
1567700,CHEMBL2396661,ALPELISIB,4681,PI3-kinase p110-alpha subunit inhibitor,INHIBITOR,11362.0,CHEMBL4005,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",1,1,1,,
1567926,CHEMBL2397415,ZAVEGEPANT,9530,"Calcitonin-gene-related peptide receptor, CALCRL/RAMP1 antagonist",ANTAGONIST,104890.0,CHEMBL2107838,"Calcitonin-gene-related peptide receptor, CALCRL/RAMP1",1,1,1,,
1279,CHEMBL24,ATENOLOL,309,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
1570706,CHEMBL2403108,CERITINIB,2293,ALK tyrosine kinase receptor inhibitor,INHIBITOR,100417.0,CHEMBL4247,ALK tyrosine kinase receptor,1,1,1,,
1570706,CHEMBL2403108,CERITINIB,8636,EML4-ALK inhibitor,INHIBITOR,117043.0,CHEMBL3883330,EML4-ALK,1,1,1,,
1570706,CHEMBL2403108,CERITINIB,8638,NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor) inhibitor,INHIBITOR,105079.0,CHEMBL2111387,NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor),1,1,1,,
1570837,CHEMBL2403238,CABOTEGRAVIR,7811,Human immunodeficiency virus type 1 integrase inhibitor,INHIBITOR,12456.0,CHEMBL3471,Human immunodeficiency virus type 1 integrase,1,1,1,,
404691,CHEMBL240597,CHENODIOL,843,Bile acid receptor FXR agonist,AGONIST,11180.0,CHEMBL2047,Bile acid receptor,1,1,1,,
31171,CHEMBL24072,PRENYLAMINE,6288,Sodium channel protein type V alpha subunit blocker,BLOCKER,11480.0,CHEMBL1980,Sodium channel protein type 5 subunit alpha,1,1,1,"Prenylamine is a potent sodium channel (NaCh) blocker during voltage clamp conditions in vitro and a long-acting local anesthetic (LA) when injected into rats for blockage of sciatic nerve in vivo. It interacts with calmodulin and inhibits, dose dependently, myosin light chain kinase (Ca2+-dependent protein kinase) and actomyosin( Ca2+-dependent ATPase) A nonselective inhibitor for slow Ca2+ channels, tends to prolong the cycle length to decrease the diastolic depolarization, the rate of rise of action potential, the amplitude of action potential. Prenylamine also affected several classic apoptosis-related proteins, including Bax, Bcl-2, and cytochrome c, and increased caspase-3 activity.","Binding of prenylamine to the sodium channels (NaChs) is highly voltage-dependent: The resting affinity (IC50 at -150 mV) for prenylamine in neuronal NaChs is 27.7 +- 1.3 uM, whereas the inactivated affinity (IC50 at -60 mV) is 0.75 +-0.02 uM a 37-fold difference."
31171,CHEMBL24072,PRENYLAMINE,6862,Calmodulin inhibitor,INHIBITOR,101444.0,CHEMBL6093,Calmodulin-1,1,1,1,"Prenylamine is a potent sodium channel (NaCh) blocker during voltage clamp conditions in vitro and a long-acting local anesthetic (LA) when injected into rats for blockage of sciatic nerve in vivo. It interacts with calmodulin and inhibits, dose dependently, myosin light chain kinase (Ca2+-dependent protein kinase) and actomyosin( Ca2+-dependent ATPase) A nonselective inhibitor for slow Ca2+ channels, tends to prolong the cycle length to decrease the diastolic depolarization, the rate of rise of action potential, the amplitude of action potential. Prenylamine also affected several classic apoptosis-related proteins, including Bax, Bcl-2, and cytochrome c, and increased caspase-3 activity.","Binding of prenylamine to the sodium channels (NaChs) is highly voltage-dependent: The resting affinity (IC50 at -150 mV) for prenylamine in neuronal NaChs is 27.7 +- 1.3 uM, whereas the inactivated affinity (IC50 at -60 mV) is 0.75 +-0.02 uM a 37-fold difference."
389011,CHEMBL243712,AMISULPRIDE,6452,Serotonin (5-HT) receptor antagonist,ANTAGONIST,104841.0,CHEMBL2096904,Serotonin (5-HT) receptor,1,1,1,"Amisulpride blocks pre- and post synaptic dopamine D2, D3 receptors as well as the 5-HT7a receptor.","The chemical structure of amisulpride contains a chiral center and, thus, is a mixture of two optical isomers: (S)-amisulpride and (R)-amisulpride. The enantiomers bind at dopamine D2/3 and 2- adrenoceptors in a stereoselective manner with marked differences in affinity: (S)-amisulpride displays high affinity binding at both D2 and D3 receptors. On the other hand, the isomers display reversed stereoselectivity (but weaker affinity) at 2-adrenoceptors."
389011,CHEMBL243712,AMISULPRIDE,6889,Dopamine receptors; D2 & D3 antagonist,ANTAGONIST,104754.0,CHEMBL2095169,Dopamine receptors; D2 & D3,1,1,1,"Amisulpride blocks pre- and post synaptic dopamine D2, D3 receptors as well as the 5-HT7a receptor.","The chemical structure of amisulpride contains a chiral center and, thus, is a mixture of two optical isomers: (S)-amisulpride and (R)-amisulpride. The enantiomers bind at dopamine D2/3 and 2- adrenoceptors in a stereoselective manner with marked differences in affinity: (S)-amisulpride displays high affinity binding at both D2 and D3 receptors. On the other hand, the isomers display reversed stereoselectivity (but weaker affinity) at 2-adrenoceptors."
1589794,CHEMBL2443262,OLICERIDINE,5814,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
1590760,CHEMBL2448612,ERGOTAMINE TARTRATE,566,Serotonin 1d (5-HT1d) receptor agonist,AGONIST,105.0,CHEMBL1983,5-hydroxytryptamine receptor 1D,1,1,1,Effect in migraine primarily attribute to binding to 5-HT1D receptor.,
1590760,CHEMBL2448612,ERGOTAMINE TARTRATE,1233,Adrenergic receptor alpha agonist,AGONIST,104787.0,CHEMBL2095203,Adrenergic receptor alpha,1,1,1,,
1590761,CHEMBL2448613,PIMAVANSERIN TARTRATE,5389,Serotonin 2a (5-HT2a) receptor inverse agonist,INVERSE AGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
33307,CHEMBL24778,SILODOSIN,238,Alpha-1a adrenergic receptor antagonist,ANTAGONIST,125.0,CHEMBL229,Alpha-1A adrenergic receptor,1,1,1,,
411854,CHEMBL247951,PEMAFIBRATE,7549,Peroxisome proliferator-activated receptor alpha agonist,AGONIST,163.0,CHEMBL239,Peroxisome proliferator-activated receptor alpha,1,1,1,,
33576,CHEMBL24828,VANDETANIB,683,Tyrosine-protein kinase SRC inhibitor,INHIBITOR,10434.0,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,1,1,1,,
33576,CHEMBL24828,VANDETANIB,984,Tyrosine-protein kinase BRK inhibitor,INHIBITOR,30026.0,CHEMBL4601,Protein-tyrosine kinase 6,1,1,1,,
33576,CHEMBL24828,VANDETANIB,1034,Tyrosine-protein kinase TIE-2 inhibitor,INHIBITOR,12913.0,CHEMBL4128,Angiopoietin-1 receptor,1,1,1,,
33576,CHEMBL24828,VANDETANIB,1265,Vascular endothelial growth factor receptor inhibitor,INHIBITOR,104799.0,CHEMBL2095227,Vascular endothelial growth factor receptor,1,1,1,,
33576,CHEMBL24828,VANDETANIB,1519,Tyrosine-protein kinase receptor RET inhibitor,INHIBITOR,100079.0,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,1,1,1,,
33576,CHEMBL24828,VANDETANIB,1541,Ephrin receptor inhibitor,INHIBITOR,105738.0,CHEMBL2363043,Ephrin receptor,1,1,1,,
33576,CHEMBL24828,VANDETANIB,1546,Epidermal growth factor receptor inhibitor,INHIBITOR,105744.0,CHEMBL2363049,Epidermal growth factor receptor,1,1,1,,
1280,CHEMBL25,ASPIRIN,1187,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
33589,CHEMBL25202,TAMIBAROTENE,7519,Retinoic acid receptor beta agonist,AGONIST,270.0,CHEMBL2008,Retinoic acid receptor beta,1,1,1,,
33589,CHEMBL25202,TAMIBAROTENE,7567,Retinoic acid receptor alpha agonist,AGONIST,57.0,CHEMBL2055,Retinoic acid receptor alpha,1,1,1,,
418736,CHEMBL252556,IDEBENONE,8249,Antioxidant and mitochondrial electron carrier,,,,,1,1,1,,
419508,CHEMBL254219,DIGITOXIN,1584,Sodium/potassium-transporting ATPase inhibitor,INHIBITOR,104770.0,CHEMBL2095186,Sodium/potassium-transporting ATPase,1,1,1,,
425650,CHEMBL256087,MENTHOL,942,Transient receptor potential cation channel subfamily M member 8 opener,OPENER,103167.0,CHEMBL1075319,Transient receptor potential cation channel subfamily M member 8,1,1,1,,
425650,CHEMBL256087,MENTHOL,1031,Transient receptor potential cation channel subfamily A member 1 opener,OPENER,101412.0,CHEMBL6007,Transient receptor potential cation channel subfamily A member 1,1,1,1,,
437583,CHEMBL256907,MARAVIROC,452,C-C chemokine receptor type 5 antagonist,ANTAGONIST,10580.0,CHEMBL274,C-C chemokine receptor type 5,1,1,1,,
426110,CHEMBL256997,ATALUREN,8024,80S Ribosome modulator,MODULATOR,117219.0,CHEMBL3987582,80S Ribosome,1,1,1,Read through agent,
427670,CHEMBL259571,TAPINAROF,8435,Aryl hydrocarbon receptor agonist,AGONIST,10694.0,CHEMBL3201,Aryl hydrocarbon receptor,1,1,1,,
429475,CHEMBL259972,MOFEZOLAC,7576,Cyclooxygenase-1 inhibitor,INHIBITOR,96.0,CHEMBL221,Prostaglandin G/H synthase 1,1,1,1,,Higher affinity for COX-1 over COX-2.
431376,CHEMBL260538,ULIPRISTAL ACETATE,1023,Progesterone receptor modulator,MODULATOR,36.0,CHEMBL208,Progesterone receptor,1,1,1,Mixed agonist/antagonist,
430250,CHEMBL261772,MECLOCYCLINE SULFOSALICYLATE,1775,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
70140,CHEMBL262777,VANCOMYCIN,8835,Peptidoglycan inhibitor,INHIBITOR,107948.0,CHEMBL3041361,Peptidoglycan,1,1,1,,
84251,CHEMBL264241,ANIDULAFUNGIN,1390,"1,3-beta-glucan synthase inhibitor",INHIBITOR,106173.0,CHEMBL2364673,"1,3-beta-glucan synthase",1,1,1,,
8873,CHEMBL267345,AMPHOTERICIN B,1804,Ergosterol sequestering agent,SEQUESTERING AGENT,106007.0,CHEMBL2364028,Ergosterol,1,1,1,forms pore in membrane by binding ergosterol,
2516,CHEMBL268869,SULFAMETHOXYPYRIDAZINE,6305,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,"It acts as competitive inhibitor of dihydropteroate synthase, an enzyme that uses PABA as a substrate for the synthesis of folic acid.",
435293,CHEMBL270190,ALVIMOPAN,716,Mu opioid receptor antagonist,ANTAGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
438435,CHEMBL271227,ABIRATERONE ACETATE,947,Cytochrome P450 17A1 inhibitor,INHIBITOR,12949.0,CHEMBL3522,"Steroid 17-alpha-hydroxylase/17,20 lyase",1,1,1,,
16580,CHEMBL276520,INDALPINE,6254,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,It potently inhibited serotonin (5-HT) uptake with Ki values in the low nanomolar range (2.7nM)
22393,CHEMBL278623,MACIMORELIN,5376,Ghrelin receptor agonist,AGONIST,11536.0,CHEMBL4616,Growth hormone secretagogue receptor type 1,1,1,1,,
33583,CHEMBL278819,MINAPRINE,6872,Acetylcholinesterase inhibitor,INHIBITOR,93.0,CHEMBL220,Acetylcholinesterase,1,1,1,"Minaprine binds to serotonin type 2 receptors and to dopamine D1 and D2 type receptors. It also binds to the serotonin reuptake pump. Therefore, minaprine blocks the reuptake of both dopamine and serotonin. It is also, to a slight degree, cholinomimetic. Thus it may exhibit both mood-brightening and nootropic properties. It also acts as a reversible inhibitor of monoamine oxidase. It has also been found to inhibit acetylcholinesterase in a reversible and competitive way.",IC50= 85M on homogenized rat striatum acetylcholinesterase.
33583,CHEMBL278819,MINAPRINE,6873,Dopamine D1 and D2 receptor agonist,AGONIST,105040.0,CHEMBL2111341,Dopamine D1 and D2 receptor,1,1,1,"Minaprine binds to serotonin type 2 receptors and to dopamine D1 and D2 type receptors. It also binds to the serotonin reuptake pump. Therefore, minaprine blocks the reuptake of both dopamine and serotonin. It is also, to a slight degree, cholinomimetic. Thus it may exhibit both mood-brightening and nootropic properties. It also acts as a reversible inhibitor of monoamine oxidase. It has also been found to inhibit acetylcholinesterase in a reversible and competitive way.",IC50= 85M on homogenized rat striatum acetylcholinesterase.
33583,CHEMBL278819,MINAPRINE,6874,Monoamine oxidase A inhibitor,INHIBITOR,86.0,CHEMBL1951,Amine oxidase [flavin-containing] A,1,1,1,"Minaprine binds to serotonin type 2 receptors and to dopamine D1 and D2 type receptors. It also binds to the serotonin reuptake pump. Therefore, minaprine blocks the reuptake of both dopamine and serotonin. It is also, to a slight degree, cholinomimetic. Thus it may exhibit both mood-brightening and nootropic properties. It also acts as a reversible inhibitor of monoamine oxidase. It has also been found to inhibit acetylcholinesterase in a reversible and competitive way.",IC50= 85M on homogenized rat striatum acetylcholinesterase.
33583,CHEMBL278819,MINAPRINE,6875,Muscarinic acetylcholine receptor M1 agonist,AGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Minaprine binds to serotonin type 2 receptors and to dopamine D1 and D2 type receptors. It also binds to the serotonin reuptake pump. Therefore, minaprine blocks the reuptake of both dopamine and serotonin. It is also, to a slight degree, cholinomimetic. Thus it may exhibit both mood-brightening and nootropic properties. It also acts as a reversible inhibitor of monoamine oxidase. It has also been found to inhibit acetylcholinesterase in a reversible and competitive way.",IC50= 85M on homogenized rat striatum acetylcholinesterase.
33583,CHEMBL278819,MINAPRINE,8641,Serotonin 2 (5-HT2) receptor antagonist,ANTAGONIST,104784.0,CHEMBL2095200,Serotonin 2 (5-HT2) receptor,1,1,1,,
24418,CHEMBL282042,SAQUINAVIR MESYLATE,1490,Human immunodeficiency virus type 1 protease inhibitor,INHIBITOR,191.0,CHEMBL243,Human immunodeficiency virus type 1 protease,1,1,1,,
22572,CHEMBL282052,METHAQUALONE,6265,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,"Methaqualone was demonstrated to be a positive allosteric modulator at human Alpha 1,2,3,5 Beta 2,3 Gamma 2S GABA A receptors (GABAARs) expressed in Xenopus oocytes, whereas it displayed highly diverse functionalities at the Alpha 4,6 Beta 1,2,3 Delta GABAAR subtypes, ranging from inactivity (Alpha4 Beta1 Delta), through negative (Alpha 6 Beta 1 Delta) or positive allosteric modulation (Alpha 4 Beta 2 Delta, Alpha 6 Beta 2,3 Delta), to superagonism (Alpha 4 Beta 3 Delta).",
23417,CHEMBL282724,SITAXENTAN,6298,"Endothelin receptor, ET-A/ET-B antagonist",ANTAGONIST,104833.0,CHEMBL2096678,"Endothelin receptor, ET-A/ET-B",1,1,1,"Sitaxentan is a competitive antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors. Under normal conditions, endothelin-1 binding of ET-A or ET-B receptors causes pulmonary vasoconstriction. By blocking this interaction, Sitaxentan decreases pulmonary vascular resistance",
50290,CHEMBL284092,GEPIRONE,9407,Serotonin 1a (5-HT1a) receptor agonist,AGONIST,51.0,CHEMBL214,5-hydroxytryptamine receptor 1A,1,1,1,May have differential action at presynaptic (agonist) and post-synaptic (partial agonist) 5-HT1A receptors (PMID: 11892924),
31289,CHEMBL284348,DALFAMPRIDINE,2102,Voltage-gated potassium channel blocker,BLOCKER,105708.0,CHEMBL2362996,Voltage-gated potassium channel,1,1,1,,
49847,CHEMBL285674,ESTAZOLAM,1602,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
62111,CHEMBL288441,BOSUTINIB,302,Tyrosine-protein kinase ABL inhibitor,INHIBITOR,8.0,CHEMBL1862,Tyrosine-protein kinase ABL1,1,1,1,,
62111,CHEMBL288441,BOSUTINIB,682,Tyrosine-protein kinase SRC inhibitor,INHIBITOR,10434.0,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,1,1,1,,
62111,CHEMBL288441,BOSUTINIB,926,Tyrosine-protein kinase HCK inhibitor,INHIBITOR,11785.0,CHEMBL3234,Tyrosine-protein kinase HCK,1,1,1,,
62111,CHEMBL288441,BOSUTINIB,940,Tyrosine-protein kinase Lyn inhibitor,INHIBITOR,11842.0,CHEMBL3905,Tyrosine-protein kinase Lyn,1,1,1,,
54547,CHEMBL289469,GRANISETRON,376,Serotonin 3a (5-HT3a) receptor antagonist,ANTAGONIST,144.0,CHEMBL1899,5-hydroxytryptamine receptor 3A,1,1,1,,
60422,CHEMBL289480,RILMENIDINE,7570,Nischarin agonist,AGONIST,11684.0,CHEMBL3923,Nischarin,1,1,1,,
56480,CHEMBL290960,NIFURTIMOX,7681,DNA inhibitor,INHIBITOR,118781.0,CHEMBL4495551,DNA,1,1,1,Not fully elucidated but reactive metabolites are throught to damage nuclear and kinetoplast DNA.,
102752,CHEMBL291657,CRINECERFONT,4924,Corticotropin releasing factor receptor 1 antagonist,ANTAGONIST,124.0,CHEMBL1800,Corticotropin-releasing factor receptor 1,1,1,1,,
91783,CHEMBL294199,CAPSAICIN,986,Vanilloid receptor opener,OPENER,10260.0,CHEMBL4794,Transient receptor potential cation channel subfamily V member 1,1,1,1,,
72036,CHEMBL295698,LEVOKETOCONAZOLE,9157,Cytochrome P450 11B1 inhibitor,INHIBITOR,76.0,CHEMBL1908,"Cytochrome P450 11B1, mitochondrial",1,1,1,,
72036,CHEMBL295698,LEVOKETOCONAZOLE,9158,Cytochrome P450 11B2 inhibitor,INHIBITOR,11541.0,CHEMBL2722,"Cytochrome P450 11B2, mitochondrial",1,1,1,,
72036,CHEMBL295698,LEVOKETOCONAZOLE,9362,Cytochrome P450 17A1 inhibitor,INHIBITOR,12949.0,CHEMBL3522,"Steroid 17-alpha-hydroxylase/17,20 lyase",1,1,1,,
72036,CHEMBL295698,LEVOKETOCONAZOLE,9462,Cytochrome P450 11A1 inhibitor,INHIBITOR,32.0,CHEMBL2033,"Cholesterol side-chain cleavage enzyme, mitochondrial",1,1,1,,
76538,CHEMBL296306,LACTULOSE,2145,Colonic bacteria substrate,,,,,1,1,1,Increases water content in the colon,
65605,CHEMBL296419,ASTEMIZOLE,2359,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
67050,CHEMBL296913,PARECOXIB SODIUM,5884,Cyclooxygenase-2 inhibitor,INHIBITOR,126.0,CHEMBL230,Prostaglandin G/H synthase 2,1,1,1,"Upon intravenous or intramuscular administration, parecoxib is hydrolyzed by hepatic carboxyesterases to its active form, valdecoxib. Valdecoxib selectively binds to and inhibits COX-2.  This prevents the conversion of arachidonic acid into prostaglandins, which are involved in the regulation of pain, inflammation, and fever.",
84655,CHEMBL298734,LONAFARNIB,5629,Protein farnesyltransferase inhibitor,INHIBITOR,104690.0,CHEMBL2094108,Protein farnesyltransferase,1,1,1,,
76963,CHEMBL299400,BUTORPHANOL TARTRATE,732,Mu opioid receptor partial agonist,PARTIAL AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,May be mixed agonist/antagonist,
76963,CHEMBL299400,BUTORPHANOL TARTRATE,1313,Kappa opioid receptor partial agonist,PARTIAL AGONIST,137.0,CHEMBL237,Kappa-type opioid receptor,1,1,1,,
115,CHEMBL3,NICOTINE,1044,Neuronal acetylcholine receptor; alpha4/beta2 agonist,AGONIST,104283.0,CHEMBL1907589,Neuronal acetylcholine receptor; alpha4/beta2,1,1,1,,
1620,CHEMBL30,CIMETIDINE,461,Histamine H2 receptor antagonist,ANTAGONIST,102.0,CHEMBL1941,Histamine H2 receptor,1,1,1,,
38588,CHEMBL30219,METHOHEXITAL SODIUM,1611,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
1592322,CHEMBL3039504,NINTEDANIB ESYLATE,2301,Platelet-derived growth factor receptor inhibitor,INHIBITOR,104773.0,CHEMBL2095189,Platelet-derived growth factor receptor,1,1,1,,
1592322,CHEMBL3039504,NINTEDANIB ESYLATE,2303,Vascular endothelial growth factor receptor inhibitor,INHIBITOR,104799.0,CHEMBL2095227,Vascular endothelial growth factor receptor,1,1,1,,
1592322,CHEMBL3039504,NINTEDANIB ESYLATE,2305,Fibroblast growth factor receptor inhibitor,INHIBITOR,104793.0,CHEMBL2095217,Fibroblast growth factor receptor,1,1,1,,"FGFR 1, 2 + 3"
1592325,CHEMBL3039507,SOTAGLIFLOZIN,5770,Sodium/glucose cotransporter 1 inhibitor,INHIBITOR,18036.0,CHEMBL4979,Sodium/glucose cotransporter 1,1,1,1,,"Human SGLT1 IC50=36 nmol/l, human SGLT2 IC50=1.8 nmol/l "
1592325,CHEMBL3039507,SOTAGLIFLOZIN,5841,Sodium/glucose cotransporter 2 inhibitor,INHIBITOR,20092.0,CHEMBL3884,Sodium/glucose cotransporter 2,1,1,1,,"Human SGLT1 IC50=36 nmol/l, human SGLT2 IC50=1.8 nmol/l "
1592326,CHEMBL3039508,NALDEMEDINE TOSYLATE,6164,Mu opioid receptor antagonist,ANTAGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
1592332,CHEMBL3039514,ELBASVIR,5510,Nonstructural protein 5A inhibitor,INHIBITOR,108438.0,CHEMBL3307224,Nonstructural protein 5A,1,1,1,,
1592338,CHEMBL3039520,LASMIDITAN,4928,Serotonin 1f (5-HT1f) receptor agonist,AGONIST,279.0,CHEMBL1805,5-hydroxytryptamine receptor 1F,1,1,1,,
1592344,CHEMBL3039526,LASMIDITAN SUCCINATE,7448,Serotonin 1f (5-HT1f) receptor agonist,AGONIST,279.0,CHEMBL1805,5-hydroxytryptamine receptor 1F,1,1,1,The prescise mechanism is unknown but is thought to be neuronal.,High affinity for the 5-HT1F receptor.
1592355,CHEMBL3039537,SEBELIPASE ALFA,2429,Cholesterol ester hydrolytic enzyme,HYDROLYTIC ENZYME,109711.0,CHEMBL3559388,Cholesterol ester,1,1,1,,
1592355,CHEMBL3039537,SEBELIPASE ALFA,2430,Triglyceride hydrolytic enzyme,HYDROLYTIC ENZYME,109712.0,CHEMBL3559389,Triglyceride,1,1,1,,
1592358,CHEMBL3039540,ADUCANUMAB,5947,Amyloid-beta A4 protein binding agent,BINDING AGENT,10656.0,CHEMBL2487,Amyloid-beta precursor protein,1,1,1,Reduces brain disease-relevant aggregated forms of amyloid-beta (Abeta) in a dose- and time-dependent manner.,"Shows >10,000-fold selectivity for aggregated Abeta over monomer"
1592363,CHEMBL3039545,LUSPATERCEPT,7446,Transforming growth factor beta inhibitor,INHIBITOR,117291.0,CHEMBL3988637,Transforming growth factor beta,1,1,1,"Erythroid maturation agent.
Luspatercept is a recombinant protein that mimics the human activin receptor type IIB and sequesters its TGF-beta ligands. 
This reduces the interaction between TGF-beta ligands and the native TGF-beta receptor reducing downstream Smad2/3 signaling with the overall result of increased erythroid maturation.",
1592407,CHEMBL3039596,FOSINOPRIL SODIUM,111,Angiotensin-converting enzyme inhibitor,INHIBITOR,69.0,CHEMBL1808,Angiotensin-converting enzyme,1,1,1,,
111060,CHEMBL305660,EBASTINE,7564,Histamine H1 receptor inverse agonist,INVERSE AGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,Converted to carebastine which displays antihistamine activity and is likely responsible for most of the therapeutic activity.,Selective for H1 over H2 receptors. Potential activity against leukotriene C4 and platelet-activating factor but not against acetylcholine.
1594639,CHEMBL3084748,TROSPIUM CHLORIDE,53,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for overactive bladder, M3 likely responsible",
1594639,CHEMBL3084748,TROSPIUM CHLORIDE,1512,Muscarinic acetylcholine receptor M2 antagonist,ANTAGONIST,47.0,CHEMBL211,Muscarinic acetylcholine receptor M2,1,1,1,"Indicated for overactive bladder, M2 likely responsible",
113138,CHEMBL308954,ETRAVIRINE,833,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,,
1712,CHEMBL31,GATIFLOXACIN,1911,DNA gyrase inhibitor,INHIBITOR,105578.0,CHEMBL2311225,DNA gyrase,1,1,1,,
1712,CHEMBL31,GATIFLOXACIN,2045,Topoisomerase IV inhibitor,INHIBITOR,105735.0,CHEMBL2363033,Topoisomerase IV,1,1,1,,
1623950,CHEMBL3127326,OMBITASVIR,2325,Nonstructural protein 5A inhibitor,INHIBITOR,108438.0,CHEMBL3307224,Nonstructural protein 5A,1,1,1,,
1626732,CHEMBL3137301,SACUBITRIL,2347,Neprilysin inhibitor,INHIBITOR,236.0,CHEMBL1944,Neprilysin,1,1,1,,
1626739,CHEMBL3137308,PEFICITINIB,4631,Janus Kinase (JAK) inhibitor,INHIBITOR,105757.0,CHEMBL2363062,Janus Kinase (JAK),1,1,1,,
1626740,CHEMBL3137309,VENETOCLAX,5516,Apoptosis regulator Bcl-2 inhibitor,INHIBITOR,100304.0,CHEMBL4860,Apoptosis regulator Bcl-2,1,1,1,,
1626741,CHEMBL3137310,BENZHYDROCODONE HYDROCHLORIDE,7630,Opioid receptors; mu/kappa/delta agonist,AGONIST,104765.0,CHEMBL2095181,Opioid receptors; mu/kappa/delta,1,1,1,,Highest affinity for the mu receptor which is primarily responsible for the analgesic activity.
1626748,CHEMBL3137317,SONIDEGIB PHOSPHATE,2400,Smoothened homolog inhibitor,INHIBITOR,101400.0,CHEMBL5971,Protein smoothened,1,1,1,,
1626749,CHEMBL3137318,TALAZOPARIB TOSYLATE,5789,Poly [ADP-ribose] polymerase 2 inhibitor,INHIBITOR,100933.0,CHEMBL5366,Poly [ADP-ribose] polymerase 2,1,1,1,,
1626749,CHEMBL3137318,TALAZOPARIB TOSYLATE,5844,Poly [ADP-ribose] polymerase-1 inhibitor,INHIBITOR,11663.0,CHEMBL3105,Poly [ADP-ribose] polymerase 1,1,1,1,,
1626751,CHEMBL3137320,TALAZOPARIB,5790,Poly [ADP-ribose] polymerase-1 inhibitor,INHIBITOR,11663.0,CHEMBL3105,Poly [ADP-ribose] polymerase 1,1,1,1,,Potent PARP1/2 inhibitor (PARP1 IC50 = 0.57 nmol/L). PARP1 Ki=1.2 nmol/L. PARP2 Ki= 0.85 nmol/L.
1626751,CHEMBL3137320,TALAZOPARIB,5842,Poly [ADP-ribose] polymerase 2 inhibitor,INHIBITOR,100933.0,CHEMBL5366,Poly [ADP-ribose] polymerase 2,1,1,1,,Potent PARP1/2 inhibitor (PARP1 IC50 = 0.57 nmol/L). PARP1 Ki=1.2 nmol/L. PARP2 Ki= 0.85 nmol/L.
1626757,CHEMBL3137326,DEUTETRABENAZINE,6905,Synaptic vesicular amine transporter inhibitor,INHIBITOR,162.0,CHEMBL1893,Synaptic vesicular amine transporter,1,1,1,,
1626761,CHEMBL3137330,CABOTEGRAVIR SODIUM,8606,Human immunodeficiency virus type 1 integrase inhibitor,INHIBITOR,12456.0,CHEMBL3471,Human immunodeficiency virus type 1 integrase,1,1,1,,
1626764,CHEMBL3137333,ISAVUCONAZONIUM SULFATE,2330,Lanosterol 14-alpha demethylase inhibitor,INHIBITOR,109549.0,CHEMBL3390824,Lanosterol 14-alpha demethylase,1,1,1,,
1626764,CHEMBL3137333,ISAVUCONAZONIUM SULFATE,2331,Lanosterol 14-alpha demethylase inhibitor,INHIBITOR,109550.0,CHEMBL3390825,Lanosterol 14-alpha demethylase,1,1,1,,
1626776,CHEMBL3137342,DINUTUXIMAB,2328,Disialoganglioside GD2 binding agent,BINDING AGENT,109548.0,CHEMBL3390823,Disialoganglioside GD2,1,1,1,,
1626777,CHEMBL3137343,PEMBROLIZUMAB,2300,Programmed cell death protein 1 inhibitor,INHIBITOR,108437.0,CHEMBL3307223,Programmed cell death protein 1,1,1,1,,
1626792,CHEMBL3137358,SIMEPREVIR SODIUM,2243,"Hepatitis C virus serine protease, NS3/NS4A inhibitor",INHIBITOR,104803.0,CHEMBL2095231,"Hepatitis C virus serine protease, NS3/NS4A",1,1,1,,
144744,CHEMBL313972,MASOPROCOL,4740,Receptor protein-tyrosine kinase erbB-2 inhibitor,INHIBITOR,188.0,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,1,1,1,,
144744,CHEMBL313972,MASOPROCOL,4741,Insulin-like growth factor I receptor inhibitor,INHIBITOR,234.0,CHEMBL1957,Insulin-like growth factor 1 receptor,1,1,1,,
1629652,CHEMBL3140361,ETHAMBUTOL HYDROCHLORIDE,356,Arabinosyltransferase A inhibitor,INHIBITOR,152.0,CHEMBL1877,Probable arabinosyltransferase A,1,1,1,,
1631832,CHEMBL3142541,BUTAMBEN PICRATE,6216,Transient receptor potential cation channel subfamily A member 1 inhibitor,INHIBITOR,101412.0,CHEMBL6007,Transient receptor potential cation channel subfamily A member 1,1,1,1,"Butamben is a pain-relieving local anesthetic. It inhibits voltage-gated channels in the sensory neurons (T-type calcium channels, Cav1.2/L-type channels, Kv4 channels). It also inhibits Transient Receptor Potential A1 (TRPA1) and Transient Receptor Potential V4 (TRPV4).",
1631832,CHEMBL3142541,BUTAMBEN PICRATE,6855,Transient receptor potential cation channel subfamily V member 4 inhibitor,INHIBITOR,11847.0,CHEMBL3119,Transient receptor potential cation channel subfamily V member 4,1,1,1,"Butamben is a pain-relieving local anesthetic. It inhibits voltage-gated channels in the sensory neurons (T-type calcium channels, Cav1.2/L-type channels, Kv4 channels). It also inhibits Transient Receptor Potential A1 (TRPA1) and Transient Receptor Potential V4 (TRPV4).",
153476,CHEMBL316561,PROGLUMIDE,6289,Cholecystokinin receptor antagonist,ANTAGONIST,104769.0,CHEMBL2095185,Cholecystokinin receptor,1,1,1,"Proglumide is a drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It specifically and competitively inhibits the effects and the receptor-binding of gastrin and the closely related peptide, cholecystokinin.",Inhibition was reversible and competitive in nature with a KI of 0.7 mM
164680,CHEMBL317094,IMIDAPRIL,7552,Angiotensin-converting enzyme inhibitor,INHIBITOR,69.0,CHEMBL1808,Angiotensin-converting enzyme,1,1,1,,
1671123,CHEMBL3181832,METHICILLIN SODIUM,1426,Penicillin-binding protein inhibitor,INHIBITOR,105733.0,CHEMBL2363021,Penicillin-binding protein,1,1,1,,
1671132,CHEMBL3181841,RAMOSETRON HYDROCHLORIDE,7530,Serotonin 3 (5-HT3) receptor antagonist,ANTAGONIST,104714.0,CHEMBL2094132,Serotonin 3 (5-HT3) receptor,1,1,1,,Selective serotonin 5-HT3 receptor antagonist.
1671238,CHEMBL3181947,BROMFENAC SODIUM,1193,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
1672024,CHEMBL3182733,PRAMIPEXOLE DIHYDROCHLORIDE,2009,D2-like dopamine receptor agonist,AGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
1672366,CHEMBL3183075,NIZATIDINE,459,Histamine H2 receptor antagonist,ANTAGONIST,102.0,CHEMBL1941,Histamine H2 receptor,1,1,1,,
1672484,CHEMBL3183193,CEFMENOXIME HYDROCHLORIDE,1701,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
1672700,CHEMBL3183409,APALUTAMIDE,5219,Androgen Receptor antagonist,ANTAGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
1672742,CHEMBL3183451,GARENOXACIN MESYLATE,7543,Bacterial DNA gyrase inhibitor,INHIBITOR,105577.0,CHEMBL2311224,Bacterial DNA gyrase,1,1,1,Antibacterial,"Active against garenoxacin-susceptible strains of Staphylococcus sp. (including MRSA), Streptococcus sp., Streptococcus pneumoniae (including multi-drug resistant Streptococcus pneumoniae), Moraxella (Branhamella) catarrhalis (including -lactamase-producing bacteria), Escherichia coli, Klebsiella sp., Enterobacter sp., Haemophilus influenzae (including BLNAR), Legionella pneumophila, Chlamydia pneumoniae, and Mycoplasma pneumoniae."
1672742,CHEMBL3183451,GARENOXACIN MESYLATE,7544,Topoisomerase IV inhibitor,INHIBITOR,105771.0,CHEMBL2363076,Topoisomerase IV,1,1,1,Antibacterial,"Active against garenoxacin-susceptible strains of Staphylococcus sp. (including MRSA), Streptococcus sp., Streptococcus pneumoniae (including multi-drug resistant Streptococcus pneumoniae), Moraxella (Branhamella) catarrhalis (including -lactamase-producing bacteria), Escherichia coli, Klebsiella sp., Enterobacter sp., Haemophilus influenzae (including BLNAR), Legionella pneumophila, Chlamydia pneumoniae, and Mycoplasma pneumoniae."
1672744,CHEMBL3183453,NOVOBIOCIN SODIUM,1939,DNA gyrase inhibitor,INHIBITOR,105636.0,CHEMBL2331040,DNA gyrase,1,1,1,,
1673434,CHEMBL3184143,GUANADREL SULFATE,879,Norepinephrine transporter substrate,SUBSTRATE,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,Taken up by transporter and displaces NE from vesicles,
1673803,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,1756,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
1674082,CHEMBL3184791,STREPTOMYCIN SULFATE,1767,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
1674090,CHEMBL3184799,MEPHENTERMINE SULFATE,2000,Adrenergic receptor agonist,AGONIST,105670.0,CHEMBL2331074,Adrenergic receptor,1,1,1,,
1674277,CHEMBL3184986,ZINC ACETATE,10098,Skin protectant,,,,,1,1,1,"Mechanism_for_indication: Skin irritation, pain, itching.",
1674277,CHEMBL3184986,ZINC ACETATE,10099,Blocks absorption of copper and induces the production of the copper-binding protein metallothionein.,,,,,1,1,1,Mechanism_for_indication: Wilson's disease.,
1675249,CHEMBL3185958,CLOMIPHENE CITRATE,861,Estrogen receptor alpha modulator,MODULATOR,19.0,CHEMBL206,Estrogen receptor,1,1,1,,
1675783,CHEMBL3186492,ONDANSETRON HYDROCHLORIDE,378,Serotonin 3a (5-HT3a) receptor antagonist,ANTAGONIST,144.0,CHEMBL1899,5-hydroxytryptamine receptor 3A,1,1,1,,Selective
1676284,CHEMBL3186993,HYDROXYZINE HYDROCHLORIDE,160,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,Activity against other receptors such as 5HT2A and D2 may underlie efficacy of anxiolytic and antipsychotic effects ,
1676537,CHEMBL3187246,METHAPYRILENE FUMARATE,6263,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
1677014,CHEMBL3187723,BINIMETINIB,5301,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,INHIBITOR,11409.0,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,1,1,1,Non-ATP-competitive allosteric inhibitor,
1677014,CHEMBL3187723,BINIMETINIB,5302,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,INHIBITOR,11046.0,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,1,1,1,Non-ATP-competitive allosteric inhibitor,
1677276,CHEMBL3187985,APOMORPHINE HYDROCHLORIDE,2020,D2-like dopamine receptor agonist,AGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
1677325,CHEMBL3188034,TRIPROLIDINE HYDROCHLORIDE,158,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
1677558,CHEMBL3188267,CAPMATINIB,4867,Hepatocyte growth factor receptor inhibitor,INHIBITOR,11451.0,CHEMBL3717,Hepatocyte growth factor receptor,1,1,1,Certain mutations in MET can lead to exon 14 skipping and reduced negative regulation of the MET kinase. Capmatinib exhibits anticancer activity in MET-driven cancer cell lines by inhibiting downstream MET signalling.,
1677867,CHEMBL3188576,DIHYDROSTREPTOMYCIN SULFATE,6236,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,"Dihydrostreptomycin binds to a specific site on the bacterial mechanosensitive channel (MscL) and modifies its conformation, thus allowing the passage of K+ and glutamate out of, and dihydrostreptomycin into, the cell. Once it is inside the cell, It binds to the S12 protein of the 30S subunit on the ribosome, inhibits translation and can cause misreading of mRNA.",
1678284,CHEMBL3188993,QUETIAPINE FUMARATE,599,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
1678284,CHEMBL3188993,QUETIAPINE FUMARATE,622,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
1678284,CHEMBL3188993,QUETIAPINE FUMARATE,2024,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
1678363,CHEMBL3189072,TIROFIBAN HYDROCHLORIDE,1079,Integrin alpha-IIb/beta-3 inhibitor,INHIBITOR,104685.0,CHEMBL2093869,Integrin alpha-IIb/beta-3,1,1,1,,
161549,CHEMBL319144,MINODRONIC ACID,7562,Farnesyl diphosphate synthase inhibitor,INHIBITOR,71.0,CHEMBL1782,Farnesyl pyrophosphate synthase,1,1,1,,
1724957,CHEMBL3218576,COPANLISIB,7412,PI3-kinase p110-alpha subunit inhibitor,INHIBITOR,11362.0,CHEMBL4005,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",1,1,1,,
1724957,CHEMBL3218576,COPANLISIB,7413,PI3-kinase p110-delta subunit inhibitor,INHIBITOR,11177.0,CHEMBL3130,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",1,1,1,,
1736091,CHEMBL3237547,CEDAZURIDINE,7620,Cytidine deaminase inhibitor,INHIBITOR,12945.0,CHEMBL4502,Cytidine deaminase,1,1,1,Inhibits cytidine deaminase (an enzyme that degrades decitabine) and increases decitabine exposure.,
1737244,CHEMBL3244648,METHOTREXATE SODIUM,849,Dihydrofolate reductase inhibitor,INHIBITOR,6.0,CHEMBL202,Dihydrofolate reductase,1,1,1,,
1746288,CHEMBL3261331,RESMETIROM,4084,Thyroid hormone receptor beta-1 agonist,AGONIST,271.0,CHEMBL1947,Thyroid hormone receptor beta,1,1,1,,
49226,CHEMBL32800,FENOTEROL,6247,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,"Beta-2 adrenergic receptor stimulation in the lung causes relaxation of bronchial smooth muscle, bronchodilation, and increased bronchial airflow.",
162444,CHEMBL328190,LASOFOXIFENE,7582,Estrogen receptor modulator,MODULATOR,104682.0,CHEMBL2093866,Estrogen receptor,1,1,1,Activates some estrogen pathways and blocks other estrogen pathways. ,
1757351,CHEMBL3286830,LORLATINIB,7370,ALK tyrosine kinase receptor inhibitor,INHIBITOR,100417.0,CHEMBL4247,ALK tyrosine kinase receptor,1,1,1,"Active against ALK-driven tumors, inhibits ALK phosphorylation.","Active against other kinases: ROS1, TYK1, FER, FPS, TRKA, TRKB, TRKC, FAK, FAK2, ACK.  Active against some ALK variants."
1757351,CHEMBL3286830,LORLATINIB,7372,EML4-ALK inhibitor,INHIBITOR,117043.0,CHEMBL3883330,EML4-ALK,1,1,1,"Active against ALK-driven tumors, inhibits ALK phosphorylation.","Active against other kinases: ROS1, TYK1, FER, FPS, TRKA, TRKB, TRKC, FAK, FAK2, ACK.  Active against some ALK variants."
1763536,CHEMBL3301574,TISAGENLECLEUCEL,7492,B-lymphocyte antigen CD19 binding agent,BINDING AGENT,109546.0,CHEMBL3390821,B-lymphocyte antigen CD19,1,1,1,T-cell immunotherapy. A patients T-cells are extracted and modified with a vector encoding an anti-CD19 chimeric antigen receptor (CAR) to eliminate CD19-expressing malignant and normal cells. The CAR is fused to intracellular signaling domains that initiate and enhance T-cell activity. ,
1763543,CHEMBL3301581,ABALOPARATIDE,6898,Parathyroid hormone receptor agonist,AGONIST,160.0,CHEMBL1793,Parathyroid hormone/parathyroid hormone-related peptide receptor,1,1,1,,
1763544,CHEMBL3301582,POLATUZUMAB VEDOTIN,6427,B-cell antigen receptor complex-associated protein beta chain binding agent,BINDING AGENT,114813.0,CHEMBL3712852,B-cell antigen receptor complex-associated protein beta chain,1,1,1,,
1763544,CHEMBL3301582,POLATUZUMAB VEDOTIN,7390,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,"The antibody binds to the B-cells, is internalised, and the linker proteolytically cleaved to release the small molecule which binds to microtubules inhibiting cell division and inducing apoptosis.",
1763545,CHEMBL3301583,ANDEXANET ALFA,7586,Rivaroxaban sequestering agent,SEQUESTERING AGENT,118785.0,CHEMBL4495555,Rivaroxaban,1,1,1,Decoy agent for anticoagulant medicines apixaban or rivaroxaban.,
1763545,CHEMBL3301583,ANDEXANET ALFA,7594,Apixaban sequestering agent,SEQUESTERING AGENT,118786.0,CHEMBL4495556,Apixaban,1,1,1,Decoy agent for anticoagulant medicines apixaban or rivaroxaban.,
1763545,CHEMBL3301583,ANDEXANET ALFA,7600,Tissue factor pathway inhibitor inhibitor,INHIBITOR,115023.0,CHEMBL3713062,Tissue factor pathway inhibitor,1,1,1,"In addition to functioning as a decoy agent for the anticoagulant medicines apixaban or rivaroxaban, ANDEXANET ALFA can also inhibit tissue factor pathway inhibitor.",
1763549,CHEMBL3301587,DURVALUMAB,5946,Programmed cell death 1 ligand 1 inhibitor,INHIBITOR,109807.0,CHEMBL3580522,Programmed cell death 1 ligand 1,1,1,1,Blocks PD-L1 binding to PD-1 (IC50 0.1 nM) and CD80 (IC50 0.04 nM).,
1763551,CHEMBL3301589,ENFORTUMAB VEDOTIN,7183,Nectin-4 binding agent,BINDING AGENT,114889.0,CHEMBL3712928,Nectin-4,1,1,1,,
1763551,CHEMBL3301589,ENFORTUMAB VEDOTIN,8623,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,,
1763554,CHEMBL3301592,SODIUM ZIRCONIUM CYCLOSILICATE,7358,Potassium chelating agent,CHELATING AGENT,109707.0,CHEMBL3545434,Potassium,1,1,1,"Potassium binder, exchanges potassium for hydrogen and sodium and lowers potassium levels.",High affinity for potassium
1763556,CHEMBL3301594,FOSTEMSAVIR,7621,Envelope polyprotein GP160 inhibitor,INHIBITOR,14044.0,CHEMBL3520,Envelope glycoprotein gp160,1,1,1,Binds the gp120 subunit of the viral gp160 envelope glycoprotein and inhibits attachment to host CD4 receptors. Also inhibits other gp120-dependent post-attachment steps. ,"Activity varied depending on tropism, less active against subtype AE. "
1763559,CHEMBL3301597,FERRIC CITRATE,2332,Phosphate sequestering agent,SEQUESTERING AGENT,106163.0,CHEMBL2364184,Phosphate,1,1,1,,
1763560,CHEMBL3301598,FOSTEMSAVIR TROMETHAMINE,7597,Envelope polyprotein GP160 inhibitor,INHIBITOR,14044.0,CHEMBL3520,Envelope glycoprotein gp160,1,1,1,Binds the gp120 subunit of the viral gp160 envelope glycoprotein and inhibits attachment to host CD4 receptors. Also inhibits other gp120-dependent post-attachment steps. ,"Activity varied depending on tropism, less active against subtype AE. "
1763565,CHEMBL3301603,GILTERITINIB FUMARATE,7350,Tyrosine-protein kinase receptor FLT3 inhibitor,INHIBITOR,12670.0,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,1,1,1,Inhibits FLT3 signalling and proliferation and induces apoptosis in leukemia cells expressing FLT3-ITD.,Inhibits multiple receptor tyrosine kinases. Active against FLT3 and certain FLT3 variants.
1763565,CHEMBL3301603,GILTERITINIB FUMARATE,7418,Tyrosine-protein kinase receptor UFO inhibitor,INHIBITOR,100410.0,CHEMBL4895,Tyrosine-protein kinase receptor UFO,1,1,1,,
1763567,CHEMBL3301605,RELEBACTAM,7391,Beta-lactamase SHV-1 inhibitor,INHIBITOR,101068.0,CHEMBL5094,Beta-lactamase SHV-1,1,1,1,Relebactam is used in combination with the beta-lactam antibacterial imipenem and protects imipenem from degradation by certain bacterial beta-lactamases. Relebactam itself has no antibacterial activity.,"Inhibits serine beta lactamases (SHV, TEM, CTX-M type and Enterobacter cloacae P99, Pseudomonase derived cephalosporinase PDC and Klebsiella pneumoniae carbapenemase KPC). Not active against MBLs, some oxacillinases and certain GES allelles. Can restore the activity of imipenem/cilastatin combinations against KPC-producing Enterobacteriaceae and PDC-producing Pseudomonas aeruginosa."
1763567,CHEMBL3301605,RELEBACTAM,7404,Bacterial beta-lactamase TEM inhibitor,INHIBITOR,106170.0,CHEMBL2364670,Beta-lactamase TEM,1,1,1,Relebactam is used in combination with the beta-lactam antibacterial imipenem and protects imipenem from degradation by certain bacterial beta-lactamases. Relebactam itself has no antibacterial activity.,"Inhibits serine beta lactamases (SHV, TEM, CTX-M type and Enterobacter cloacae P99, Pseudomonase derived cephalosporinase PDC and Klebsiella pneumoniae carbapenemase KPC). Not active against MBLs, some oxacillinases and certain GES allelles. Can restore the activity of imipenem/cilastatin combinations against KPC-producing Enterobacteriaceae and PDC-producing Pseudomonas aeruginosa."
1763567,CHEMBL3301605,RELEBACTAM,7405,Beta-lactamase inhibitor,INHIBITOR,18040.0,CHEMBL5031,Beta-lactamase,1,1,1,Relebactam is used in combination with the beta-lactam antibacterial imipenem and protects imipenem from degradation by certain bacterial beta-lactamases. Relebactam itself has no antibacterial activity.,"Inhibits serine beta lactamases (SHV, TEM, CTX-M type and Enterobacter cloacae P99, Pseudomonase derived cephalosporinase PDC and Klebsiella pneumoniae carbapenemase KPC). Not active against MBLs, some oxacillinases and certain GES allelles. Can restore the activity of imipenem/cilastatin combinations against KPC-producing Enterobacteriaceae and PDC-producing Pseudomonas aeruginosa."
1763567,CHEMBL3301605,RELEBACTAM,7406,Beta-lactamase inhibitor,INHIBITOR,12802.0,CHEMBL2725,Beta-lactamase,1,1,1,Relebactam is used in combination with the beta-lactam antibacterial imipenem and protects imipenem from degradation by certain bacterial beta-lactamases. Relebactam itself has no antibacterial activity.,"Inhibits serine beta lactamases (SHV, TEM, CTX-M type and Enterobacter cloacae P99, Pseudomonase derived cephalosporinase PDC and Klebsiella pneumoniae carbapenemase KPC). Not active against MBLs, some oxacillinases and certain GES allelles. Can restore the activity of imipenem/cilastatin combinations against KPC-producing Enterobacteriaceae and PDC-producing Pseudomonas aeruginosa."
1763567,CHEMBL3301605,RELEBACTAM,7407,Carbapenem-hydrolyzing beta-lactamase KPC inhibitor,INHIBITOR,109776.0,CHEMBL3562180,Carbapenem-hydrolyzing beta-lactamase KPC,1,1,1,Relebactam is used in combination with the beta-lactam antibacterial imipenem and protects imipenem from degradation by certain bacterial beta-lactamases. Relebactam itself has no antibacterial activity.,"Inhibits serine beta lactamases (SHV, TEM, CTX-M type and Enterobacter cloacae P99, Pseudomonase derived cephalosporinase PDC and Klebsiella pneumoniae carbapenemase KPC). Not active against MBLs, some oxacillinases and certain GES allelles. Can restore the activity of imipenem/cilastatin combinations against KPC-producing Enterobacteriaceae and PDC-producing Pseudomonas aeruginosa."
1763567,CHEMBL3301605,RELEBACTAM,7408,Beta-lactamase CTX-M inhibitor,INHIBITOR,101456.0,CHEMBL6131,Beta-lactamase CTX-M,1,1,1,Relebactam is used in combination with the beta-lactam antibacterial imipenem and protects imipenem from degradation by certain bacterial beta-lactamases. Relebactam itself has no antibacterial activity.,"Inhibits serine beta lactamases (SHV, TEM, CTX-M type and Enterobacter cloacae P99, Pseudomonase derived cephalosporinase PDC and Klebsiella pneumoniae carbapenemase KPC). Not active against MBLs, some oxacillinases and certain GES allelles. Can restore the activity of imipenem/cilastatin combinations against KPC-producing Enterobacteriaceae and PDC-producing Pseudomonas aeruginosa."
1763569,CHEMBL3301607,FILGOTINIB,4723,Tyrosine-protein kinase JAK1 inhibitor,INHIBITOR,10919.0,CHEMBL2835,Tyrosine-protein kinase JAK1,1,1,1,,
1763569,CHEMBL3301607,FILGOTINIB,9795,Tyrosine-protein kinase JAK2 inhibitor,INHIBITOR,10938.0,CHEMBL2971,Tyrosine-protein kinase JAK2,1,1,1,JAK1 preferential inhibitory activity,
1763569,CHEMBL3301607,FILGOTINIB,9796,Tyrosine-protein kinase TYK2 inhibitor,INHIBITOR,12694.0,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,1,1,1,JAK1 preferential inhibitory activity,
1763569,CHEMBL3301607,FILGOTINIB,9797,Tyrosine-protein kinase JAK3 inhibitor,INHIBITOR,10849.0,CHEMBL2148,Tyrosine-protein kinase JAK3,1,1,1,JAK1 preferential inhibitory activity,
1763572,CHEMBL3301610,ABEMACICLIB,4758,Cyclin-dependent kinase 4 inhibitor,INHIBITOR,12946.0,CHEMBL331,Cyclin-dependent kinase 4,1,1,1,,
1763572,CHEMBL3301610,ABEMACICLIB,4759,Cyclin-dependent kinase 6 inhibitor,INHIBITOR,10480.0,CHEMBL2508,Cyclin-dependent kinase 6,1,1,1,,
1763573,CHEMBL3301611,AMIFAMPRIDINE PHOSPHATE,7346,Voltage-gated potassium channel blocker,BLOCKER,105708.0,CHEMBL2362996,Voltage-gated potassium channel,1,1,1,Mechanism for therapeutic effect not fully elucidated. ,Broad spectrum potassium channel blocker
1763574,CHEMBL3301612,ENCORAFENIB,5298,Serine/threonine-protein kinase B-raf inhibitor,INHIBITOR,100126.0,CHEMBL5145,Serine/threonine-protein kinase B-raf,1,1,1,Selective for mutation containing BRAF (V600E mutation) with little or no activity against wild-type BRAF.,
1763584,CHEMBL3301622,GILTERITINIB,5110,Tyrosine-protein kinase receptor FLT3 inhibitor,INHIBITOR,12670.0,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,1,1,1,Inhibits FLT3 signalling and proliferation and induces apoptosis in leukemia cells expressing FLT3-ITD.,Inhibits multiple receptor tyrosine kinases. Active against FLT3 and certain FLT3 variants.
1763584,CHEMBL3301622,GILTERITINIB,5111,Tyrosine-protein kinase receptor UFO inhibitor,INHIBITOR,100410.0,CHEMBL4895,Tyrosine-protein kinase receptor UFO,1,1,1,,
1763586,CHEMBL3301624,SETMELANOTIDE,5091,Melanocortin receptor 4 agonist,AGONIST,10142.0,CHEMBL259,Melanocortin receptor 4,1,1,1,Peptide,20-fold less active at the melanocortin 3 and melanocortin 1 receptors.
1763589,CHEMBL3301627,TENAPANOR HYDROCHLORIDE,5804,Sodium/hydrogen exchanger 3 inhibitor,INHIBITOR,12588.0,CHEMBL3273,Sodium/hydrogen exchanger 3,1,1,1,"Acts locally in the gut, where it reduces absorption of sodium and phosphate.",
1763612,CHEMBL3301650,DALBAVANCIN HYDROCHLORIDE,2288,Peptidoglycan inhibitor,INHIBITOR,107948.0,CHEMBL3041361,Peptidoglycan,1,1,1,,
1763646,CHEMBL3301675,LINACLOTIDE,1046,Heat-stable enterotoxin receptor agonist,AGONIST,104277.0,CHEMBL1795197,Guanylyl cyclase C,1,1,1,,
1763651,CHEMBL3301680,TELAVANCIN HYDROCHLORIDE,1813,Cell outer membrane inhibitor,INHIBITOR,106011.0,CHEMBL2364032,Cell outer membrane,1,1,1,,
1768774,CHEMBL3306803,LUMATEPERONE,5438,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,"Atypical antipsychotic, shows partial agonism at the presynaptic D2 receptors and acts as an antagonist at postsynaptic D2 receptors (PMID: 25120104).",
1768774,CHEMBL3306803,LUMATEPERONE,5439,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,"Atypical antipsychotic, shows partial agonism at the presynaptic D2 receptors and acts as an antagonist at postsynaptic D2 receptors (PMID: 25120104).",
1768774,CHEMBL3306803,LUMATEPERONE,5440,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,"Atypical antipsychotic, shows partial agonism at the presynaptic D2 receptors and acts as an antagonist at postsynaptic D2 receptors (PMID: 25120104).",
1780336,CHEMBL3311228,OTESECONAZOLE,9442,Lanosterol 14-alpha demethylase inhibitor,INHIBITOR,120052.0,CHEMBL4662933,Lanosterol 14-alpha demethylase,1,1,1,,
1782496,CHEMBL3317857,VABORBACTAM,6918,Carbepenem-hydrolyzing beta-lactamase KPC inhibitor,INHIBITOR,101457.0,CHEMBL6132,Carbapenem-hydrolyzing beta-lactamase KPC,1,1,1,,
1797534,CHEMBL3348923,TOVORAFENIB,4286,RAF serine/threonine protein kinase inhibitor,INHIBITOR,109740.0,CHEMBL3559685,RAF serine/threonine protein kinase,1,1,1,,
1797574,CHEMBL3348963,TELOTRISTAT ETIPRATE,6917,Tryptophan 5-hydroxylase inhibitor,INHIBITOR,116867.0,CHEMBL3831287,Tryptophan 5-hydroxylase,1,1,1,,
217548,CHEMBL334966,CANGRELOR,9891,Purinergic receptor P2Y12 inhibitor,INHIBITOR,176.0,CHEMBL2001,P2Y purinoceptor 12,1,1,1,,
1817518,CHEMBL3353410,OSIMERTINIB,5260,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,"Binds irreversibly to certain mutant forms of EGFR (T790M, L858R, and exon 19 deletion)",
1823083,CHEMBL3358920,ETRASIMOD,4440,Sphingosine 1-phosphate receptor Edg-1 agonist,AGONIST,11631.0,CHEMBL4333,Sphingosine 1-phosphate receptor 1,1,1,1,,
1825632,CHEMBL3391662,PARITAPREVIR,2364,"Hepatitis C virus serine protease, NS3/NS4A inhibitor",INHIBITOR,104803.0,CHEMBL2095231,"Hepatitis C virus serine protease, NS3/NS4A",1,1,1,,
1832976,CHEMBL3402762,TEPOTINIB,4865,Hepatocyte growth factor receptor inhibitor,INHIBITOR,11451.0,CHEMBL3717,Hepatocyte growth factor receptor,1,1,1,,
219327,CHEMBL340978,BENOXAPROFEN,6208,Arachidonate 12-lipoxygenase inhibitor,INHIBITOR,11134.0,CHEMBL3687,Polyunsaturated fatty acid lipoxygenase ALOX12,1,1,1,"It acts directly on mononuclear cells, inhibiting their chemotactic response; it inhibits the lipoxygenase enzyme which converts arachidonic acid to hydroxy derivatives and the leukotrienes; and it has a mild inhibitory action on the formation of other prostaglandins.",
228897,CHEMBL341812,IBUFENAC,6253,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
49931,CHEMBL34259,METHOTREXATE,2256,Dihydrofolate reductase inhibitor,INHIBITOR,6.0,CHEMBL202,Dihydrofolate reductase,1,1,1,,
246935,CHEMBL343448,ROMIDEPSIN,1067,Histone deacetylase inhibitor,INHIBITOR,104681.0,CHEMBL2093865,Histone deacetylase,1,1,1,,
227437,CHEMBL344159,TOLVAPTAN,64,Vasopressin V2 receptor antagonist,ANTAGONIST,112.0,CHEMBL1790,Vasopressin V2 receptor,1,1,1,,
254983,CHEMBL345524,ANTRAFENINE,6204,Prostaglandin-H2 D-isomerase inhibitor,INHIBITOR,109622.0,CHEMBL3430865,Prostaglandin-H2 D-isomerase,1,1,1,"Non-narcotic analgesic, which also has some anti-inflammatory properties",
2046,CHEMBL35,FUROSEMIDE,340,Sodium-(potassium)-chloride cotransporter 2 inhibitor,INHIBITOR,167.0,CHEMBL1874,Solute carrier family 12 member 1,1,1,1,,
282661,CHEMBL354077,AMIFAMPRIDINE,7311,Voltage-gated potassium channel blocker,BLOCKER,105708.0,CHEMBL2362996,Voltage-gated potassium channel,1,1,1,Mechanism for therapeutic effect not fully elucidated. ,Broad spectrum potassium channel blocker
1926755,CHEMBL3544906,BENZPHETAMINE HYDROCHLORIDE,887,Norepinephrine transporter releasing agent,RELEASING AGENT,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
1926755,CHEMBL3544906,BENZPHETAMINE HYDROCHLORIDE,1484,Synaptic vesicular amine transporter inhibitor,INHIBITOR,162.0,CHEMBL1893,Synaptic vesicular amine transporter,1,1,1,,
1926757,CHEMBL3544908,AZATADINE MALEATE,137,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
1926758,CHEMBL3544909,CALCIFEDIOL,520,Vitamin D receptor agonist,AGONIST,64.0,CHEMBL1977,Vitamin D3 receptor,1,1,1,,
1926763,CHEMBL3544914,TEZACAFTOR,5167,Cystic fibrosis transmembrane conductance regulator positive modulator,POSITIVE MODULATOR,11540.0,CHEMBL4051,Cystic fibrosis transmembrane conductance regulator,1,1,1,"CF-drug in development for people with one or two copies of the F508del mutation. A CFTR corrector that modulates the folding and trafficking of CFTR protein. In Ph3 in combination with CFTR potentiator Ivacaftor.
Indication: Cystic Fibrosis, COPD",
1926770,CHEMBL3544921,CERLIPONASE ALFA,6922,Polypeptides proteolytic enzyme,PROTEOLYTIC ENZYME,106160.0,CHEMBL2364181,Polypeptides,1,1,1,Cerliponase alfa is activated in the lysosome and the activated proteolytic form of rhTPP1 cleaves tripeptides from the N-terminus of proteins ,
1926775,CHEMBL3544926,OBILTOXAXIMAB,5513,Protective antigen binding agent,BINDING AGENT,101164.0,CHEMBL5352,Protective antigen,1,1,1,,
1926820,CHEMBL3544971,DEXTROAMPHETAMINE SULFATE,695,Dopamine transporter releasing agent,RELEASING AGENT,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
1926820,CHEMBL3544971,DEXTROAMPHETAMINE SULFATE,893,Norepinephrine transporter releasing agent,RELEASING AGENT,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
1926820,CHEMBL3544971,DEXTROAMPHETAMINE SULFATE,1483,Synaptic vesicular amine transporter inhibitor,INHIBITOR,162.0,CHEMBL1893,Synaptic vesicular amine transporter,1,1,1,,
1926822,CHEMBL3544973,CEFTAROLINE FOSAMIL ACETATE,1704,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
1926823,CHEMBL3544974,ASENAPINE MALEATE,204,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
1926823,CHEMBL3544974,ASENAPINE MALEATE,586,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
1926834,CHEMBL3544985,DASABUVIR SODIUM MONOHYDRATE,2341,RNA-directed RNA polymerase inhibitor,INHIBITOR,118447.0,CHEMBL4296320,RNA-directed RNA polymerase,1,1,1,,
1926835,CHEMBL3544986,PERINDOPRIL ARGININE,2399,Angiotensin-converting enzyme inhibitor,INHIBITOR,69.0,CHEMBL1808,Angiotensin-converting enzyme,1,1,1,,
1926837,CHEMBL3544988,DAPRODUSTAT,5811,Hypoxia-inducible factor prolyl hydroxylase inhibitor,INHIBITOR,116860.0,CHEMBL3831261,Hypoxia-inducible factor prolyl hydroxylase,1,1,1,,
1926838,CHEMBL3544989,VOLANESORSEN SODIUM,7588,Apolipoprotein C-III mRNA 3'UTR antisense inhibitor,ANTISENSE INHIBITOR,118788.0,CHEMBL4495602,Apolipoprotein C-III mRNA 3'UTR,1,1,1,"Antisense oligonucleotide that binds to the 3-UTR of apoC-III mRNA causing it's degradation. Inhibits production of apoC-III, a regulator of triglyceride metabolism/hepatic clearance of triglyceride-rich lipoproteins, enhancing triglyceride clearance.",
1926845,CHEMBL3544996,IDARUCIZUMAB,2413,Dabigatran sequestering agent,SEQUESTERING AGENT,109706.0,CHEMBL3545433,Dabigatran,1,1,1,,
1926906,CHEMBL3545057,ACETYLDIGITOXIN,1586,Sodium/potassium-transporting ATPase inhibitor,INHIBITOR,104770.0,CHEMBL2095186,Sodium/potassium-transporting ATPase,1,1,1,,
1926907,CHEMBL3545058,DEXTROTHYROXINE SODIUM,1300,Thyroid hormone receptor agonist,AGONIST,104987.0,CHEMBL2111462,Thyroid hormone receptor,1,1,1,,
1926908,CHEMBL3545059,ALISKIREN FUMARATE,640,Renin inhibitor,INHIBITOR,11225.0,CHEMBL286,Renin,1,1,1,,
1926909,CHEMBL3545060,ERYTHROMYCIN GLUCEPTATE,1760,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
1926911,CHEMBL3545062,VELPATASVIR,6156,Nonstructural protein 5A inhibitor,INHIBITOR,108438.0,CHEMBL3307224,Nonstructural protein 5A,1,1,1,,
1926912,CHEMBL3545063,OSIMERTINIB MESYLATE,2424,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,"Binds irreversibly to certain mutant forms of EGFR (T790M, L858R, and exon 19 deletion)",
1926917,CHEMBL3545068,COPANLISIB HYDROCHLORIDE,6902,PI3-kinase p110-alpha subunit inhibitor,INHIBITOR,11362.0,CHEMBL4005,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",1,1,1,,
1926917,CHEMBL3545068,COPANLISIB HYDROCHLORIDE,7253,PI3-kinase p110-delta subunit inhibitor,INHIBITOR,11177.0,CHEMBL3130,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",1,1,1,,
1926959,CHEMBL3545110,RIBOCICLIB,5296,Cyclin-dependent kinase 4 inhibitor,INHIBITOR,12946.0,CHEMBL331,Cyclin-dependent kinase 4,1,1,1,,
1926959,CHEMBL3545110,RIBOCICLIB,5297,Cyclin-dependent kinase 6 inhibitor,INHIBITOR,10480.0,CHEMBL2508,Cyclin-dependent kinase 6,1,1,1,,
1926972,CHEMBL3545123,PIBRENTASVIR,6913,Nonstructural protein 5A inhibitor,INHIBITOR,108438.0,CHEMBL3307224,Nonstructural protein 5A,1,1,1,,
1926980,CHEMBL3545131,ISATUXIMAB,6401,Lymphocyte differentiation antigen CD38 inhibitor,INHIBITOR,100622.0,CHEMBL4660,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1,1,1,,
1926981,CHEMBL3545132,MIRVETUXIMAB SORAVTANSINE,6356,Folate receptor alpha binding agent,BINDING AGENT,10103.0,CHEMBL2121,Folate receptor alpha,1,1,1,,
1926981,CHEMBL3545132,MIRVETUXIMAB SORAVTANSINE,6438,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,,
1927030,CHEMBL3545181,TIOTROPIUM BROMIDE,37,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for COPD, M3 likely responsible",
1927032,CHEMBL3545183,ETELCALCETIDE HYDROCHLORIDE,9815,Calcium sensing receptor agonist,AGONIST,282.0,CHEMBL1878,Extracellular calcium-sensing receptor,1,1,1,Peptide,
1927033,CHEMBL3545184,ETELCALCETIDE,5409,Calcium sensing receptor agonist,AGONIST,282.0,CHEMBL1878,Extracellular calcium-sensing receptor,1,1,1,Peptide,
1927034,CHEMBL3545185,SELINEXOR,5815,Exportin-1 inhibitor,INHIBITOR,101280.0,CHEMBL5661,Exportin-1,1,1,1,,
1927038,CHEMBL3545189,LANADELUMAB,7047,Plasma kallikrein inhibitor,INHIBITOR,23.0,CHEMBL2000,Plasma kallikrein,1,1,1,,
1927040,CHEMBL3545191,EVINACUMAB,6437,Angiopoietin-related protein 3 inhibitor,INHIBITOR,112446.0,CHEMBL3710485,Angiopoietin-related protein 3,1,1,1,,
1927101,CHEMBL3545252,DOCETAXEL,1103,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,,
1927111,CHEMBL3545262,SACITUZUMAB GOVITECAN,6419,Tumor-associated calcium signal transducer 2 binding agent,BINDING AGENT,116939.0,CHEMBL3856163,Tumor-associated calcium signal transducer 2,1,1,1,,
1927111,CHEMBL3545262,SACITUZUMAB GOVITECAN,7646,DNA topoisomerase I inhibitor,INHIBITOR,62.0,CHEMBL1781,DNA topoisomerase 1,1,1,1,"Binds TROP-2 on cancer cells and is internalised. Hydrolysis of the linker releases SN-38, a topoisomerase I inhibitor, that causes DNA damage and cell death.",
1927158,CHEMBL3545309,LEFAMULIN ACETATE,7447,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,Antibacterial. Interacts with the bacterial ribosome and functions as a bacterial protein synthesis inhibitor.,"Indicated for infections caused by Streptococcus pneumoniae, Staphylococcus aureus (methicillin-susceptible isolates), Haemophilus influenzae, Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydophila pneumoniae.
Also active against Staphylococcus aureus (methicillin-resistant isolates) Streptococcus agalactiae, Streptococcus anginosus, Streptococcus mitis, Streptococcus pyogenes, Streptococcus salivarius, Haemophilus parainfluenzae and Moraxella catarrhalis but not validated for these bacteria in clinical trials."
1927160,CHEMBL3545311,BRIGATINIB,4622,ALK tyrosine kinase receptor inhibitor,INHIBITOR,100417.0,CHEMBL4247,ALK tyrosine kinase receptor,1,1,1,Inhibits ALK and EGFR gatekeeper mutants. Does not inhibit wild type (native) EGFR.,
1927160,CHEMBL3545311,BRIGATINIB,4623,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,Inhibits ALK and EGFR gatekeeper mutants. Does not inhibit wild type (native) EGFR.,
1927162,CHEMBL3545313,BEMPEDOIC ACID,7480,ATP-citrate synthase inhibitor,INHIBITOR,12028.0,CHEMBL3720,ATP-citrate synthase,1,1,1,"Bempedoic acid is activated to a CoA-ester that inhibits ACL. ACL is upstream of HMG-CoA, an enzyme involved in the cholesterol biosynthesis pathway. Overall, bempedoic acid lowers low-density lipoprotein cholesterol by inhibition of cholesterol synthesis in the liver.",
1927212,CHEMBL3545363,GLECAPREVIR,6908,"Hepatitis C virus serine protease, NS3/NS4A inhibitor",INHIBITOR,104803.0,CHEMBL2095231,"Hepatitis C virus serine protease, NS3/NS4A",1,1,1,,
1927216,CHEMBL3545367,LEMBOREXANT,4996,Orexin receptor 1 antagonist,ANTAGONIST,10009.0,CHEMBL5113,Orexin/Hypocretin receptor type 1,1,1,1,,
1927216,CHEMBL3545367,LEMBOREXANT,4997,Orexin receptor 2 antagonist,ANTAGONIST,12968.0,CHEMBL4792,Orexin receptor type 2,1,1,1,,
1927217,CHEMBL3545368,PANOBINOSTAT LACTATE,2340,Histone deacetylase inhibitor,INHIBITOR,104681.0,CHEMBL2093865,Histone deacetylase,1,1,1,,
1927225,CHEMBL3545376,ERDAFITINIB,7379,Fibroblast growth factor receptor inhibitor,INHIBITOR,104793.0,CHEMBL2095217,Fibroblast growth factor receptor,1,1,1,Inhibits FGFR phosphorylation and signalling which decreases viability in cells with abnormal FGFR. ,"Active against FGFR1, FGFR2, FGFR3 and FGFR4. Also binds to RET, CSF1R, PDGFRA, PDGFRB, FLT4, KIT and VEGFR2. "
1927281,CHEMBL3545432,IXAZOMIB CITRATE,2426,26S proteasome inhibitor,INHIBITOR,106197.0,CHEMBL2364701,26S proteasome,1,1,1,Prodrug of ixazomib,
1941483,CHEMBL3559672,RAUWOLFIA SERPENTINA,1238,Adrenergic receptor alpha antagonist,ANTAGONIST,104787.0,CHEMBL2095203,Adrenergic receptor alpha,1,1,1,,
1951344,CHEMBL3590187,CLASCOTERONE,4561,Androgen Receptor antagonist,ANTAGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
462435,CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,102,DNA topoisomerase II alpha inhibitor,INHIBITOR,63.0,CHEMBL1806,DNA topoisomerase 2-alpha,1,1,1,,
462435,CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,1878,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
2080,CHEMBL36,PYRIMETHAMINE,453,Dihydrofolate reductase inhibitor,INHIBITOR,70.0,CHEMBL1939,Bifunctional dihydrofolate reductase-thymidylate synthase,1,1,1,,
1959536,CHEMBL3608680,FEZOLINETANT,7929,Neurokinin 3 receptor antagonist,ANTAGONIST,10982.0,CHEMBL4429,Neuromedin-K receptor,1,1,1,,
314132,CHEMBL361506,PENTAMIDINE ISETHIONATE,1935,DNA inhibitor,INHIBITOR,106219.0,CHEMBL2366046,DNA,1,1,1,,
314132,CHEMBL361506,PENTAMIDINE ISETHIONATE,1936,Kinetoplast DNA inhibitor,INHIBITOR,106220.0,CHEMBL2366047,Kinetoplast DNA,1,1,1,"Binds DNA, concentrated in kinetoplast",
302297,CHEMBL361812,RAMATROBAN,7522,G protein-coupled receptor 44 antagonist,ANTAGONIST,20174.0,CHEMBL5071,Prostaglandin D2 receptor 2,1,1,1,,
302297,CHEMBL361812,RAMATROBAN,7561,Thromboxane A2 receptor antagonist,ANTAGONIST,246.0,CHEMBL2069,Thromboxane A2 receptor,1,1,1,,
328286,CHEMBL363392,MARALIXIBAT,7695,Ileal bile acid transporter inhibitor,INHIBITOR,12909.0,CHEMBL2778,Ileal sodium/bile acid cotransporter,1,1,1,,
1976141,CHEMBL3643413,LENIOLISIB,8305,PI3-kinase p110-delta subunit inhibitor,INHIBITOR,11177.0,CHEMBL3130,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",1,1,1,,
1978977,CHEMBL3646221,VADADUSTAT,7671,Egl nine homolog 1 inhibitor,INHIBITOR,101502.0,CHEMBL5697,Egl nine homolog 1,1,1,1,May exert its effect on renal anemia by increasing Hb via activation of the HIF pathway. Active against PHD1-3 but activity against PHD2 may be the most significant for the therapeutic effect.,
1978977,CHEMBL3646221,VADADUSTAT,7672,Egl nine homolog 3 inhibitor,INHIBITOR,101510.0,CHEMBL5705,Prolyl hydroxylase EGLN3,1,1,1,May exert its effect on renal anemia by increasing Hb via activation of the HIF pathway. Active against PHD1-3 but activity against PHD2 may be the most significant for the therapeutic effect.,
1978977,CHEMBL3646221,VADADUSTAT,7673,Hypoxia-inducible factor prolyl hydroxylase 1 inhibitor,INHIBITOR,10857.0,CHEMBL3028,Prolyl hydroxylase EGLN2,1,1,1,May exert its effect on renal anemia by increasing Hb via activation of the HIF pathway. Active against PHD1-3 but activity against PHD2 may be the most significant for the therapeutic effect.,
1987927,CHEMBL3655081,ABROCITINIB,4318,Tyrosine-protein kinase JAK1 inhibitor,INHIBITOR,10919.0,CHEMBL2835,Tyrosine-protein kinase JAK1,1,1,1,,
2000990,CHEMBL3668014,LINZAGOLIX,5054,Gonadotropin-releasing hormone receptor antagonist,ANTAGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,,
2034550,CHEMBL3701238,FUTIBATINIB,8365,Fibroblast growth factor receptor inhibitor,INHIBITOR,104793.0,CHEMBL2095217,Fibroblast growth factor receptor,1,1,1,Covalent inhibitor,
2039153,CHEMBL3707183,QUINIDINE SULFATE,1965,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
2039194,CHEMBL3707223,SOFPIRONIUM BROMIDE,7706,Muscarinic acetylcholine receptor inhibitor,INHIBITOR,104691.0,CHEMBL2094109,Muscarinic acetylcholine receptor,1,1,1,,
2039197,CHEMBL3707226,DEFIBROTIDE SODIUM,5521,Plasminogen activator,ACTIVATOR,12.0,CHEMBL1801,Plasminogen,1,1,1,,
2039198,CHEMBL3707227,ATEZOLIZUMAB,5518,Programmed cell death 1 ligand 1 inhibitor,INHIBITOR,109807.0,CHEMBL3580522,Programmed cell death 1 ligand 1,1,1,1,,
2039200,CHEMBL3707229,TEZEPELUMAB,6432,Thymic stromal lymphopoietin inhibitor,INHIBITOR,114892.0,CHEMBL3712931,Thymic stromal lymphopoietin,1,1,1,,
2039200,CHEMBL3707229,TEZEPELUMAB,6433,Thymic stromal lymphopoietin inhibitor,INHIBITOR,114892.0,CHEMBL3712931,Thymic stromal lymphopoietin,1,1,1,,
2039214,CHEMBL3707243,GLYCOPYRRONIUM TOSYLATE,9683,Muscarinic acetylcholine receptor inhibitor,INHIBITOR,104691.0,CHEMBL2094109,Muscarinic acetylcholine receptor,1,1,1,,
2039217,CHEMBL3707246,OZANIMOD HYDROCHLORIDE,7466,Sphingosine 1-phosphate receptor Edg-1 modulator,MODULATOR,11631.0,CHEMBL4333,Sphingosine 1-phosphate receptor 1,1,1,1,The mechanism by which ozanimod exerts therapeutic effects in multiple sclerosis is unknown but Ozanimod treatment reduces lymphocytes in peripheral blood and their migration into the central nervous system,Binds with high affinity to S1P receptors 1 and 5.
2039218,CHEMBL3707247,OZANIMOD,10122,Sphingosine 1-phosphate receptor 5 modulator,MODULATOR,12023.0,CHEMBL2274,Sphingosine 1-phosphate receptor 5,1,1,1,,
2039219,CHEMBL3707248,VALBENAZINE TOSYLATE,6919,Synaptic vesicular amine transporter inhibitor,INHIBITOR,162.0,CHEMBL1893,Synaptic vesicular amine transporter,1,1,1,,
2039237,CHEMBL3707266,RIBOCICLIB SUCCINATE,6161,Cyclin-dependent kinase 4 inhibitor,INHIBITOR,12946.0,CHEMBL331,Cyclin-dependent kinase 4,1,1,1,,
2039237,CHEMBL3707266,RIBOCICLIB SUCCINATE,6162,Cyclin-dependent kinase 6 inhibitor,INHIBITOR,10480.0,CHEMBL2508,Cyclin-dependent kinase 6,1,1,1,,
2039246,CHEMBL3707275,VORETIGENE NEPARVOVEC,7493,Retinoid isomerohydrolase exogenous gene,EXOGENOUS GENE,116832.0,CHEMBL3831182,Retinoid isomerohydrolase,1,1,1,Virus vector-based gene therapy that provides a correct copy of the human RPE65 gene.,
2039247,CHEMBL3707276,VOSORITIDE,8470,Atrial natriuretic peptide receptor B binding agent,BINDING AGENT,10708.0,CHEMBL1795,Atrial natriuretic peptide receptor 2,1,1,1,,
2039261,CHEMBL3707290,SOMAPACITAN,7732,Growth hormone receptor agonist,AGONIST,60.0,CHEMBL1976,Growth hormone receptor,1,1,1,,
2039281,CHEMBL3707310,LOTILANER,9766,Ectoparasiticide,,,,,1,1,1,Approved veterinary. Inhibits gammaaminobutyric acid (GABA)-gated chloride channels in ticks/fleas.,"Active against fleas (Ctenocephalides felis and Ctenocephalides canis) and tick species Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus and Rhipicephalus sanguineus."
2039284,CHEMBL3707313,TRIFAROTENE,7445,Retinoic acid receptor gamma agonist,AGONIST,240.0,CHEMBL2003,Retinoic acid receptor gamma,1,1,1,"Activation of RAR has downstream effects including anti-inflammatory effects. However, the precise role in alleviating acne is unknown.
The gamma subtype is most relevant to acne.","Most active at the gamma subtype, > 20-fold selectivity over RAR alpha and RAR beta."
2039285,CHEMBL3707314,METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA,7537,Erythropoietin receptor agonist,AGONIST,201.0,CHEMBL1817,Erythropoietin receptor,1,1,1,"Supplements levels of the natural hormone erythropoietin and stimulates the production of red blood cells. Anemia is caused by a deficiency of red blood cells. The PEGylated protein is a continuous erythropoietin receptor activator with a slower association and faster dissociation from the receptor, increased in vivo activity and an increased in vivo half-life compared to erythropoietin.",
2039291,CHEMBL3707320,ALECTINIB HYDROCHLORIDE,2431,ALK tyrosine kinase receptor inhibitor,INHIBITOR,100417.0,CHEMBL4247,ALK tyrosine kinase receptor,1,1,1,,
2039291,CHEMBL3707320,ALECTINIB HYDROCHLORIDE,2432,Tyrosine-protein kinase receptor RET inhibitor,INHIBITOR,100079.0,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,1,1,1,,
2039291,CHEMBL3707320,ALECTINIB HYDROCHLORIDE,8634,EML4-ALK inhibitor,INHIBITOR,117043.0,CHEMBL3883330,EML4-ALK,1,1,1,,
2039293,CHEMBL3707322,LETIBOTULINUMTOXINA,9939,Synaptosomal nerve-associated protein 25 (SNAP-25) hydrolytic enzyme,HYDROLYTIC ENZYME,106138.0,CHEMBL2364159,Synaptosomal-associated protein 25,1,1,1,,
2039297,CHEMBL3707326,BUROSUMAB,5951,Fibroblast growth factor 23 inhibitor,INHIBITOR,115874.0,CHEMBL3713913,Fibroblast growth factor 23,1,1,1,,
2039299,CHEMBL3707328,GALCANEZUMAB,6399,Calcitonin gene-related peptide inhibitor,INHIBITOR,116903.0,CHEMBL3832947,Calcitonin gene-related peptide,1,1,1,,
2039301,CHEMBL3707330,ROLAPITANT HYDROCHLORIDE,2406,Neurokinin 1 receptor antagonist,ANTAGONIST,250.0,CHEMBL249,Substance-P receptor,1,1,1,,
2039319,CHEMBL3707348,ACALABRUTINIB,6899,Tyrosine-protein kinase BTK inhibitor,INHIBITOR,100097.0,CHEMBL5251,Tyrosine-protein kinase BTK,1,1,1,,
2039328,CHEMBL3707357,BROLUCIZUMAB,5949,Vascular endothelial growth factor A inhibitor,INHIBITOR,187.0,CHEMBL1783,"Vascular endothelial growth factor A, long form",1,1,1,,Binds to all isoforms of VEGF-A including VEGF165.
2039329,CHEMBL3707358,OLIPUDASE ALFA,9062,Sphingomyelin hydrolytic enzyme,HYDROLYTIC ENZYME,120064.0,CHEMBL4662961,Sphingomyelin,1,1,1,,
2039330,CHEMBL3707359,DAXIBOTULINUMTOXINA,8916,Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor,INHIBITOR,106138.0,CHEMBL2364159,Synaptosomal-associated protein 25,1,1,1,,
2039343,CHEMBL3707372,VOXILAPREVIR,6920,"Hepatitis C virus serine protease, NS3/NS4A inhibitor",INHIBITOR,104803.0,CHEMBL2095231,"Hepatitis C virus serine protease, NS3/NS4A",1,1,1,,
2039348,CHEMBL3707377,SEGESTERONE ACETATE,7395,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,Suppresses ovulation.,
2039353,CHEMBL3707382,VESTRONIDASE ALFA,7690,Glycosaminoglycans hydrolytic enzyme,HYDROLYTIC ENZYME,117301.0,CHEMBL3991481,Glycosaminoglycans,1,1,1,Lysosomal beta glucuronidase enzyme replacement. Reduces the build-up of glycosaminoglycans due to a deficiency in endogenous lysosomal beta glucuronidase.,
2039364,CHEMBL3707393,OSILODROSTAT PHOSPHATE,7465,Cytochrome P450 11B1 inhibitor,INHIBITOR,76.0,CHEMBL1908,"Cytochrome P450 11B1, mitochondrial",1,1,1,"Inhibits 11beta-hydroxylase (CYP11B1), the enzyme responsible for the final step of cortisol biosynthesis in the adrenal gland (IC50 2.5  0.1 nM in a cell-line assay).",
2039366,CHEMBL3707395,ELAFIBRANOR,8049,Peroxisome proliferator-activated receptor alpha agonist,AGONIST,163.0,CHEMBL239,Peroxisome proliferator-activated receptor alpha,1,1,1,,
2039366,CHEMBL3707395,ELAFIBRANOR,8073,Peroxisome proliferator-activated receptor delta agonist,AGONIST,12227.0,CHEMBL3979,Peroxisome proliferator-activated receptor delta,1,1,1,,
2041038,CHEMBL3716057,GEFAPIXANT,5137,P2X purinoceptor 3 antagonist,ANTAGONIST,11904.0,CHEMBL2998,P2X purinoceptor 3,1,1,1,P2RX3 and P2RX2/3 trimers allosteric antagonist,
366860,CHEMBL373742,VASOPRESSIN,2295,Vasopressin receptor agonist,AGONIST,105773.0,CHEMBL2363078,Vasopressin receptor,1,1,1,,
365189,CHEMBL374478,RIFAMPIN,1386,Bacterial DNA-directed RNA polymerase inhibitor,INHIBITOR,106172.0,CHEMBL2364672,Bacterial DNA-directed RNA polymerase,1,1,1,,
366271,CHEMBL374731,TELBIVUDINE,1925,DNA polymerase/reverse transcriptase inhibitor,INHIBITOR,105706.0,CHEMBL2362994,DNA polymerase/reverse transcriptase,1,1,1,,
373970,CHEMBL376140,TIGECYCLINE,1764,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
355917,CHEMBL378544,VINBLASTINE SULFATE,1110,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,,
2077913,CHEMBL3786343,OLMUTINIB,4231,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,EGFR mutant selective including both activating mutations and T790M (PMID: 26508839). Covalent binder (PMID: 27357069).,
2208,CHEMBL38,TRETINOIN,1575,Retinoic acid receptor agonist,AGONIST,105764.0,CHEMBL2363069,Retinoic acid receptor,1,1,1,,
2089491,CHEMBL3813873,PEXIDARTINIB,4796,Macrophage colony stimulating factor receptor inhibitor,INHIBITOR,12840.0,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,1,1,1,Overexpression of the CSF1R ligand promotes tumor cell proliferation which is inhibited by pexidartinib in CSF1R-dependent tumors. Pexidartinib inhibited a CSF1R dependent cell line in vivo.,
2089491,CHEMBL3813873,PEXIDARTINIB,4797,Tyrosine-protein kinase receptor FLT3 inhibitor,INHIBITOR,12670.0,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,1,1,1,,
2089491,CHEMBL3813873,PEXIDARTINIB,4798,Stem cell growth factor receptor inhibitor,INHIBITOR,238.0,CHEMBL1936,Mast/stem cell growth factor receptor Kit,1,1,1,,
332615,CHEMBL382301,ATOSIBAN,6737,Oxytocin receptor antagonist,ANTAGONIST,116.0,CHEMBL2049,Oxytocin receptor,1,1,1,"Atosiban is a synthetic peptide which acts as a competitive antagonist of oxytocin (and vasopressin) at human uterine oxytocin receptors. Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane. As a result, there is reduced release of intracellular, stored calcium from the sarcoplasmic reticulum of myometrial cells, and reduced influx of Ca2+ from the extracellular space through voltage gated channels. As a result there is a rapid inhibition of uterine contractility. In addition, atosiban suppresses oxytocin-mediated release of prostaglandin E and F from the decidua.",
2096358,CHEMBL3833307,SATRALIZUMAB,5973,IL6Ralpha/GP130 antagonist,ANTAGONIST,108122.0,CHEMBL3137266,IL6Ralpha/GP130,1,1,1,It blocks IL-6-mediated signal transduction by inhibiting IL-6 binding to transmembrane and soluble IL-6R.,
2096368,CHEMBL3833317,FERRIC PYROPHOSPHATE CITRATE,7489,Supplement,,,,,1,1,1,Iron replacement product,
2096370,CHEMBL3833319,REVEFENACIN,7356,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,Inhibits the muscarinic M3 receptor leading to bronchodilation.,Similar affinity for muscarinic receptors M1-M5 but bronchodilation mediated via receptor M3.
2096371,CHEMBL3833320,EPTINEZUMAB,5969,Calcitonin gene-related peptide inhibitor,INHIBITOR,116903.0,CHEMBL3832947,Calcitonin gene-related peptide,1,1,1,"Inhibits the calcitonin gene-related peptide, or CGRP, a small protein involved in the transmission of, and heightened sensitivity to, pain experienced in migraine.",Kd <20 pM towards CGRP
2096372,CHEMBL3833321,LECANEMAB,6168,Amyloid-beta A4 protein inhibitor,INHIBITOR,10656.0,CHEMBL2487,Amyloid-beta precursor protein,1,1,1,,selectively binds soluble amyloid  (A) protofibrils
2096380,CHEMBL3833329,ERENUMAB,5970,Calcitonin gene-related peptide type 1 receptor antagonist,ANTAGONIST,19904.0,CHEMBL3798,Calcitonin gene-related peptide type 1 receptor,1,1,1,Binds to the CGRP receptor and inhibits the function of CGRP.,
2096391,CHEMBL3833340,AZTREONAM LYSINE,9816,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
2096393,CHEMBL3833342,NUSINERSEN SODIUM,6160,SMN2 pre-mRNA positive modulator,POSITIVE MODULATOR,116819.0,CHEMBL3826841,SMN2 pre-mRNA,1,1,1,SPINRAZA was shown to increase exon 7 inclusion in SMN2 messenger ribonucleic acid (mRNA) transcripts and production of full-length SMN protein ,
2096393,CHEMBL3833342,NUSINERSEN SODIUM,6932,SMN2 pre-mRNA positive modulator,POSITIVE MODULATOR,116819.0,CHEMBL3826841,SMN2 pre-mRNA,1,1,1,SPINRAZA was shown to increase exon 7 inclusion in SMN2 messenger ribonucleic acid (mRNA) transcripts and production of full-length SMN protein ,
2096397,CHEMBL3833346,TOFERSEN,6172,SOD1 mRNA antisense inhibitor,ANTISENSE INHIBITOR,116921.0,CHEMBL3833461,SOD1 mRNA,1,1,1,Thought to reduce the production of SOD1 protein,
2096404,CHEMBL3833353,PRAMLINTIDE ACETATE,1156,"Amylin receptor AMY1, CALCR/RAMP1 agonist",AGONIST,104908.0,CHEMBL2111189,"Amylin receptor AMY1, CALCR/RAMP1",1,1,1,"Is amylin analogue, calcitonin receptor is binding site",
2096404,CHEMBL3833353,PRAMLINTIDE ACETATE,1157,Amylin receptor AMY3; CALCR/RAMP3 agonist,AGONIST,104909.0,CHEMBL2111190,Amylin receptor AMY3; CALCR/RAMP3,1,1,1,"Is amylin analogue, calcitonin receptor is binding site",
2096404,CHEMBL3833353,PRAMLINTIDE ACETATE,2043,Amylin receptor AMY2; CALCR/RAMP2 agonist,AGONIST,106152.0,CHEMBL2364173,Amylin receptor AMY2; CALCR/RAMP2,1,1,1,"Is amylin analogue, calcitonin receptor is binding site",
2096419,CHEMBL3833368,RUCAPARIB CAMSYLATE,6159,"PARP 1, 2 and 3 inhibitor",INHIBITOR,109545.0,CHEMBL3390820,"PARP 1, 2 and 3",1,1,1,In patients with BRCA mutation,
2096420,CHEMBL3833369,FISH OIL,9738,Supplement,,,,,1,1,1,,
2096424,CHEMBL3833373,AVELUMAB,5967,Programmed cell death 1 ligand 1 other,OTHER,109807.0,CHEMBL3580522,Programmed cell death 1 ligand 1,1,1,1,"Avelumab binds to PD-L1 and prevents the interaction of PD-L1 with its receptor programmed cell death protein 1 (PD-1). This inhibits the activation of PD-1 and its downstream signalling pathways. This results in the activation of cytotoxic T-lymphocytes (CTLs) targeted to PD-L1-overexpressing tumor cells. In addition, avelumab induces an antibody-dependent cellular cytotoxic (ADCC) response against PD-L1-expressing tumor cells.",
2096435,CHEMBL3833384,EFLAPEGRASTIM,9207,Granulocyte colony stimulating factor receptor agonist,AGONIST,207.0,CHEMBL1996,Granulocyte colony-stimulating factor receptor,1,1,1,,
2096444,CHEMBL3833393,EMICIZUMAB,5971,Coagulation factor IX and X other,OTHER,104934.0,CHEMBL2111424,Coagulation factor IX and X,1,1,1,"Binds to and bridges activated factor IX (factor IXa) and factor X, thereby acting as a factor VIIImimetic agent ",Very weak antigen-binding affinity
365281,CHEMBL384467,DEXAMETHASONE,813,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
364520,CHEMBL386630,TESTOSTERONE,1329,Androgen Receptor agonist,AGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
374037,CHEMBL387675,DAPTOMYCIN,1811,Cell membrane inhibitor,INHIBITOR,106010.0,CHEMBL2364031,Cell membrane,1,1,1,It binds to bacterial membranes and causes a rapid depolarization of membrane potential,
56095,CHEMBL38827,LUMEFANTRINE,1004,Ferriprotoporphyrin IX inhibitor,INHIBITOR,100262.0,CHEMBL613897,Ferriprotoporphyrin IX,1,1,1,,
374182,CHEMBL388590,BENZBROMARONE,6472,Solute carrier family 22 member 12 inhibitor,INHIBITOR,102767.0,CHEMBL6120,Solute carrier family 22 member 12,1,1,1,Benzbromarone acts by suppressing uric acid reabsorption via inhibition of the uric acid transporter 1 (URAT1) in renal tubular cells. Benzbromarone (BBR) is an inhibitor of Fatty acid-binding protein 4 (FABP4). This indicates that BBR might be a new potential therapeutic agent for type 2 diabetes. Benzbromarone is a very potent inhibitor of CYP2C9.,
2099025,CHEMBL3889654,LAROTRECTINIB,4261,Neurotrophic tyrosine kinase receptor inhibitor,INHIBITOR,109739.0,CHEMBL3559684,Neurotrophic tyrosine kinase receptor,1,1,1,,
2104231,CHEMBL3894860,TRILACICLIB,4498,Cyclin-dependent kinase 4 inhibitor,INHIBITOR,12946.0,CHEMBL331,Cyclin-dependent kinase 4,1,1,1,,
2104231,CHEMBL3894860,TRILACICLIB,4499,Cyclin-dependent kinase 6 inhibitor,INHIBITOR,10480.0,CHEMBL2508,Cyclin-dependent kinase 6,1,1,1,,
2104231,CHEMBL3894860,TRILACICLIB,7894,Cyclin-dependent kinase 4 inhibitor,INHIBITOR,12946.0,CHEMBL331,Cyclin-dependent kinase 4,1,1,1,Myeloprotection therapy,
2104231,CHEMBL3894860,TRILACICLIB,7895,Cyclin-dependent kinase 6 inhibitor,INHIBITOR,10480.0,CHEMBL2508,Cyclin-dependent kinase 6,1,1,1,Myeloprotection therapy,
374052,CHEMBL389621,HYDROCORTISONE,765,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
407354,CHEMBL393220,ATORVASTATIN CALCIUM,1058,HMG-CoA reductase inhibitor,INHIBITOR,24.0,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,1,1,1,,
2146132,CHEMBL3936761,ZANUBRUTINIB,7458,Tyrosine-protein kinase BTK inhibitor,INHIBITOR,100097.0,CHEMBL5251,Tyrosine-protein kinase BTK,1,1,1,Forms an active site covalent bond with the target kinase. Inhibition of BTK on B-cells impacts downstream signalling effects such as B-cell proliferation.,
2150261,CHEMBL3940890,ACORAMIDIS,8153,Transthyretin stabiliser,STABILISER,12704.0,CHEMBL3194,Transthyretin,1,1,1,,
390556,CHEMBL395091,ESKETAMINE,5581,Glutamate [NMDA] receptor negative allosteric modulator,NEGATIVE ALLOSTERIC MODULATOR,104706.0,CHEMBL2094124,Glutamate [NMDA] receptor,1,1,1,Noncompetitive binding to NMDA glutamate receptors,NMDA subtype non-selective 
392195,CHEMBL395429,OXYTOCIN,844,Oxytocin receptor agonist,AGONIST,116.0,CHEMBL2049,Oxytocin receptor,1,1,1,,
388574,CHEMBL396778,SAFINAMIDE,5725,Monoamine oxidase B inhibitor,INHIBITOR,104.0,CHEMBL2039,Amine oxidase [flavin-containing] B,1,1,1,Highly selective and reversible MAO-B inhibitor ,
416772,CHEMBL398435,TICAGRELOR,1503,Purinergic receptor P2Y12 negative allosteric modulator,NEGATIVE ALLOSTERIC MODULATOR,176.0,CHEMBL2001,P2Y purinoceptor 12,1,1,1,,
2196851,CHEMBL3988900,ZINC OXIDE,8335,Sunscreen/skin protectant,,,,,1,1,1,,
2197272,CHEMBL3989401,PAMIDRONATE DISODIUM,1051,Farnesyl diphosphate synthase inhibitor,INHIBITOR,71.0,CHEMBL1782,Farnesyl pyrophosphate synthase,1,1,1,"Binds to the bone matrix (hydroxyapatite), and when the bone starts to be reabsorbed the compound is released and taken up by osteoclasts, inhibiting protein prenylation of the GTPases involved in the formation of the ruffled border",
2197273,CHEMBL3989402,PERAMIVIR,2333,Neuraminidase inhibitor,INHIBITOR,10738.0,CHEMBL3377,Neuraminidase,1,1,1,,
2197273,CHEMBL3989402,PERAMIVIR,2334,Neuraminidase inhibitor,INHIBITOR,21.0,CHEMBL2051,Neuraminidase,1,1,1,,
2197277,CHEMBL3989406,ENALAPRILAT,109,Angiotensin-converting enzyme inhibitor,INHIBITOR,69.0,CHEMBL1808,Angiotensin-converting enzyme,1,1,1,,
2197279,CHEMBL3989408,IBUPROFEN SODIUM,1171,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
2197281,CHEMBL3989410,INDOMETHACIN SODIUM,1199,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
2197349,CHEMBL3989478,THIETHYLPERAZINE MALEATE,192,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
2197378,CHEMBL3989507,EDETATE DISODIUM,2182,Calcium chelating agent,CHELATING AGENT,106009.0,CHEMBL2364030,Calcium,1,1,1,Divalent and Trivalent metal chelating agent. Removes Ca2+ in case of hypercalciemia,
2197380,CHEMBL3989509,PENTAZOCINE LACTATE,333,Sigma opioid receptor modulator,MODULATOR,11272.0,CHEMBL287,Sigma non-opioid intracellular receptor 1,1,1,1,Mixed agonist/antagonist,
2197381,CHEMBL3989510,PENTAZOCINE HYDROCHLORIDE,334,Sigma opioid receptor modulator,MODULATOR,11272.0,CHEMBL287,Sigma non-opioid intracellular receptor 1,1,1,1,Mixed agonist/antagonist,
2197385,CHEMBL3989514,IRINOTECAN HYDROCHLORIDE,54,DNA topoisomerase I inhibitor,INHIBITOR,62.0,CHEMBL1781,DNA topoisomerase 1,1,1,1,,
2197386,CHEMBL3989515,PENICILLIN G BENZATHINE,1728,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
2197387,CHEMBL3989516,FOSTAMATINIB DISODIUM,7349,Tyrosine-protein kinase SYK inhibitor,INHIBITOR,10906.0,CHEMBL2599,Tyrosine-protein kinase SYK,1,1,1,Inhibits signalling in FC-activating and B-cell receptors.,
2197390,CHEMBL3989519,DOXAPRAM HYDROCHLORIDE,2049,Potassium channel subfamily K member 3 blocker,BLOCKER,105602.0,CHEMBL2321613,Potassium channel subfamily K member 3,1,1,1,,
2197390,CHEMBL3989519,DOXAPRAM HYDROCHLORIDE,2055,Potassium channel subfamily K member 9 blocker,BLOCKER,105603.0,CHEMBL2321614,Potassium channel subfamily K member 9,1,1,1,,
2197391,CHEMBL3989520,HISTAMINE PHOSPHATE,154,Histamine H1 receptor agonist,AGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,Positive control for allegy test,
2197392,CHEMBL3989521,ISOPROTERENOL SULFATE,1123,Adrenergic receptor beta agonist,AGONIST,104700.0,CHEMBL2094118,Adrenergic receptor beta,1,1,1,,
2197400,CHEMBL3989529,ETHANOLAMINE OLEATE,1808,Calcium chelating agent,CHELATING AGENT,106009.0,CHEMBL2364030,Calcium,1,1,1,,
2197422,CHEMBL3989551,LINCOMYCIN HYDROCHLORIDE,2066,70S ribosome inhibitor,INHIBITOR,105832.0,CHEMBL2363853,70S ribosome,1,1,1,"Indicated for Staphylococcus aureus, Streptococcus pneumoniae",
2197426,CHEMBL3989555,MECLIZINE HYDROCHLORIDE,153,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
2197427,CHEMBL3989556,REMOXIPRIDE HYDROCHLORIDE,6295,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,"Remoxipride binds specifically to the D2 receptor and has little affinity for other central receptors e.g. adrenergic, muscarinic and 5-HT receptors. Therefore, the incidence of adverse effects is less than with other antipsychotics. Dopamine binding to the D2 receptor inhibits the prolactin release from the pituitary into plasma, and therefore, D2 antagonism induces its release.",
2197430,CHEMBL3989559,PANTOPRAZOLE SODIUM,1084,Potassium-transporting ATPase inhibitor,INHIBITOR,104758.0,CHEMBL2095173,Potassium-transporting ATPase,1,1,1,,
2197433,CHEMBL3989562,TERAZOSIN HYDROCHLORIDE,1170,Adrenergic receptor alpha-1 antagonist,ANTAGONIST,104723.0,CHEMBL2094251,Adrenergic receptor alpha-1,1,1,1,,
2197435,CHEMBL3989564,TOBRAMYCIN SULFATE,2072,70S ribosome inhibitor,INHIBITOR,106001.0,CHEMBL2364022,70S ribosome,1,1,1,,
2197437,CHEMBL3989566,METOPROLOL FUMARATE,324,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
2197438,CHEMBL3989567,OXACILLIN SODIUM,1736,Penicillin-binding protein inhibitor,INHIBITOR,105685.0,CHEMBL2362972,Penicillin-binding protein,1,1,1,,
2197439,CHEMBL3989568,OXYTETRACYCLINE CALCIUM,1754,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
2197440,CHEMBL3989569,IBANDRONATE SODIUM,1050,Farnesyl diphosphate synthase inhibitor,INHIBITOR,71.0,CHEMBL1782,Farnesyl pyrophosphate synthase,1,1,1,"Binds to the bone matrix (hydroxyapatite), and when the bone starts to be reabsorbed the compound is released and taken up by osteoclasts, inhibiting protein prenylation of the GTPases involved in the formation of the ruffled border",
2197442,CHEMBL3989571,SPECTINOMYCIN HYDROCHLORIDE,1784,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
2197547,CHEMBL3989676,OXYPHENBUTAZONE,1184,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
2197548,CHEMBL3989677,HYDROCODONE BITARTRATE,1099,Opioid receptors; mu/kappa/delta agonist,AGONIST,104765.0,CHEMBL2095181,Opioid receptors; mu/kappa/delta,1,1,1,,
2197549,CHEMBL3989678,PIPERAZINE CITRATE,1395,Nematode GABA-A receptor positive modulator,POSITIVE MODULATOR,106176.0,CHEMBL2364676,Nematode GABA-A receptor,1,1,1,,
2197562,CHEMBL3989691,ELTROMBOPAG OLAMINE,306,Thrombopoietin receptor agonist,AGONIST,265.0,CHEMBL1864,Thrombopoietin receptor,1,1,1,,
2197564,CHEMBL3989693,LEVALBUTEROL TARTRATE,1348,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
2197565,CHEMBL3989694,OLANZAPINE PAMOATE,595,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
2197565,CHEMBL3989694,OLANZAPINE PAMOATE,621,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
2197565,CHEMBL3989694,OLANZAPINE PAMOATE,2008,D2-like dopamine receptor antagonist,ANTAGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
2197566,CHEMBL3989695,REGADENOSON,668,Adenosine A2a receptor agonist,AGONIST,252.0,CHEMBL251,Adenosine receptor A2a,1,1,1,,
2197569,CHEMBL3989698,TRANYLCYPROMINE SULFATE,1244,Monoamine oxidase inhibitor,INHIBITOR,104789.0,CHEMBL2095205,Monoamine oxidase,1,1,1,,
2197586,CHEMBL3989715,MUPIROCIN CALCIUM,563,Isoleucyl-tRNA synthetase inhibitor,INHIBITOR,139.0,CHEMBL1982,Isoleucine--tRNA ligase,1,1,1,,
2197586,CHEMBL3989715,MUPIROCIN CALCIUM,1670,Isoleucyl-tRNA synthetase inhibitor,INHIBITOR,106171.0,CHEMBL2364671,Isoleucine--tRNA ligase,1,1,1,,
2197587,CHEMBL3989716,PROPOXYPHENE NAPSYLATE,715,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
2197595,CHEMBL3989724,FLURAZEPAM HYDROCHLORIDE,1626,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
2197611,CHEMBL3989740,DOXYCYCLINE HYCLATE,968,Matrix metalloproteinase 7 inhibitor,INHIBITOR,12738.0,CHEMBL4073,Matrilysin,1,1,1,"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation",
2197611,CHEMBL3989740,DOXYCYCLINE HYCLATE,980,Matrix metalloproteinase 8 inhibitor,INHIBITOR,11110.0,CHEMBL4588,Neutrophil collagenase,1,1,1,"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation",
2197611,CHEMBL3989740,DOXYCYCLINE HYCLATE,983,Matrix metalloproteinase 13 inhibitor,INHIBITOR,11024.0,CHEMBL280,Collagenase 3,1,1,1,"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation",
2197611,CHEMBL3989740,DOXYCYCLINE HYCLATE,988,Matrix metalloproteinase-1 inhibitor,INHIBITOR,13000.0,CHEMBL332,Interstitial collagenase,1,1,1,"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation",
2197611,CHEMBL3989740,DOXYCYCLINE HYCLATE,7259,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
2197622,CHEMBL3989751,NEOMYCIN,8922,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
2197625,CHEMBL3989754,FLURBIPROFEN SODIUM,1186,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
2197637,CHEMBL3989766,ORITAVANCIN DIPHOSPHATE,2280,Peptidoglycan inhibitor,INHIBITOR,107948.0,CHEMBL3041361,Peptidoglycan,1,1,1,,
2197638,CHEMBL3989767,CALCITONIN SALMON,217,Calcitonin receptor agonist,AGONIST,119.0,CHEMBL1832,Calcitonin receptor,1,1,1,,
2197639,CHEMBL3989768,LEVORPHANOL TARTRATE,720,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
2197640,CHEMBL3989769,NEOMYCIN SULFATE,1785,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
2197648,CHEMBL3989777,TRIENTINE HYDROCHLORIDE,1560,Copper chelating agent,CHELATING AGENT,105752.0,CHEMBL2363057,Copper,1,1,1,,
2197669,CHEMBL3989798,FORMOTEROL FUMARATE,1349,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,Long acting,
2197674,CHEMBL3989803,DIPYRONE,6238,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,"The pharmacologically active dipyrone metabolite, 4-methylamino-antipyrine (MAA), targets the initiation of the catalytic reaction of both COX isoforms by reducing the higher oxidation states of COX or sequestering activating peroxides. It does not compete with arachidonic acid for the catalytic site of COX. Instead it binds to the Fe3+ in the haem. In the next step, the Fe3+ is reduced and an MAA radical is formed.",
2197691,CHEMBL3989820,ZOLPIDEM TARTRATE,1632,GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,105087.0,CHEMBL2111392,GABA A receptor alpha-1/beta-1/gamma-2,1,1,1,,
2197692,CHEMBL3989821,TUBOCURARINE CHLORIDE,1539,Muscle-type nicotinic acetylcholine receptor antagonist,ANTAGONIST,105709.0,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,1,1,1,,
2197694,CHEMBL3989823,VIOMYCIN SULFATE,2069,70S ribosome inhibitor,INHIBITOR,105944.0,CHEMBL2363965,70S ribosome,1,1,1,,
2197695,CHEMBL3989824,THIOTHIXENE HYDROCHLORIDE,213,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
2197695,CHEMBL3989824,THIOTHIXENE HYDROCHLORIDE,609,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
2197697,CHEMBL3989826,OXYCODONE TEREPHTHALATE,705,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
2197700,CHEMBL3989829,NETILMICIN SULFATE,1772,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
2197701,CHEMBL3989830,SIBUTRAMINE HYDROCHLORIDE,1569,Monoamine transporter inhibitor,INHIBITOR,105759.0,CHEMBL2363064,Monoamine transporter,1,1,1,,
2197704,CHEMBL3989833,ZIPRASIDONE MESYLATE,613,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
2197704,CHEMBL3989833,ZIPRASIDONE MESYLATE,630,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
2197704,CHEMBL3989833,ZIPRASIDONE MESYLATE,2030,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
2197715,CHEMBL3989844,DEXTROAMPHETAMINE SACCHARATE,696,Dopamine transporter releasing agent,RELEASING AGENT,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
2197715,CHEMBL3989844,DEXTROAMPHETAMINE SACCHARATE,894,Norepinephrine transporter releasing agent,RELEASING AGENT,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
2197715,CHEMBL3989844,DEXTROAMPHETAMINE SACCHARATE,1482,Synaptic vesicular amine transporter inhibitor,INHIBITOR,162.0,CHEMBL1893,Synaptic vesicular amine transporter,1,1,1,,
2197716,CHEMBL3989845,IMIPRAMINE PAMOATE,411,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
2197716,CHEMBL3989845,IMIPRAMINE PAMOATE,898,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
2197721,CHEMBL3989850,ECAMSULE,8991,Sunscreen,,,,,1,1,1,,
2197726,CHEMBL3989855,PSEUDOEPHEDRINE SULFATE,903,Norepinephrine transporter releasing agent,RELEASING AGENT,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
2197730,CHEMBL3989859,TOCOPHEROL ACETATE,7677,Supplement,,,,,1,1,1,Parenteral nutrition supplement.,
2197732,CHEMBL3989861,DESVENLAFAXINE FUMARATE,2249,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
2197732,CHEMBL3989861,DESVENLAFAXINE FUMARATE,2250,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
2197737,CHEMBL3989866,BICTEGRAVIR,6927,Human immunodeficiency virus type 1 integrase inhibitor,INHIBITOR,12456.0,CHEMBL3471,Human immunodeficiency virus type 1 integrase,1,1,1,HIV-1 integrase strand transfer inhibitor,
2197738,CHEMBL3989867,BICTEGRAVIR SODIUM,7385,Human immunodeficiency virus type 1 integrase inhibitor,INHIBITOR,12456.0,CHEMBL3471,Human immunodeficiency virus type 1 integrase,1,1,1,Inhibition of the integrase prevents viral integration into the host DNA which is required for propagation.,Active against a range of clinical HIV-1 isolates across different groups and subgroups. Also displayed activity against an HIV-2 strain included in the assay (EC50 1.1nM).
2197739,CHEMBL3989868,TUCATINIB,4298,Receptor protein-tyrosine kinase erbB-2 inhibitor,INHIBITOR,188.0,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,1,1,1,,
2197740,CHEMBL3989869,UMBRALISIB TOSYLATE,4404,PI3-kinase p110-delta subunit inhibitor,INHIBITOR,11177.0,CHEMBL3130,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",1,1,1,,
2197740,CHEMBL3989869,UMBRALISIB TOSYLATE,9122,Casein kinase I epsilon inhibitor,INHIBITOR,10967.0,CHEMBL4937,Casein kinase I isoform epsilon,1,1,1,,
2197740,CHEMBL3989869,UMBRALISIB TOSYLATE,9123,Tyrosine-protein kinase ABL inhibitor,INHIBITOR,8.0,CHEMBL1862,Tyrosine-protein kinase ABL1,1,1,1,,
2197742,CHEMBL3989871,AVACOPAN,4951,C5a anaphylatoxin chemotactic receptor antagonist,ANTAGONIST,12679.0,CHEMBL2373,C5a anaphylatoxin chemotactic receptor 1,1,1,1,,
2197756,CHEMBL3989885,TRIMEPRAZINE TARTRATE,132,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
2197758,CHEMBL3989887,TACROLIMUS,386,FK506-binding protein 1A inhibitor,INHIBITOR,80.0,CHEMBL1902,Peptidyl-prolyl cis-trans isomerase FKBP1A,1,1,1,,
2197780,CHEMBL3989909,LENIOLISIB PHOSPHATE,9613,PI3-kinase p110-delta subunit inhibitor,INHIBITOR,11177.0,CHEMBL3130,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",1,1,1,,
2197786,CHEMBL3989915,DIFELIKEFALIN,7848,Kappa opioid receptor agonist,AGONIST,137.0,CHEMBL237,Kappa-type opioid receptor,1,1,1,,
2197790,CHEMBL3989919,FOSNETUPITANT CHLORIDE HYDROCHLORIDE,7359,Neurokinin 1 receptor antagonist,ANTAGONIST,250.0,CHEMBL249,Substance-P receptor,1,1,1,"Inhibits substance P mediated activation of NK1 receptors, activation is linked to delayed emesis.",
2197791,CHEMBL3989920,PITAVASTATIN SODIUM,6915,HMG-CoA reductase inhibitor,INHIBITOR,24.0,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,1,1,1,,
2197792,CHEMBL3989921,NERATINIB MALEATE,7421,Receptor protein-tyrosine kinase erbB-2 inhibitor,INHIBITOR,188.0,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,1,1,1,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,
2197792,CHEMBL3989921,NERATINIB MALEATE,7422,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,
2197792,CHEMBL3989921,NERATINIB MALEATE,7423,Receptor protein-tyrosine kinase erbB-4 inhibitor,INHIBITOR,12699.0,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,1,1,1,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,
2197793,CHEMBL3989922,NIRAPARIB TOSYLATE MONOHYDRATE,7424,Poly [ADP-ribose] polymerase 2 inhibitor,INHIBITOR,100933.0,CHEMBL5366,Poly [ADP-ribose] polymerase 2,1,1,1,,IC(50) inhibition PARP2 (2.1 nM)
2197793,CHEMBL3989922,NIRAPARIB TOSYLATE MONOHYDRATE,7425,Poly [ADP-ribose] polymerase-1 inhibitor,INHIBITOR,11663.0,CHEMBL3105,Poly [ADP-ribose] polymerase 1,1,1,1,,IC(50) inhibition PARP1 (3.8 nM) 
2197794,CHEMBL3989923,PITAVASTATIN MAGNESIUM,6914,HMG-CoA reductase inhibitor,INHIBITOR,24.0,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,1,1,1,,
2197799,CHEMBL3989928,REZAFUNGIN ACETATE,9616,Candida inhibitor,INHIBITOR,50441.0,CHEMBL612867,Candida,1,1,1,,
2197802,CHEMBL3989931,ENASIDENIB MESYLATE,6907,"Isocitrate dehydrogenase [NADP], mitochondrial inhibitor",INHIBITOR,117303.0,CHEMBL3991501,"Isocitrate dehydrogenase [NADP], mitochondrial",1,1,1,,
2197802,CHEMBL3989931,ENASIDENIB MESYLATE,8647,"Isocitrate dehydrogenase [NADP], mitochondrial inhibitor",INHIBITOR,117303.0,CHEMBL3991501,"Isocitrate dehydrogenase [NADP], mitochondrial",1,1,1,,
2197803,CHEMBL3989932,ANGIOTENSIN II ACETATE,6921,Type-1 angiotensin II receptor agonist,AGONIST,115.0,CHEMBL227,Type-1 angiotensin II receptor,1,1,1,,
2197804,CHEMBL3989933,ETRASIMOD ARGININE,9652,Sphingosine 1-phosphate receptor Edg-6 modulator,MODULATOR,10809.0,CHEMBL3230,Sphingosine 1-phosphate receptor 4,1,1,1,,
2197804,CHEMBL3989933,ETRASIMOD ARGININE,9662,Sphingosine 1-phosphate receptor Edg-1 modulator,MODULATOR,11631.0,CHEMBL4333,Sphingosine 1-phosphate receptor 1,1,1,1,,
2197804,CHEMBL3989933,ETRASIMOD ARGININE,9665,Sphingosine 1-phosphate receptor Edg-8 modulator,MODULATOR,12023.0,CHEMBL2274,Sphingosine 1-phosphate receptor 5,1,1,1,,
2197808,CHEMBL3989937,CAPMATINIB HYDROCHLORIDE,7763,Hepatocyte growth factor receptor inhibitor,INHIBITOR,11451.0,CHEMBL3717,Hepatocyte growth factor receptor,1,1,1,Certain mutations in MET can lead to exon 14 skipping and reduced negative regulation of the MET kinase. Capmatinib exhibits anticancer activity in MET-driven cancer cell lines by inhibiting downstream MET signalling.,Active against MET and MET mutants that cause exon 14 skipping. Indicated for metastatic tumors with a confirmed MET mutation that can lead to exon 14 skipping.
2197810,CHEMBL3989939,LAROTRECTINIB SULFATE,7386,Neurotrophic tyrosine kinase receptor inhibitor,INHIBITOR,109739.0,CHEMBL3559684,Neurotrophic tyrosine kinase receptor,1,1,1,"Fusions between the neurotrophic kinase receptor (NTKR) genes can result in their constitutive activation which promotes tumor growth, larotrectinib inhibits these targets. ","Lower level affinity for TNK2. Limited activity against TRKA resistance variants with point mutation G595R or against TRKC with point mutations G623R, G696A or F617L."
2197815,CHEMBL3989944,DIROXIMEL FUMARATE,7642,Kelch-like ECH-associated protein 1 inhibitor,INHIBITOR,104593.0,CHEMBL2069156,Kelch-like ECH-associated protein 1,1,1,1,"Not fully elucidated. Activates the Nrf2 pathway involved in cellular response to oxidative stress, potentially through S-alkylation of the Nrf2 inhibitor Keap1",MMF is also a nicotinic acid receptor agonist in vitro.
2197820,CHEMBL3989949,CENOBAMATE,7441,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,The precise mechanism in seizures is unknown. ,
2197820,CHEMBL3989949,CENOBAMATE,7442,Sodium channel alpha subunit inhibitor,INHIBITOR,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,"The precise mechanism in seizures is unknown. 
Reduces neuronal firing associated with sodium currents and increases the activity of the GABA-A channels. 
It appears to inhibit the non-inactivated, persistent (repetitive) component of sodium currents that may be associated with epilepsy.  ",
2197829,CHEMBL3989958,IVOSIDENIB,7352,Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor,INHIBITOR,104483.0,CHEMBL2007625,Isocitrate dehydrogenase [NADP] cytoplasmic,1,1,1,Inhibits isocitrate dehydrogenase 1 resulting in decreased 2-hydroxyglutarate levels and induced myloid differentiation.,Active against Isocitrate dehydrogenase 1 and certain mutations that increase 2-hydroxyglutarate levels (most commonly R132 mutant forms). 
2197831,CHEMBL3989960,SELADELPAR LYSINE,9933,Peroxisome proliferator-activated receptor delta agonist,AGONIST,12227.0,CHEMBL3979,Peroxisome proliferator-activated receptor delta,1,1,1,,
2197833,CHEMBL3989962,PEMETREXED TROMETHAMINE,9594,Dihydrofolate reductase inhibitor,INHIBITOR,6.0,CHEMBL202,Dihydrofolate reductase,1,1,1,,
2197833,CHEMBL3989962,PEMETREXED TROMETHAMINE,9595,GAR transformylase inhibitor,INHIBITOR,12291.0,CHEMBL3972,Trifunctional purine biosynthetic protein adenosine-3,1,1,1,,
2197833,CHEMBL3989962,PEMETREXED TROMETHAMINE,9597,Thymidylate synthase inhibitor,INHIBITOR,10792.0,CHEMBL2555,Thymidylate synthase,1,1,1,,
2197844,CHEMBL3989973,PEXIDARTINIB HYDROCHLORIDE,7389,Macrophage colony stimulating factor receptor inhibitor,INHIBITOR,12840.0,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,1,1,1,Overexpression of the CSF1R ligand promotes tumor cell proliferation which is inhibited by pexidartinib in CSF1R-dependent tumors. Pexidartinib inhibited a CSF1R dependent cell line in vivo.,
2197844,CHEMBL3989973,PEXIDARTINIB HYDROCHLORIDE,7426,Tyrosine-protein kinase receptor FLT3 inhibitor,INHIBITOR,12670.0,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,1,1,1,,
2197844,CHEMBL3989973,PEXIDARTINIB HYDROCHLORIDE,7427,Stem cell growth factor receptor inhibitor,INHIBITOR,238.0,CHEMBL1936,Mast/stem cell growth factor receptor Kit,1,1,1,,
2197845,CHEMBL3989974,CEFIDEROCOL,7450,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,"Antibacterial.
Cefiderocol is a siderophore conjugated to a cephalosporin.
Cephalosporins bind to penicillin binding proteins disrupting bacterial cell wall biosynthesis. Siderophores (ferric iron binding compound) are taken up into bacterial cells both passively and also through dedicated siderophore import mechanisms. 
Conjugation of the active compound to a siderophore facilitates uptake.","Active against Gram-negative bacteria. No relevant activity against Gram-positives and anaerobes. 
Indicated for Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Enterobacter cloacae complex.

Also active against (but not necessarily indicated for) certain S. maltophilia, meropenemresistant Enterobacteriaceae, P. aeruginosa, and A. baumannii isolates. This includes some meropenem, ciprofloxacin, and amikacin-resistant isolates including some isolates with genetically confirmed resistance genes. 
Also displays in vitro against the following bacteria but the clinical relevance is unknown - Acinetobacter baumannii, Citrobacter freundii complex, Citrobacter koseri, Klebsiella aerogenes, Klebsiella oxytoca, Morganella morganii, Proteus vulgaris, Providencia rettgeri, Serratia marcescens, Stenotrophomonas maltophilia."
2197848,CHEMBL3989977,EMAPALUMAB,7400,Interferon gamma inhibitor,INHIBITOR,108375.0,CHEMBL3286073,Interferon gamma,1,1,1,IFNgamma is neutralised by emapalumab reducing the concentration of CXCL9 chemokine (induced by IFNgamma).,
2197857,CHEMBL3989986,RAVULIZUMAB,7364,Complement C5 inhibitor,INHIBITOR,106142.0,CHEMBL2364163,Complement C5,1,1,1,Prevents cleavage of complement protein C5 into the C5a proinflammatory anaphylatoxin and the C5b subunit of the terminal complement complex C5b-9 ultimately preventing hemolysis.,High affinity for the complement protein C5.
2197860,CHEMBL3989989,AXICABTAGENE CILOLEUCEL,7468,B-lymphocyte antigen CD19 binding agent,BINDING AGENT,109546.0,CHEMBL3390821,B-lymphocyte antigen CD19,1,1,1,T cell immunotherapy. A patients T cells are extracted and modified with a vector that encodes an anti-CD19 chimeric antigen receptor (CAR) to bind and eliminate CD19-expressing cancer cells and normal B cell. The CAR is fused to domains that enhance T-cell activity.,
2197879,CHEMBL3990008,TABELECLEUCEL,9628,The T-cell receptor recognises an EBV peptide in complex with a specific HLA molecule on the surface of target cells to exert cytotoxic activity,,,,,1,1,1,,
2197885,CHEMBL3990014,MIRIKIZUMAB,7872,Interleukin-23 inhibitor,INHIBITOR,106133.0,CHEMBL2364154,Interleukin-23,1,1,1,,
2197897,CHEMBL3990026,ELAPEGADEMASE,7369,2'-deoxyadenosine hydrolytic enzyme,HYDROLYTIC ENZYME,106156.0,CHEMBL2364177,2'-deoxyadenosine,1,1,1,Complements a deficiency of adenosine deaminase.,
2197897,CHEMBL3990026,ELAPEGADEMASE,7402,Adenosine hydrolytic enzyme,HYDROLYTIC ENZYME,106157.0,CHEMBL2364178,Adenosine,1,1,1,Complements a deficiency of adenosine deaminase.,
2197900,CHEMBL3990029,RISANKIZUMAB,7381,Interleukin-23 inhibitor,INHIBITOR,106133.0,CHEMBL2364154,Interleukin-23,1,1,1,Selectively binds the p19 subunit of human interleukin-23 inhibiting it's interaction with the receptor and the subsequent release of pro-inflammatory cytokines and chemokines.,Selective for human interleukin-23.
2197905,CHEMBL3990034,FIDANACOGENE ELAPARVOVEC,9074,Coagulation factor IX exogenous gene,EXOGENOUS GENE,193.0,CHEMBL2016,Coagulation factor IX,1,1,1,"Gene therapy, factor IX replacement",
2197910,CHEMBL3990039,MARSTACIMAB,8003,Tissue factor pathway inhibitor inhibitor,INHIBITOR,115023.0,CHEMBL3713062,Tissue factor pathway inhibitor,1,1,1,,
2197915,CHEMBL3990044,RELATLIMAB,7971,Lymphocyte activation gene 3 protein inhibitor,INHIBITOR,119974.0,CHEMBL4630881,Lymphocyte activation gene 3 protein,1,1,1,,
2197918,CHEMBL3990047,OZENOXACIN,6925,DNA gyrase inhibitor,INHIBITOR,117304.0,CHEMBL3991502,DNA gyrase,1,1,1,,
2197918,CHEMBL3990047,OZENOXACIN,7255,Topoisomerase IV inhibitor,INHIBITOR,107934.0,CHEMBL3038508,Topoisomerase IV,1,1,1,,
2197918,CHEMBL3990047,OZENOXACIN,7256,DNA gyrase inhibitor,INHIBITOR,107908.0,CHEMBL3038482,DNA gyrase,1,1,1,,
2197918,CHEMBL3990047,OZENOXACIN,7257,DNA topoisomerase IV inhibitor,INHIBITOR,117305.0,CHEMBL3991503,DNA topoisomerase IV,1,1,1,,
2198936,CHEMBL3991065,ATOGEPANT,8414,Calcitonin gene-related peptide type 1 receptor antagonist,ANTAGONIST,19904.0,CHEMBL3798,Calcitonin gene-related peptide type 1 receptor,1,1,1,,
146,CHEMBL4,OFLOXACIN,1899,Bacterial DNA gyrase inhibitor,INHIBITOR,105577.0,CHEMBL2311224,Bacterial DNA gyrase,1,1,1,,
418415,CHEMBL400599,BENFLUOREX,6207,Acyl coenzyme A:cholesterol acyltransferase 1 inhibitor,INHIBITOR,12920.0,CHEMBL2782,Sterol O-acyltransferase 1,1,1,1,"Benfluorex and its metabolite have a great affinity for hydrophobic domains such us lipid bilayers. Both compounds can be incorporated into cellular membranes and modify their physical and biological properties. As a consequence they inhibit the activity of several membrane-bound enzymes involved with lipid metabolism: Acyl Coenzyme A: cholesterol-acyltransferase , phosphatidate phosphohydrolase and diacylglycerol acyltransferase. Some in vitro experiments focusing on carbohydrate metabolism have suggested that the antihyperglycemicactivity of benfluorex results from a postinsulin binding effect(s).",High afnity to 5-HT2B receptors (TID: 227 /  UniProt ID: P41595) with agonist properties on these receptors. This mechanism is responsible for the induce valvular heart disease caused by benfluorex.
424824,CHEMBL404108,LUMIRACOXIB,6258,Cyclooxygenase-2 inhibitor,INHIBITOR,126.0,CHEMBL230,Prostaglandin G/H synthase 2,1,1,1,"Cyclooxygenase 2 (COX2) is involved in the production of prostaglandins, in response to injury or certain diseases. These prostaglandins cause pain, swelling and inflammation. When COX2 is inhibited the production of these prostaglandins is blocked, and that relieves pain and inflammation.",It has the highest COX-2 selectivity of any NSAID.
436875,CHEMBL404271,ACARBOSE,841,Pancreatic alpha-amylase inhibitor,INHIBITOR,10705.0,CHEMBL2045,Pancreatic alpha-amylase,1,1,1,Competitive reversible inhibitor,
436875,CHEMBL404271,ACARBOSE,873,Maltase-glucoamylase inhibitor,INHIBITOR,1.0,CHEMBL2074,Maltase-glucoamylase,1,1,1,,
418491,CHEMBL404849,SULOCTIDIL,6306,Voltage-gated calcium channel blocker,BLOCKER,105734.0,CHEMBL2363032,Voltage-gated calcium channel,1,1,1,Suloctidil is a molecule with calcium antagonist properties and anti-ionophoretic effect. The stimulatory effect of suloctidil on the release of the platelet inhibitor PGI2 from the vascular endothelium might contribute to the known antiplatelet and antithrombotic activity of this drug. Suloctidil acts to inhibit serum TxB2 generation.,
543,CHEMBL405,AMPHETAMINE,687,Dopamine transporter releasing agent,RELEASING AGENT,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
543,CHEMBL405,AMPHETAMINE,902,Norepinephrine transporter releasing agent,RELEASING AGENT,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
431806,CHEMBL405110,METHYLENE BLUE ANHYDROUS,9914,Soluble guanylate cyclase inhibitor,INHIBITOR,105048.0,CHEMBL2111348,Soluble guanylate cyclase,1,1,1,,
619,CHEMBL406,INDAPAMIDE,342,Thiazide-sensitive sodium-chloride cotransporter inhibitor,INHIBITOR,151.0,CHEMBL1876,Solute carrier family 12 member 3,1,1,1,,
442077,CHEMBL406393,DEOXYCHOLIC ACID,2353,Cell membrane disrupting agent,DISRUPTING AGENT,109551.0,CHEMBL3390826,Cell membrane,1,1,1,,
2205527,CHEMBL4065616,REMDESIVIR,7481,RNA-directed RNA polymerase L inhibitor,INHIBITOR,118697.0,CHEMBL4303062,RNA-directed RNA polymerase L,1,1,1,Remdesivir is intracellularly converted to the pharmacologically active ingredient GS-443902 which competes with adenosine triphosphate (ATP) and is incorporated into viral RNA causing delayed chain termination.,"Broad spectrum activity against filoviruses (eg, EBOV, MARV), CoVs (eg, SARS-CoV, MERS-CoV), and paramyxoviruses (eg, respiratory syncytial virus [RSV], Nipah virus [NiV], and Hendra virus). Inhibits RNA-dependent RNA polymerase from MERS-CoV."
2205527,CHEMBL4065616,REMDESIVIR,7689,Replicase polyprotein 1ab inhibitor,INHIBITOR,119301.0,CHEMBL4523582,Replicase polyprotein 1ab,1,1,1,Remdesivir is intracellularly converted to the pharmacologically active ingredient GS-443902 which competes with adenosine triphosphate (ATP) and is incorporated into viral RNA causing delayed chain termination.,"Broad spectrum activity against filoviruses (eg, EBOV, MARV), CoVs (eg, SARS-CoV, MERS-CoV), and paramyxoviruses (eg, respiratory syncytial virus [RSV], Nipah virus [NiV], and Hendra virus). Inhibits RNA-dependent RNA polymerase from MERS-CoV. Weak inhibitor of mammalian DNA and RNA polymerases."
2206847,CHEMBL4066936,VERICIGUAT,7988,Soluble guanylate cyclase activator,ACTIVATOR,105048.0,CHEMBL2111348,Soluble guanylate cyclase,1,1,1,,
635,CHEMBL407,FLUMAZENIL,1588,GABA-A receptor; anion channel allosteric antagonist,ALLOSTERIC ANTAGONIST,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,Antagonist at benzodiazepine site to treat overdose,
2211072,CHEMBL4071161,TIRABRUTINIB,4297,Tyrosine-protein kinase BTK inhibitor,INHIBITOR,100097.0,CHEMBL5251,Tyrosine-protein kinase BTK,1,1,1,,
666,CHEMBL408,TROGLITAZONE,424,Peroxisome proliferator-activated receptor gamma agonist,AGONIST,133.0,CHEMBL235,Peroxisome proliferator-activated receptor gamma,1,1,1,,
2224030,CHEMBL4084119,LIRAGLUTIDE,59,Glucagon-like peptide 1 receptor agonist,AGONIST,11758.0,CHEMBL1784,Glucagon-like peptide 1 receptor,1,1,1,,
435188,CHEMBL408513,BELINOSTAT,2279,Histone deacetylase inhibitor,INHIBITOR,104681.0,CHEMBL2093865,Histone deacetylase,1,1,1,,
2225368,CHEMBL4085457,RITLECITINIB,7430,Tyrosine-protein kinase JAK3 inhibitor,INHIBITOR,10849.0,CHEMBL2148,Tyrosine-protein kinase JAK3,1,1,1,,
2225368,CHEMBL4085457,RITLECITINIB,7431,TEC family kinase inhibitor,INHIBITOR,118691.0,CHEMBL4296642,TEC family kinase,1,1,1,,
717,CHEMBL409,BICALUTAMIDE,1320,Androgen Receptor antagonist,ANTAGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
2241718,CHEMBL4101807,VOXELOTOR,7443,Hemoglobin HbA positive modulator,POSITIVE MODULATOR,104753.0,CHEMBL2095168,Hemoglobin HbA,1,1,1,"Haemoglobin A is an oxygen-transporting metalloprotein complex in blood (composed of two alpha and two beta subunits). 
In sickle cell disease, a single mutation is found in the beta subunit and the and this form of the protein complex is referred to as Haemoglobin S. 
Haemoglobin S forms an abnormal cell shape (sickles) and polymerises in the absence of oxygen.
Voxelotor binds Haemoglobin S and increases the oxygen affinity of Haemoglobin S which reduces sickling, Voxelotor inhibits HbS polymerisation.",
2245541,CHEMBL4105630,ZURANOLONE,9277,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
860,CHEMBL411,DIETHYLSTILBESTROL,867,Estrogen receptor alpha agonist,AGONIST,19.0,CHEMBL206,Estrogen receptor,1,1,1,,
2252482,CHEMBL4113131,ENSARTINIB,4415,ALK tyrosine kinase receptor inhibitor,INHIBITOR,100417.0,CHEMBL4247,ALK tyrosine kinase receptor,1,1,1,,
923,CHEMBL413,SIROLIMUS,383,FK506-binding protein 1A inhibitor,INHIBITOR,80.0,CHEMBL1902,Peptidyl-prolyl cis-trans isomerase FKBP1A,1,1,1,,
61945,CHEMBL41355,EZOGABINE,9051,KCNQ (Kv7) potassium channel opener,OPENER,105758.0,CHEMBL2363063,KCNQ (Kv7) potassium channel,1,1,1,,
390990,CHEMBL414357,EXENATIDE,60,Glucagon-like peptide 1 receptor agonist,AGONIST,11758.0,CHEMBL1784,Glucagon-like peptide 1 receptor,1,1,1,,
243124,CHEMBL414804,OXALIPLATIN,1853,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
1063,CHEMBL416,METHOXSALEN,1862,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
6706,CHEMBL416146,ETORICOXIB,5689,Cyclooxygenase-2 inhibitor,INHIBITOR,126.0,CHEMBL230,Prostaglandin G/H synthase 2,1,1,1,,Selectively inhibits COX-2 (IC(50) = 1.1 +/- 0.1microM) compared with COX-1 IC(50)=116 +/- 8 microM.
2267090,CHEMBL4164059,PITOLISANT HYDROCHLORIDE,7459,Histamine H3 receptor inverse agonist,INVERSE AGONIST,10280.0,CHEMBL264,Histamine H3 receptor,1,1,1,Therapeutic effect unclear. Possibly mediated by activity against the Histamine H3 receptor which enhances histaminergic neuron activity linked to wakefulness. ,"High affinity for Histamine H3 receptors (Ki = 1nM) with minimal binding at other histamine receptors (H1, H2, or H4 receptors; Ki >10 M)."
2276425,CHEMBL4173394,BRILLIANT BLUE G,8896,Membrane staining aid in ophthalmic surgery,,,,,1,1,1,"Aid in ophthalmic surgery. Selectively stains the internal limiting membrane (ILM) but not the epiretinal membrane nor the retina, making it easier to visualize the membrane for removal.",
176014,CHEMBL418995,AMINEPTINE,6198,Dopamine D1 and D2 receptor antagonist,ANTAGONIST,105040.0,CHEMBL2111341,Dopamine D1 and D2 receptor,1,1,1,"Amineptine is a selective inhibitor of dopamine reuptake and its effects are selectively exerted on the mesolimbocortical system, resulting in reactivation of this system.",
189204,CHEMBL419213,LISINOPRIL,116,Angiotensin-converting enzyme inhibitor,INHIBITOR,69.0,CHEMBL1808,Angiotensin-converting enzyme,1,1,1,,
2261,CHEMBL42,CLOZAPINE,579,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
2261,CHEMBL42,CLOZAPINE,2007,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
2282945,CHEMBL4204794,AVAPRITINIB,7482,Stem cell growth factor receptor inhibitor,INHIBITOR,238.0,CHEMBL1936,Mast/stem cell growth factor receptor Kit,1,1,1,"Receptor tyrosine kinases have a role in cell proliferation and are targeted by cancer chemotherapy. Avapritinib inhibits autophosphorylation in KIT D816V and PDGFRA D842V mutants (IC50 of 4 nM and 30 nM, respectively) in vitro and was active in a mouse xenograft model.","Active against PDGFRA and PDGFRA D842 and multiple KIT exon 11, 11/17 and 17 mutants (IC50s < 25 nM). Other potential targets: wild-type KIT, PDGFRB, CSFR1."
2282945,CHEMBL4204794,AVAPRITINIB,7483,Platelet-derived growth factor receptor alpha inhibitor,INHIBITOR,12627.0,CHEMBL2007,Platelet-derived growth factor receptor alpha,1,1,1,"Receptor tyrosine kinases have a role in cell proliferation and are targeted by cancer chemotherapy. Avapritinib inhibits autophosphorylation in KIT D816V and PDGFRA D842V mutants (IC50 of 4 nM and 30 nM, respectively) in vitro and was active in a mouse xenograft model.","Active against PDGFRA and PDGFRA D842 and multiple KIT exon 11, 11/17 and 17 mutants (IC50s < 25 nM). Other potential targets: wild-type KIT, PDGFRB, CSFR1."
129399,CHEMBL420762,MOZAVAPTAN,7558,Vasopressin V2 receptor antagonist,ANTAGONIST,112.0,CHEMBL1790,Vasopressin V2 receptor,1,1,1,,Increased affinity for the V2 over V1a receptor.
2286380,CHEMBL4208229,ASCIMINIB,4093,Tyrosine-protein kinase ABL inhibitor,INHIBITOR,8.0,CHEMBL1862,Tyrosine-protein kinase ABL1,1,1,1,"ABL001 binds to a pocket on the BCR-ABL kinase domain that is normally occupied by the myristoylated N-terminus of ABL1 (""ABL001, a potent allosteric inhibitor of BCR-ABL, prevents emergence of resistant disease when administered in combination with nilotinib in an in vivo murine model of chronic myeloid leukemia"". Blood. 2014;124(21) [abstract 398])",
2287105,CHEMBL4208954,AMIKACIN SULFATE,1752,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
1223,CHEMBL421,SULFASALAZINE,272,Arachidonate 5-lipoxygenase inhibitor,INHIBITOR,55.0,CHEMBL215,Polyunsaturated fatty acid 5-lipoxygenase,1,1,1,,
1223,CHEMBL421,SULFASALAZINE,1179,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
2294618,CHEMBL4216467,RIPRETINIB,7607,Stem cell growth factor receptor inhibitor,INHIBITOR,238.0,CHEMBL1936,Mast/stem cell growth factor receptor Kit,1,1,1,,"Active against wild type, primary, and secondary mutations. Also inhibits PDGFRB, TIE2, VEGFR2, and BRAF in vitro. "
2294618,CHEMBL4216467,RIPRETINIB,7656,Platelet-derived growth factor receptor alpha inhibitor,INHIBITOR,12627.0,CHEMBL2007,Platelet-derived growth factor receptor alpha,1,1,1,,"Active against wild type, primary, and secondary mutations. Also inhibits PDGFRB, TIE2, VEGFR2, and BRAF in vitro. "
2315431,CHEMBL4250860,DANICOPAN,8512,Complement factor D inhibitor,INHIBITOR,105346.0,CHEMBL2176771,Complement factor D,1,1,1,,
324544,CHEMBL426084,SAMIDORPHAN,4940,Mu opioid receptor antagonist,ANTAGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,"Compound is art of the combination product ALKS-5461, where samidorphan is combined with buprenorphine ALKS-5461 is being developed as an as antidepressant drug.",
367314,CHEMBL426559,LAROPIPRANT,5172,Prostanoid DP receptor antagonist,ANTAGONIST,12659.0,CHEMBL4427,Prostaglandin D2 receptor,1,1,1,"Laropiprant was in Ph4 in combination with niacin to reduce blood cholesterol but drug was withdrawn due to adverse effects out weighing benefits. Laropiprant itself has no cholesterol lowering effect, but it reduces facial flushes induced by niacin (https://en.wikipedia.org/wiki/Laropiprant). Indication: Rosacea, Seasonal Allergies",
1470,CHEMBL427,MECHLORETHAMINE,9811,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,Alkylating agent,
2318498,CHEMBL4279047,VORASIDENIB,8918,IDH1/IDH2 inhibitor,INHIBITOR,119376.0,CHEMBL4523659,IDH1/IDH2,1,1,1,,
1616,CHEMBL428,TROVAFLOXACIN,9870,Topoisomerase IV inhibitor,INHIBITOR,105771.0,CHEMBL2363076,Topoisomerase IV,1,1,1,,
1616,CHEMBL428,TROVAFLOXACIN,9967,Bacterial DNA gyrase inhibitor,INHIBITOR,105577.0,CHEMBL2311224,Bacterial DNA gyrase,1,1,1,,
8062,CHEMBL428647,PACLITAXEL,1102,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,,
2335035,CHEMBL4297064,MILNACIPRAN HYDROCHLORIDE,412,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
2335035,CHEMBL4297064,MILNACIPRAN HYDROCHLORIDE,908,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
2335036,CHEMBL4297065,SPINOSAD,1581,Nicotinic acetylcholine receptor agonist,AGONIST,106002.0,CHEMBL2364023,Nicotinic acetylcholine receptor,1,1,1,,
2335059,CHEMBL4297088,CHLORHEXIDINE GLUCONATE,1812,Cell membrane inhibitor,INHIBITOR,106010.0,CHEMBL2364031,Cell membrane,1,1,1,Disrupts cell membrane,
2335062,CHEMBL4297091,CODEINE SULFATE,1094,Opioid receptors; mu/kappa/delta agonist,AGONIST,104765.0,CHEMBL2095181,Opioid receptors; mu/kappa/delta,1,1,1,,
2335072,CHEMBL4297101,CEFTOBIPROLE MEDOCARIL SODIUM,9888,Penicillin-binding protein 1 inhibitor,INHIBITOR,100045.0,CHEMBL4268,Penicillin-binding protein 1,1,1,1,,
2335072,CHEMBL4297101,CEFTOBIPROLE MEDOCARIL SODIUM,9910,Penicillin-binding protein 2 inhibitor,INHIBITOR,19657.0,CHEMBL3825,Penicillin-binding protein 2,1,1,1,,
2335072,CHEMBL4297101,CEFTOBIPROLE MEDOCARIL SODIUM,9943,Penicillin-binding protein inhibitor,INHIBITOR,105686.0,CHEMBL2362973,Penicillin-binding protein,1,1,1,,
2335072,CHEMBL4297101,CEFTOBIPROLE MEDOCARIL SODIUM,9949,Penicillin-binding protein 4 inhibitor,INHIBITOR,19610.0,CHEMBL2549,Penicillin-binding protein 4,1,1,1,,
2335072,CHEMBL4297101,CEFTOBIPROLE MEDOCARIL SODIUM,9956,Penicillin-binding protein 3 inhibitor,INHIBITOR,100046.0,CHEMBL4269,Penicillin-binding protein 3,1,1,1,,
2335072,CHEMBL4297101,CEFTOBIPROLE MEDOCARIL SODIUM,9998,MecA inhibitor,INHIBITOR,102466.0,CHEMBL6187,MecA,1,1,1,,
2335118,CHEMBL4297147,HALOPERIDOL LACTATE,604,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
2335118,CHEMBL4297147,HALOPERIDOL LACTATE,2027,D2-like dopamine receptor inverse agonist,INVERSE AGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
2335136,CHEMBL4297165,CHLOROQUINE HYDROCHLORIDE,1003,Ferriprotoporphyrin IX binding agent,BINDING AGENT,100262.0,CHEMBL613897,Ferriprotoporphyrin IX,1,1,1,prevents crystallisation,
2335156,CHEMBL4297185,DAROLUTAMIDE,5217,Androgen Receptor antagonist,ANTAGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
2335163,CHEMBL4297192,SIMETHICONE,2139,Antifoaming agent,,,,,1,1,1,Rupture of thick liquid films by surface tension disruption,
2335182,CHEMBL4297211,CEFIDEROCOL SULFATE TOSYLATE,7661,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,Antibacterial. Cefiderocol is a siderophore conjugated to a cephalosporin. Cephalosporins bind to penicillin binding proteins disrupting bacterial cell wall biosynthesis. Siderophores (ferric iron binding compound) are taken up into bacterial cells both passively and also through dedicated siderophore import mechanisms. Conjugation of the active compound to a siderophore facilitates uptake.,"Active against Gram-negative bacteria. No relevant activity against Gram-positives and anaerobes. Indicated for Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Enterobacter cloacae complex. Also active against (but not necessarily indicated for) certain S. maltophilia, meropenemresistant Enterobacteriaceae, P. aeruginosa, and A. baumannii isolates. This includes some meropenem, ciprofloxacin, and amikacin-resistant isolates including some isolates with genetically confirmed resistance genes. Also displays in vitro against the following bacteria but the clinical relevance is unknown - Acinetobacter baumannii, Citrobacter freundii complex, Citrobacter koseri, Klebsiella aerogenes, Klebsiella oxytoca, Morganella morganii, Proteus vulgaris, Providencia rettgeri, Serratia marcescens, Stenotrophomonas maltophilia."
2335184,CHEMBL4297213,AFAMELANOTIDE ACETATE,7444,Melanocortin receptor 1 agonist,AGONIST,11869.0,CHEMBL3795,Melanocyte-stimulating hormone receptor,1,1,1,"Structural analog of -melanocyte stimulating hormone (-MSH), increases production of eumelanin in the skin.",Binds predominantly to MCR-1.
2335187,CHEMBL4297216,FEDRATINIB HYDROCHLORIDE,7451,Tyrosine-protein kinase JAK2 inhibitor,INHIBITOR,10938.0,CHEMBL2971,Tyrosine-protein kinase JAK2,1,1,1,"Active against wild-type Jak2 and FLT3 and mutationally activated forms (e.g. JAK2V617F and FLT3ITD).
Mutant Jak2 is implicated in myeloproliferative neoplasms (MPNs). 
In cell models, fedratinib reduced signalling associated with these mutant kinases with the overall effect of decreasing cell proliferation and inducing apoptosis.
In animal models, fedratinib improved survival.","Higher selectivity for JAK2 over family members JAK1, JAK3 and TYK2."
2335187,CHEMBL4297216,FEDRATINIB HYDROCHLORIDE,7452,Tyrosine-protein kinase receptor FLT3 inhibitor,INHIBITOR,12670.0,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,1,1,1,"Active against wild-type Jak2 and FLT3 and mutationally activated forms (e.g. JAK2V617F and FLT3ITD).
Mutant Jak2 is implicated in myeloproliferative neoplasms (MPNs). 
In cell models, fedratinib reduced signalling associated with these mutant kinases with the overall effect of decreasing cell proliferation and inducing apoptosis.
In animal models, fedratinib improved survival.",
2335191,CHEMBL4297220,ASCIMINIB HYDROCHLORIDE,9527,Bcr/Abl fusion protein inhibitor,INHIBITOR,104811.0,CHEMBL2096618,Bcr/Abl fusion protein,1,1,1,,
2335194,CHEMBL4297223,MITAPIVAT SULFATE,9266,Pyruvate kinase isozymes R/L activator,ACTIVATOR,103054.0,CHEMBL1075126,Pyruvate kinase PKLR,1,1,1,,
2335200,CHEMBL4297229,PRABOTULINUMTOXIN A,7384,Synaptosomal nerve-associated protein 25 (SNAP-25) proteolytic enzyme,PROTEOLYTIC ENZYME,106138.0,CHEMBL2364159,Synaptosomal-associated protein 25,1,1,1,"Binds to and is taken up by nerves that use acetylcholine. Once internalised, the catalytic domain of PrabotulinumtoxinA cleaves SNAP-25, a SNARE protein, preventing membrane fusion and release of acetlycholine required for nerve signalling. ",Toxin A is selective for SNAP-25.
2335211,CHEMBL4297240,ONASEMNOGENE ABEPARVOVEC,7469,Survival motor neuron protein exogenous gene,EXOGENOUS GENE,103665.0,CHEMBL1293232,Survival motor neuron protein,1,1,1,Virus vector-based gene therapy that provides a correct copy of the human SMN1 gene.,
2335216,CHEMBL4297245,DONANEMAB,8080,Amyloid-beta A4 protein disrupting agent,DISRUPTING AGENT,10656.0,CHEMBL2487,Amyloid-beta precursor protein,1,1,1,Specifically binds the N-terminal pyroglutamate for of beta-amyloid.,
2335311,CHEMBL4297340,EDOTREOTIDE GALLIUM GA-68,9755,Diagnostic,,,,,1,1,1,Somatostatin binding substance used to visualise neuroendocrine tumours when radiolabelled,
2335349,CHEMBL4297378,DURLOBACTAM SODIUM,9617,Beta-lactamase inhibitor,INHIBITOR,103098.0,CHEMBL1075159,Beta-lactamase,1,1,1,,
2335349,CHEMBL4297378,DURLOBACTAM SODIUM,9623,Beta-lactamase inhibitor,INHIBITOR,120865.0,CHEMBL5223041,Beta-lactamase,1,1,1,,
2335349,CHEMBL4297378,DURLOBACTAM SODIUM,9624,Beta-lactamase inhibitor,INHIBITOR,120866.0,CHEMBL5223042,Beta-lactamase,1,1,1,,
2335349,CHEMBL4297378,DURLOBACTAM SODIUM,9625,Beta-lactamase inhibitor,INHIBITOR,120867.0,CHEMBL5223043,Beta-lactamase,1,1,1,,
2335374,CHEMBL4297403,MELPHALAN FLUFENAMIDE HYDROCHLORIDE,8577,DNA cross-linking agent,CROSS-LINKING AGENT,105574.0,CHEMBL2311221,DNA,1,1,1,,
2335383,CHEMBL4297412,PAFOLACIANINE,9348,Diagnostic,,,,,1,1,1,,
2335474,CHEMBL4297503,BALOXAVIR MARBOXIL,7362,Polymerase acidic protein inhibitor,INHIBITOR,103467.0,CHEMBL1169598,Polymerase acidic protein,1,1,1,Inhibits viral replication. PA is one component of the viral RNA polymerase complex. ,"Higher activity against Influenza A (IC50 1.4-3.1 nM) versus Influenza B (4.5-8.9 nM). Active in cell culture against subtypes A/H1N1, A/H3N2, A/H7N9 and Type B."
2335474,CHEMBL4297503,BALOXAVIR MARBOXIL,7365,Polymerase acidic protein inhibitor,INHIBITOR,104525.0,CHEMBL2028641,Polymerase acidic protein,1,1,1,Inhibits viral replication. PA is one component of the viral RNA polymerase complex. ,"Higher activity against Influenza A (IC50 1.4-3.1 nM) versus Influenza B (4.5-8.9 nM). Active in cell culture against subtypes A/H1N1, A/H3N2, A/H7N9 and Type B."
2335480,CHEMBL4297509,ELACESTRANT,4552,Estrogen receptor alpha degrader,DEGRADER,19.0,CHEMBL206,Estrogen receptor,1,1,1,FDA accepted IND-application in December 2014. Is a SERM (selective estrogen receptor modulator) and SERD (selective estrogen receptor down-regulator/degrader),
2335484,CHEMBL4297513,IBREXAFUNGERP,8233,"1,3-beta-glucan synthase inhibitor",INHIBITOR,106174.0,CHEMBL2364674,"1,3-beta-glucan synthase",1,1,1,,
2335484,CHEMBL4297513,IBREXAFUNGERP,8234,"1,3-beta-glucan synthase inhibitor",INHIBITOR,106173.0,CHEMBL2364673,"1,3-beta-glucan synthase",1,1,1,,
2335487,CHEMBL4297516,LURBINECTEDIN,7653,DNA negative modulator,NEGATIVE MODULATOR,105574.0,CHEMBL2311221,DNA,1,1,1,Alkylating drug. Binds guanine residues in the minor groove of DNA and forms adducts that bend DNA and affects DNA binding proteins. Ultimately leads to cell death.,
2335488,CHEMBL4297517,MAVACAMTEN,9582,Cardiac myosin inhibitor,INHIBITOR,116866.0,CHEMBL3831286,Cardiac myosin,1,1,1,,
2335493,CHEMBL4297522,PEMIGATINIB,7598,Fibroblast growth factor receptor 2 inhibitor,INHIBITOR,10264.0,CHEMBL4142,Fibroblast growth factor receptor 2,1,1,1,Inhibits FGFR1/2/3-dependent phosphorylation and signaling in cells that have activating FGFR amplifications/fusions and decreases cancer cell viability.,IC50s for FGFR1/2/3 < 2 nM. The IC50 for FGFR4 is 100x higher in vitro. Indicated for cancers with FGFR2 fusions or other rearrangements as detected by an FDA-approved test.
2335493,CHEMBL4297522,PEMIGATINIB,7654,Fibroblast growth factor receptor 3 inhibitor,INHIBITOR,11926.0,CHEMBL2742,Fibroblast growth factor receptor 3,1,1,1,Inhibits FGFR1/2/3-dependent phosphorylation and signaling in cells that have activating FGFR amplifications/fusions and decreases cancer cell viability.,IC50s for FGFR1/2/3 < 2 nM. The IC50 for FGFR4 is 100x higher in vitro. Indicated for cancers with FGFR2 fusions or other rearrangements as detected by an FDA-approved test.
2335493,CHEMBL4297522,PEMIGATINIB,7655,Fibroblast growth factor receptor 1 inhibitor,INHIBITOR,10266.0,CHEMBL3650,Fibroblast growth factor receptor 1,1,1,1,Inhibits FGFR1/2/3-dependent phosphorylation and signaling in cells that have activating FGFR amplifications/fusions and decreases cancer cell viability.,IC50s for FGFR1/2/3 < 2 nM. The IC50 for FGFR4 is 100x higher in vitro. Indicated for cancers with FGFR2 fusions or other rearrangements as detected by an FDA-approved test.
2335499,CHEMBL4297528,RISDIPLAM,7638,SMN2 pre-mRNA positive modulator,POSITIVE MODULATOR,116819.0,CHEMBL3826841,SMN2 pre-mRNA,1,1,1,,May cause alternative splicing of additional non-target genes inc. FOXM1 and MADD which may contribute to adverse effects.
2335504,CHEMBL4297533,BREMELANOTIDE ACETATE,7387,Melanocortin receptor 4 agonist,AGONIST,10142.0,CHEMBL259,Melanocortin receptor 4,1,1,1,"Alpha-MSH analogue. Binds MC1R, MC3R, MC4R and MC5R but most potent against MC1R and MC4R. MC4R is expressed on neurons in the central nervous system and likely to be involved in efficacy. MC3R may also be involved, but role poorly understood.","Active against melanocortin receptors. In order of potency: MC1R, MC4R, MC3R, MC5R, MC2R. MCR1R & MC4R are most relevant at therapeutic doses. "
2335505,CHEMBL4297534,GLASDEGIB MALEATE,7351,Smoothened homolog antagonist,ANTAGONIST,101400.0,CHEMBL5971,Protein smoothened,1,1,1,Inhibits smoothened which is involved in hedgehog pathway signalling and inhibited tumor growth in a mouse model.,
2335506,CHEMBL4297535,FISH OIL TRIGLYCERIDES,7360,Supplement,,,,,1,1,1,Provides a source of calories and fatty acids. Fatty acids are an essential component of cellular structures and bioactive molecules.,
2335507,CHEMBL4297536,PATISIRAN SODIUM,7361,Transthyretin mRNA RNAi inhibitor,RNAI INHIBITOR,118393.0,CHEMBL4296221,Transthyretin mRNA,1,1,1,Short interfering RNA (siRNA) which binds the 3-UTR region of wild-type and mutant transthyretin mRNA leading to degradation and reduced TTR protein levels. ,
2335508,CHEMBL4297537,INOTERSEN SODIUM,7396,Transthyretin mRNA antisense inhibitor,ANTISENSE INHIBITOR,118393.0,CHEMBL4296221,Transthyretin mRNA,1,1,1,Binds wild-type and mutant TTR mRNA which is subsequently degraded reducing TTR protein levels.,
2335516,CHEMBL4297545,LUTETIUM OXODOTREOTIDE LU-177,6929,Somatostatin receptor binding agent,BINDING AGENT,104951.0,CHEMBL2111436,Somatostatin receptor,1,1,1,,Highest affinity for SSTR2
2335520,CHEMBL4297549,HUMAN C1-ESTERASE INHIBITOR,7647,Plasma kallikrein inhibitor,INHIBITOR,23.0,CHEMBL2000,Plasma kallikrein,1,1,1,C1 esterase inhibitor (C1INH) is a serine protease inhibitor (serpin) found in human blood. Regulates the complement and contact systems by irreversibly binding several proteases.,
2335520,CHEMBL4297549,HUMAN C1-ESTERASE INHIBITOR,7750,Coagulation factor XII inhibitor,INHIBITOR,11288.0,CHEMBL2821,Coagulation factor XII,1,1,1,C1 esterase inhibitor (C1INH) is a serine protease inhibitor (serpin) found in human blood. Regulates the complement and contact systems by irreversibly binding several proteases.,
2335520,CHEMBL4297549,HUMAN C1-ESTERASE INHIBITOR,7751,Coagulation factor XI inhibitor,INHIBITOR,11287.0,CHEMBL2820,Coagulation factor XI,1,1,1,C1 esterase inhibitor (C1INH) is a serine protease inhibitor (serpin) found in human blood. Regulates the complement and contact systems by irreversibly binding several proteases.,
2335520,CHEMBL4297549,HUMAN C1-ESTERASE INHIBITOR,7752,Complement C1s inhibitor,INHIBITOR,10684.0,CHEMBL3913,Complement C1s subcomponent,1,1,1,C1 esterase inhibitor (C1INH) is a serine protease inhibitor (serpin) found in human blood. Regulates the complement and contact systems by irreversibly binding several proteases.,
2335522,CHEMBL4297551,EFGARTIGIMOD ALFA,8425,IgG receptor FcRn large subunit p51 antagonist,ANTAGONIST,101395.0,CHEMBL5966,IgG receptor FcRn large subunit p51,1,1,1,,
2335537,CHEMBL4297566,CASIMERSEN,8158,Dystrophin pre-mRNA positive modulator,POSITIVE MODULATOR,116818.0,CHEMBL3826826,Dystrophin pre-mRNA,1,1,1,,
2335544,CHEMBL4297573,TAGRAXOFUSP,7363,Interleukin-3 receptor subunit alpha binding agent,BINDING AGENT,114948.0,CHEMBL3712987,Interleukin-3 receptor subunit alpha,1,1,1,CD123 directed cytotoxin. ,
2335544,CHEMBL4297573,TAGRAXOFUSP,7376,Elongation factor 2 inhibitor,INHIBITOR,104188.0,CHEMBL1795108,Elongation factor 2,1,1,1,CD123 directed cytotoxin. ,
2335546,CHEMBL4297575,NIRSEVIMAB,8784,Fusion glycoprotein F0 inhibitor,INHIBITOR,106144.0,CHEMBL2364165,Fusion glycoprotein F0,1,1,1,,
2335550,CHEMBL4297579,VALOCTOCOGENE ROXAPARVOVEC,9612,Coagulation factor IX exogenous protein,EXOGENOUS PROTEIN,193.0,CHEMBL2016,Coagulation factor IX,1,1,1,AAV5 based vector containing the cDNA of the B-domain deleted SQ form of human coagulation factor VIII gene under the control of a liver-specific promoter,
2335556,CHEMBL4297585,TRIHEPTANOIN,7625,Supplement,,,,,1,1,1,Source of calories and fatty acids in long-chain FAOD enzyme deficiencies.,
2335559,CHEMBL4297588,ODEVIXIBAT,7696,Ileal bile acid transporter inhibitor,INHIBITOR,12909.0,CHEMBL2778,Ileal sodium/bile acid cotransporter,1,1,1,,
2335561,CHEMBL4297590,DARIDOREXANT,8020,Orexin receptor antagonist,ANTAGONIST,108439.0,CHEMBL3307226,Orexin receptor,1,1,1,,
2335563,CHEMBL4297592,AMENAMEVIR,7644,Helicase primate complex inhibitor,INHIBITOR,119394.0,CHEMBL4523677,Helicase primase complex,1,1,1,,"Amenamevir inhibited DNA replication of VZV, HSV-1, and HSV-2 at 0.03 mol/L, but not HCMV."
2335574,CHEMBL4297603,DEUTIVACAFTOR,9954,Cystic fibrosis transmembrane conductance regulator activator,ACTIVATOR,11540.0,CHEMBL4051,Cystic fibrosis transmembrane conductance regulator,1,1,1,,
2335581,CHEMBL4297610,OLUTASIDENIB,7613,Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor,INHIBITOR,104483.0,CHEMBL2007625,Isocitrate dehydrogenase [NADP] cytoplasmic,1,1,1,,
2335637,CHEMBL4297666,OMIDENEPAG ISOPROPYL,7765,Prostanoid EP2 receptor agonist,AGONIST,142.0,CHEMBL1881,Prostaglandin E2 receptor EP2 subtype,1,1,1,,
2335671,CHEMBL4297700,BIMEKIZUMAB,7924,Interleukin 17A inhibitor,INHIBITOR,109547.0,CHEMBL3390822,Interleukin-17A,1,1,1,,
2335671,CHEMBL4297700,BIMEKIZUMAB,8132,Interleukin-17F inhibitor,INHIBITOR,119973.0,CHEMBL4630880,Interleukin-17F,1,1,1,,
2335694,CHEMBL4297723,CEMIPLIMAB,7397,Programmed cell death protein 1 inhibitor,INHIBITOR,108437.0,CHEMBL3307223,Programmed cell death protein 1,1,1,1,Binds to the T-cell PD-1 receptor preventing it's interaction with the PD-L1 and PD-L2 ligands and removing inhibition of immune response. ,
2335700,CHEMBL4297729,COSIBELIMAB,9229,Programmed cell death 1 ligand 1 inhibitor,INHIBITOR,109807.0,CHEMBL3580522,Programmed cell death 1 ligand 1,1,1,1,,
2335701,CHEMBL4297730,CONCIZUMAB,8167,Tissue factor pathway inhibitor inhibitor,INHIBITOR,115023.0,CHEMBL3713062,Tissue factor pathway inhibitor,1,1,1,,
2335705,CHEMBL4297734,CRIZANLIZUMAB,7453,P-selectin blocker,BLOCKER,12723.0,CHEMBL5378,P-selectin,1,1,1,"Binds P-selectin on the surface of the activated endothelium and platelets and blocks it's interaction with ligands on other cells, this reduces cell adhesion. ",
2335721,CHEMBL4297750,FARICIMAB,8357,Angiopoietin-2 inhibitor,INHIBITOR,109785.0,CHEMBL3580489,Angiopoietin-2,1,1,1,,
2335721,CHEMBL4297750,FARICIMAB,8358,Vascular endothelial growth factor A inhibitor,INHIBITOR,187.0,CHEMBL1783,"Vascular endothelial growth factor A, long form",1,1,1,,
2335727,CHEMBL4297756,FREMANEZUMAB,7398,Calcitonin gene-related peptide antagonist,ANTAGONIST,116903.0,CHEMBL3832947,Calcitonin gene-related peptide,1,1,1,Binds to calcitonin gene-related peptide blocking binding to it's receptor.,
2335733,CHEMBL4297762,GOLODIRSEN,7461,Dystrophin pre-mRNA positive modulator,POSITIVE MODULATOR,116818.0,CHEMBL3826826,Dystrophin pre-mRNA,1,1,1,"In Duchenne muscular dystrophy, deletion of exon 53 prevents synthesis of a functional dystrophin protein. Golodirsen is a 'molecular patch' that allows skipping of exon 53 and the assembly of remaining exons (54 onwards) to produce an internally truncated but functional dystrophin protein (that is missing exons 52/53).",
2335745,CHEMBL4297774,AMIVANTAMAB,8684,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,,"Including exon 20 deletions, C797S, T790M"
2335745,CHEMBL4297774,AMIVANTAMAB,8821,Hepatocyte growth factor receptor inhibitor,INHIBITOR,11451.0,CHEMBL3717,Hepatocyte growth factor receptor,1,1,1,,
2335749,CHEMBL4297778,LONCASTUXIMAB TESIRINE,7950,B-lymphocyte antigen CD19 binding agent,BINDING AGENT,109546.0,CHEMBL3390821,B-lymphocyte antigen CD19,1,1,1,,
2335749,CHEMBL4297778,LONCASTUXIMAB TESIRINE,7951,DNA cross-linking agent,CROSS-LINKING AGENT,105574.0,CHEMBL2311221,DNA,1,1,1,,
2335759,CHEMBL4297788,MOSUNETUZUMAB,8884,T cell surface glycoprotein CD3 binding agent,BINDING AGENT,106147.0,CHEMBL2364168,T cell surface glycoprotein CD3,1,1,1,Directs cytotoxic T-cells to tumours,
2335759,CHEMBL4297788,MOSUNETUZUMAB,9019,B-lymphocyte antigen CD20 binding agent,BINDING AGENT,181.0,CHEMBL2058,B-lymphocyte antigen CD20,1,1,1,Directs cytotoxic T-cells to tumours,
2335765,CHEMBL4297794,NEMOLIZUMAB,7899,Interleukin-31 receptor subunit alpha inhibitor,INHIBITOR,119987.0,CHEMBL4630894,Interleukin-31 receptor subunit alpha,1,1,1,,
2335772,CHEMBL4297801,PEGUNIGALSIDASE ALFA,8924,Globotriosylceramide hydrolytic enzyme,HYDROLYTIC ENZYME,106213.0,CHEMBL2366040,Globotriosylceramide,1,1,1,,
2335773,CHEMBL4297802,PEGVALIASE,7399,Phenylalanine hydrolytic enzyme,HYDROLYTIC ENZYME,118392.0,CHEMBL4296171,Phenylalanine,1,1,1,Substitutes for deficient phenylalanine hydroxylase. Hydrolyses phenylalanine to reduce blood concentrations.,
2335774,CHEMBL4297803,PEGZILARGINASE,8668,L-arginine hydrolytic enzyme,HYDROLYTIC ENZYME,120033.0,CHEMBL4651302,L-arginine,1,1,1,,
2335780,CHEMBL4297809,ELRANATAMAB,8686,T cell surface glycoprotein CD3 binding agent,BINDING AGENT,106147.0,CHEMBL2364168,T cell surface glycoprotein CD3,1,1,1,Directs cytotoxic T-cells to tumours,
2335780,CHEMBL4297809,ELRANATAMAB,9032,Tumor necrosis factor receptor superfamily member 17 binding agent,BINDING AGENT,119306.0,CHEMBL4523587,Tumor necrosis factor receptor superfamily member 17,1,1,1,Directs cytotoxic T-cells to tumours,
2335790,CHEMBL4297819,ROPEGINTERFERON ALFA-2B,7512,Interferon alpha/beta receptor positive modulator,POSITIVE MODULATOR,106149.0,CHEMBL2364170,Interferon alpha/beta receptor,1,1,1,Binds to interferon alfa receptor (IFNAR) and impacts downstream signalling/transcription and proliferation of hematopoietic and bone marrow fibroblast progenitor cells. Polycythaemia vera is linked to mutant JAK2 and interferons can block the growth of cancer cells.,
2335791,CHEMBL4297820,ROZANOLIXIZUMAB,7879,IgG receptor FcRn large subunit p51 inhibitor,INHIBITOR,101395.0,CHEMBL5966,IgG receptor FcRn large subunit p51,1,1,1,,
2335801,CHEMBL4297830,SOMATROGON,9312,Growth hormone receptor agonist,AGONIST,60.0,CHEMBL1976,Growth hormone receptor,1,1,1,,
2335803,CHEMBL4297832,SUTIMLIMAB,8303,Complement C1s inhibitor,INHIBITOR,10684.0,CHEMBL3913,Complement C1s subcomponent,1,1,1,,
2335810,CHEMBL4297839,TIRZEPATIDE,8862,Gastric inhibitory polypeptide receptor agonist,AGONIST,100290.0,CHEMBL4383,Gastric inhibitory polypeptide receptor,1,1,1,,
2335810,CHEMBL4297839,TIRZEPATIDE,8994,Glucagon-like peptide 1 receptor agonist,AGONIST,11758.0,CHEMBL1784,Glucagon-like peptide 1 receptor,1,1,1,,
2335811,CHEMBL4297840,TISLELIZUMAB,8286,Programmed cell death protein 1 inhibitor,INHIBITOR,108437.0,CHEMBL3307223,Programmed cell death protein 1,1,1,1,,
2335812,CHEMBL4297841,TISOTUMAB VEDOTIN,7718,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,,
2335812,CHEMBL4297841,TISOTUMAB VEDOTIN,7728,Coagulation factor III binding agent,BINDING AGENT,11092.0,CHEMBL4081,Tissue factor,1,1,1,,
2335814,CHEMBL4297843,TORIPALIMAB,7963,Programmed cell death protein 1 antagonist,ANTAGONIST,108437.0,CHEMBL3307223,Programmed cell death protein 1,1,1,1,,
2335815,CHEMBL4297844,TRASTUZUMAB DERUXTECAN,7490,Receptor protein-tyrosine kinase erbB-2 binding agent,BINDING AGENT,188.0,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,1,1,1,"The antibody binds to HER2-expressing tumor cells, is internalised and the small molecule DXd is released. DXd causes DNA damage and apoptotic cell death. Approval based on tumor response rate and duration of response.",
2335815,CHEMBL4297844,TRASTUZUMAB DERUXTECAN,7491,DNA topoisomerase I inhibitor,INHIBITOR,62.0,CHEMBL1781,DNA topoisomerase 1,1,1,1,"The antibody binds to HER2-expressing tumor cells, is internalised and the small molecule DXd is released. DXd causes DNA damage and apoptotic cell death. Approval based on tumor response rate and duration of response.",
2335823,CHEMBL4297852,CENEGERMIN,7371,Neurotrophic tyrosine kinase receptor agonist,AGONIST,109739.0,CHEMBL3559684,Neurotrophic tyrosine kinase receptor,1,1,1,Acts through nerve growth factor receptors in the eye to support nerve integrity.,
2335833,CHEMBL4297862,BOTULINUM TOXIN TYPE A,9533,Synaptosomal nerve-associated protein 25 (SNAP-25) hydrolytic enzyme,HYDROLYTIC ENZYME,106138.0,CHEMBL2364159,Synaptosomal-associated protein 25,1,1,1,,
2335844,CHEMBL4297873,OCTOCOG ALFA,9507,Coagulation factor VIII exogenous protein,EXOGENOUS PROTEIN,10210.0,CHEMBL3143,Coagulation factor VIII,1,1,1,,
2335850,CHEMBL4297879,.ALPHA.1-PROTEINASE INHIBITOR HUMAN,8245,Leukocyte elastase inhibitor,INHIBITOR,235.0,CHEMBL248,Neutrophil elastase,1,1,1,Replacement enzyme,
2335860,CHEMBL4297889,AVACINCAPTAD PEGOL SODIUM,9890,Complement C5 inhibitor,INHIBITOR,106142.0,CHEMBL2364163,Complement C5,1,1,1,,
2335882,CHEMBL4297911,SPESOLIMAB,9069,IL36 receptor antagonist,ANTAGONIST,120084.0,CHEMBL4665591,IL36 receptor,1,1,1,,
2335916,CHEMBL4297945,EFMOROCTOCOG ALFA,9506,Coagulation factor VIII exogenous protein,EXOGENOUS PROTEIN,10210.0,CHEMBL3143,Coagulation factor VIII,1,1,1,,
2335921,CHEMBL4297950,EFBEMALENOGRASTIM ALFA,9643,Granulocyte colony stimulating factor receptor agonist,AGONIST,207.0,CHEMBL1996,Granulocyte colony-stimulating factor receptor,1,1,1,,
2335922,CHEMBL4297951,COAGULATION FACTOR X HUMAN,9583,Coagulation factor X exogenous protein,EXOGENOUS PROTEIN,194.0,CHEMBL244,Coagulation factor X,1,1,1,,
2335926,CHEMBL4297955,FOLLITROPIN,749,Follicle stimulating hormone receptor agonist,AGONIST,99.0,CHEMBL2024,Follicle-stimulating hormone receptor,1,1,1,"It's FSH, for the stimulation of ovarian follicular growth",
2335944,CHEMBL4297973,HEPATITIS B VIRUS HBSAG SURFACE PROTEIN ANTIGEN,9817,Surface antigen (HBsAg) vaccine antigen,VACCINE ANTIGEN,121142.0,CHEMBL5308521,Surface antigen (HBsAg),1,1,1,,
2335946,CHEMBL4297975,VARICELLA ZOSTER VIRUS ENVELOPE GLYCOPROTEIN E,9946,Envelope glycoprotein E vaccine antigen,VACCINE ANTIGEN,121582.0,CHEMBL5500290,Envelope glycoprotein E,1,1,1,,
2335952,CHEMBL4297981,IMLIFIDASE,8605,Antibodies hydrolytic enzyme,HYDROLYTIC ENZYME,119802.0,CHEMBL4630661,Antibodies,1,1,1,Reduces the level of donor-specific antibodies thus enabling transplantation.,
2335955,CHEMBL4297984,NAXITAMAB,7693,Disialoganglioside GD2 binding agent,BINDING AGENT,109548.0,CHEMBL3390823,Disialoganglioside GD2,1,1,1,GD2 is a glycolipid overexpressed on neuroblastoma cells.,
2335957,CHEMBL4297986,COAGULATION FACTOR IX HUMAN,9818,Coagulation factor IX exogenous protein,EXOGENOUS PROTEIN,193.0,CHEMBL2016,Coagulation factor IX,1,1,1,,
2335961,CHEMBL4297990,TEBENTAFUSP,7992,Melanocyte protein PMEL binding agent,BINDING AGENT,114949.0,CHEMBL3712988,Melanocyte protein PMEL,1,1,1,,
2335981,CHEMBL4298010,VELMANASE ALFA,7634,High mannose oligosaccharides hydrolytic enzyme,HYDROLYTIC ENZYME,118783.0,CHEMBL4495553,High mannose oligosaccharides,1,1,1,"Degrades oligosaccharides in the lysosome, reducing their accumulation. Supplements or replaces natural enzyme.",
2335996,CHEMBL4298025,ZENOCUTUZUMAB,8128,ErbB-2/ErbB-3 heterodimer inhibitor,INHIBITOR,119842.0,CHEMBL4630723,ErbB-2/ErbB-3 heterodimer,1,1,1,,
2336008,CHEMBL4298037,RETIFANLIMAB,7786,Programmed cell death protein 1 antagonist,ANTAGONIST,108437.0,CHEMBL3307223,Programmed cell death protein 1,1,1,1,,
2336018,CHEMBL4298047,TAFASITAMAB,7645,B-lymphocyte antigen CD19 binding agent,BINDING AGENT,109546.0,CHEMBL3390821,B-lymphocyte antigen CD19,1,1,1,Antibody mediated B-cell lysis through apoptosis and immune effector mechanisms,
2336025,CHEMBL4298054,STEM BROMELAIN,9630,Removal of necrotic tissue,,,,,1,1,1,The mechanism is not fully understood but thiol endopeptidases and escharase are present and may promote wound healing by removing necrotic tissue.,
2336033,CHEMBL4298062,VILTOLARSEN,7669,Dystrophin pre-mRNA positive modulator,POSITIVE MODULATOR,116818.0,CHEMBL3826826,Dystrophin pre-mRNA,1,1,1,,
2336035,CHEMBL4298064,BERDAZIMER SODIUM,8278,"Releases NO, antimicrobial",,,,,1,1,1,,
2336057,CHEMBL4298086,POZELIMAB,8295,Complement C5 inhibitor,INHIBITOR,106142.0,CHEMBL2364163,Complement C5,1,1,1,,
2336063,CHEMBL4298092,GLOFITAMAB,8725,B-lymphocyte antigen CD20 binding agent,BINDING AGENT,181.0,CHEMBL2058,B-lymphocyte antigen CD20,1,1,1,Directs cytotoxic T-cells to tumours,
2336063,CHEMBL4298092,GLOFITAMAB,8883,T cell surface glycoprotein CD3 binding agent,BINDING AGENT,106147.0,CHEMBL2364168,T cell surface glycoprotein CD3,1,1,1,Directs cytotoxic T-cells to tumours,
2336081,CHEMBL4298110,FERRIC MALTOL,7388,Supplement,,,,,1,1,1,Iron replacement product that delivers iron for intestinal uptake which is then transferred to ferritin and transferrin.,
2336095,CHEMBL4298124,DOSTARLIMAB,7783,Programmed cell death protein 1 antagonist,ANTAGONIST,108437.0,CHEMBL3307223,Programmed cell death protein 1,1,1,1,,
2336097,CHEMBL4298126,VON WILLEBRAND FACTOR HUMAN,9331,von Willebrand factor exogenous protein,EXOGENOUS PROTEIN,104515.0,CHEMBL2021748,von Willebrand factor,1,1,1,,
2336097,CHEMBL4298126,VON WILLEBRAND FACTOR HUMAN,9681,von Willebrand factor exogenous protein,EXOGENOUS PROTEIN,104515.0,CHEMBL2021748,von Willebrand factor,1,1,1,,
2336099,CHEMBL4298128,ELEXACAFTOR,7457,Cystic fibrosis transmembrane conductance regulator positive modulator,POSITIVE MODULATOR,11540.0,CHEMBL4051,Cystic fibrosis transmembrane conductance regulator,1,1,1,"Facilitates processing and trafficking of CFTR mutants to increase the amount of mature protein at the cell surface. 
Has an additive effect with IVACAFTOR AND TEZACAFTOR on functional CFTR.",
2336109,CHEMBL4298138,REPOTRECTINIB,9663,Nerve growth factor receptor Trk-A inhibitor,INHIBITOR,11902.0,CHEMBL2815,High affinity nerve growth factor receptor,1,1,1,,
2336109,CHEMBL4298138,REPOTRECTINIB,9668,Neurotrophic tyrosine kinase receptor type 2 inhibitor,INHIBITOR,100413.0,CHEMBL4898,BDNF/NT-3 growth factors receptor,1,1,1,,
2336109,CHEMBL4298138,REPOTRECTINIB,9674,Proto-oncogene tyrosine-protein kinase ROS inhibitor,INHIBITOR,101019.0,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,1,1,1,,"Also active against ROS1 variants G2032R, D2033N, L2026M."
2336109,CHEMBL4298138,REPOTRECTINIB,9675,NT-3 growth factor receptor inhibitor,INHIBITOR,101034.0,CHEMBL5608,NT-3 growth factor receptor,1,1,1,,
2336109,CHEMBL4298138,REPOTRECTINIB,9704,CD74-ROS1 inhibitor,INHIBITOR,120114.0,CHEMBL4680046,CD74-ROS1,1,1,1,,"Also active against ROS1 variants G2032R, D2033N, L2026M."
2336109,CHEMBL4298138,REPOTRECTINIB,9724,ROS1-SDC4 inhibitor,INHIBITOR,121124.0,CHEMBL5303568,ROS1-SDC4,1,1,1,,"Also active against ROS1 variants G2032R, D2033N, L2026M."
2336110,CHEMBL4298139,SERDEXMETHYLPHENIDATE CHLORIDE,8582,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
2336110,CHEMBL4298139,SERDEXMETHYLPHENIDATE CHLORIDE,8583,Dopamine transporter inhibitor,INHIBITOR,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
2336121,CHEMBL4298150,SIPONIMOD FUMARIC ACID,7383,Sphingosine 1-phosphate receptor Edg-1 agonist,AGONIST,11631.0,CHEMBL4333,Sphingosine 1-phosphate receptor 1,1,1,1,Siponimod reduces lymphocyte numbers in peripheral blood by blocking their release from the lymph nodes. The mechanism of theraputic effects in MS are unknown.,High binding affinity for S1P receptors 1 and 5. 
2336124,CHEMBL4298153,NIROGACESTAT HYDROBROMIDE,9937,Gamma-secretase inhibitor,INHIBITOR,104717.0,CHEMBL2094135,Gamma-secretase,1,1,1,,
2336138,CHEMBL4298167,FILGOTINIB MALEATE,9819,Tyrosine-protein kinase JAK1 inhibitor,INHIBITOR,10919.0,CHEMBL2835,Tyrosine-protein kinase JAK1,1,1,1,JAK1 preferential inhibitory activity,
2336138,CHEMBL4298167,FILGOTINIB MALEATE,9820,Tyrosine-protein kinase JAK3 inhibitor,INHIBITOR,10849.0,CHEMBL2148,Tyrosine-protein kinase JAK3,1,1,1,JAK1 preferential inhibitory activity,
2336138,CHEMBL4298167,FILGOTINIB MALEATE,9821,Tyrosine-protein kinase TYK2 inhibitor,INHIBITOR,12694.0,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,1,1,1,JAK1 preferential inhibitory activity,
2336138,CHEMBL4298167,FILGOTINIB MALEATE,9822,Tyrosine-protein kinase JAK2 inhibitor,INHIBITOR,10938.0,CHEMBL2971,Tyrosine-protein kinase JAK2,1,1,1,JAK1 preferential inhibitory activity,
2336139,CHEMBL4298168,IBREXAFUNGERP CITRATE,8677,"1,3-beta-glucan synthase inhibitor",INHIBITOR,106173.0,CHEMBL2364673,"1,3-beta-glucan synthase",1,1,1,,
2336139,CHEMBL4298168,IBREXAFUNGERP CITRATE,8875,"1,3-beta-glucan synthase inhibitor",INHIBITOR,106174.0,CHEMBL2364674,"1,3-beta-glucan synthase",1,1,1,,
2336142,CHEMBL4298171,LINZAGOLIX CHOLINE,9823,Gonadotropin-releasing hormone receptor antagonist,ANTAGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,,
2336154,CHEMBL4298183,ATOLTIVIMAB,7701,Envelope glycoprotein inhibitor,INHIBITOR,117434.0,CHEMBL4105829,Envelope glycoprotein,1,1,1,Binds to and inactivates the viral glycoprotein which mediates virus attachment to host cells. The viral glycoprotein is also expressed on the surface of virus-infected cells.,
2336155,CHEMBL4298184,MAFTIVIMAB,7702,Envelope glycoprotein inhibitor,INHIBITOR,117434.0,CHEMBL4105829,Envelope glycoprotein,1,1,1,Binds to and inactivates the viral glycoprotein which mediates virus attachment to host cells. The viral glycoprotein is also expressed on the surface of virus-infected cells.,"In a viral-infected cell line, maftivimab neutralized Mayinga, Kikwit, and Makona strains of Zaire ebolavirus."
2336156,CHEMBL4298185,LONAPEGSOMATROPIN,8657,Growth hormone receptor agonist,AGONIST,60.0,CHEMBL1976,Growth hormone receptor,1,1,1,,
2336158,CHEMBL4298187,FERRIC DERISOMALTOSE,7609,Supplement,,,,,1,1,1,Iron replacement product.,
2336159,CHEMBL4298188,ODESIVIMAB,7703,Envelope glycoprotein inhibitor,INHIBITOR,117434.0,CHEMBL4105829,Envelope glycoprotein,1,1,1,Binds to and inactivates the viral glycoprotein which mediates virus attachment to host cells. The viral glycoprotein is also expressed on the surface of virus-infected cells.,
2336160,CHEMBL4298189,ELADOCAGENE EXUPARVOVEC,9607,DDC exogenous gene,EXOGENOUS GENE,121130.0,CHEMBL5303723,DDC,1,1,1,AAV2 based vector containing the cDNA of the human dopa decarboxylase (DDC) gene under the control of the cytomegalovirus immediate-early promoter,
2336161,CHEMBL4298190,OMIDUBICEL,9878,Somatic cell supplemental therapy,,,,,1,1,1,Cryopreserved nicotinamide modified allogeneic hematopoietic progenitor cell therapy derived from cord blood.,
2336170,CHEMBL4298199,IDECABTAGENE VICLEUCEL,7989,Tumor necrosis factor receptor superfamily member 17 binding agent,BINDING AGENT,119306.0,CHEMBL4523587,Tumor necrosis factor receptor superfamily member 17,1,1,1,T cell immunotherapy product (CAR-T),
2336171,CHEMBL4298200,LIFILEUCEL,10043,Somatic cell supplemental therapy,,,,,1,1,1,Tumor-derived autologous T cell immunotherapy composed primarily of T cells of the CD4+T and CD8+T cell lineages.,
2336180,CHEMBL4298209,BELANTAMAB MAFODOTIN,7637,Tumor necrosis factor receptor superfamily member 17 binding agent,BINDING AGENT,119306.0,CHEMBL4523587,Tumor necrosis factor receptor superfamily member 17,1,1,1,"Binds to BCMA on normal B lymphocytes and multiple myeloma cells, is internalised and MMAF is released by proteolytic cleavage. MMAF binds microtubules leading to apoptosis.",
2336180,CHEMBL4298209,BELANTAMAB MAFODOTIN,7723,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,"Binds to BCMA on normal B lymphocytes and multiple myeloma cells, is internalised and MMAF is released by proteolytic cleavage. MMAF binds microtubules leading to apoptosis.",
2336182,CHEMBL4298211,PEGCETACOPLAN,8359,Complement C3 inhibitor,INHIBITOR,100170.0,CHEMBL4917,Complement C3,1,1,1,,
441579,CHEMBL429910,DAPAGLIFLOZIN,7267,Sodium/glucose cotransporter 2 inhibitor,INHIBITOR,20092.0,CHEMBL3884,Sodium/glucose cotransporter 2,1,1,1,,
2337891,CHEMBL4299940,MITAPIVAT,9466,Pyruvate kinase isozymes R/L activator,ACTIVATOR,103054.0,CHEMBL1075126,Pyruvate kinase PKLR,1,1,1,,
2337891,CHEMBL4299940,MITAPIVAT,9588,Pyruvate kinase isozymes R/L activator,ACTIVATOR,103054.0,CHEMBL1075126,Pyruvate kinase PKLR,1,1,1,,
2580,CHEMBL43,AMSACRINE,6455,DNA topoisomerase II inhibitor,INHIBITOR,104727.0,CHEMBL2094255,DNA topoisomerase II,1,1,1,"Amsacrine may intercalate into DNA and inhibit topoisomerase II, resulting in DNA double-strand breaks, arrest of the S/G2 phase of the cell cycle, and cell death. This agent's cytotoxicity is maximal during the S phase of the cell cycle when topoisomerase levels are greatest. In addition, amsacrine may induce transcription of tumor promoter p53 protein and block p53 ubiquitination and proteasomal degradation, resulting in p53-dependent tumor cell apoptosis.",
2339113,CHEMBL4301162,SERDEXMETHYLPHENIDATE,8603,Dopamine transporter inhibitor,INHIBITOR,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
2339113,CHEMBL4301162,SERDEXMETHYLPHENIDATE,8604,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
2341085,CHEMBL4303214,FRUQUINTINIB,4737,Vascular endothelial growth factor receptor inhibitor,INHIBITOR,104799.0,CHEMBL2095227,Vascular endothelial growth factor receptor,1,1,1,,
2341103,CHEMBL4303232,CEFOTIAM HYDROCHLORIDE,1694,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
2341159,CHEMBL4303288,ABACAVIR SULFATE,829,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,,
2341325,CHEMBL4303454,DORIPENEM MONOHYDRATE,9832,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
2341396,CHEMBL4303525,OMAVELOXOLONE,9217,Nuclear factor erythroid 2-related factor 2 activator,ACTIVATOR,103144.0,CHEMBL1075094,Nuclear factor erythroid 2-related factor 2,1,1,1,,
2341540,CHEMBL4303669,ZOLEDRONIC ACID,1049,Farnesyl diphosphate synthase inhibitor,INHIBITOR,71.0,CHEMBL1782,Farnesyl pyrophosphate synthase,1,1,1,"Binds to the bone matrix (hydroxyapatite), and when the bone starts to be reabsorbed the compound is released and taken up by osteoclasts, inhibiting protein prenylation of the GTPases involved in the formation of the ruffled border",
122252,CHEMBL431770,ISTRADEFYLLINE,5688,Adenosine A2a receptor antagonist,ANTAGONIST,252.0,CHEMBL251,Adenosine receptor A2a,1,1,1,,
1991,CHEMBL433,VALPROATE SODIUM,391,Succinate semialdehyde dehydrogenase inhibitor,INHIBITOR,283.0,CHEMBL1911,"Succinate-semialdehyde dehydrogenase, mitochondrial",1,1,1,,
63100,CHEMBL43452,POMALIDOMIDE,5877,CRL4(CRBN) E3 ubiquitin ligase inhibitor,INHIBITOR,116917.0,CHEMBL3833061,CRL4(CRBN) E3 ubiquitin ligase,1,1,1,,
2045,CHEMBL435,HYDROCHLOROTHIAZIDE,350,Thiazide-sensitive sodium-chloride cotransporter inhibitor,INHIBITOR,151.0,CHEMBL1876,Solute carrier family 12 member 3,1,1,1,,
317541,CHEMBL435298,ESFLURBIPROFEN,7550,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
2084,CHEMBL436,TOLRESTAT,6313,Aldose reductase inhibitor,INHIBITOR,242.0,CHEMBL1900,Aldo-keto reductase family 1 member B1,1,1,1,"It reduces the flux of glucose through the polyol pathway, inhibiting tissue accumulation of sorbitol and fructose and preventing reduction of redox potentials.","Tolrestat inhibited in dose-dependent fashion the aldose reductase from bovine lenses (IC50, 3.5 X 10(-8) mol/L) and the formation of sorbitol in human red blood cells incubated with glucose (IC50, 3 X 10(-8) mol/L)"
2095,CHEMBL437,SULFATHIAZOLE,1645,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,
610112,CHEMBL43708,IMIPENEM,1732,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,Lethal effect due to binding PBP 2 and PBP 1B in Enterobacteriaceae and Pseudomonas aeruginosa,
2130,CHEMBL438,SULFAMERAZINE,1657,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,Broad spectrum
2131,CHEMBL439,SULFADIAZINE,1660,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,Broad spectrum
54825,CHEMBL441738,AFAMELANOTIDE,7660,Melanocortin receptor 1 agonist,AGONIST,11869.0,CHEMBL3795,Melanocyte-stimulating hormone receptor,1,1,1,"Structural analog of -melanocyte stimulating hormone (-MSH), increases production of eumelanin in the skin.",Binds predominantly to MCR-1.
2247,CHEMBL443,SULFAMETHOXAZOLE,1653,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,Broad spectrum
353270,CHEMBL443052,TAVABOROLE,2292,Leucine-tRNA ligase inhibitor,INHIBITOR,108436.0,CHEMBL3307222,Leucine-tRNA ligase,1,1,1,,
2342179,CHEMBL4435170,DEUCRAVACITINIB,8904,Tyrosine-protein kinase TYK2 negative allosteric modulator,NEGATIVE ALLOSTERIC MODULATOR,12694.0,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,1,1,1,,
61682,CHEMBL44354,CEFTAZIDIME,1721,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
397074,CHEMBL444633,RIFABUTIN,1387,Bacterial DNA-directed RNA polymerase inhibitor,INHIBITOR,106172.0,CHEMBL2364672,Bacterial DNA-directed RNA polymerase,1,1,1,,
2365285,CHEMBL4458276,ENMETAZOBACTAM,9983,Bacterial beta-lactamase TEM inhibitor,INHIBITOR,106170.0,CHEMBL2364670,Beta-lactamase TEM,1,1,1,,
2265,CHEMBL446,SULFAMETHAZINE,1647,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,Broad spectrum
68607,CHEMBL44657,ETOPOSIDE,1209,DNA topoisomerase II inhibitor,INHIBITOR,104727.0,CHEMBL2094255,DNA topoisomerase II,1,1,1,,
2327,CHEMBL448,PENTOBARBITAL,1618,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
3012,CHEMBL45,MELATONIN,7514,Melatonin receptor agonist,AGONIST,104733.0,CHEMBL2094268,Melatonin receptor,1,1,1,Sleep promoting activity.,"Active at the MT1, MT2 and MT3 receptors but the MT1 and MT2 are thought to be most relevant to the mechanism of action."
2408,CHEMBL450,METHARBITAL,1610,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
493099,CHEMBL450449,TRABECTEDIN,2415,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,Alkylating agent,
2431,CHEMBL451,CHLORDIAZEPOXIDE,1590,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
520664,CHEMBL451887,CARFILZOMIB,1430,26S proteasome inhibitor,INHIBITOR,106197.0,CHEMBL2364701,26S proteasome,1,1,1,,
484950,CHEMBL451930,PLITIDEPSIN,8914,Elongation factor 1-alpha 2 inhibitor,INHIBITOR,104202.0,CHEMBL1795122,Elongation factor 1-alpha 2,1,1,1,,
2465,CHEMBL452,CLONAZEPAM,1600,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
453046,CHEMBL452231,TENIPOSIDE,1210,DNA topoisomerase II inhibitor,INHIBITOR,104727.0,CHEMBL2094255,DNA topoisomerase II,1,1,1,,
2484,CHEMBL453,SULFISOXAZOLE,1658,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,Broad spectrum
2406188,CHEMBL4535757,SOTORASIB,8492,GTPase KRas inhibitor,INHIBITOR,105451.0,CHEMBL2189121,GTPase KRas,1,1,1,Covalent inhibitor,
2524,CHEMBL454,BUTALBITAL,1599,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
506444,CHEMBL454446,CEFDITOREN PIVOXIL,1724,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
455284,CHEMBL454950,TETRACYCLINE HYDROCHLORIDE,1768,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
2525,CHEMBL455,SULFACETAMIDE,1662,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,Broad spectrum
452239,CHEMBL455186,TREOSULFAN,9685,DNA cross-linking agent,CROSS-LINKING AGENT,105574.0,CHEMBL2311221,DNA,1,1,1,,
2428752,CHEMBL4558324,LAZERTINIB,9248,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,,
2428752,CHEMBL4558324,LAZERTINIB,9249,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,,
2428752,CHEMBL4558324,LAZERTINIB,9503,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,,
2429562,CHEMBL4559134,SELPERCATINIB,7624,Tyrosine-protein kinase receptor RET inhibitor,INHIBITOR,100079.0,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,1,1,1,,"Selpercatinib inhibited wild-type RET and multiple mutated RET isoforms (inc. RET V804M, and RET M918T). Mutations and rearrangements in RET can drive cancers. Selpercatinib also inhibited VEGFR1 and VEGFR3 (IC50 values 0.92 - 67.8 nM) and FGFR 1, 2, and 3 at higher concentrations. Active against RET in cell assays at 60-fold lower concentration than FGFR1/2 and 8-fold lower concentration than VEGFR3. "
2429562,CHEMBL4559134,SELPERCATINIB,7657,Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET inhibitor,INHIBITOR,109645.0,CHEMBL3430888,Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET,1,1,1,,"Selpercatinib inhibited wild-type RET and multiple mutated RET isoforms (inc. RET V804M, and RET M918T). Mutations and rearrangements in RET can drive cancers. Selpercatinib also inhibited VEGFR1 and VEGFR3 (IC50 values 0.92 - 67.8 nM) and FGFR 1, 2, and 3 at higher concentrations. Active against RET in cell assays at 60-fold lower concentration than FGFR1/2 and 8-fold lower concentration than VEGFR3. "
2429562,CHEMBL4559134,SELPERCATINIB,7658,Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RET inhibitor,INHIBITOR,109661.0,CHEMBL3430904,Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RET,1,1,1,,"Selpercatinib inhibited wild-type RET and multiple mutated RET isoforms (inc. RET V804M, and RET M918T). Mutations and rearrangements in RET can drive cancers. Selpercatinib also inhibited VEGFR1 and VEGFR3 (IC50 values 0.92 - 67.8 nM) and FGFR 1, 2, and 3 at higher concentrations. Active against RET in cell assays at 60-fold lower concentration than FGFR1/2 and 8-fold lower concentration than VEGFR3. "
2654,CHEMBL456,ETHACRYNIC ACID,338,Sodium-(potassium)-chloride cotransporter 2 inhibitor,INHIBITOR,167.0,CHEMBL1874,Solute carrier family 12 member 1,1,1,1,,
2994,CHEMBL457,GEMFIBROZIL,432,Peroxisome proliferator-activated receptor alpha agonist,AGONIST,163.0,CHEMBL239,Peroxisome proliferator-activated receptor alpha,1,1,1,,
2453082,CHEMBL4582651,PRALSETINIB,7700,Tyrosine-protein kinase receptor RET inhibitor,INHIBITOR,100079.0,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,1,1,1,"Inhibits wild-type and oncogenic RET fusions and mutations (CCDC6-RET, RET V804L, RET V804M, RET M918T) with IC50s < 0.5 nM. Mutations can drive tumorigenesis. ","Inhibits wild-type and oncogenic RET fusions and mutations (CCDC6-RET, KIF5B-RET, RET V804L, RET V804M, C634W, RET V804E and RET M918T). Also inhibited DDR1, TRKC, FLT3, JAK1-2, TRKA, VEGFR2, PDGFRb, and FGFR1 in vitro at clinically relevant concentrations. In cellular assays, inhibited RET at approximately 14-, 40-, and 12-fold lower concentrations than VEGFR2, FGFR2, and JAK2, respectively."
2453082,CHEMBL4582651,PRALSETINIB,7736,Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RET inhibitor,INHIBITOR,109661.0,CHEMBL3430904,Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RET,1,1,1,"Inhibits wild-type and oncogenic RET fusions and mutations (CCDC6-RET, RET V804L, RET V804M, RET M918T) with IC50s < 0.5 nM. Mutations can drive tumorigenesis. ","Inhibits wild-type and oncogenic RET fusions and mutations (CCDC6-RET, KIF5B-RET, RET V804L, RET V804M, C634W, RET V804E and RET M918T). Also inhibited DDR1, TRKC, FLT3, JAK1-2, TRKA, VEGFR2, PDGFRb, and FGFR1 in vitro at clinically relevant concentrations. In cellular assays, inhibited RET at approximately 14-, 40-, and 12-fold lower concentrations than VEGFR2, FGFR2, and JAK2, respectively."
2453082,CHEMBL4582651,PRALSETINIB,7737,Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET inhibitor,INHIBITOR,109645.0,CHEMBL3430888,Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET,1,1,1,"Inhibits wild-type and oncogenic RET fusions and mutations (CCDC6-RET, RET V804L, RET V804M, RET M918T) with IC50s < 0.5 nM. Mutations can drive tumorigenesis. ","Inhibits wild-type and oncogenic RET fusions and mutations (CCDC6-RET, KIF5B-RET, RET V804L, RET V804M, C634W, RET V804E and RET M918T). Also inhibited DDR1, TRKC, FLT3, JAK1-2, TRKA, VEGFR2, PDGFRb, and FGFR1 in vitro at clinically relevant concentrations. In cellular assays, inhibited RET at approximately 14-, 40-, and 12-fold lower concentrations than VEGFR2, FGFR2, and JAK2, respectively."
2456099,CHEMBL4585668,BELZUTIFAN,8567,Endothelial PAS domain-containing protein 1 inhibitor,INHIBITOR,104103.0,CHEMBL1744522,Endothelial PAS domain-containing protein 1,1,1,1,,
3730,CHEMBL459,METHYLDOPA,1147,Adrenergic receptor alpha-2 agonist,AGONIST,104743.0,CHEMBL2095158,Adrenergic receptor alpha-2,1,1,1,,
2464645,CHEMBL4594214,ZICONOTIDE,8560,Voltage-gated N-type calcium channel alpha-1B subunit blocker,BLOCKER,10511.0,CHEMBL4478,Voltage-dependent N-type calcium channel subunit alpha-1B,1,1,1,,
2464648,CHEMBL4594217,CANAGLIFLOZIN,939,Sodium/glucose cotransporter 2 inhibitor,INHIBITOR,20092.0,CHEMBL3884,Sodium/glucose cotransporter 2,1,1,1,,
2464661,CHEMBL4594230,LIPEGFILGRASTIM,5685,Granulocyte colony stimulating factor receptor agonist,AGONIST,207.0,CHEMBL1996,Granulocyte colony-stimulating factor receptor,1,1,1,,
2464673,CHEMBL4594242,CALCITONIN,6646,Calcitonin receptor agonist,AGONIST,119.0,CHEMBL1832,Calcitonin receptor,1,1,1,"Calcitonin acts to reduce blood calcium (Ca2+), opposing the effects of parathyroid hormone (PTH). More specifically, calcitonin lowers blood Ca2+ levels in two ways: Major effect: Inhibits osteoclast activity in bones. Minor effect: Inhibits renal tubular cell reabsorption of Ca2+ and phosphate, allowing them to be excreted in the urine.",
2464677,CHEMBL4594246,SULOPENEM ETZADROXIL,7840,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
2464679,CHEMBL4594248,CALCITONIN HUMAN,216,Calcitonin receptor agonist,AGONIST,119.0,CHEMBL1832,Calcitonin receptor,1,1,1,,
2464682,CHEMBL4594251,NETARSUDIL DIMESYLATE,6924,Rho-associated protein kinase inhibitor,INHIBITOR,104981.0,CHEMBL2111459,Rho-associated protein kinase,1,1,1,,
2464691,CHEMBL4594260,TAZEMETOSTAT HYDROBROMIDE,7484,Histone-lysine N-methyltransferase EZH2 inhibitor,INHIBITOR,105440.0,CHEMBL2189110,Histone-lysine N-methyltransferase EZH2,1,1,1,,Inhibits some EZH2 mutants including Y646X and A687V and inhibits EZH1 at an IC50 of 392 nM (36 x higher than for EZH2). 
2464693,CHEMBL4594262,AMLODIPINE BENZOATE,7608,Voltage-gated L-type calcium channel blocker,BLOCKER,104801.0,CHEMBL2095229,Voltage-gated L-type calcium channel,1,1,1,,
2464695,CHEMBL4594264,AIR POLYMER-TYPE A,8692,Ultrasound contrast agent,,,,,1,1,1,Intrauterine foam for use as an ultrasound contrast agent during visualisation of the fallopian tubes and peritoneal cavity for evaluation of fertility.,
2464696,CHEMBL4594265,GIVOSIRAN SODIUM,7659,5-aminolevulinate synthase mRNA RNAi inhibitor,RNAI INHIBITOR,118694.0,CHEMBL4296741,5-aminolevulinate synthase mRNA,1,1,1,"The double stranded RNA interferes with aminolevulinate synthase 1 mRNA in the liver, leading to it's degradation and therefore reduces levels of toxic metabolites (aminolevulinic acid and porphobilinogen) that would otherwise be produced by functional ALAS1.",
2464704,CHEMBL4594273,ELACESTRANT HYDROCHLORIDE,9606,Estrogen receptor alpha degrader,DEGRADER,19.0,CHEMBL206,Estrogen receptor,1,1,1,,
2464709,CHEMBL4594278,GEFAPIXANT CITRATE,9892,P2X purinoceptor 3 antagonist,ANTAGONIST,11904.0,CHEMBL2998,P2X purinoceptor 3,1,1,1,,
2464716,CHEMBL4594285,PADELIPORFIN POTASSIUM,9195,Vascular targeted photodynamic therapy,,,,,1,1,1,The compound becomes pharmaceutically active when illuminated by light to generate free radicals and other reactive species.,
2464718,CHEMBL4594287,ENSIFENTRINE,9523,Phosphodiesterase 4 inhibitor,INHIBITOR,104679.0,CHEMBL2093863,Phosphodiesterase 4,1,1,1,,
2464718,CHEMBL4594287,ENSIFENTRINE,9528,Phosphodiesterase 3 inhibitor,INHIBITOR,104707.0,CHEMBL2094125,Phosphodiesterase 3,1,1,1,,
2464719,CHEMBL4594288,LEVAMLODIPINE MALEATE,7618,Voltage-gated L-type calcium channel blocker,BLOCKER,104801.0,CHEMBL2095229,Voltage-gated L-type calcium channel,1,1,1,,
2464723,CHEMBL4594292,TEPOTINIB HYDROCHLORIDE,7764,Hepatocyte growth factor receptor inhibitor,INHIBITOR,11451.0,CHEMBL3717,Hepatocyte growth factor receptor,1,1,1,,
2464724,CHEMBL4594293,ACALABRUTINIB MALEATE,9590,Tyrosine-protein kinase BTK inhibitor,INHIBITOR,100097.0,CHEMBL5251,Tyrosine-protein kinase BTK,1,1,1,,
2464732,CHEMBL4594301,REMIMAZOLAM BESYLATE,7623,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,No clear selectivity between GABAA receptor subtypes
2464742,CHEMBL4594311,BETIBEGLOGENE AUTOTEMCEL,7685,Hemoglobin beta chain exogenous gene,EXOGENOUS GENE,11544.0,CHEMBL4331,Hemoglobin subunit beta,1,1,1,Provides a source of beta-globin.,
2464747,CHEMBL4594316,CROVALIMAB,8829,Complement C5 inhibitor,INHIBITOR,106142.0,CHEMBL2364163,Complement C5,1,1,1,,
2464751,CHEMBL4594320,AVALGLUCOSIDASE ALFA,9096,Glycogen hydrolytic enzyme,HYDROLYTIC ENZYME,120072.0,CHEMBL4662969,Glycogen,1,1,1,,
2464759,CHEMBL4594328,BEREMAGENE GEPERPAVEC,9917,Collagen alpha-1(VII) chain exogenous gene,EXOGENOUS GENE,121567.0,CHEMBL5498505,Collagen alpha-1(VII) chain,1,1,1,,
2464760,CHEMBL4594329,CIPAGLUCOSIDASE ALFA,9703,Glycogen hydrolytic enzyme,HYDROLYTIC ENZYME,120072.0,CHEMBL4662969,Glycogen,1,1,1,Provides an exogenous source of lysosomal acid alpha-glucosidase.,
2464763,CHEMBL4594332,DONISLECEL,9988,Somatic cell supplemental therapy,,,,,1,1,1,Allogeneic islets of Langerhans derived from a donor pancreas.,
2464764,CHEMBL4594333,ELIVALDOGENE AUTOTEMCEL,9729,ABCD1 exogenous gene,EXOGENOUS GENE,121129.0,CHEMBL5303722,ABCD1,1,1,1,Gene therapy.,
2464766,CHEMBL4594335,EPLONTERSEN SODIUM,9940,Transthyretin mRNA antisense inhibitor,ANTISENSE INHIBITOR,118393.0,CHEMBL4296221,Transthyretin mRNA,1,1,1,An antisense oligonucleotide-GalNAc conjugate,
2464769,CHEMBL4594338,NEDOSIRAN SODIUM,7914,L-lactate dehydrogenase A chain mRNA RNAi inhibitor,RNAI INHIBITOR,119793.0,CHEMBL4627242,L-lactate dehydrogenase A chain mRNA,1,1,1,,
2464781,CHEMBL4594350,ADAGRASIB,8840,GTPase KRas inhibitor,INHIBITOR,105451.0,CHEMBL2189121,GTPase KRas,1,1,1,,
2464810,CHEMBL4594379,FOSLEVODOPA,9952,Beta-1 adrenergic receptor agonist,AGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
2464813,CHEMBL4594382,DEURUXOLITINIB PHOSPHATE,9864,Tyrosine-protein kinase JAK3 inhibitor,INHIBITOR,10849.0,CHEMBL2148,Tyrosine-protein kinase JAK3,1,1,1,"Geater inhibitory potency for JAK1, JAK2 and TYK2 relative to JAK3.",
2464813,CHEMBL4594382,DEURUXOLITINIB PHOSPHATE,9908,Tyrosine-protein kinase JAK2 inhibitor,INHIBITOR,10938.0,CHEMBL2971,Tyrosine-protein kinase JAK2,1,1,1,,
2464813,CHEMBL4594382,DEURUXOLITINIB PHOSPHATE,9931,Tyrosine-protein kinase JAK1 inhibitor,INHIBITOR,10919.0,CHEMBL2835,Tyrosine-protein kinase JAK1,1,1,1,,
2464813,CHEMBL4594382,DEURUXOLITINIB PHOSPHATE,9953,Tyrosine-protein kinase TYK2 inhibitor,INHIBITOR,12694.0,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,1,1,1,,
2464814,CHEMBL4594383,PAFOLACIANINE SODIUM,9302,Diagnostic,,,,,1,1,1,,
2464819,CHEMBL4594388,ANSUVIMAB,7759,Envelope glycoprotein binding agent,BINDING AGENT,117434.0,CHEMBL4105829,Envelope glycoprotein,1,1,1,Binds the viral glycoprotein and prevents interaction with the host receptor.,
2464824,CHEMBL4594393,CALCIUM OXYBATE,7733,GABA-B receptor agonist,AGONIST,104988.0,CHEMBL2111463,GABA-B receptor,1,1,1,"Contains oxybate, a CNS depressant. Mechanism is not fully elucidated but proposed mechanism through GABAB.",
2464825,CHEMBL4594394,MAGNESIUM OXYBATE,7734,GABA-B receptor agonist,AGONIST,104988.0,CHEMBL2111463,GABA-B receptor,1,1,1,"Contains oxybate, a CNS depressant. Mechanism is not fully elucidated but proposed mechanism through GABAB.",
2464826,CHEMBL4594395,POTASSIUM OXYBATE,7735,GABA-B receptor agonist,AGONIST,104988.0,CHEMBL2111463,GABA-B receptor,1,1,1,"Contains oxybate, a CNS depressant. Mechanism is not fully elucidated but proposed mechanism through GABAB.",
2464837,CHEMBL4594406,LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN,9129,Glutamate carboxypeptidase II binding agent,BINDING AGENT,184.0,CHEMBL1892,Glutamate carboxypeptidase 2,1,1,1,,
2464837,CHEMBL4594406,LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN,9283,DNA disrupting agent,DISRUPTING AGENT,105574.0,CHEMBL2311221,DNA,1,1,1,,
2464842,CHEMBL4594411,"XENON XE-129, HYPERPOLARIZED",9629,MRI contrast agent,,,,,1,1,1,,
2464869,CHEMBL4594438,LENACAPAVIR,8789,Structural capsid protein inhibitor,INHIBITOR,106648.0,CHEMBL2366504,Structural capsid protein,1,1,1,,
2464879,CHEMBL4594448,IPTACOPAN,7909,Complement factor B inhibitor,INHIBITOR,101521.0,CHEMBL5731,Complement factor B,1,1,1,,
2464934,CHEMBL4594503,TALQUETAMAB,8787,T cell surface glycoprotein CD3 binding agent,BINDING AGENT,106147.0,CHEMBL2364168,T cell surface glycoprotein CD3,1,1,1,Directs cytotoxic T-cells to tumours,
2464934,CHEMBL4594503,TALQUETAMAB,8966,G-protein coupled receptor family C group 5 member D binding agent,BINDING AGENT,119642.0,CHEMBL4523925,G-protein coupled receptor family C group 5 member D,1,1,1,Directs cytotoxic T-cells to tumours,
2464936,CHEMBL4594505,TECLISTAMAB,8687,T cell surface glycoprotein CD3 binding agent,BINDING AGENT,106147.0,CHEMBL2364168,T cell surface glycoprotein CD3,1,1,1,Directs cytotoxic T-cells to tumours,
2464936,CHEMBL4594505,TECLISTAMAB,8929,Tumor necrosis factor receptor superfamily member 17 binding agent,BINDING AGENT,119306.0,CHEMBL4523587,Tumor necrosis factor receptor superfamily member 17,1,1,1,Directs cytotoxic T-cells to tumours,
2464942,CHEMBL4594511,VUTRISIRAN,9589,Transthyretin mRNA rnai inhibitor,RNAI INHIBITOR,118393.0,CHEMBL4296221,Transthyretin mRNA,1,1,1,,
2464966,CHEMBL4594535,SUGEMALIMAB,7791,Programmed cell death 1 ligand 1 binding agent,BINDING AGENT,109807.0,CHEMBL3580522,Programmed cell death 1 ligand 1,1,1,1,,
2465012,CHEMBL4594581,INSULIN ICODEC,9977,Insulin receptor agonist,AGONIST,35.0,CHEMBL1981,Insulin receptor,1,1,1,,
2465015,CHEMBL4594584,"ANTIHEMOPHILIC FACTOR, PEGYLATED (MW 20000) HUMAN SEQUENCE RECOMBINANT",9258,Coagulation factor VIII exogenous protein,EXOGENOUS PROTEIN,10210.0,CHEMBL3143,Coagulation factor VIII,1,1,1,,
2465029,CHEMBL4594598,EFTRENONACOG ALFA,9208,Coagulation factor IX exogenous protein,EXOGENOUS PROTEIN,193.0,CHEMBL2016,Coagulation factor IX,1,1,1,,
2465034,CHEMBL4594603,LONOCTOCOG ALFA,9647,Coagulation factor VIII exogenous protein,EXOGENOUS PROTEIN,10210.0,CHEMBL3143,Coagulation factor VIII,1,1,1,,
2465038,CHEMBL4594607,APADAMTASE ALFA,9984,A disintegrin and metalloproteinase with thrombospondin motifs 13 exogenous protein,EXOGENOUS PROTEIN,105680.0,CHEMBL2346492,A disintegrin and metalloproteinase with thrombospondin motifs 13,1,1,1,,
2465039,CHEMBL4594608,AXATILIMAB,8708,Macrophage colony stimulating factor receptor inhibitor,INHIBITOR,12840.0,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,1,1,1,,
2465049,CHEMBL4594618,BREXUCABTAGENE AUTOLEUCEL,7686,B-lymphocyte antigen CD19 binding agent,BINDING AGENT,109546.0,CHEMBL3390821,B-lymphocyte antigen CD19,1,1,1,A patients T-cells are harvested and modified to express a CAR comprising an anti-CD19 fragment linked to CD28 and CD3-zeta co-stimulatory domains. Re-introduced cells recognize and eliminate CD19-expressing target cells inc. cancer cells.,
3183,CHEMBL46,ONDANSETRON,374,Serotonin 3a (5-HT3a) receptor antagonist,ANTAGONIST,144.0,CHEMBL1899,5-hydroxytryptamine receptor 3A,1,1,1,,Selective
452538,CHEMBL462547,URETHANE,6319,Excipient,,,,,1,1,1,,
454365,CHEMBL462605,PITOLISANT,5381,Histamine H3 receptor inverse agonist,INVERSE AGONIST,10280.0,CHEMBL264,Histamine H3 receptor,1,1,1,,
69277,CHEMBL46286,OMACETAXINE MEPESUCCINATE,2216,Protein synthesis inhibitor,,,,,1,1,1,Inhibition of protein synthesis independent of direct BCR-ABL binding,
4193,CHEMBL464,ETRETINATE,1579,Retinoid receptor agonist,AGONIST,105766.0,CHEMBL2363071,Retinoid receptor,1,1,1,Precise mechanism uncertain. RARG/RXRA are predominant forms in skin,
4496,CHEMBL465,DRONABINOL,1466,Cannabinoid CB1 receptor agonist,AGONIST,87.0,CHEMBL218,Cannabinoid receptor 1,1,1,1,CB1 mediates the effect in appetite stimulation,
2486475,CHEMBL4650215,INAVOLISIB,8223,PI3-kinase p110-alpha subunit inhibitor,INHIBITOR,11362.0,CHEMBL4005,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",1,1,1,,
2486476,CHEMBL4650216,DARIDOREXANT HYDROCHLORIDE,9585,Orexin receptor 1 antagonist,ANTAGONIST,10009.0,CHEMBL5113,Orexin/Hypocretin receptor type 1,1,1,1,,
2486476,CHEMBL4650216,DARIDOREXANT HYDROCHLORIDE,9586,Orexin receptor 2 antagonist,ANTAGONIST,12968.0,CHEMBL4792,Orexin receptor type 2,1,1,1,,
2486480,CHEMBL4650220,ZAVEGEPANT HYDROCHLORIDE,9614,Calcitonin gene-related peptide type 1 receptor antagonist,ANTAGONIST,19904.0,CHEMBL3798,Calcitonin gene-related peptide type 1 receptor,1,1,1,,
2486486,CHEMBL4650226,ACORAMIDIS HYDROCHLORIDE,9865,Transthyretin stabiliser,STABILISER,12704.0,CHEMBL3194,Transthyretin,1,1,1,,
2486501,CHEMBL4650241,DELANDISTROGENE MOXEPARVOVEC,10028,Dystrophin exogenous gene,EXOGENOUS GENE,121566.0,CHEMBL5498504,Dystrophin,1,1,1,,
2486516,CHEMBL4650256,ZANIDATAMAB,9309,Receptor protein-tyrosine kinase erbB-2 inhibitor,INHIBITOR,188.0,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,1,1,1,,
2486529,CHEMBL4650269,LOVOTIBEGLOGENE AUTOTEMCEL,9934,Hemoglobin beta chain exogenous gene,EXOGENOUS GENE,11544.0,CHEMBL4331,Hemoglobin subunit beta,1,1,1,Autologous genome edited cell therapy,
2486532,CHEMBL4650272,TRILACICLIB DIHYDROCHLORIDE,8552,Cyclin-dependent kinase 6 inhibitor,INHIBITOR,10480.0,CHEMBL2508,Cyclin-dependent kinase 6,1,1,1,Myeloprotection therapy,
2486532,CHEMBL4650272,TRILACICLIB DIHYDROCHLORIDE,8608,Cyclin-dependent kinase 4 inhibitor,INHIBITOR,12946.0,CHEMBL331,Cyclin-dependent kinase 4,1,1,1,Myeloprotection therapy,
2486533,CHEMBL4650273,SETMELANOTIDE ACETATE,8553,Melanocortin receptor 4 agonist,AGONIST,10142.0,CHEMBL259,Melanocortin receptor 4,1,1,1,Peptide,20-fold less active at the melanocortin 3 and melanocortin 1 receptors.
2486534,CHEMBL4650274,DASIGLUCAGON HYDROCHLORIDE,8550,Glucagon receptor agonist,AGONIST,146.0,CHEMBL1985,Glucagon receptor,1,1,1,,
2486535,CHEMBL4650275,LUMASIRAN SODIUM,8554,Hydroxyacid oxidase 1 mRNA RNAi inhibitor,RNAI INHIBITOR,119772.0,CHEMBL4524134,Hydroxyacid oxidase 1 mRNA,1,1,1,,
2486559,CHEMBL4650299,HEPARIN,9504,Antithrombin-III activator,ACTIVATOR,16.0,CHEMBL1950,Antithrombin-III,1,1,1,,
2486579,CHEMBL4650319,MOBOCERTINIB,9098,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,,"Inhibits EGFR exon 20 insertion mutants at lower concentrations than wild type. Also inhibits HER2, HER4 and BLK kinases."
2486653,CHEMBL4650393,EPCORITAMAB,8681,B-lymphocyte antigen CD20 binding agent,BINDING AGENT,181.0,CHEMBL2058,B-lymphocyte antigen CD20,1,1,1,Directs cytotoxic T-cells to tumours,
2486653,CHEMBL4650393,EPCORITAMAB,8882,T cell surface glycoprotein CD3 binding agent,BINDING AGENT,106147.0,CHEMBL2364168,T cell surface glycoprotein CD3,1,1,1,Directs cytotoxic T-cells to tumours,
2486689,CHEMBL4650429,TOZINAMERAN,9871,Spike glycoprotein vaccine antigen,VACCINE ANTIGEN,120055.0,CHEMBL4662936,Spike glycoprotein,1,1,1,,
2486722,CHEMBL4650462,REGDANVIMAB,9483,Spike glycoprotein inhibitor,INHIBITOR,120055.0,CHEMBL4662936,Spike glycoprotein,1,1,1,,
2486745,CHEMBL4650485,PIRTOBRUTINIB,8956,Tyrosine-protein kinase BTK inhibitor,INHIBITOR,100097.0,CHEMBL5251,Tyrosine-protein kinase BTK,1,1,1,,
2486751,CHEMBL4650491,ELASOMERAN,9541,Spike glycoprotein vaccine antigen,VACCINE ANTIGEN,120055.0,CHEMBL4662936,Spike glycoprotein,1,1,1,,
2486784,CHEMBL4650524,SOTROVIMAB,9105,Spike glycoprotein inhibitor,INHIBITOR,120055.0,CHEMBL4662936,Spike glycoprotein,1,1,1,,
4730,CHEMBL467,HYDROXYUREA,1258,Ribonucleoside-diphosphate reductase RR1 inhibitor,INHIBITOR,104791.0,CHEMBL2095215,Ribonucleoside-diphosphate reductase RR1,1,1,1,,
479445,CHEMBL467058,LANINAMIVIR OCTANOATE,7546,Neuraminidase inhibitor,INHIBITOR,102438.0,CHEMBL6135,Neuraminidase,1,1,1,,
479445,CHEMBL467058,LANINAMIVIR OCTANOATE,7547,Neuraminidase inhibitor,INHIBITOR,10738.0,CHEMBL3377,Neuraminidase,1,1,1,,
5028,CHEMBL468,THALIDOMIDE,5875,CRL4(CRBN) E3 ubiquitin ligase inhibitor,INHIBITOR,116917.0,CHEMBL3833061,CRL4(CRBN) E3 ubiquitin ligase,1,1,1,,
448872,CHEMBL471737,IVABRADINE,7273,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker,BLOCKER,103531.0,CHEMBL1250417,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,1,1,1,,
5582,CHEMBL472,GLYBURIDE,1246,"Sulfonylurea receptor 1, Kir6.2 blocker",BLOCKER,104852.0,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",1,1,1,,
5638,CHEMBL473,DOFETILIDE,500,HERG blocker,BLOCKER,165.0,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,1,1,1,,
460092,CHEMBL473417,VISMODEGIB,1030,Smoothened homolog inhibitor,INHIBITOR,101400.0,CHEMBL5971,Protein smoothened,1,1,1,,
5772,CHEMBL476,DACARBAZINE,1868,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
490151,CHEMBL476960,VOGLIBOSE,5898,Alpha glucosidase inhibitor,INHIBITOR,116927.0,CHEMBL3833502,Alpha glucosidase,1,1,1,"Voglibose inhibits, in a competitive way, maltase and sucrase enzymes (alpha-glucosidases) in the small intestine (IC50=0.015uM for maltase enzymes and 0.0046uM for sucrase enzymes).  This prevents the breakdown of larger carbohydrates into glucose and decreases the rise in postprandial blood glucose levels.",
5797,CHEMBL477,ADENOSINE,1215,Adenosine receptor agonist,AGONIST,105024.0,CHEMBL2111329,Adenosine receptor,1,1,1,,
5970,CHEMBL479,THIORIDAZINE,606,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
5970,CHEMBL479,THIORIDAZINE,624,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
5970,CHEMBL479,THIORIDAZINE,2019,D2-like dopamine receptor antagonist,ANTAGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
5975,CHEMBL480,LANSOPRAZOLE,1085,Potassium-transporting ATPase inhibitor,INHIBITOR,104758.0,CHEMBL2095173,Potassium-transporting ATPase,1,1,1,,
2537381,CHEMBL4802130,BELUMOSUDIL MESYLATE,8780,Rho-associated protein kinase inhibitor,INHIBITOR,104981.0,CHEMBL2111459,Rho-associated protein kinase,1,1,1,,Higher potency against ROCK2 vs. ROCK1
2537386,CHEMBL4802135,NIRMATRELVIR,9615,SARS coronavirus 3C-like proteinase inhibitor,INHIBITOR,20012.0,CHEMBL3927,Replicase polyprotein 1a,1,1,1,,
2537474,CHEMBL4802223,LEUPROLIDE MESYLATE,8996,Gonadotropin-releasing hormone receptor agonist,AGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,,
2537475,CHEMBL4802224,FERRIC OXYHYDROXIDE,2255,Phosphate sequestering agent,SEQUESTERING AGENT,106163.0,CHEMBL2364184,Phosphate,1,1,1,It is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis,
2537490,CHEMBL4802239,MOBOCERTINIB SUCCINATE,9502,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,,"Inhibits EGFR exon 20 insertion mutants at lower concentrations than wild type. Also inhibits HER2, HER4 and BLK kinases."
2537491,CHEMBL4802240,FOSCARBIDOPA,9859,DOPA decarboxylase inhibitor,INHIBITOR,83.0,CHEMBL1843,Aromatic-L-amino-acid decarboxylase,1,1,1,,
2537500,CHEMBL4802249,LENACAPAVIR SODIUM,9618,Structural capsid protein inhibitor,INHIBITOR,106648.0,CHEMBL2366504,Structural capsid protein,1,1,1,,
2537505,CHEMBL4802254,AFAMITRESGENE AUTOLEUCEL,10001,Melanoma-associated antigen 4 binding agent,BINDING AGENT,118267.0,CHEMBL4296022,Melanoma-associated antigen 4,1,1,1,T cell immunotherapy product consisting of genetically modified autologous CD4 and CD8 positive T cells.,
2537513,CHEMBL4802262,ATIDARSAGENE AUTOTEMCEL,9728,ARSA exogenous gene,EXOGENOUS GENE,121128.0,CHEMBL5303721,ARSA,1,1,1,Gene therapy.,
2537514,CHEMBL4802263,CILTACABTAGENE AUTOLEUCEL,9620,Tumor necrosis factor receptor superfamily member 17 binding agent,BINDING AGENT,119306.0,CHEMBL4523587,Tumor necrosis factor receptor superfamily member 17,1,1,1,"Patient derived T cells with a transgene encoding a chimeric antigen receptor (CAR) against B-cell maturation antigen (BCMA or BCM), also known as tumor necrosis factor receptor superfamily member 17 (TNFRSF17)",
520269,CHEMBL484785,CRISABOROLE,5821,Phosphodiesterase 4 inhibitor,INHIBITOR,104679.0,CHEMBL2093863,Phosphodiesterase 4,1,1,1,,
76760,CHEMBL48582,SAFINAMIDE MESYLATE,6163,Monoamine oxidase B inhibitor,INHIBITOR,104.0,CHEMBL2039,Amine oxidase [flavin-containing] B,1,1,1,Highly selective and reversible MAO-B inhibitor ,
6317,CHEMBL488,AMINOGLUTETHIMIDE,526,Cytochrome P450 19A1 inhibitor,INHIBITOR,65.0,CHEMBL1978,Aromatase,1,1,1,,
6317,CHEMBL488,AMINOGLUTETHIMIDE,758,Cytochrome P450 11A1 inhibitor,INHIBITOR,32.0,CHEMBL2033,"Cholesterol side-chain cleavage enzyme, mitochondrial",1,1,1,,
514258,CHEMBL490665,NALFURAFINE HYDROCHLORIDE,5748,Kappa opioid receptor agonist,AGONIST,137.0,CHEMBL237,Kappa-type opioid receptor,1,1,1,,
460466,CHEMBL491571,DORIPENEM,1716,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
7494,CHEMBL494,ILOPROST,665,Prostanoid IP receptor agonist,AGONIST,143.0,CHEMBL1995,Prostacyclin receptor,1,1,1,,
8130,CHEMBL495,ALPROSTADIL,120,Prostanoid EP1 receptor agonist,AGONIST,261.0,CHEMBL1811,Prostaglandin E2 receptor EP1 subtype,1,1,1,,
8130,CHEMBL495,ALPROSTADIL,358,Prostanoid EP2 receptor agonist,AGONIST,142.0,CHEMBL1881,Prostaglandin E2 receptor EP2 subtype,1,1,1,,
8167,CHEMBL496,HEXACHLOROPHENE,1399,Bacterial enoyl-[acyl-carrier-protein] reductase inhibitor,INHIBITOR,106178.0,CHEMBL2364678,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,1,1,1,,Broad spectrum
8193,CHEMBL497,CLIOQUINOL,1558,Zinc chelating agent,CHELATING AGENT,105751.0,CHEMBL2363056,Zinc,1,1,1,"Used as antibiotic against diarrhea in the 70s, but nowadays considered in cancer treatments (off-label), for its chelator and ionophore properties with capacity to inhibit proteosome",
8193,CHEMBL497,CLIOQUINOL,1561,Copper chelating agent,CHELATING AGENT,105752.0,CHEMBL2363057,Copper,1,1,1,"Used as antibiotic against diarrhea in the 70s, but nowadays considered in cancer treatments (off-label), for its chelator and ionophore properties with capacity to inhibit proteosome",
8193,CHEMBL497,CLIOQUINOL,1564,Iron chelating agent,CHELATING AGENT,105753.0,CHEMBL2363058,Iron,1,1,1,"Used as antibiotic against diarrhea in the 70s, but nowadays considered in cancer treatments (off-label), for its chelator and ionophore properties with capacity to inhibit proteosome",
8516,CHEMBL498,CHLORPROPAMIDE,1247,"Sulfonylurea receptor 1, Kir6.2 blocker",BLOCKER,104852.0,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",1,1,1,,
497784,CHEMBL498847,SECNIDAZOLE,6916,DNA inhibitor,INHIBITOR,106020.0,CHEMBL2364041,DNA,1,1,1,Enters bacterial cell as an inactive prodrug where the nitro group is reduced by bacterial enzymes to radical anions. It is believed that these radical anions interfere with bacterial DNA synthesis,
8531,CHEMBL499,TIMOLOL,331,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
8531,CHEMBL499,TIMOLOL,1365,Beta-2 adrenergic receptor antagonist,ANTAGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
147,CHEMBL5,NALIDIXIC ACID,1905,Bacterial DNA gyrase inhibitor,INHIBITOR,105577.0,CHEMBL2311224,Bacterial DNA gyrase,1,1,1,,
8543,CHEMBL500,PINDOLOL,316,Beta-1 adrenergic receptor partial agonist,PARTIAL AGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
8543,CHEMBL500,PINDOLOL,1360,Beta-2 adrenergic receptor partial agonist,PARTIAL AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
469705,CHEMBL500576,TEMOPORFIN,5889,Photosensitizer,,,,,1,1,1,"Temoporfin is taken up by tumor cells. Its activity is initiated by photoactivation with non-thermal light at a wavelength of 652 nm. The cytotoxic effect is mediated through the generation of highly reactive oxygen species, such as singlet oxygen, resulting from intracellular interaction of temoporn with light and oxygen.  These reactive oxygen species cause the  loss of cell viability.",
8838,CHEMBL501,AMPHETAMINE SULFATE,688,Dopamine transporter releasing agent,RELEASING AGENT,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
8838,CHEMBL501,AMPHETAMINE SULFATE,900,Norepinephrine transporter releasing agent,RELEASING AGENT,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
497230,CHEMBL501122,CEFTAROLINE FOSAMIL,9866,Penicillin-binding protein 2a inhibitor,INHIBITOR,19669.0,CHEMBL3512,Penicillin-binding protein 2a,1,1,1,,
497230,CHEMBL501122,CEFTAROLINE FOSAMIL,9936,Penicillin-binding protein 2x inhibitor,INHIBITOR,102467.0,CHEMBL6188,Penicillin-binding protein 2x,1,1,1,,
497230,CHEMBL501122,CEFTAROLINE FOSAMIL,10004,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
490427,CHEMBL501867,VINCRISTINE SULFATE,1108,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,,
456123,CHEMBL502097,MIPOMERSEN SODIUM,2094,Apo-B 100 mRNA antisense inhibitor,ANTISENSE INHIBITOR,106164.0,CHEMBL2364185,Apo-B 100 mRNA,1,1,1,"It's an antisense oligonucleotide against apo b-100, the principal apoliprotein of LDL and its metabolic precursor VLDL",
515206,CHEMBL502182,ELAGOLIX SODIUM,7403,Gonadotropin-releasing hormone receptor antagonist,ANTAGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,Reduces GnRH signalling and ultimately decreases levels of the ovarian sex hormones.,
9495,CHEMBL503,LOVASTATIN,1052,HMG-CoA reductase inhibitor,INHIBITOR,24.0,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,1,1,1,,
2739480,CHEMBL5095049,PACRITINIB CITRATE,9591,Tyrosine-protein kinase JAK2 inhibitor,INHIBITOR,10938.0,CHEMBL2971,Tyrosine-protein kinase JAK2,1,1,1,,
2739480,CHEMBL5095049,PACRITINIB CITRATE,9592,Tyrosine-protein kinase receptor FLT3 inhibitor,INHIBITOR,12670.0,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,1,1,1,,
2739480,CHEMBL5095049,PACRITINIB CITRATE,9593,Tyrosine-protein kinase JAK2 inhibitor,INHIBITOR,10938.0,CHEMBL2971,Tyrosine-protein kinase JAK2,1,1,1,,
2739480,CHEMBL5095049,PACRITINIB CITRATE,10133,Activin receptor type-1 inhibitor,INHIBITOR,101598.0,CHEMBL5903,Activin receptor type-1,1,1,1,,
2739480,CHEMBL5095049,PACRITINIB CITRATE,10134,Interleukin-1 receptor-associated kinase 1 inhibitor,INHIBITOR,19623.0,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,1,1,1,,
2739481,CHEMBL5095050,FINGOLIMOD LAURYL SULFATE,9596,Sphingosine 1-phosphate receptor binding agent,BINDING AGENT,105736.0,CHEMBL2363041,Sphingosine 1-phosphate receptor,1,1,1,,
2739483,CHEMBL5095052,INCLISIRAN SODIUM,9587,PCSK9 mRNA rnai inhibitor,RNAI INHIBITOR,119803.0,CHEMBL4630662,PCSK9 mRNA,1,1,1,,
2739706,CHEMBL5095275,EFANESOCTOCOG ALFA,9995,Coagulation factor VIII exogenous protein,EXOGENOUS PROTEIN,10210.0,CHEMBL3143,Coagulation factor VIII,1,1,1,,
2739723,CHEMBL5095292,TARLATAMAB,9945,T cell surface glycoprotein CD3 binding agent,BINDING AGENT,106147.0,CHEMBL2364168,T cell surface glycoprotein CD3,1,1,1,,
2739723,CHEMBL5095292,TARLATAMAB,10035,Delta-like protein 3 binding agent,BINDING AGENT,119981.0,CHEMBL4630888,Delta-like protein 3,1,1,1,,
2739734,CHEMBL5095303,VUTRISIRAN SODIUM,9619,Transthyretin mRNA rnai inhibitor,RNAI INHIBITOR,118393.0,CHEMBL4296221,Transthyretin mRNA,1,1,1,,
2739832,CHEMBL5095401,IPTACOPAN HYDROCHLORIDE,9957,Complement factor B inhibitor,INHIBITOR,101521.0,CHEMBL5731,Complement factor B,1,1,1,,
2739851,CHEMBL5095420,TRIENTINE TETRAHYDROCHLORIDE,9584,Copper chelating agent,CHELATING AGENT,105752.0,CHEMBL2363057,Copper,1,1,1,,
2739871,CHEMBL5095440,OBECABTAGENE AUTOLEUCEL,9893,B-lymphocyte antigen CD19 binding agent,BINDING AGENT,109546.0,CHEMBL3390821,B-lymphocyte antigen CD19,1,1,1,,
2739882,CHEMBL5095451,ETRANACOGENE DEZAPARVOVEC,9611,Coagulation factor IX exogenous protein,EXOGENOUS PROTEIN,193.0,CHEMBL2016,Coagulation factor IX,1,1,1,AAV5 based vector containing a codon-optimised cDNA of the human coagulation Factor IX variant R338L (FIX-Padua) gene under the control of a liver-specific promoter (LP1),
2739905,CHEMBL5095474,EXAGAMGLOGENE AUTOTEMCEL,9922,B-cell lymphoma/leukemia 11A gene editing negative modulator,GENE EDITING NEGATIVE MODULATOR,121564.0,CHEMBL5498502,B-cell lymphoma/leukemia 11A,1,1,1,Autologous CD34+ cell enriched population with a CRISPR/Cas9 mediated DNA double-strand break at the enhancer region of the BCL11A. Reduced BCL11A expression results in an increase in gamma-globin expression and foetal haemoglobin (HbF) protein production.,
2739906,CHEMBL5095475,PALOPEGTERIPARATIDE,9927,Parathyroid hormone receptor agonist,AGONIST,160.0,CHEMBL1793,Parathyroid hormone/parathyroid hormone-related peptide receptor,1,1,1,Prodrug of teriparatide (md_id 10928),
2739906,CHEMBL5095475,PALOPEGTERIPARATIDE,9951,Parathyroid hormone receptor agonist,AGONIST,160.0,CHEMBL1793,Parathyroid hormone/parathyroid hormone-related peptide receptor,1,1,1,,
446784,CHEMBL511142,BUPRENORPHINE,733,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
446784,CHEMBL511142,BUPRENORPHINE,1311,Kappa opioid receptor agonist,AGONIST,137.0,CHEMBL237,Kappa-type opioid receptor,1,1,1,,
459679,CHEMBL512351,BETRIXABAN,5586,Coagulation factor X inhibitor,INHIBITOR,194.0,CHEMBL244,Coagulation factor X,1,1,1,,
10840,CHEMBL513,CARMUSTINE,933,Glutathione reductase inhibitor,INHIBITOR,12642.0,CHEMBL2755,"Glutathione reductase, mitochondrial",1,1,1,,
10840,CHEMBL513,CARMUSTINE,1882,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
10840,CHEMBL513,CARMUSTINE,1892,RNA inhibitor,INHIBITOR,105575.0,CHEMBL2311222,RNA,1,1,1,,
10898,CHEMBL514,LOMUSTINE,1852,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
458773,CHEMBL514800,APREMILAST,2264,Phosphodiesterase 4 inhibitor,INHIBITOR,104679.0,CHEMBL2093863,Phosphodiesterase 4,1,1,1,,Selective
11002,CHEMBL515,CHLORAMBUCIL,1859,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,Alkylating agent,
460014,CHEMBL515387,GOSOGLIPTIN,5599,Dipeptidyl peptidase IV inhibitor,INHIBITOR,11140.0,CHEMBL284,Dipeptidyl peptidase 4,1,1,1,,
519284,CHEMBL515408,MARIBAVIR,5896,Serine/threonine-protein kinase BGLF4 inhibitor,INHIBITOR,116924.0,CHEMBL3833483,Serine/threonine-protein kinase BGLF4,1,1,1,"Inhibits the Epstein-Barr virus (EBV) protein kinase (BGLF4), resulting in inhibition of phosphorylation of the EBV DNA processivity factor BMRF1.",
519284,CHEMBL515408,MARIBAVIR,5920,Phosphotransferase pUL97 inhibitor,INHIBITOR,103610.0,CHEMBL1287608,Serine/threonine protein kinase UL97,1,1,1,"Inhibits viral DNA synthesis by inhibiting UL97 protein kinase activity. More specifically, it inhibits UL97s mediated phosphorylation of nuclear Lamin A/C.",
453649,CHEMBL515914,AZARIBINE,6205,Uridine 5'-monophosphate synthase inhibitor,INHIBITOR,101114.0,CHEMBL5216,Uridine 5'-monophosphate synthase,1,1,1,"The primary action of this compound is related to the activity of the nucleoside 6-azauridine, which is a structural analog of uridine. In mammalian systems, 6-azauridine, after its metabolic conversion to 6-azauridine-5-phosphate, competitively inhibits intracellular pyrimidine nucleotide synthesis. The mechanism of inhibition is related to a competition beween orotidine-5'-phosphate and 6-azauridine-5'-phosphate for the enzyme orotidylate decarboxylase.",
445395,CHEMBL517712,ATROPINE,31,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for mydriasis and regulating gastric secretion, M3 likely involved (main form in iris)",
445395,CHEMBL517712,ATROPINE,289,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Role in regulating gastric secretion, M1 likely involved",
445395,CHEMBL517712,ATROPINE,1510,Muscarinic acetylcholine receptor M2 antagonist,ANTAGONIST,47.0,CHEMBL211,Muscarinic acetylcholine receptor M2,1,1,1,"Indicated for bradycardia, M2 likely responsible",
470800,CHEMBL518520,RALTEGRAVIR POTASSIUM,946,Human immunodeficiency virus type 1 integrase inhibitor,INHIBITOR,12456.0,CHEMBL3471,Human immunodeficiency virus type 1 integrase,1,1,1,,
508408,CHEMBL518924,MAVORIXAFOR,8514,C-X-C chemokine receptor type 4 antagonist,ANTAGONIST,10473.0,CHEMBL2107,C-X-C chemokine receptor type 4,1,1,1,,
11674,CHEMBL521,IBUPROFEN,1180,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
461225,CHEMBL521606,NADOLOL,320,Beta-1 adrenergic receptor antagonist,ANTAGONIST,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
461225,CHEMBL521606,NADOLOL,1354,Beta-2 adrenergic receptor antagonist,ANTAGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
469866,CHEMBL521686,OLAPARIB,2320,"PARP 1, 2 and 3 inhibitor",INHIBITOR,109545.0,CHEMBL3390820,"PARP 1, 2 and 3",1,1,1,,
478003,CHEMBL522038,XIMELAGATRAN,6323,Thrombin inhibitor,INHIBITOR,11.0,CHEMBL204,Prothrombin,1,1,1,"Ximelagatran is a prodrug that undergoes rapid enzymatic conversion to the active compound melagatran. Melagatran is a potent, competitive, and reversible direct inhibitor binding to the active site of soluble and clot-bound -thrombin. It inhibits coagulation.",
499120,CHEMBL523299,UMECLIDINIUM BROMIDE,2246,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for COPD, M3 responsible",
508828,CHEMBL525076,ENFUVIRTIDE,1740,Transmembrane glycoprotein gp41 inhibitor,INHIBITOR,105699.0,CHEMBL2362987,Transmembrane glycoprotein gp41,1,1,1,,
500007,CHEMBL525610,TERIPARATIDE,68,Parathyroid hormone receptor agonist,AGONIST,160.0,CHEMBL1793,Parathyroid hormone/parathyroid hormone-related peptide receptor,1,1,1,It's a recombinant protein of the parathyroid hormone for the treatment of postmenopausal women with osteoporosis,
11819,CHEMBL526,PROPOFOL,1616,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
11968,CHEMBL527,PIROXICAM,1206,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
12428,CHEMBL529,AZITHROMYCIN,1788,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
447955,CHEMBL529437,COCAINE HYDROCHLORIDE,8842,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,Mechanism_for_indication: anasthesia. Blocks voltage-gated sodium channels and prevents a rise in sodium conductance.,
12465,CHEMBL530,AMDINOCILLIN,1733,Bacterial penicillin-binding protein 2 inhibitor,INHIBITOR,105684.0,CHEMBL2354313,"Peptidoglycan D,D-transpeptidase MrdA",1,1,1,,
2831992,CHEMBL5314341,GLUCAGON,638,Glucagon receptor agonist,AGONIST,146.0,CHEMBL1985,Glucagon receptor,1,1,1,,
2831993,CHEMBL5314342,GLUCAGON HYDROCHLORIDE,637,Glucagon receptor agonist,AGONIST,146.0,CHEMBL1985,Glucagon receptor,1,1,1,,
2831997,CHEMBL5314346,VERTEPORFIN,2149,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,Photodynamic therapy,
2831999,CHEMBL5314348,BIVALIRUDIN,74,Thrombin inhibitor,INHIBITOR,11.0,CHEMBL204,Prothrombin,1,1,1,,
2832006,CHEMBL5314355,POLYMYXIN B SULFATE,1815,Cell outer membrane inhibitor,INHIBITOR,106011.0,CHEMBL2364032,Cell outer membrane,1,1,1,,
2832013,CHEMBL5314362,ENTECAVIR,1923,DNA polymerase/reverse transcriptase inhibitor,INHIBITOR,105706.0,CHEMBL2362994,DNA polymerase/reverse transcriptase,1,1,1,,
2832017,CHEMBL5314366,ESOMEPRAZOLE MAGNESIUM,1087,Potassium-transporting ATPase inhibitor,INHIBITOR,104758.0,CHEMBL2095173,Potassium-transporting ATPase,1,1,1,,
2832024,CHEMBL5314373,"CEFPROZIL, (E)-",1696,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
2832026,CHEMBL5314375,CIDOFOVIR,1468,Human herpesvirus 1 DNA polymerase inhibitor,INHIBITOR,27.0,CHEMBL1872,DNA polymerase catalytic subunit,1,1,1,,
2832028,CHEMBL5314377,GANIRELIX ACETATE,264,Gonadotropin-releasing hormone receptor antagonist,ANTAGONIST,118.0,CHEMBL1855,Gonadotropin-releasing hormone receptor,1,1,1,,
2832029,CHEMBL5314378,CASPOFUNGIN ACETATE,1391,"1,3-beta-glucan synthase inhibitor",INHIBITOR,106173.0,CHEMBL2364673,"1,3-beta-glucan synthase",1,1,1,,
2832029,CHEMBL5314378,CASPOFUNGIN ACETATE,1393,"1,3-beta-glucan synthase inhibitor",INHIBITOR,106174.0,CHEMBL2364674,"1,3-beta-glucan synthase",1,1,1,,
2832030,CHEMBL5314379,VOCLOSPORIN,8487,"Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform inhibitor",INHIBITOR,12579.0,CHEMBL4445,Protein phosphatase 3 catalytic subunit alpha,1,1,1,,
2832031,CHEMBL5314380,PASIREOTIDE DIASPARTATE,66,Somatostatin receptor 5 agonist,AGONIST,11265.0,CHEMBL1792,Somatostatin receptor type 5,1,1,1,,Non-selective but type 5 receptor is overexpressed in Cushing's disease
2832031,CHEMBL5314380,PASIREOTIDE DIASPARTATE,94,Somatostatin receptor 2 agonist,AGONIST,117.0,CHEMBL1804,Somatostatin receptor type 2,1,1,1,,Non-selective but type 5 receptor is overexpressed in Cushing's disease
2832031,CHEMBL5314380,PASIREOTIDE DIASPARTATE,419,Somatostatin receptor 1 agonist,AGONIST,12786.0,CHEMBL1917,Somatostatin receptor type 1,1,1,1,,Non-selective but type 5 receptor is overexpressed in Cushing's disease
2832031,CHEMBL5314380,PASIREOTIDE DIASPARTATE,754,Somatostatin receptor 3 agonist,AGONIST,11261.0,CHEMBL2028,Somatostatin receptor type 3,1,1,1,,Non-selective but type 5 receptor is overexpressed in Cushing's disease
2832033,CHEMBL5314382,PASIREOTIDE PAMOATE,2395,Somatostatin receptor 3 agonist,AGONIST,11261.0,CHEMBL2028,Somatostatin receptor type 3,1,1,1,,Non-selective but type 5 receptor is overexpressed in Cushing's disease
2832033,CHEMBL5314382,PASIREOTIDE PAMOATE,2396,Somatostatin receptor 5 agonist,AGONIST,11265.0,CHEMBL1792,Somatostatin receptor type 5,1,1,1,,Non-selective but type 5 receptor is overexpressed in Cushing's disease
2832033,CHEMBL5314382,PASIREOTIDE PAMOATE,2397,Somatostatin receptor 2 agonist,AGONIST,117.0,CHEMBL1804,Somatostatin receptor type 2,1,1,1,,Non-selective but type 5 receptor is overexpressed in Cushing's disease
2832033,CHEMBL5314382,PASIREOTIDE PAMOATE,2398,Somatostatin receptor 1 agonist,AGONIST,12786.0,CHEMBL1917,Somatostatin receptor type 1,1,1,1,,Non-selective but type 5 receptor is overexpressed in Cushing's disease
2832300,CHEMBL5314649,RITLECITINIB TOSYLATE,9653,Tyrosine-protein kinase JAK3 inhibitor,INHIBITOR,10849.0,CHEMBL2148,Tyrosine-protein kinase JAK3,1,1,1,,
2832300,CHEMBL5314649,RITLECITINIB TOSYLATE,9701,TEC family kinase inhibitor,INHIBITOR,118691.0,CHEMBL4296642,TEC family kinase,1,1,1,,
2832378,CHEMBL5314727,BEVACIZUMAB GAMMA,9905,Vascular endothelial growth factor A binding agent,BINDING AGENT,187.0,CHEMBL1783,"Vascular endothelial growth factor A, long form",1,1,1,,
2832447,CHEMBL5314796,SELVACOVATEIN,10005,Spike glycoprotein vaccine antigen,VACCINE ANTIGEN,120055.0,CHEMBL4662936,Spike glycoprotein,1,1,1,,
2832585,CHEMBL5314934,VANZACAFTOR,9955,Cystic fibrosis transmembrane conductance regulator positive modulator,POSITIVE MODULATOR,11540.0,CHEMBL4051,Cystic fibrosis transmembrane conductance regulator,1,1,1,,
2832699,CHEMBL5315048,ZILUCOPLAN SODIUM,9696,Complement C5 binding agent,BINDING AGENT,106142.0,CHEMBL2364163,Complement C5,1,1,1,,
2832700,CHEMBL5315049,SITAGLIPTIN FUMARATE,9654,Dipeptidyl peptidase IV inhibitor,INHIBITOR,11140.0,CHEMBL284,Dipeptidyl peptidase 4,1,1,1,,
2832701,CHEMBL5315050,ATOSIBAN ACETATE,9641,Oxytocin receptor antagonist,ANTAGONIST,116.0,CHEMBL2049,Oxytocin receptor,1,1,1,,
2832704,CHEMBL5315053,PEMETREXED MONOHYDRATE,9824,GAR transformylase inhibitor,INHIBITOR,12291.0,CHEMBL3972,Trifunctional purine biosynthetic protein adenosine-3,1,1,1,,
2832704,CHEMBL5315053,PEMETREXED MONOHYDRATE,9825,Dihydrofolate reductase inhibitor,INHIBITOR,6.0,CHEMBL202,Dihydrofolate reductase,1,1,1,,
2832704,CHEMBL5315053,PEMETREXED MONOHYDRATE,9826,Thymidylate synthase inhibitor,INHIBITOR,28.0,CHEMBL1952,Thymidylate synthase,1,1,1,,
2832705,CHEMBL5315054,ERTUGLIFLOZIN PIDOLATE,9827,Sodium/glucose cotransporter 2 inhibitor,INHIBITOR,20092.0,CHEMBL3884,Sodium/glucose cotransporter 2,1,1,1,,
2832706,CHEMBL5315055,NALMEFENE HYDROCHLORIDE DIHYDRATE,9608,Mu opioid receptor antagonist,ANTAGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
2832706,CHEMBL5315055,NALMEFENE HYDROCHLORIDE DIHYDRATE,9609,Delta opioid receptor antagonist,ANTAGONIST,136.0,CHEMBL236,Delta-type opioid receptor,1,1,1,,
2832706,CHEMBL5315055,NALMEFENE HYDROCHLORIDE DIHYDRATE,9610,Kappa opioid receptor partial agonist,PARTIAL AGONIST,137.0,CHEMBL237,Kappa-type opioid receptor,1,1,1,,
2832707,CHEMBL5315056,NALOXONE HYDROCHLORIDE DIHYDRATE,9684,Opioid receptors; mu/kappa/delta antagonist,ANTAGONIST,104765.0,CHEMBL2095181,Opioid receptors; mu/kappa/delta,1,1,1,,
2832715,CHEMBL5315064,FOLLITROPIN DELTA,9639,Follicle stimulating hormone receptor agonist,AGONIST,99.0,CHEMBL2024,Follicle-stimulating hormone receptor,1,1,1,,
2832718,CHEMBL5315067,AUTOLOGOUS PERIPHERAL-BLOOD MONONUCLEAR CELLS INCLUDING A MINIMUM OF 50 MILLION AUTOLOGOUS CD54+ CELLS ACTIVATED WITH PROSTATIC ACID PHOSPHATASE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR,9789,Somatic cell supplemental therapy,,,,,1,1,1,Autologous peripheral blood mononuclear cells activated with PAP-GM-CSF,
2832719,CHEMBL5315068,DINUTUXIMAB BETA,9697,Disialoganglioside GD2 inhibitor,INHIBITOR,109548.0,CHEMBL3390823,Disialoganglioside GD2,1,1,1,A mouse-human chimeric monoclonal IgG1 antibody produced in a mammalian cell line (CHO) by recombinant DNA technology,
2832720,CHEMBL5315069,DAMOCTOCOG ALFA PEGOL,9644,Coagulation factor VIII exogenous protein,EXOGENOUS PROTEIN,10210.0,CHEMBL3143,Coagulation factor VIII,1,1,1,"Site specifically PEGylated B-domain deleted recombinant human coagulation factor VIII, produced in baby hamster kidney cells (BHK), with a 60 kDa branched polyethylene-glycol (two 30 kDa PEG) moiety",
2832722,CHEMBL5315071,TUROCTOCOG ALFA PEGOL,9645,Coagulation factor VIII exogenous protein,EXOGENOUS PROTEIN,10210.0,CHEMBL3143,Coagulation factor VIII,1,1,1,Recombinant human factor VIII covalently conjugated to a 40 kDa polyethylene-glycol (PEG).,
2832726,CHEMBL5315075,SUSOCTOCOG ALFA,9649,Coagulation factor VIII exogenous protein,EXOGENOUS PROTEIN,10210.0,CHEMBL3143,Coagulation factor VIII,1,1,1,,
2832727,CHEMBL5315076,ALBUTREPENONACOG ALFA,9642,Coagulation factor IX exogenous protein,EXOGENOUS PROTEIN,193.0,CHEMBL2016,Coagulation factor IX,1,1,1,Recombinant coagulation factor IX fused to albumin,
2832729,CHEMBL5315078,EPTACOG BETA (ACTIVATED),9664,Coagulation factor VII exogenous protein,EXOGENOUS PROTEIN,12000.0,CHEMBL3991,Coagulation factor VII,1,1,1,,
2832731,CHEMBL5315080,BULEVIRTIDE ACETATE,9667,Bile acid transporter inhibitor,INHIBITOR,100159.0,CHEMBL5287,Hepatic sodium/bile acid cotransporter,1,1,1,,
2832732,CHEMBL5315081,PATIROMER SORBITEX CALCIUM,9698,Potassium chelating agent,CHELATING AGENT,109707.0,CHEMBL3545434,Potassium,1,1,1,,
2832735,CHEMBL5315084,"PANCREAS POWDER, PORCINE",9758,Pancreatic enzyme replacement treatment,,,,,1,1,1,,
2832738,CHEMBL5315087,PROTEIN C CONCENTRATE (HUMAN),9829,Vitamin K-dependent protein C exogenous protein,EXOGENOUS PROTEIN,12847.0,CHEMBL4444,Vitamin K-dependent protein C,1,1,1,,
2832740,CHEMBL5315089,"DEFATTED POWDER OF ARACHIS HYPOGAEA L., SEMEN (PEANUTS)",9769,Food allergy desensitisation,,,,,1,1,1,,
2832743,CHEMBL5315092,AUTOLOGOUS CULTURED CHONDROCYTES,9752,May promote synthesis of hyaline-like cartilage repair tissue,,,,,1,1,1,,
2832744,CHEMBL5315093,AUTOLOGOUS CD34+ ENRICHED CELL FRACTION THAT CONTAINS CD34+ CELLS TRANSDUCED WITH RETROVIRAL VECTOR THAT ENCODES FOR THE HUMAN ADA CDNA SEQUENCE,9730,ADA exogenous gene,EXOGENOUS GENE,121131.0,CHEMBL5303724,ADA,1,1,1,Autologous CD34+ cells with retrovirally delivered cDNA for expression of adenosine deaminase,
2832748,CHEMBL5315097,ALLOGENEIC T CELLS GENETICALLY MODIFIED WITH A RETROVIRAL VECTOR ENCODING FOR A TRUNCATED FORM OF THE HUMAN LOW AFFINITY NERVE GROWTH FACTOR RECEPTOR (DELTALNGFR) AND THE HERPES SIMPLEX I VIRUS THYMIDINE KINASE (HSV-TK MUT2),9765,Somatic cell supplemental therapy,,,,,1,1,1,Modified allgenic T cells for stimulation of immunereconstitution following hematopoietic stem-cell transplantation,
2832750,CHEMBL5315099,EX VIVO EXPANDED AUTOLOGOUS HUMAN CORNEAL EPITHELIAL CELLS CONTAINING STEM CELLS,9741,Somatic cell supplemental therapy,,,,,1,1,1,Autologous corneal epithelial cells,
2832764,CHEMBL5315113,SPHEROIDS OF HUMAN AUTOLOGOUS MATRIX-ASSOCIATED CHONDROCYTES,9770,Somatic cell supplemental therapy,,,,,1,1,1,Autologous chondrocyte implantation,
2832768,CHEMBL5315117,ZANAMIVIR HYDRATE,9830,Neuraminidase inhibitor,INHIBITOR,118085.0,CHEMBL4295840,Neuraminidase,1,1,1,,
2832768,CHEMBL5315117,ZANAMIVIR HYDRATE,9831,Neuraminidase inhibitor,INHIBITOR,102438.0,CHEMBL6135,Neuraminidase,1,1,1,,
2832769,CHEMBL5315118,ILOPROST TROMETHAMINE,9833,Prostanoid IP receptor agonist,AGONIST,143.0,CHEMBL1995,Prostacyclin receptor,1,1,1,,
2832770,CHEMBL5315119,UPADACITINIB HEMIHYDRATE,9834,Tyrosine-protein kinase TYK2 inhibitor,INHIBITOR,12694.0,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,1,1,1,,
2832770,CHEMBL5315119,UPADACITINIB HEMIHYDRATE,9835,Tyrosine-protein kinase JAK3 inhibitor,INHIBITOR,10849.0,CHEMBL2148,Tyrosine-protein kinase JAK3,1,1,1,,
2832770,CHEMBL5315119,UPADACITINIB HEMIHYDRATE,9836,Tyrosine-protein kinase JAK2 inhibitor,INHIBITOR,10938.0,CHEMBL2971,Tyrosine-protein kinase JAK2,1,1,1,,
2832770,CHEMBL5315119,UPADACITINIB HEMIHYDRATE,9837,Tyrosine-protein kinase JAK1 inhibitor,INHIBITOR,10919.0,CHEMBL2835,Tyrosine-protein kinase JAK1,1,1,1,,
2832771,CHEMBL5315120,ODEVIXIBAT SESQUIHYDRATE,9838,Ileal bile acid transporter inhibitor,INHIBITOR,12909.0,CHEMBL2778,Ileal sodium/bile acid cotransporter,1,1,1,,
2832772,CHEMBL5315121,TECOVIRIMAT MONOHYDRATE,7375,Envelope phospholipase OPG057 inhibitor,INHIBITOR,121143.0,CHEMBL5308522,Envelope phospholipase OPG057,1,1,1,Antiviral inhibiting the orthopoxvirus envelope wrapping protein VP37 and preventing its interaction with cellular components and the subsequent production of virion particles.,
2832772,CHEMBL5315121,TECOVIRIMAT MONOHYDRATE,9839,Envelope phospholipase OPG057 inhibitor,INHIBITOR,121145.0,CHEMBL5308524,Envelope phospholipase OPG057,1,1,1,,
2832772,CHEMBL5315121,TECOVIRIMAT MONOHYDRATE,9840,Envelope phospholipase OPG057 inhibitor,INHIBITOR,121144.0,CHEMBL5308523,Envelope phospholipase OPG057,1,1,1,,
2832773,CHEMBL5315122,BORTEZOMIB D-MANNITOL,9841,26S proteasome inhibitor,INHIBITOR,106197.0,CHEMBL2364701,26S proteasome,1,1,1,,
2832774,CHEMBL5315123,DIFELIKEFALIN ACETATE,9842,Kappa opioid receptor agonist,AGONIST,137.0,CHEMBL237,Kappa-type opioid receptor,1,1,1,,
2832775,CHEMBL5315124,LEVOFLOXACIN,1909,DNA gyrase inhibitor,INHIBITOR,105578.0,CHEMBL2311225,DNA gyrase,1,1,1,,
2832775,CHEMBL5315124,LEVOFLOXACIN,2047,Topoisomerase IV inhibitor,INHIBITOR,105735.0,CHEMBL2363033,Topoisomerase IV,1,1,1,,
2832776,CHEMBL5315125,DUVELISIB MONOHYDRATE,9843,PI3-kinase p110-delta subunit inhibitor,INHIBITOR,11177.0,CHEMBL3130,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",1,1,1,,
2832776,CHEMBL5315125,DUVELISIB MONOHYDRATE,9844,PI3-kinase p110-gamma subunit inhibitor,INHIBITOR,11939.0,CHEMBL3267,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",1,1,1,,
2832777,CHEMBL5315126,FOLLITROPIN BETA,751,Follicle stimulating hormone receptor agonist,AGONIST,99.0,CHEMBL2024,Follicle-stimulating hormone receptor,1,1,1,"It's FSH, for the stimulation of ovarian follicular growth",
12506,CHEMBL532,ERYTHROMYCIN,1783,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
78364,CHEMBL53292,ISOXICAM,6257,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,"It inhibits the action of cyclooxygenase enzyme (COX), which produces the pro-inflammatory prostaglandins from arachidonic acids.",
82895,CHEMBL53418,DANTHRON,6231,Retinoid X receptor alpha antagonist,ANTAGONIST,275.0,CHEMBL2061,Retinoic acid receptor RXR-alpha,1,1,1,Danthron binds to the tetrameric RXRalpha-LBD and transformed the 9cRA-induced RXRalpha-LBD dimer to tetramer. It binds to RXRalpha-LBD with a stoichimetric ratio of 1:2.,
13048,CHEMBL535,SUNITINIB,9798,Macrophage colony stimulating factor receptor inhibitor,INHIBITOR,12840.0,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,1,1,1,,
13048,CHEMBL535,SUNITINIB,9799,Vascular endothelial growth factor receptor 2 inhibitor,INHIBITOR,10980.0,CHEMBL279,Vascular endothelial growth factor receptor 2,1,1,1,,
13048,CHEMBL535,SUNITINIB,9800,Stem cell growth factor receptor inhibitor,INHIBITOR,238.0,CHEMBL1936,Mast/stem cell growth factor receptor Kit,1,1,1,,
13048,CHEMBL535,SUNITINIB,9801,Platelet-derived growth factor receptor beta inhibitor,INHIBITOR,197.0,CHEMBL1913,Platelet-derived growth factor receptor beta,1,1,1,,
13048,CHEMBL535,SUNITINIB,9802,Platelet-derived growth factor receptor alpha inhibitor,INHIBITOR,12627.0,CHEMBL2007,Platelet-derived growth factor receptor alpha,1,1,1,,
13048,CHEMBL535,SUNITINIB,9803,Vascular endothelial growth factor receptor 1 inhibitor,INHIBITOR,10979.0,CHEMBL1868,Vascular endothelial growth factor receptor 1,1,1,1,,
13048,CHEMBL535,SUNITINIB,9804,Vascular endothelial growth factor receptor 3 inhibitor,INHIBITOR,11752.0,CHEMBL1955,Vascular endothelial growth factor receptor 3,1,1,1,,
13048,CHEMBL535,SUNITINIB,9805,Tyrosine-protein kinase receptor FLT3 inhibitor,INHIBITOR,12670.0,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,1,1,1,,
13048,CHEMBL535,SUNITINIB,9806,Tyrosine-protein kinase receptor RET inhibitor,INHIBITOR,100079.0,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,1,1,1,,
549674,CHEMBL535396,RIMANTADINE HYDROCHLORIDE,847,Influenza virus A matrix protein M2 inhibitor,INHIBITOR,22.0,CHEMBL2052,Matrix protein 2,1,1,1,,
543171,CHEMBL535650,MEFLOQUINE HYDROCHLORIDE,997,Ferriprotoporphyrin IX inhibitor,INHIBITOR,100262.0,CHEMBL613897,Ferriprotoporphyrin IX,1,1,1,,
564219,CHEMBL538943,VINORELBINE TARTRATE,1109,Tubulin inhibitor,INHIBITOR,104766.0,CHEMBL2095182,Tubulin,1,1,1,,
298316,CHEMBL539423,SPARSENTAN,5004,Endothelin receptor ET-A antagonist,ANTAGONIST,249.0,CHEMBL252,Endothelin-1 receptor,1,1,1,,
298316,CHEMBL539423,SPARSENTAN,5005,Type-1 angiotensin II receptor antagonist,ANTAGONIST,115.0,CHEMBL227,Type-1 angiotensin II receptor,1,1,1,,
551160,CHEMBL539770,TERODILINE HYDROCHLORIDE,6309,Muscarinic acetylcholine receptor antagonist,ANTAGONIST,104691.0,CHEMBL2094109,Muscarinic acetylcholine receptor,1,1,1,"Terodiline has non-selective anticholinergic and calcium blocking effects within the same concentration range, the anticholinergic effect predominating at low and the calcium entry blocking action at high concentrations.",
551160,CHEMBL539770,TERODILINE HYDROCHLORIDE,6867,Voltage-gated calcium channel blocker,BLOCKER,105734.0,CHEMBL2363032,Voltage-gated calcium channel,1,1,1,"Terodiline has non-selective anticholinergic and calcium blocking effects within the same concentration range, the anticholinergic effect predominating at low and the calcium entry blocking action at high concentrations.","It was reported that the drug inhibits guinea-pig bladder L-type Ca2+ current (ICa,L) with an IC50 of 1.7 uM."
3859,CHEMBL54,HALOPERIDOL,602,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
3859,CHEMBL54,HALOPERIDOL,2026,D2-like dopamine receptor inverse agonist,INVERSE AGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
2856578,CHEMBL5416410,DASATINIB,9999,Bcr/Abl fusion protein inhibitor,INHIBITOR,104811.0,CHEMBL2096618,Bcr/Abl fusion protein,1,1,1,,
83245,CHEMBL54349,ALPIDEM,6197,Translocator protein partial agonist,PARTIAL AGONIST,101532.0,CHEMBL5742,Translocator protein,1,1,1,The anxiolytic and anticonvulsant properties of alpidem appear to be elicited both with a direct mechanism through the interaction with central benzodiazepine receptor (CBR) and with an indirect mechanism by the interaction with peripheral benzodiazepine receptor (PBR) as well as the stimulation of pregnenolone formation.,Alpidem binds with nanomolar affinity both peripheral benzodiazepine receptor (PBR) (Ki =0.5-7 nM) and central benzodiazepine receptor CBR (Ki =1-28 nM).
13474,CHEMBL544,MEQUINOL,509,Tyrosinase inhibitor,INHIBITOR,73.0,CHEMBL1973,Tyrosinase,1,1,1,,
543306,CHEMBL544665,FINGOLIMOD HYDROCHLORIDE,1914,Sphingosine 1-phosphate receptor agonist,AGONIST,105736.0,CHEMBL2363041,Sphingosine 1-phosphate receptor,1,1,1,,EDG5 less relevant
2882612,CHEMBL5465559,NYSTATIN,1805,Ergosterol sequestering agent,SEQUESTERING AGENT,106007.0,CHEMBL2364028,Ergosterol,1,1,1,,
13928,CHEMBL547,ISOTRETINOIN,2365,Retinoic acid receptor agonist,AGONIST,105764.0,CHEMBL2363069,Retinoic acid receptor,1,1,1,Prodrug. RARG/RXRA are predominant forms in skin,
14125,CHEMBL548,DINOPROSTONE,1573,Prostaglandin E2 receptor agonist,AGONIST,105763.0,CHEMBL2363068,Prostaglandin E2 receptor,1,1,1,,
2882636,CHEMBL5483015,ARSENIC TRIOXIDE,436,Thioredoxin reductase 1 inhibitor,INHIBITOR,172.0,CHEMBL1927,"Thioredoxin reductase 1, cytoplasmic",1,1,1,,
14406,CHEMBL550,PILOCARPINE,42,Muscarinic acetylcholine receptor M3 agonist,AGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for miosis, M3 likely involved (main form in iris)",
14406,CHEMBL550,PILOCARPINE,2369,Muscarinic acetylcholine receptor M1 agonist,AGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,"Indicated for dry mouth, M1 likely involved",
564990,CHEMBL550348,DEFERASIROX,1562,Iron chelating agent,CHELATING AGENT,105753.0,CHEMBL2363058,Iron,1,1,1,,Selective
563451,CHEMBL550495,METHYLENE BLUE,7488,Reducing agent,,,,,1,1,1,Non-enyzmatic (oxidation-reduction agent): methylene blue is first metabolised to leucomethylene blue via NADPH reductase which then reduces the ferric iron of metHb to the ferrous state of normal hemoglobin. ,
565417,CHEMBL550755,FORODESINE HYDROCHLORIDE,5700,Purine nucleoside phosphorylase inhibitor,INHIBITOR,12690.0,CHEMBL4338,Purine nucleoside phosphorylase,1,1,1,Highly specific and potent transition state analog inhibitor of PNP that inhibits T-cell proliferation.,
562404,CHEMBL551466,ACLIDINIUM BROMIDE,35,Muscarinic acetylcholine receptor M3 antagonist,ANTAGONIST,219.0,CHEMBL245,Muscarinic acetylcholine receptor M3,1,1,1,"Indicated for COPD, M3 likely responsible",
563655,CHEMBL557555,CIPROFIBRATE,6676,Peroxisome proliferator-activated receptor alpha agonist,AGONIST,163.0,CHEMBL239,Peroxisome proliferator-activated receptor alpha,1,1,1,"Ciprofibrate, a PPAR activator, is used to treat hyperlipidaemia and was found to be beneficial in the prevention of ischemic heart disease in individuals with elevated levels of LDL cholesterol. In addition ciprofibrate is also found to modestly decrease elevated fibrinogen and plasminogen activator inhibitor-1 levels and elevate level of plasma HDL cholesterol.",
15990,CHEMBL559,DEXTROTHYROXINE,1302,Thyroid hormone receptor agonist,AGONIST,104987.0,CHEMBL2111462,Thyroid hormone receptor,1,1,1,,
557938,CHEMBL561157,TREPROSTINIL SODIUM,9814,Prostanoid IP receptor agonist,AGONIST,143.0,CHEMBL1995,Prostacyclin receptor,1,1,1,,
16303,CHEMBL562,GRISEOFULVIN,1433,Tubulin inhibitor,INHIBITOR,106199.0,CHEMBL2364703,Tubulin,1,1,1,,
16308,CHEMBL563,FLURBIPROFEN,1194,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
88882,CHEMBL56337,EPALRESTAT,7566,Aldose reductase inhibitor,INHIBITOR,242.0,CHEMBL1900,Aldo-keto reductase family 1 member B1,1,1,1,,
559106,CHEMBL564085,TROLEANDOMYCIN,2068,70S ribosome inhibitor,INHIBITOR,105832.0,CHEMBL2363853,70S ribosome,1,1,1,"Indicated for Streptococcus pneumoniae, Streptococcus pyogenes, Diplococcus pneumoniae",
16415,CHEMBL565,CLOFIBRATE,434,Peroxisome proliferator-activated receptor alpha agonist,AGONIST,163.0,CHEMBL239,Peroxisome proliferator-activated receptor alpha,1,1,1,,
574221,CHEMBL566315,OBETICHOLIC ACID,5221,Bile acid receptor FXR agonist,AGONIST,11180.0,CHEMBL2047,Bile acid receptor,1,1,1,,
573926,CHEMBL566534,ARTEMETHER,1001,Ferriprotoporphyrin IX inhibitor,INHIBITOR,100262.0,CHEMBL613897,Ferriprotoporphyrin IX,1,1,1,prevents crystallisation,
16505,CHEMBL567,PERPHENAZINE,194,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
16506,CHEMBL568,OXAZEPAM,1594,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
579689,CHEMBL569713,SCOPOLAMINE,291,Muscarinic acetylcholine receptor M1 antagonist,ANTAGONIST,61.0,CHEMBL216,Muscarinic acetylcholine receptor M1,1,1,1,antiemetic,
4345,CHEMBL57,NEVIRAPINE,830,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,,
16584,CHEMBL570,TRIFLUPROMAZINE,214,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
16591,CHEMBL571,KETOPROFEN,1208,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
579824,CHEMBL571546,TIRBANIBULIN,4751,Tyrosine-protein kinase SRC inhibitor,INHIBITOR,10434.0,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,1,1,1,Targets the peptide substrate-binding site and is a non-ATP competitive inhibitor.,
16592,CHEMBL572,NITROFURANTOIN,1832,DNA inhibitor,INHIBITOR,106020.0,CHEMBL2364041,DNA,1,1,1,Generates free radicals causing DNA damage.,
2956480,CHEMBL5723563,ELIGLUSTAT TARTRATE,2298,Ceramide glucosyltransferase inhibitor,INHIBITOR,286.0,CHEMBL2063,Ceramide glucosyltransferase,1,1,1,,
573133,CHEMBL576982,QUIZARTINIB,5248,Macrophage colony stimulating factor receptor inhibitor,INHIBITOR,12840.0,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,1,1,1,,
573133,CHEMBL576982,QUIZARTINIB,5249,Tyrosine-protein kinase receptor FLT3 inhibitor,INHIBITOR,12670.0,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,1,1,1,,
573133,CHEMBL576982,QUIZARTINIB,5250,Stem cell growth factor receptor inhibitor,INHIBITOR,238.0,CHEMBL1936,Mast/stem cell growth factor receptor Kit,1,1,1,,
573133,CHEMBL576982,QUIZARTINIB,5251,Platelet-derived growth factor receptor inhibitor,INHIBITOR,104773.0,CHEMBL2095189,Platelet-derived growth factor receptor,1,1,1,,
573133,CHEMBL576982,QUIZARTINIB,5252,Tyrosine-protein kinase receptor RET inhibitor,INHIBITOR,100079.0,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,1,1,1,,
16959,CHEMBL580,LORAZEPAM,1607,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
88739,CHEMBL58323,LACOSAMIDE,1975,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
17411,CHEMBL585,TRIAMTERENE,1255,"Amiloride-sensitive sodium channel, ENaC blocker",BLOCKER,104888.0,CHEMBL2107836,"Amiloride-sensitive sodium channel, ENaC",1,1,1,,
90635,CHEMBL58510,CHLOROQUINE PHOSPHATE,1000,Ferriprotoporphyrin IX inhibitor,INHIBITOR,100262.0,CHEMBL613897,Ferriprotoporphyrin IX,1,1,1,prevents crystallisation,
598560,CHEMBL589586,MONOMETHYL FUMARATE,7643,Kelch-like ECH-associated protein 1 inhibitor,INHIBITOR,104593.0,CHEMBL2069156,Kelch-like ECH-associated protein 1,1,1,1,"Not fully elucidated. Activates the Nrf2 pathway involved in cellular response to oxidative stress, potentially through S-alkylation of the Nrf2 inhibitor Keap1",MMF is also a nicotinic acid receptor agonist in vitro.
19469,CHEMBL591,ETHCHLORVYNOL,1609,GABA-A receptor; anion channel positive modulator,POSITIVE MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
19915,CHEMBL596,FENTANYL,725,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
20496,CHEMBL599,MELOXICAM,1459,Cyclooxygenase-2 inhibitor,INHIBITOR,126.0,CHEMBL230,Prostaglandin G/H synthase 2,1,1,1,,
173,CHEMBL6,INDOMETHACIN,1192,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
20881,CHEMBL600,ACETYLCYSTEINE,7470,Glutathione precursor,,,,,1,1,1,"Antidote for acetaminophen overdose. Upon overdose, significant amounts of a reactive intermediate are formed which reacts with glutathione, depleting hepatic glutathione stores, and then reacts with hepatocyte proteins. Acetylcysteine provides an alternative substrate for conjugation with the reactive intermediate potentially restoring glutathione levels.",
20881,CHEMBL600,ACETYLCYSTEINE,7471,Mycolytic,,,,,1,1,1,"Mucolytic agent, cleaves disulfide linkages reducing mucous viscosity. May also have a role in managing the oxidant burden.",
602271,CHEMBL601719,CRIZOTINIB,955,Hepatocyte growth factor receptor inhibitor,INHIBITOR,11451.0,CHEMBL3717,Hepatocyte growth factor receptor,1,1,1,,
602271,CHEMBL601719,CRIZOTINIB,973,ALK tyrosine kinase receptor inhibitor,INHIBITOR,100417.0,CHEMBL4247,ALK tyrosine kinase receptor,1,1,1,,
602271,CHEMBL601719,CRIZOTINIB,8635,EML4-ALK inhibitor,INHIBITOR,117043.0,CHEMBL3883330,EML4-ALK,1,1,1,,
602271,CHEMBL601719,CRIZOTINIB,8637,NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor) inhibitor,INHIBITOR,105079.0,CHEMBL2111387,NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor),1,1,1,,
602271,CHEMBL601719,CRIZOTINIB,10125,Proto-oncogene tyrosine-protein kinase ROS inhibitor,INHIBITOR,101019.0,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,1,1,1,,
602271,CHEMBL601719,CRIZOTINIB,10127,Macrophage-stimulating protein receptor inhibitor,INHIBITOR,11379.0,CHEMBL2689,Macrophage-stimulating protein receptor,1,1,1,,
21523,CHEMBL603,ZAFIRLUKAST,71,Cysteinyl leukotriene receptor 1 antagonist,ANTAGONIST,179.0,CHEMBL1798,Cysteinyl leukotriene receptor 1,1,1,1,,
21845,CHEMBL605,PROCAINAMIDE HYDROCHLORIDE,1981,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
22391,CHEMBL606,MISOPROSTOL,953,Prostanoid EP3 receptor agonist,AGONIST,10329.0,CHEMBL3710,Prostaglandin E2 receptor EP3 subtype,1,1,1,,
604643,CHEMBL606260,CARBENICILLIN DISODIUM,1714,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
3283073,CHEMBL6067482,COLISTIN SULFATE,1814,Cell outer membrane inhibitor,INHIBITOR,106011.0,CHEMBL2364032,Cell outer membrane,1,1,1,Disrupts cell membrane,
3283074,CHEMBL6067483,COLISTIMETHATE,8788,Cell membrane disrupting agent,DISRUPTING AGENT,106010.0,CHEMBL2364031,Cell membrane,1,1,1,,
3283075,CHEMBL6067484,GENTAMICIN SULFATE,1780,Bacterial 70S ribosome inhibitor,INHIBITOR,105830.0,CHEMBL2363135,Bacterial 70S ribosome,1,1,1,,
3283078,CHEMBL6067487,IVERMECTIN,1547,Glutamate-gated chloride channel modulator,MODULATOR,105745.0,CHEMBL2363050,Glutamate-gated chloride channel,1,1,1,,
3283078,CHEMBL6067487,IVERMECTIN,1548,Glutamate-gated chloride channel modulator,MODULATOR,105746.0,CHEMBL2363051,Glutamate-gated chloride channel,1,1,1,,
3283084,CHEMBL6067493,BLEOMYCIN SULFATE,1860,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
3283085,CHEMBL6067494,SECRETIN,430,Secretin receptor agonist,AGONIST,147.0,CHEMBL1925,Secretin receptor,1,1,1,,
3283133,CHEMBL6067642,CODEINE PHOSPHATE,1093,Opioid receptors; mu/kappa/delta agonist,AGONIST,104765.0,CHEMBL2095181,Opioid receptors; mu/kappa/delta,1,1,1,,
3283141,CHEMBL6067650,PAROXETINE HYDROCHLORIDE,394,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,reuptake inhibitor,
3283141,CHEMBL6067650,PAROXETINE HYDROCHLORIDE,8459,Serotonin transporter inhibitor,INHIBITOR,121.0,CHEMBL228,Sodium-dependent serotonin transporter,1,1,1,,
3283147,CHEMBL6067656,CEFTRIAXONE SODIUM,1708,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
3283463,CHEMBL6067972,VARENICLINE TARTRATE,1045,Neuronal acetylcholine receptor; alpha4/beta2 agonist,AGONIST,104283.0,CHEMBL1907589,Neuronal acetylcholine receptor; alpha4/beta2,1,1,1,,
3283471,CHEMBL6067980,SUCRALFATE,941,Pepsin A inhibitor,INHIBITOR,12327.0,CHEMBL3295,Pepsin A,1,1,1,,
3283471,CHEMBL6067980,SUCRALFATE,1556,Glycoproteins cross-linking agent,CROSS-LINKING AGENT,105749.0,CHEMBL2363054,Glycoproteins,1,1,1,cytoprotective barrier,
3283479,CHEMBL6067988,RASAGILINE TARTRATE,9640,Monoamine oxidase B inhibitor,INHIBITOR,104.0,CHEMBL2039,Amine oxidase [flavin-containing] B,1,1,1,Irreversible inhibitor,
3283481,CHEMBL6067990,CANDICIDIN,1817,Cell membrane inhibitor,INHIBITOR,106014.0,CHEMBL2364035,Cell membrane,1,1,1,"Disrupts bacterial membrane, promotes potassium outflux",
3283486,CHEMBL6067995,BEROTRALSTAT HYDROCHLORIDE,7694,Plasma kallikrein inhibitor,INHIBITOR,23.0,CHEMBL2000,Plasma kallikrein,1,1,1,,
3283489,CHEMBL6067998,LASOFOXIFENE TARTRATE,9682,Estrogen receptor modulator,MODULATOR,104682.0,CHEMBL2093866,Estrogen receptor,1,1,1,,
3283818,CHEMBL6068327,ACETYLCYSTEINE LYSINE,9884,Glutathione precursor,,,,,1,1,1,,
3283819,CHEMBL6068328,ELTROMBOPAG CHOLINE,9860,Thrombopoietin receptor agonist,AGONIST,265.0,CHEMBL1864,Thrombopoietin receptor,1,1,1,,
3283820,CHEMBL6068329,PEMETREXED DIPOTASSIUM,9932,GAR transformylase inhibitor,INHIBITOR,12291.0,CHEMBL3972,Trifunctional purine biosynthetic protein adenosine-3,1,1,1,,
3283820,CHEMBL6068329,PEMETREXED DIPOTASSIUM,9950,Thymidylate synthase inhibitor,INHIBITOR,10792.0,CHEMBL2555,Thymidylate synthase,1,1,1,,
3283820,CHEMBL6068329,PEMETREXED DIPOTASSIUM,9994,Dihydrofolate reductase inhibitor,INHIBITOR,6.0,CHEMBL202,Dihydrofolate reductase,1,1,1,,
3283821,CHEMBL6068330,NOGAPENDEKIN ALFA INBAKICEPT,9874,Interleukin-15 receptor agonist,AGONIST,120085.0,CHEMBL4665592,Interleukin-15 receptor,1,1,1,,
3283823,CHEMBL6068332,TENOFOVIR DISOPROXIL MALEATE,9978,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,,
3283823,CHEMBL6068332,TENOFOVIR DISOPROXIL MALEATE,10007,DNA polymerase/reverse transcriptase inhibitor,INHIBITOR,105706.0,CHEMBL2362994,DNA polymerase/reverse transcriptase,1,1,1,,
3283824,CHEMBL6068333,CLOPIDOGREL BESILATE,9963,Purinergic receptor P2Y12 antagonist,ANTAGONIST,176.0,CHEMBL2001,P2Y purinoceptor 12,1,1,1,,
3283825,CHEMBL6068334,SITAGLIPTIN HYDROCHLORIDE MONOHYDRATE,10022,Dipeptidyl peptidase IV inhibitor,INHIBITOR,11140.0,CHEMBL284,Dipeptidyl peptidase 4,1,1,1,,
3283827,CHEMBL6068336,MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE,9909,Tyrosine-protein kinase JAK2 inhibitor,INHIBITOR,10938.0,CHEMBL2971,Tyrosine-protein kinase JAK2,1,1,1,,
3283827,CHEMBL6068336,MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE,9996,Tyrosine-protein kinase JAK1 inhibitor,INHIBITOR,10919.0,CHEMBL2835,Tyrosine-protein kinase JAK1,1,1,1,,
3283827,CHEMBL6068336,MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE,9997,Tyrosine-protein kinase JAK2 inhibitor,INHIBITOR,10938.0,CHEMBL2971,Tyrosine-protein kinase JAK2,1,1,1,,
3283827,CHEMBL6068336,MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE,10024,Activin receptor type-1 inhibitor,INHIBITOR,101598.0,CHEMBL5903,Activin receptor type-1,1,1,1,,
3283828,CHEMBL6068337,LENALIDOMIDE HYDROCHLORIDE MONOHYDRATE,10034,CRL4(CRBN) E3 ubiquitin ligase modulator,MODULATOR,116917.0,CHEMBL3833061,CRL4(CRBN) E3 ubiquitin ligase,1,1,1,,
3283829,CHEMBL6068338,CLOPIDOGREL HYDROCHLORIDE,9915,Purinergic receptor P2Y12 antagonist,ANTAGONIST,176.0,CHEMBL2001,P2Y purinoceptor 12,1,1,1,,
3283830,CHEMBL6068339,IRBESARTAN HYDROCHLORIDE,9928,Type-1 angiotensin II receptor antagonist,ANTAGONIST,115.0,CHEMBL227,Type-1 angiotensin II receptor,1,1,1,,
3283831,CHEMBL6068340,PRASUGREL BESYLATE,9942,Purinergic receptor P2Y12 antagonist,ANTAGONIST,176.0,CHEMBL2001,P2Y purinoceptor 12,1,1,1,,
3283832,CHEMBL6068341,TENOFOVIR DISOPROXIL PHOSPHATE,9897,DNA polymerase/reverse transcriptase inhibitor,INHIBITOR,105706.0,CHEMBL2362994,DNA polymerase/reverse transcriptase,1,1,1,,
3283832,CHEMBL6068341,TENOFOVIR DISOPROXIL PHOSPHATE,10023,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,,
3283834,CHEMBL6068343,CLOPIDOGREL HYDROBROMIDE,10003,Purinergic receptor P2Y12 antagonist,ANTAGONIST,176.0,CHEMBL2001,P2Y purinoceptor 12,1,1,1,,
3283836,CHEMBL6068345,CHARACTERISED VIABLE AUTOLOGOUS CARTILAGE CELLS EXPANDED EX VIVO EXPRESSING SPECIFIC MARKER PROTEINS,9879,Somatic cell supplemental therapy,,,,,1,1,1,Autologous cartilage cell implantation,
3283837,CHEMBL6068346,"HEPATITIS B VIRUS S PROTEIN, PRE-S1 PROTEIN AND PRE-S2 PROTEIN VIRUS LIKE PARTICLES",9944,Large envelope protein vaccine antigen,VACCINE ANTIGEN,121135.0,CHEMBL5305041,Large envelope protein,1,1,1,,
3283839,CHEMBL6068348,BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ,10012,Filamentous hemagglutinin vaccine antigen,VACCINE ANTIGEN,121579.0,CHEMBL5500287,Filamentous hemagglutinin,1,1,1,,
3283840,CHEMBL6068349,BORDETELLA PERTUSSIS TOXIN,9896,Pertussis toxin vaccine antigen,VACCINE ANTIGEN,121584.0,CHEMBL5500292,Pertussis toxin,1,1,1,,
3283841,CHEMBL6068350,BORDETELLA PERTUSSIS PERTACTIN AUTOTRANSPORTER,9918,Pertactin autotransporter vaccine antigen,VACCINE ANTIGEN,121580.0,CHEMBL5500288,Pertactin autotransporter,1,1,1,,
3283842,CHEMBL6068351,"ROTAVIRUS, LIVE ATTENUATED",9902,Biological vaccine - induces immune response,,,,,1,1,1,,
3283843,CHEMBL6068352,VIBRIO CHOLERAE TOXIN B SUBUNIT,9872,Cholera enterotoxin subunit B vaccine antigen,VACCINE ANTIGEN,121576.0,CHEMBL5500284,Cholera enterotoxin subunit B,1,1,1,,
3283844,CHEMBL6068353,"VIBRIO CHOLERAE, INACTIVATED",9972,Biological vaccine - induces immune response,,,,,1,1,1,,
3283845,CHEMBL6068354,"MEASLES VIRUS, LIVE ATTENUATED",9883,Biological vaccine - induces immune response,,,,,1,1,1,,
3283846,CHEMBL6068355,"RUBELLA VIRUS, LIVE ATTENUATED",9948,Biological vaccine - induces immune response,,,,,1,1,1,,
3283847,CHEMBL6068356,"MUMPS VIRUS, LIVE ATTENUATED",9947,Biological vaccine - induces immune response,,,,,1,1,1,,
3283848,CHEMBL6068357,"VARICELLA ZOSTER VIRUS, LIVE ATTENUATED",9971,Biological vaccine - induces immune response,,,,,1,1,1,,
3283849,CHEMBL6068358,"ROTAVIRUS, LIVE",9969,Biological vaccine - induces immune response,,,,,1,1,1,,
3283850,CHEMBL6068359,"HUMAN PAPILLOMAVIRUS, L1 PROTEIN VIRUS LIKE PARTICLES",9904,Biological vaccine - induces immune response,,,,,1,1,1,,
3283851,CHEMBL6068360,"INFLUENZA A VIRUS, INACTIVATED WHOLE VIRION",9924,Biological vaccine - induces immune response,,,,,1,1,1,,
3283852,CHEMBL6068361,"INFLUENZA A VIRUS, INACTIVATED HEMAGGLUTININ",10025,Hemagglutinin vaccine antigen,VACCINE ANTIGEN,104401.0,CHEMBL1932897,Hemagglutinin,1,1,1,,
3283853,CHEMBL6068362,"INFLUENZA A VIRUS, INACTIVATED NEURAMINIDASE",9941,Neuraminidase vaccine antigen,VACCINE ANTIGEN,103609.0,CHEMBL1287607,Neuraminidase,1,1,1,,
3283854,CHEMBL6068363,"INFLUENZA A VIRUS, SPLIT VIRION",9925,Biological vaccine - induces immune response,,,,,1,1,1,,
3283855,CHEMBL6068364,"JAPANESE ENCEPHALITIS VIRUS, INACTIVATED",9885,Biological vaccine - induces immune response,,,,,1,1,1,,
3283856,CHEMBL6068365,STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE TOXOID,9880,Immunostimulant,,,,,1,1,1,Conjugated Corynebacterium diphtheriae toxoid is an immunostimulant in this vaccine,
3283856,CHEMBL6068365,STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE TOXOID,9981,Polysaccharide conjugated to Corynebacterium diphtheriae toxoid vaccine antigen,VACCINE ANTIGEN,121589.0,CHEMBL5500297,Polysaccharide conjugated to Corynebacterium diphtheriae toxoid,1,1,1,,
3283857,CHEMBL6068366,STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID,9982,Polysaccharide conjugated to Tetanus toxoid vaccine antigen,VACCINE ANTIGEN,121591.0,CHEMBL5500299,Polysaccharide conjugated to Tetanus toxoid,1,1,1,,
3283857,CHEMBL6068366,STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID,10042,Immunostimulant,,,,,1,1,1,Conjugated Tetanus toxoid is an immunostimulant in this vaccine,
3283858,CHEMBL6068367,STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE CONJUGATED TO HAEMOPHILUS INFLUENZAE PROTEIN D,9881,Immunostimulant,,,,,1,1,1,Conjugated Haemophilus influenzae Protein D is an immunostimulant in this vaccine,
3283858,CHEMBL6068367,STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE CONJUGATED TO HAEMOPHILUS INFLUENZAE PROTEIN D,10029,Polysaccharide conjugated to Haemophilus influenzae Protein D vaccine antigen,VACCINE ANTIGEN,121590.0,CHEMBL5500298,Polysaccharide conjugated to Haemophilus influenzae Protein D,1,1,1,,
3283859,CHEMBL6068368,NEISSERIA MENINGITIDIS OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197,9869,Oligosaccharide conjugated to Corynebacterium ciphtheriae CRM197 vaccine antigen,VACCINE ANTIGEN,121588.0,CHEMBL5500296,Oligosaccharide conjugated to Corynebacterium ciphtheriae CRM197,1,1,1,,
3283859,CHEMBL6068368,NEISSERIA MENINGITIDIS OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197,10039,Immunostimulant,,,,,1,1,1,Conjugated Corynebacterium diphtheriae CRM197 is an immunostimulant in this vaccine,
3283860,CHEMBL6068369,"INFLUENZA A VIRUS, LIVE ATTENUATED",10018,Biological vaccine - induces immune response,,,,,1,1,1,,
3283861,CHEMBL6068370,NEISSERIA MENINGITIDIS OUTER MEMBRANE VESICLES,9964,Outer membrane vesicles vaccine antigen,VACCINE ANTIGEN,121585.0,CHEMBL5500293,Outer membrane vesicles,1,1,1,,
3283862,CHEMBL6068371,NEISSERIA MENINGITIDIS NEISSERIAL HEPARIN BINDING ANTIGEN,9966,Neisserial heparin binding antigen vaccine antigen,VACCINE ANTIGEN,121583.0,CHEMBL5500291,Neisserial heparin binding antigen,1,1,1,,
3283863,CHEMBL6068372,NEISSERIA MENINGITIDIS ADHESIN A,9894,Neisseria adhesin A vaccine antigen,VACCINE ANTIGEN,121578.0,CHEMBL5500286,Neisseria adhesin A,1,1,1,,
3283864,CHEMBL6068373,"VACCINIA VIRUS, LIVE MODIFIED",9970,Biological vaccine - induces immune response,,,,,1,1,1,,
3283865,CHEMBL6068374,"CHIMERIC YELLOW FEVER DENGUE VIRUS, LIVE ATTENUATED",10044,Biological vaccine - induces immune response,,,,,1,1,1,,
3283866,CHEMBL6068375,VESICULAR STOMATITIS VIRUS ENCODING EBOLA VIRUS GLYCOPROTEIN,9868,Envelope glycoprotein vaccine antigen,VACCINE ANTIGEN,117434.0,CHEMBL4105829,Envelope glycoprotein,1,1,1,,
3283867,CHEMBL6068376,"DENGUE VIRUS, LIVE ATTENUATED",10017,Biological vaccine - induces immune response,,,,,1,1,1,,
3283868,CHEMBL6068377,INFLUENZA A VIRUS HEMAGGLUTININ,9980,Hemagglutinin vaccine antigen,VACCINE ANTIGEN,104401.0,CHEMBL1932897,Hemagglutinin,1,1,1,,
3283869,CHEMBL6068378,ADENOVIRUS TYPE 26 ENCODING EBOLA VIRUS GLYCOPROTEIN,9938,Envelope glycoprotein vaccine antigen,VACCINE ANTIGEN,117434.0,CHEMBL4105829,Envelope glycoprotein,1,1,1,,
3283870,CHEMBL6068379,"VACCINIA VIRUS, MODIFIED ENCODING EBOLA VIRUS GLYCOPROTEIN AND NUCLEOPROTEIN",9899,Nucleoprotein vaccine antigen,VACCINE ANTIGEN,121581.0,CHEMBL5500289,Nucleoprotein,1,1,1,,
3283870,CHEMBL6068379,"VACCINIA VIRUS, MODIFIED ENCODING EBOLA VIRUS GLYCOPROTEIN AND NUCLEOPROTEIN",9961,Envelope glycoprotein vaccine antigen,VACCINE ANTIGEN,117434.0,CHEMBL4105829,Envelope glycoprotein,1,1,1,,
3283871,CHEMBL6068380,CHIMPANZEE ADENOVIRUS ENCODING SARS-COV-2 SPIKE GLYCOPROTEIN,10006,Spike glycoprotein vaccine antigen,VACCINE ANTIGEN,120055.0,CHEMBL4662936,Spike glycoprotein,1,1,1,,
3283872,CHEMBL6068381,ADENOVIRUS TYPE 26 ENCODING SARS-COV-2 SPIKE GLYCOPROTEIN,10031,Spike glycoprotein vaccine antigen,VACCINE ANTIGEN,120055.0,CHEMBL4662936,Spike glycoprotein,1,1,1,,
3283873,CHEMBL6068382,SARS-COV-2 VIRUS SPIKE PROTEIN,9986,Spike glycoprotein vaccine antigen,VACCINE ANTIGEN,120055.0,CHEMBL4662936,Spike glycoprotein,1,1,1,,
3283874,CHEMBL6068383,"SARS-COV-2 VIRUS, INACTIVATED",10038,Biological vaccine - induces immune response,,,,,1,1,1,,
3283875,CHEMBL6068384,"INFLUENZA B VIRUS, INACTIVATED HEMAGGLUTININ",9987,Hemagglutinin vaccine antigen,VACCINE ANTIGEN,121577.0,CHEMBL5500285,Hemagglutinin,1,1,1,,
3283876,CHEMBL6068385,"INFLUENZA B VIRUS, INACTIVATED NEURAMINIDASE",9979,Neuraminidase vaccine antigen,VACCINE ANTIGEN,10738.0,CHEMBL3377,Neuraminidase,1,1,1,,
3283877,CHEMBL6068386,"INFLUENZA B VIRUS, SPLIT VIRION",9926,Biological vaccine - induces immune response,,,,,1,1,1,,
3283878,CHEMBL6068387,"INFLUENZA B VIRUS, LIVE ATTENUATED",9990,Biological vaccine - induces immune response,,,,,1,1,1,,
3283879,CHEMBL6068388,INFLUENZA B VIRUS HEMAGGLUTININ,9873,Hemagglutinin vaccine antigen,VACCINE ANTIGEN,121577.0,CHEMBL5500285,Hemagglutinin,1,1,1,,
3283886,CHEMBL6068395,REVUMENIB CITRATE,9912,Menin inhibitor,INHIBITOR,103767.0,CHEMBL1615381,Menin,1,1,1,,
3283891,CHEMBL6068400,GIVINOSTAT HYDROCHLORIDE,9959,Histone deacetylase inhibitor,INHIBITOR,104681.0,CHEMBL2093865,Histone deacetylase,1,1,1,,
3283914,CHEMBL6068423,ESTETROL,8551,Estrogen receptor agonist,AGONIST,104682.0,CHEMBL2093866,Estrogen receptor,1,1,1,,
3283922,CHEMBL6068431,BENZGALANTAMINE GLUCONATE,9930,Acetylcholinesterase inhibitor,INHIBITOR,93.0,CHEMBL220,Acetylcholinesterase,1,1,1,,
3283969,CHEMBL6068478,LAZERTINIB MESYLATE,10020,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,,Inhibits EGFR exon 19 deletions at lower concentrations than wildtype EGFR.
3283969,CHEMBL6068478,LAZERTINIB MESYLATE,10021,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,,
3283980,CHEMBL6068489,RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION GLYCOPROTEIN F,10027,Fusion glycoprotein F0 vaccine antigen,VACCINE ANTIGEN,106144.0,CHEMBL2364165,Fusion glycoprotein F0,1,1,1,,
3283981,CHEMBL6068490,COAGULATION FACTOR VII HUMAN,9911,Coagulation factor VII exogenous protein,EXOGENOUS PROTEIN,12000.0,CHEMBL3991,Coagulation factor VII,1,1,1,,
3283982,CHEMBL6068491,PROTEIN S HUMAN,10008,Vitamin K-dependent protein S exogenous protein,EXOGENOUS PROTEIN,121563.0,CHEMBL5498501,Vitamin K-dependent protein S,1,1,1,,
3283983,CHEMBL6068492,PROTHROMBIN,9974,Thrombin exogenous protein,EXOGENOUS PROTEIN,11.0,CHEMBL204,Prothrombin,1,1,1,,
3283984,CHEMBL6068493,STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197,10011,Polysaccharide conjugated to Corynebacterium diphtheriae CRM197 vaccine antigen,VACCINE ANTIGEN,121568.0,CHEMBL5498506,Polysaccharide conjugated to Corynebacterium diphtheriae CRM197,1,1,1,,
3283984,CHEMBL6068493,STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197,10041,Immunostimulant,,,,,1,1,1,Conjugated Corynebacterium diphtheriae CRM197 is an immunostimulant in this vaccine,
3283985,CHEMBL6068494,"BACILLUS ANTHRACIS PROTECTIVE ANTIGEN, ADSORBED",9935,Protective antigen vaccine antigen,VACCINE ANTIGEN,101164.0,CHEMBL5352,Protective antigen,1,1,1,,
3283986,CHEMBL6068495,"CHIKUNGUNYA VIRUS, LIVE ATTENUATED",10016,Biological vaccine - induces immune response,,,,,1,1,1,,
3283987,CHEMBL6068496,RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION GLYCOPROTEIN F MRNA,9962,Fusion glycoprotein F0 vaccine antigen,VACCINE ANTIGEN,106144.0,CHEMBL2364165,Fusion glycoprotein F0,1,1,1,,
3283988,CHEMBL6068497,OMIDUBICEL NON-CULTURED FRACTION,9923,Somatic cell supplemental therapy,,,,,1,1,1,"Cryopreserved allogeneic cells derived from cord blood; hematopoietic mature myeloid and lymphoid cells, as well as other cell populations, including more lineage committed hematopoietic cells.",
3283989,CHEMBL6068498,NEISSERIA MENINGITIDIS POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID,9876,Polysaccharide conjugated to Tetanus toxoid vaccine antigen,VACCINE ANTIGEN,121569.0,CHEMBL5498507,Polysaccharide conjugated to Tetanus toxoid,1,1,1,,
3283989,CHEMBL6068498,NEISSERIA MENINGITIDIS POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID,10040,Immunostimulant,,,,,1,1,1,Conjugated Tetanus toxoid is a carrier protein in this vaccine,
3283990,CHEMBL6068499,NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN,9916,Factor H binding protein vaccine antigen,VACCINE ANTIGEN,121565.0,CHEMBL5498503,Factor H binding protein,1,1,1,,
609761,CHEMBL607400,BRIVARACETAM,5512,Synaptic vesicle glycoprotein 2A modulator,MODULATOR,31000.0,CHEMBL1998,Synaptic vesicle glycoprotein 2A,1,1,1,,
22641,CHEMBL608,PROBUCOL,1739,ATP-binding cassette sub-family A member 1 inhibitor,INHIBITOR,105698.0,CHEMBL2362986,Phospholipid-transporting ATPase ABCA1,1,1,1,,
608601,CHEMBL608533,MIDOSTAURIN,5314,Tyrosine-protein kinase receptor FLT3 inhibitor,INHIBITOR,12670.0,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,1,1,1,Multi-kinase inhibitor,
608601,CHEMBL608533,MIDOSTAURIN,5315,Stem cell growth factor receptor inhibitor,INHIBITOR,238.0,CHEMBL1936,Mast/stem cell growth factor receptor Kit,1,1,1,Multi-kinase inhibitor,
608601,CHEMBL608533,MIDOSTAURIN,5316,Platelet-derived growth factor receptor inhibitor,INHIBITOR,104773.0,CHEMBL2095189,Platelet-derived growth factor receptor,1,1,1,Multi-kinase inhibitor,
608601,CHEMBL608533,MIDOSTAURIN,5317,Protein kinase C (PKC) inhibitor,INHIBITOR,104683.0,CHEMBL2093867,Protein kinase C (PKC),1,1,1,Multi-kinase inhibitor,
608601,CHEMBL608533,MIDOSTAURIN,5318,Vascular endothelial growth factor receptor 2 inhibitor,INHIBITOR,10980.0,CHEMBL279,Vascular endothelial growth factor receptor 2,1,1,1,Multi-kinase inhibitor,
23199,CHEMBL612,DEXTROAMPHETAMINE,693,Dopamine transporter releasing agent,RELEASING AGENT,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
23199,CHEMBL612,DEXTROAMPHETAMINE,891,Norepinephrine transporter releasing agent,RELEASING AGENT,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
23199,CHEMBL612,DEXTROAMPHETAMINE,1486,Synaptic vesicular amine transporter inhibitor,INHIBITOR,162.0,CHEMBL1893,Synaptic vesicular amine transporter,1,1,1,,
23522,CHEMBL614,PYRAZINAMIDE,678,Fatty acid synthase inhibitor,INHIBITOR,19909.0,CHEMBL2011,Fatty acid synthase,1,1,1,,
23522,CHEMBL614,PYRAZINAMIDE,2071,70S ribosome inhibitor,INHIBITOR,105944.0,CHEMBL2363965,70S ribosome,1,1,1,,
24806,CHEMBL615,PENICILLIN V,1684,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,"Indicated for streptococcal, pneumococcal and staphylococcal infections",
92458,CHEMBL61593,CYCLOTHIAZIDE,344,Thiazide-sensitive sodium-chloride cotransporter inhibitor,INHIBITOR,151.0,CHEMBL1876,Solute carrier family 12 member 3,1,1,1,,
93930,CHEMBL62193,SULFADIMETHOXINE,6303,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,"Bacteria and some protozoa are unable to obtain folic acid from the environment, and must synthesize it by converting PABA (para-aminobenzoate) to dihydropteroate using the enzyme dihydropteroate synthase. Sulfadimethoxine, being structurally similar to PABA, acts as a competitive inhibitor. It binds to the enzyme's active site and prevents the synthesis of folic acid from progressing. Folic acid is necessary for these organisms to produce nucleic acids, which are required for cell division. Thus, it has a microbiostatic effect rather than a microbiocidal one, and has the strongest effect in the beginning stages of an infection, when the pathogen is rapidly dividing.",
26431,CHEMBL622,ETODOLAC,1463,Cyclooxygenase-2 inhibitor,INHIBITOR,126.0,CHEMBL230,Prostaglandin G/H synthase 2,1,1,1,,
26590,CHEMBL625,THIABENDAZOLE,1435,Tubulin inhibitor,INHIBITOR,106200.0,CHEMBL2364704,Tubulin,1,1,1,,
26590,CHEMBL625,THIABENDAZOLE,1439,Tubulin inhibitor,INHIBITOR,106201.0,CHEMBL2364705,Tubulin,1,1,1,,
27029,CHEMBL628,PENTOXIFYLLINE,1211,Adenosine A2 receptor antagonist,ANTAGONIST,104729.0,CHEMBL2094257,Adenosine A2 receptor,1,1,1,,
27029,CHEMBL628,PENTOXIFYLLINE,1571,"3',5'-cyclic phosphodiesterase inhibitor",INHIBITOR,105761.0,CHEMBL2363066,"3',5'-cyclic phosphodiesterase",1,1,1,,
27152,CHEMBL632,BETAMETHASONE,764,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
27229,CHEMBL635,PREDNISONE,760,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
27251,CHEMBL636,RIVASTIGMINE,1286,Cholinesterases; ACHE & BCHE inhibitor,INHIBITOR,104805.0,CHEMBL2095233,Cholinesterases; ACHE & BCHE,1,1,1,,
27308,CHEMBL638,VORICONAZOLE,1444,Cytochrome P450 51 inhibitor,INHIBITOR,58.0,CHEMBL1780,Lanosterol 14-alpha demethylase,1,1,1,,
104250,CHEMBL63857,PHENOLPHTHALEIN,9241,Laxative,,,,,1,1,1,,
4941,CHEMBL64,ISONIAZID,249,Enoyl-[acyl-carrier-protein] reductase inhibitor,INHIBITOR,145.0,CHEMBL1849,Enoyl-[acyl-carrier-protein] reductase [NADH],1,1,1,,
97867,CHEMBL64391,ITRACONAZOLE,1447,Cytochrome P450 51 inhibitor,INHIBITOR,58.0,CHEMBL1780,Lanosterol 14-alpha demethylase,1,1,1,,
27419,CHEMBL646,TRIAZOLAM,1598,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
98346,CHEMBL64894,GENTIAN VIOLET,1825,DNA inhibitor,INHIBITOR,106020.0,CHEMBL2364041,DNA,1,1,1,Generates free radicals causing DNA damage.,
27575,CHEMBL650,METHYLPREDNISOLONE,790,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
102584,CHEMBL65375,TIPIRACIL HYDROCHLORIDE,2408,Thymidine phosphorylase inhibitor,INHIBITOR,11723.0,CHEMBL3106,Thymidine phosphorylase,1,1,1,,
27610,CHEMBL654,MIRTAZAPINE,591,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
27610,CHEMBL654,MIRTAZAPINE,618,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
27610,CHEMBL654,MIRTAZAPINE,1141,Adrenergic receptor alpha-2 antagonist,ANTAGONIST,104743.0,CHEMBL2095158,Adrenergic receptor alpha-2,1,1,1,,
27611,CHEMBL655,MIDAZOLAM,7284,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
27624,CHEMBL656,OXYCODONE,6176,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
27648,CHEMBL661,ALPRAZOLAM,1597,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
556,CHEMBL6622,ISOSORBIDE DINITRATE,1222,Soluble guanylate cyclase activator,ACTIVATOR,105048.0,CHEMBL2111348,Soluble guanylate cyclase,1,1,1,,
28310,CHEMBL671,THIOTEPA,1861,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
28331,CHEMBL672,FENOFIBRATE,433,Peroxisome proliferator-activated receptor alpha agonist,AGONIST,163.0,CHEMBL239,Peroxisome proliferator-activated receptor alpha,1,1,1,,
28699,CHEMBL675,ALENDRONATE SODIUM,1047,Farnesyl diphosphate synthase inhibitor,INHIBITOR,71.0,CHEMBL1782,Farnesyl pyrophosphate synthase,1,1,1,"Binds to the bone matrix (hydroxyapatite), and when the bone starts to be reabsorbed the compound is released and taken up by osteoclasts, inhibiting protein prenylation of the GTPases involved in the formation of the ruffled border",
28939,CHEMBL677,LEVONORDEFRIN,1149,Adrenergic receptor alpha-2 agonist,AGONIST,104743.0,CHEMBL2095158,Adrenergic receptor alpha-2,1,1,1,,
28976,CHEMBL679,EPINEPHRINE,1999,Adrenergic receptor agonist,AGONIST,105670.0,CHEMBL2331074,Adrenergic receptor,1,1,1,,
29090,CHEMBL681,ETOMIDATE,1625,GABA-A receptor; anion channel positive modulator,POSITIVE MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,selectivity for beta-3 containing complexes
29637,CHEMBL685,MEBENDAZOLE,1434,Tubulin inhibitor,INHIBITOR,106200.0,CHEMBL2364704,Tubulin,1,1,1,,
29637,CHEMBL685,MEBENDAZOLE,1438,Tubulin inhibitor,INHIBITOR,106201.0,CHEMBL2364705,Tubulin,1,1,1,,
29989,CHEMBL686,MEFENAMIC ACID,1201,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
30072,CHEMBL688,FENTANYL CITRATE,712,Mu opioid receptor agonist,AGONIST,129.0,CHEMBL233,Mu-type opioid receptor,1,1,1,,
30602,CHEMBL690,PRAVASTATIN SODIUM,1057,HMG-CoA reductase inhibitor,INHIBITOR,24.0,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,1,1,1,,
31241,CHEMBL691,ETHINYL ESTRADIOL,862,Estrogen receptor alpha agonist,AGONIST,19.0,CHEMBL206,Estrogen receptor,1,1,1,,
31804,CHEMBL695,TRIMETHADIONE,2100,Voltage-gated T-type calcium channel blocker,BLOCKER,105707.0,CHEMBL2362995,Voltage-gated T-type calcium channel,1,1,1,,
31811,CHEMBL696,ETHOSUXIMIDE,2099,Voltage-gated T-type calcium channel blocker,BLOCKER,105707.0,CHEMBL2362995,Voltage-gated T-type calcium channel,1,1,1,,
31857,CHEMBL697,METHSUXIMIDE,2098,Voltage-gated T-type calcium channel blocker,BLOCKER,105707.0,CHEMBL2362995,Voltage-gated T-type calcium channel,1,1,1,,
32027,CHEMBL698,TETRACAINE,1974,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
1380,CHEMBL6995,PRACTOLOL,8353,Beta-1 adrenergic receptor inhibitor,INHIBITOR,50.0,CHEMBL213,Beta-1 adrenergic receptor,1,1,1,,
32842,CHEMBL700,SULFAPYRIDINE,1659,Bacterial dihydropteroate synthase inhibitor,INHIBITOR,106168.0,CHEMBL2364668,Dihydropteroate synthase,1,1,1,,Broad spectrum
110103,CHEMBL70046,SORIVUDINE,6300,DNA polymerase catalytic subunit inhibitor,INHIBITOR,101616.0,CHEMBL5944,DNA polymerase catalytic subunit,1,1,1,"It derives its antiviral activity from selective conversion by a specific thymidine kinase, present in certain DNA viruses, to nucleotides which in turn interfere with viral DNA synthesis. This viral thymidine kinase is different from the thymidine kinase present in mammalian cells. Sorivudine isnot a substrate for mammalian thymidine kinase, thus explaining the selectivity of this drug.","Sorivudine has antiviral activity against several viruses including varicella zoster virus, herpes simplex type 1 virus, Epstein-Barr virus."
110103,CHEMBL70046,SORIVUDINE,6896,DNA polymerase inhibitor,INHIBITOR,100303.0,CHEMBL4859,DNA polymerase catalytic subunit,1,1,1,"It derives its antiviral activity from selective conversion by a specific thymidine kinase, present in certain DNA viruses, to nucleotides which in turn interfere with viral DNA synthesis. This viral thymidine kinase is different from the thymidine kinase present in mammalian cells. Sorivudine isnot a substrate for mammalian thymidine kinase, thus explaining the selectivity of this drug.","Sorivudine has antiviral activity against several viruses including varicella zoster virus, herpes simplex type 1 virus, Epstein-Barr virus."
32869,CHEMBL701,BACLOFEN,1306,GABA-B receptor agonist,AGONIST,104988.0,CHEMBL2111463,GABA-B receptor,1,1,1,,
33202,CHEMBL704,MESALAMINE,270,Arachidonate 5-lipoxygenase inhibitor,INHIBITOR,55.0,CHEMBL215,Polyunsaturated fatty acid 5-lipoxygenase,1,1,1,,
33202,CHEMBL704,MESALAMINE,426,Peroxisome proliferator-activated receptor gamma agonist,AGONIST,133.0,CHEMBL235,Peroxisome proliferator-activated receptor gamma,1,1,1,,
33202,CHEMBL704,MESALAMINE,1202,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
111390,CHEMBL70418,CLOBAZAM,1596,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
33216,CHEMBL705,ALITRETINOIN,1577,Retinoid receptor agonist,AGONIST,105766.0,CHEMBL2363071,Retinoid receptor,1,1,1,,
33254,CHEMBL706,CETYL ALCOHOL,2215,Surfactant,,,,,1,1,1,,
111798,CHEMBL70972,SERATRODAST,5916,Thromboxane A2 receptor antagonist,ANTAGONIST,246.0,CHEMBL2069,Thromboxane A2 receptor,1,1,1,It inhibits bronchoconstriction by the competitive inhibition of specific binding of thromboxane A2  with its receptor.,
6216,CHEMBL71,CHLORPROMAZINE,581,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
6216,CHEMBL71,CHLORPROMAZINE,2005,D2-like dopamine receptor antagonist,ANTAGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
33679,CHEMBL710,FINASTERIDE,266,Steroid 5-alpha-reductase 2 inhibitor,INHIBITOR,120.0,CHEMBL1856,3-oxo-5-alpha-steroid 4-dehydrogenase 2,1,1,1,,
33727,CHEMBL711,PHENINDIONE,441,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,INHIBITOR,224.0,CHEMBL1930,Vitamin K epoxide reductase complex subunit 1,1,1,1,,
33809,CHEMBL712,ANISINDIONE,679,Vitamin K-dependent gamma-carboxylase inhibitor,INHIBITOR,19910.0,CHEMBL2012,Vitamin K-dependent gamma-carboxylase,1,1,1,,
34094,CHEMBL714,ALBUTEROL,1338,Beta-2 adrenergic receptor agonist,AGONIST,43.0,CHEMBL210,Beta-2 adrenergic receptor,1,1,1,,
34197,CHEMBL715,OLANZAPINE,594,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
34197,CHEMBL715,OLANZAPINE,620,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
34197,CHEMBL715,OLANZAPINE,2023,D2-like dopamine receptor antagonist,ANTAGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
34608,CHEMBL717,MEDROXYPROGESTERONE ACETATE,1014,Progesterone receptor agonist,AGONIST,36.0,CHEMBL208,Progesterone receptor,1,1,1,,
35271,CHEMBL719,MUPIROCIN,562,Isoleucyl-tRNA synthetase inhibitor,INHIBITOR,139.0,CHEMBL1982,Isoleucine--tRNA ligase,1,1,1,,
35271,CHEMBL719,MUPIROCIN,1671,Isoleucyl-tRNA synthetase inhibitor,INHIBITOR,106171.0,CHEMBL2364671,Isoleucine--tRNA ligase,1,1,1,,
36662,CHEMBL723,CARVEDILOL,1120,Adrenergic receptor beta antagonist,ANTAGONIST,104700.0,CHEMBL2094118,Adrenergic receptor beta,1,1,1,,
36662,CHEMBL723,CARVEDILOL,1160,Adrenergic receptor alpha-1 antagonist,ANTAGONIST,104723.0,CHEMBL2094251,Adrenergic receptor alpha-1,1,1,1,,
36864,CHEMBL727,THIOGUANINE,1226,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,INHIBITOR,105058.0,CHEMBL2111369,Inosine-5'-monophosphate dehydrogenase (IMPDH),1,1,1,,
36864,CHEMBL727,THIOGUANINE,1887,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
37266,CHEMBL728,PROCHLORPERAZINE,196,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
37316,CHEMBL729,LOPINAVIR,1496,Human immunodeficiency virus type 1 protease inhibitor,INHIBITOR,191.0,CHEMBL243,Human immunodeficiency virus type 1 protease,1,1,1,,
37493,CHEMBL730,NITROGLYCERIN,1218,Soluble guanylate cyclase activator,ACTIVATOR,105048.0,CHEMBL2111348,Soluble guanylate cyclase,1,1,1,,
37820,CHEMBL734,ACETOHYDROXAMIC ACID,1408,Bacterial urease inhibitor,INHIBITOR,106183.0,CHEMBL2364683,Bacterial urease,1,1,1,,
38569,CHEMBL738,THIOPENTAL SODIUM,1624,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
38727,CHEMBL741,LAMOTRIGINE,1991,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
38898,CHEMBL744,RILUZOLE,1956,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
39624,CHEMBL748,PRALIDOXIME CHLORIDE,747,Acetylcholinesterase activator,ACTIVATOR,93.0,CHEMBL220,Acetylcholinesterase,1,1,1,reactivates acetylcholinesterase deactivated by organophosphates,
39857,CHEMBL750,ZONISAMIDE,1995,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
41644,CHEMBL754,FOSCARNET SODIUM,1467,Human herpesvirus 1 DNA polymerase inhibitor,INHIBITOR,27.0,CHEMBL1872,DNA polymerase catalytic subunit,1,1,1,,
117758,CHEMBL75435,DEXKETOPROFEN,6692,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,"Ketoprofen is a non-steroidal anti-inammatory drug. It is a racemic mixture and its analgesic efcacy is due to the (S)-enantiomer, dexketoprofen. The analgesic action of the (R)-enantiomer is considered to be less signicant, but causes the majority of adverse effects, that is gastric mucosa irritation. Its mechanism of action is the non-selective inhibition of cyclooxygenase-1 and cyclooxygenase-2.",Dexketoprofen was found to be a potent inhibitor of the prostaglandin F2 alpha (PGF2 alpha) production in rat brain (IC50 = 6.2 nM)
43261,CHEMBL766,CILASTATIN,7329,Renal dipeptidase inhibitor,INHIBITOR,245.0,CHEMBL1989,Dipeptidase 1,1,1,1,,
43740,CHEMBL771,CYCLOSERINE,755,D-alanylalanine synthetase inhibitor,INHIBITOR,327.0,CHEMBL2030,D-alanine--D-alanine ligase,1,1,1,,
43740,CHEMBL771,CYCLOSERINE,1378,Alanine racemase inhibitor,INHIBITOR,328.0,CHEMBL2031,Alanine racemase,1,1,1,,
43952,CHEMBL772,RESERPINE,1479,Synaptic vesicular amine transporter inhibitor,INHIBITOR,162.0,CHEMBL1893,Synaptic vesicular amine transporter,1,1,1,,
44920,CHEMBL779,TADALAFIL,185,Phosphodiesterase 5A inhibitor,INHIBITOR,3.0,CHEMBL1827,"cGMP-specific 3',5'-cyclic phosphodiesterase",1,1,1,,Selective
46385,CHEMBL781,MAZINDOL,1568,Monoamine transporter inhibitor,INHIBITOR,105759.0,CHEMBL2363064,Monoamine transporter,1,1,1,,
46726,CHEMBL782,TOLBUTAMIDE,1254,"Sulfonylurea receptor 1, Kir6.2 blocker",BLOCKER,104852.0,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",1,1,1,,
46727,CHEMBL783,NATEGLINIDE,1253,"Sulfonylurea receptor 1, Kir6.2 blocker",BLOCKER,104852.0,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",1,1,1,,Selective
47340,CHEMBL786,TAMOXIFEN CITRATE,856,Estrogen receptor alpha modulator,MODULATOR,19.0,CHEMBL206,Estrogen receptor,1,1,1,Mixed agonist/antagonist. Used to treat (ER)positive breast carcinoma and the alpha subform is the drug target.,
47675,CHEMBL788,IDOXURIDINE,1929,DNA inhibitor,INHIBITOR,106215.0,CHEMBL2366042,DNA,1,1,1,Incorporation into DNA,
6723,CHEMBL79,LIDOCAINE,1992,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
49842,CHEMBL796,METHYLPHENIDATE,700,Dopamine transporter inhibitor,INHIBITOR,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
49842,CHEMBL796,METHYLPHENIDATE,909,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
49869,CHEMBL797,PHENSUXIMIDE,2096,Voltage-gated T-type calcium channel blocker,BLOCKER,105707.0,CHEMBL2362995,Voltage-gated T-type calcium channel,1,1,1,,
50440,CHEMBL799,CILOSTAZOL,1380,Phosphodiesterase 3A inhibitor,INHIBITOR,170.0,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",1,1,1,,
241,CHEMBL8,CIPROFLOXACIN,1901,Bacterial DNA gyrase inhibitor,INHIBITOR,105577.0,CHEMBL2311224,Bacterial DNA gyrase,1,1,1,,
241,CHEMBL8,CIPROFLOXACIN,8639,Topoisomerase IV inhibitor,INHIBITOR,105771.0,CHEMBL2363076,Topoisomerase IV,1,1,1,,
51042,CHEMBL802,MINOXIDIL,1229,"Sulfonylurea receptor 2, Kir6.2 opener",OPENER,104782.0,CHEMBL2095198,"Sulfonylurea receptor 2, Kir6.2",1,1,1,,
51182,CHEMBL803,CYTARABINE,1883,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
51182,CHEMBL803,CYTARABINE,1893,RNA inhibitor,INHIBITOR,105575.0,CHEMBL2311222,RNA,1,1,1,,
51182,CHEMBL803,CYTARABINE,1916,DNA polymerase (alpha/delta/epsilon) inhibitor,INHIBITOR,105737.0,CHEMBL2363042,DNA polymerase (alpha/delta/epsilon),1,1,1,,
52087,CHEMBL806,FLUTAMIDE,1317,Androgen Receptor antagonist,ANTAGONIST,56.0,CHEMBL1871,Androgen receptor,1,1,1,,
6914,CHEMBL81,RALOXIFENE,10131,Estrogen receptor modulator,MODULATOR,19.0,CHEMBL206,Estrogen receptor,1,1,1,,
53686,CHEMBL810,TEMOZOLOMIDE,1865,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
54149,CHEMBL812,PYRIDOSTIGMINE BROMIDE,740,Acetylcholinesterase inhibitor,INHIBITOR,93.0,CHEMBL220,Acetylcholinesterase,1,1,1,,
56131,CHEMBL817,TOLAZAMIDE,1251,"Sulfonylurea receptor 1, Kir6.2 blocker",BLOCKER,104852.0,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",1,1,1,,
56644,CHEMBL820,BUSULFAN,1851,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
56831,CHEMBL822,TERBINAFINE,1403,Squalene monooxygenase inhibitor,INHIBITOR,106179.0,CHEMBL2364679,Squalene monooxygenase,1,1,1,,
57175,CHEMBL826,ENOXACIN,1642,Topoisomerase IV inhibitor,INHIBITOR,105772.0,CHEMBL2363077,Topoisomerase IV,1,1,1,,
57175,CHEMBL826,ENOXACIN,1913,DNA gyrase inhibitor,INHIBITOR,105597.0,CHEMBL2311244,DNA gyrase,1,1,1,,
59519,CHEMBL831,LOXAPINE,576,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
59519,CHEMBL831,LOXAPINE,614,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
59519,CHEMBL831,LOXAPINE,2003,D2-like dopamine receptor antagonist,ANTAGONIST,105671.0,CHEMBL2331075,D2-like dopamine receptor,1,1,1,,
60232,CHEMBL832,SULFINPYRAZONE,1032,Solute carrier family 22 member 12 inhibitor,INHIBITOR,102767.0,CHEMBL6120,Solute carrier family 22 member 12,1,1,1,,
62615,CHEMBL842,CHLOROTHIAZIDE,346,Thiazide-sensitive sodium-chloride cotransporter inhibitor,INHIBITOR,151.0,CHEMBL1876,Solute carrier family 12 member 3,1,1,1,,
62701,CHEMBL843,ROSIGLITAZONE MALEATE,423,Peroxisome proliferator-activated receptor gamma agonist,AGONIST,133.0,CHEMBL235,Peroxisome proliferator-activated receptor gamma,1,1,1,,Selective
63252,CHEMBL846,CALCITRIOL,519,Vitamin D receptor agonist,AGONIST,64.0,CHEMBL1977,Vitamin D3 receptor,1,1,1,,
63445,CHEMBL847,OXAMNIQUINE,1932,DNA inhibitor,INHIBITOR,106216.0,CHEMBL2366043,DNA,1,1,1,,
63649,CHEMBL848,LENALIDOMIDE,5876,CRL4(CRBN) E3 ubiquitin ligase inhibitor,INHIBITOR,116917.0,CHEMBL3833061,CRL4(CRBN) E3 ubiquitin ligase,1,1,1,,
64200,CHEMBL849,TRICLOSAN,1400,Bacterial enoyl-[acyl-carrier-protein] reductase inhibitor,INHIBITOR,106178.0,CHEMBL2364678,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,1,1,1,,Broad spectrum
7714,CHEMBL85,RISPERIDONE,601,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
7714,CHEMBL85,RISPERIDONE,623,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
7714,CHEMBL85,RISPERIDONE,2012,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
65351,CHEMBL850,SPARFLOXACIN,1640,Topoisomerase IV inhibitor,INHIBITOR,105771.0,CHEMBL2363076,Topoisomerase IV,1,1,1,,Broad spectrum
65351,CHEMBL850,SPARFLOXACIN,1907,Bacterial DNA gyrase inhibitor,INHIBITOR,105577.0,CHEMBL2311224,Bacterial DNA gyrase,1,1,1,,
65415,CHEMBL852,MELPHALAN,1858,DNA inhibitor,INHIBITOR,105574.0,CHEMBL2311221,DNA,1,1,1,,
65494,CHEMBL853,ZALCITABINE,822,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,,
65728,CHEMBL856,PRIMIDONE,1615,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
65728,CHEMBL856,PRIMIDONE,1960,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
66016,CHEMBL861,MEPHENYTOIN,1971,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
139099,CHEMBL86304,MOCLOBEMIDE,7525,Monoamine oxidase A inhibitor,INHIBITOR,86.0,CHEMBL1951,Amine oxidase [flavin-containing] A,1,1,1,Reversible inhibitor. ,
67010,CHEMBL865,VALDECOXIB,1461,Cyclooxygenase-2 inhibitor,INHIBITOR,126.0,CHEMBL230,Prostaglandin G/H synthase 2,1,1,1,,
68396,CHEMBL866,MYCOPHENOLIC ACID,1224,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,INHIBITOR,105058.0,CHEMBL2111369,Inosine-5'-monophosphate dehydrogenase (IMPDH),1,1,1,,
70239,CHEMBL869,NITROFURAZONE,1828,DNA inhibitor,INHIBITOR,106020.0,CHEMBL2364041,DNA,1,1,1,"Prodrug; its activated by the type I nitroreductase (NTR), who produces reactive species, leading to an increase in oxidative stress",
73547,CHEMBL877,TRANEXAMIC ACID,85,Plasminogen inhibitor,INHIBITOR,12.0,CHEMBL1801,Plasminogen,1,1,1,,
73548,CHEMBL878,METOLAZONE,343,Thiazide-sensitive sodium-chloride cotransporter inhibitor,INHIBITOR,151.0,CHEMBL1876,Solute carrier family 12 member 3,1,1,1,,
139940,CHEMBL87992,ESLICARBAZEPINE ACETATE,2244,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
74284,CHEMBL880,FAMCICLOVIR,1476,Human herpesvirus 1 DNA polymerase inhibitor,INHIBITOR,27.0,CHEMBL1872,DNA polymerase catalytic subunit,1,1,1,,
74911,CHEMBL885,EMTRICITABINE,826,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,,
141484,CHEMBL89598,VIGABATRIN,1384,Gamma-amino-N-butyrate transaminase inhibitor,INHIBITOR,153.0,CHEMBL2044,"4-aminobutyrate aminotransferase, mitochondrial",1,1,1,Irreversible inhibitor,
77474,CHEMBL897,PROBENECID,1036,Solute carrier family 22 member 6 inhibitor,INHIBITOR,103829.0,CHEMBL1641347,Solute carrier family 22 member 6,1,1,1,,
77474,CHEMBL897,PROBENECID,1037,Solute carrier family 22 member 8 inhibitor,INHIBITOR,103830.0,CHEMBL1641348,Organic anion transporter 3,1,1,1,,
77474,CHEMBL897,PROBENECID,1042,Solute carrier family 22 member 11 inhibitor,INHIBITOR,104618.0,CHEMBL2073677,Solute carrier family 22 member 11,1,1,1,,
77652,CHEMBL898,DIFLUNISAL,1178,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
246,CHEMBL9,NORFLOXACIN,1639,Topoisomerase IV inhibitor,INHIBITOR,105771.0,CHEMBL2363076,Topoisomerase IV,1,1,1,,Broad spectrum
246,CHEMBL9,NORFLOXACIN,1904,Bacterial DNA gyrase inhibitor,INHIBITOR,105577.0,CHEMBL2311224,Bacterial DNA gyrase,1,1,1,,
78303,CHEMBL902,FAMOTIDINE,456,Histamine H2 receptor antagonist,ANTAGONIST,102.0,CHEMBL1941,Histamine H2 receptor,1,1,1,,
78902,CHEMBL904,DEXMETHYLPHENIDATE HYDROCHLORIDE,691,Dopamine transporter inhibitor,INHIBITOR,155.0,CHEMBL238,Sodium-dependent dopamine transporter,1,1,1,,
78902,CHEMBL904,DEXMETHYLPHENIDATE HYDROCHLORIDE,890,Norepinephrine transporter inhibitor,INHIBITOR,100.0,CHEMBL222,Sodium-dependent noradrenaline transporter,1,1,1,,
80209,CHEMBL908,CHLORPROTHIXENE,202,Dopamine D2 receptor antagonist,ANTAGONIST,72.0,CHEMBL217,D(2) dopamine receptor,1,1,1,,
80209,CHEMBL908,CHLORPROTHIXENE,247,Dopamine D3 receptor antagonist,ANTAGONIST,130.0,CHEMBL234,D(3) dopamine receptor,1,1,1,,
80209,CHEMBL908,CHLORPROTHIXENE,577,Serotonin 2a (5-HT2a) receptor antagonist,ANTAGONIST,107.0,CHEMBL224,5-hydroxytryptamine receptor 2A,1,1,1,,
80209,CHEMBL908,CHLORPROTHIXENE,632,Serotonin 2c (5-HT2c) receptor antagonist,ANTAGONIST,108.0,CHEMBL225,5-hydroxytryptamine receptor 2C,1,1,1,,
8917,CHEMBL91,MICONAZOLE,1446,Cytochrome P450 51 inhibitor,INHIBITOR,58.0,CHEMBL1780,Lanosterol 14-alpha demethylase,1,1,1,,
147769,CHEMBL91397,RUPATADINE,7556,Platelet activating factor receptor antagonist,ANTAGONIST,251.0,CHEMBL250,Platelet-activating factor receptor,1,1,1,,"Selective for histamine H1 receptors; no effects on acetylcholine, serotonin or leukotriene receptors."
147769,CHEMBL91397,RUPATADINE,7557,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,"Selective for histamine H1 receptors; no effects on acetylcholine, serotonin or leukotriene receptors."
82983,CHEMBL917,FLOXURIDINE,483,Thymidylate synthase inhibitor,INHIBITOR,28.0,CHEMBL1952,Thymidylate synthase,1,1,1,,
83000,CHEMBL918,PHENACEMIDE,1952,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
83044,CHEMBL919,FOSPHENYTOIN SODIUM,1989,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
9097,CHEMBL92,DOCETAXEL ANHYDROUS,9960,Tubulin stabiliser,STABILISER,104766.0,CHEMBL2095182,Tubulin,1,1,1,,
83515,CHEMBL922,ADEFOVIR DIPIVOXIL,1924,DNA polymerase/reverse transcriptase inhibitor,INHIBITOR,105706.0,CHEMBL2362994,DNA polymerase/reverse transcriptase,1,1,1,,
84624,CHEMBL927,CEFDINIR,1700,Bacterial penicillin-binding protein inhibitor,INHIBITOR,105683.0,CHEMBL2354204,Bacterial penicillin-binding protein,1,1,1,,
84644,CHEMBL928,DANTROLENE SODIUM,248,Ryanodine receptor 1 antagonist,ANTAGONIST,89.0,CHEMBL1846,Ryanodine receptor 1,1,1,1,,
84644,CHEMBL928,DANTROLENE SODIUM,1299,Ryanodine receptor 3 antagonist,ANTAGONIST,223.0,CHEMBL2062,Ryanodine receptor 3,1,1,1,,
85233,CHEMBL929,DELAVIRDINE MESYLATE,823,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,,
9217,CHEMBL93,ZILEUTON,267,Arachidonate 5-lipoxygenase inhibitor,INHIBITOR,55.0,CHEMBL215,Polyunsaturated fatty acid 5-lipoxygenase,1,1,1,,
85649,CHEMBL931,HALOTHANE,1553,Glycine receptor (alpha-1/beta) positive modulator,POSITIVE MODULATOR,105747.0,CHEMBL2363052,Glycine receptor (alpha-1/beta),1,1,1,alpha1/beta is main adult form,
85649,CHEMBL931,HALOTHANE,1628,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
85649,CHEMBL931,HALOTHANE,1942,Potassium channel subfamily K member 10 opener,OPENER,105637.0,CHEMBL2331041,Potassium channel subfamily K member 10,1,1,1,,
85649,CHEMBL931,HALOTHANE,1947,Potassium channel subfamily K member 18 opener,OPENER,105638.0,CHEMBL2331042,Potassium channel subfamily K member 18,1,1,1,,
85649,CHEMBL931,HALOTHANE,2051,Potassium channel subfamily K member 3 opener,OPENER,105602.0,CHEMBL2321613,Potassium channel subfamily K member 3,1,1,1,,
85649,CHEMBL931,HALOTHANE,2057,Potassium channel subfamily K member 9 opener,OPENER,105603.0,CHEMBL2321614,Potassium channel subfamily K member 9,1,1,1,,
85649,CHEMBL931,HALOTHANE,2063,Potassium channel subfamily K member 2 opener,OPENER,105604.0,CHEMBL2321615,Potassium channel subfamily K member 2,1,1,1,,
86042,CHEMBL932,DIPYRIDAMOLE,671,Equilibrative nucleoside transporter 1 inhibitor,INHIBITOR,175.0,CHEMBL1997,Equilibrative nucleoside transporter 1,1,1,1,,
86042,CHEMBL932,DIPYRIDAMOLE,2260,"3',5'-cyclic phosphodiesterase inhibitor",INHIBITOR,105761.0,CHEMBL2363066,"3',5'-cyclic phosphodiesterase",1,1,1,,
86284,CHEMBL934,METYRAPONE,10126,"Cytochrome P450 11B1, mitochondrial inhibitor",INHIBITOR,76.0,CHEMBL1908,"Cytochrome P450 11B1, mitochondrial",1,1,1,Mechanism_for_indication: Cushing's syndrome.,
86784,CHEMBL937,DIETHYLCARBAMAZINE CITRATE,1396,Nematode GABA-A receptor positive modulator,POSITIVE MODULATOR,106176.0,CHEMBL2364676,Nematode GABA-A receptor,1,1,1,,
88232,CHEMBL939,GEFITINIB,244,Epidermal growth factor receptor erbB1 inhibitor,INHIBITOR,9.0,CHEMBL203,Epidermal growth factor receptor,1,1,1,,
88316,CHEMBL940,GABAPENTIN,1921,Voltage-gated calcium channel modulator,MODULATOR,105734.0,CHEMBL2363032,Voltage-gated calcium channel,1,1,1,,
150722,CHEMBL94081,ALCLOFENAC,6196,Cyclooxygenase-1 inhibitor,INHIBITOR,96.0,CHEMBL221,Prostaglandin G/H synthase 1,1,1,1,"It acts by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions.",
89357,CHEMBL944,CHLOROPROCAINE HYDROCHLORIDE,1954,Sodium channel alpha subunit blocker,BLOCKER,105639.0,CHEMBL2331043,Sodium channel alpha subunit,1,1,1,,
152819,CHEMBL94454,MIZOLASTINE,7575,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
92412,CHEMBL953,ENTACAPONE,736,Catechol O-methyltransferase inhibitor,INHIBITOR,91.0,CHEMBL2023,Catechol O-methyltransferase,1,1,1,,
93117,CHEMBL956,SUPROFEN,1207,Cyclooxygenase inhibitor,INHIBITOR,104725.0,CHEMBL2094253,Cyclooxygenase,1,1,1,,
93617,CHEMBL957,BOSENTAN,1040,"Endothelin receptor, ET-A/ET-B antagonist",ANTAGONIST,104833.0,CHEMBL2096678,"Endothelin receptor, ET-A/ET-B",1,1,1,,
160056,CHEMBL95889,BETAINE,7286,Betaine-homocysteine S-methyltransferase substrate,SUBSTRATE,109554.0,CHEMBL3391661,Betaine-homocysteine S-methyltransferase,1,1,1,,
93895,CHEMBL960,LEFLUNOMIDE,497,Dihydroorotate dehydrogenase inhibitor,INHIBITOR,157.0,CHEMBL1966,"Dihydroorotate dehydrogenase (quinone), mitochondrial",1,1,1,,
94408,CHEMBL962,EPOPROSTENOL SODIUM,666,Prostanoid IP receptor agonist,AGONIST,143.0,CHEMBL1995,Prostacyclin receptor,1,1,1,,
94571,CHEMBL964,DISULFIRAM,445,Aldehyde dehydrogenase inhibitor,INHIBITOR,30.0,CHEMBL1935,"Aldehyde dehydrogenase, mitochondrial",1,1,1,,
95909,CHEMBL967,TEMAZEPAM,1622,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
95969,CHEMBL969,PRAZEPAM,1614,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
95970,CHEMBL970,HALAZEPAM,1627,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
95978,CHEMBL971,PENTOBARBITAL SODIUM,1619,GABA-A receptor; anion channel positive allosteric modulator,POSITIVE ALLOSTERIC MODULATOR,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
96021,CHEMBL972,SELEGILINE,837,Monoamine oxidase B inhibitor,INHIBITOR,104.0,CHEMBL2039,Amine oxidase [flavin-containing] B,1,1,1,Irreversible inhibitor,
96107,CHEMBL973,TERIFLUNOMIDE,498,Dihydroorotate dehydrogenase inhibitor,INHIBITOR,157.0,CHEMBL1966,"Dihydroorotate dehydrogenase (quinone), mitochondrial",1,1,1,,
99024,CHEMBL976,PRAZIQUANTEL,1749,Voltage-activated calcium channel beta 1 subunit blocker,BLOCKER,105774.0,CHEMBL2363079,Voltage-activated calcium channel beta 1 subunit,1,1,1,,
99024,CHEMBL976,PRAZIQUANTEL,1750,Voltage-activated calcium channel beta 2 subunit blocker,BLOCKER,105775.0,CHEMBL2363080,Voltage-activated calcium channel beta 2 subunit,1,1,1,,
99389,CHEMBL979,MEPROBAMATE,1595,GABA-A receptor; anion channel agonist,AGONIST,104688.0,CHEMBL2093872,GABA-A receptor; anion channel,1,1,1,,
11305,CHEMBL98,VORINOSTAT,121,Histone deacetylase 1 inhibitor,INHIBITOR,12697.0,CHEMBL325,Histone deacetylase 1,1,1,1,,
11305,CHEMBL98,VORINOSTAT,190,Histone deacetylase 3 inhibitor,INHIBITOR,11208.0,CHEMBL1829,Histone deacetylase 3,1,1,1,,
11305,CHEMBL98,VORINOSTAT,307,Histone deacetylase 6 inhibitor,INHIBITOR,11307.0,CHEMBL1865,Histone deacetylase 6,1,1,1,,
11305,CHEMBL98,VORINOSTAT,1489,Histone deacetylase 2 inhibitor,INHIBITOR,11206.0,CHEMBL1937,Histone deacetylase 2,1,1,1,,
100310,CHEMBL981,FENOFIBRIC ACID,435,Peroxisome proliferator-activated receptor alpha agonist,AGONIST,163.0,CHEMBL239,Peroxisome proliferator-activated receptor alpha,1,1,1,,
101810,CHEMBL983,SUCCINYLCHOLINE CHLORIDE,1538,Muscle-type nicotinic acetylcholine receptor agonist,AGONIST,105709.0,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,1,1,1,,
101924,CHEMBL984,MIVACURIUM CHLORIDE,1536,Muscle-type nicotinic acetylcholine receptor antagonist,ANTAGONIST,105709.0,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,1,1,1,,
105252,CHEMBL989,FLUOCINOLONE ACETONIDE,810,Glucocorticoid receptor agonist,AGONIST,25.0,CHEMBL2034,Glucocorticoid receptor,1,1,1,,
107119,CHEMBL991,STAVUDINE,831,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,INHIBITOR,228.0,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,1,1,1,,
109797,CHEMBL995,LOSARTAN POTASSIUM,220,Type-1 angiotensin II receptor antagonist,ANTAGONIST,115.0,CHEMBL227,Type-1 angiotensin II receptor,1,1,1,,
110803,CHEMBL998,LORATADINE,147,Histamine H1 receptor antagonist,ANTAGONIST,127.0,CHEMBL231,Histamine H1 receptor,1,1,1,,
